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Abstract 1 
Abstract 
The enzymes of the diaminopimelate (dap) pathway, which is responsible for the 
biosynthesis of (S)-lysine in plants and micro-organisms, are of interest as potential 
targets for herbicide and antibacterial research. This thesis has investigated two key 
enzymes of this pathway: dihydrodipicolinate synthase (DHDPS) and dihydrodipicolinate 
reductase (DHDPR). DHDPS, the first enzyme committed specifically to (S)-lysine 
biosynthesis, catalyses the condensation of pyruvate and (S)-aspartate ~-semialdehyde 
«(S)-ASA) to form an unstable heterocycle. Dihydrodipicolinate reductase (DHDPR), 
the next enzyme in the pathway, mediates the reduction of this product to tetrahydro-
dipic olin ate. 
A coupled assay measuring the activities of DHDPS and DHDPR was optimised. 
Both DHDPS and DHDPR were purified from E. coli strains that had been genetically 
engineered to overproduce these enzymes. This assay monitored the utilisation of 
NADPH, at 340 nm, by DHDPR. 
Kinetic studies were performed on DHDPS, giving Km and Vrnax parameters for both 
substrates, (S)-aspartate ~-semialdehyde (synthesised from (S)-allylglycine) and 
pyruvate. It was shown that (S)-aspartate ~-semialdehyde did not inhibit the DHDPS 
enzyme even at high substrate concentrations, although (S)-lysine was found to be a 
feedback inhibitor, acting in a reversible uncompetitive manner with respect to both 
substrates, thus, binding at an allosteric site. 
Kinetic studies were performed on DHDPR, giving Krn and Vrnax values for the 
substrate. DHDPR was shown to utilise either NADPH or NADH as a redox coenzyme. 
Of these NADPH is generally used in the assay due to its greater chemical stability, even 
though the Km for NADH is lower. 
Structural and enzymatic inhibition studies on DHDPS revealed that (S)-aspartate ~­
semialdehyde exists predominantly as a linear hydrate in solution at physiological pH. 
Inhibition studies on DHDPS showed that the cyclic molecule homoserine lactone and 
related compounds, such as 2-aminocyclopentanone, which mimic a possible cyclic form 
of (S)-aspartate ~-semialdehyde are allosteric site inhibitors acting in a reversible 
noncompetitive manner. Analogues of the hydrate form of (S)-aspartate ~-semialdehyde 
such as the amino acids (R)-cysteine sulfinic acid, and (S)-glutarnic acid inhibited in a 
reversible uncompetitive manner. (S)-Aspartic acid also inhibited DHDPS, but was a 
reversible mixed type inhibitor. 
NMR studies were used to investigate the structure of the product of the DHDPS 
catalysed reaction, and the data was consistent with it being 4-hydroxy-2,3,4,5-
tetrahydrodipicolinic acid. Various mimics of this compound were tested as possible 
product inhibitors of DHDPS, and as possible substrate inhibitors of DHDPR. The most 
potent inhibitors of DHDPR evaluated were dipicolinic acid and isophthalic acid which 
both inhibited in a reversible competitive manner. Tetrahydroisophthalic acid analogues 
were tested for inhibition of DHDPS and DHDPR. /).3_ Tetrahydroisophthalic acid 
showed moderate inhibition of both enzymes, while /).2-tetrahydroisophthalic acid 
showed only very slight inhibition. 
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Introduction 
Background 
Herbicide and antibacterial research focuses on inhibiting the growth of specific 
plants and bacteria. The advent of herbicides has greatly increased crop production, 
while antibacterial agents have revolutionised the treatment of bacterial infections. 
However, resistance to herbicides and antibacterial agents is becoming a crisis. I.2 Plants 
that are resistant to traditional herbicides are now emerging and posing a threat to crop 
production. There are also new strains of bacteria that are resistant to many of the 
antibacterial agents currently in use. Thus, there is an ongoing challenge to produce new 
herbicides and antibacterial agents, preferably with novel modes of action, to overcome 
these problems of resistance. 
Herbicides act by inhibiting the growth of plants. It is important that they selectively 
inhibit plants and that they are environmentally safe. Many herbicides act by inhibiting 
amino acid biosynthesis. For example chlorsulfuron (1)3 blocks the synthesis of 
branched chain amino acids, while aminotriazole (2)3 blocks histidine synthesis, 
phosphinothricin (3i blocks glutamine synthesis, and glyphosate (4)2.3 blocks the 
synthesis of aromatic amino acids, see figure 1-1. Herbicide resistance may be caused by 
the uptake of the herbicide becoming impaired, the plant acquiring the ability to detoxify 
the herbicide, the target enzyme becoming insensitive to the herbicide by mutation, or by 
the plant adapting to overproduce the target enzymes.2 New herbicides are required to 
overcome these problems of resistance. 
Figure /-1: Herbicides that block amino acid biosynthesis 
Chlorsulfuron (1) 
Inhibits acetolactate synthetase. 
o 
H3C--. 11 /P~NH2 
HO . I 
C02H 
Phosphinothricin (3) 
Inhibits glutamine synthetase. 
H 
N, l-Z 
NH2 
Aminotriazole (2) 
Inhibits imidazole glycerol 
phosphate dehydratase. 
o 
HO II H 
-P N CO H 
m/V V 2 
Glyphosate (4) 
Inhibits 5-enolpyruvyl shikimate-
3-phosphoric acid synthase. 
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Micro-organisms are also continually acquiring resistance to antibacterial agents. 
Thus, an ever increasing range of antibacterial agents is required. Not only is there the 
need to modify the drugs currently used, but also to find new drugs that have different 
modes of action. Antimicrobial agents are known to act against a number of targets.4 
Some act to inhibit bacterial cell wall synthesis, rendering growing bacteria osmotically 
sensitive. This class includes the classical ~-lactam antibiotics-penicillins and 
cephalosporins, for example Penicillin G (5), see figure 1-2. A second class of drugs 
affect the cell membrane, for example by disrupting the membrane. Amphotericin act" in 
this way. Two other classes of action are the inhibition of protein and nucleic acid 
synthesis. Common protein synthesis inhibitors include the tetracyclines and 
chloramphenicol (6), while common nucleic acid synthesis inhibitors include the 
sulfonamides, for example sulfanilamide (7), and the rifamycins. 
Figure 1-2: Examples of antimicrobial agents 
OH 
H 
Ny CH2Cl 
CH20HO 
Penicillin G (5) 
Chloramphenicol (6) 
Sulfanilamide (7) 
Mechanisms of bacterial drug resistance often involve the genetic spread of resistance 
via plasmids.5 Modes of resistance include: alteration of the drug target; modification of 
metabolism of the drug leading to its detoxification; altered permeation andlor transport of 
the drug; the formation of a metabolic bypass; or overproduction of antagonistic 
metabolites andlor target enzymes. 
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(S)-Lysine and the aspartate family of amino acids 
(S)-Lysine is part of the aspartate family of amino acids, which also includes (S)-
methionine, (S)-threonine, and (S)-isoleucine. The aspartate family of amino acids are 
interesting subjects for research as their synthesis occurs via complex biochemical 
pathways which are incompletely understood. Many of the enzymes, their chemical 
substrates and products, as well as their regulation, are ill-characterised. All four 
aspartate family amino acids are essential (that is while they are required by animals their 
biosynthesis is carried out only by plants and micrQ-organisms) and their biosynthesis is 
of interest for two reasons. Firstly, inhibitors of these amino acids have the potential to 
be herbicides and/or antibacterial agents. Secondly, these essential amino acids are 
nutritionally important in foods. 6 By investigating the enzymology of their biosynthesis 
there is the potential to develop crops enriched in these nutritionally limiting amino acids. 
This is especially important for (S)-lysine which is a nutritionally limiting amino acid in 
many cereal cropS.7,8 
(S)-Lysine biosynthesis as a target for a new class of herbicides and/or 
antibacterial agents9 
Since (S)-lysine is an essential amino acid, inhibitors of (S)-lysine biosynthesis 
would be selectively toxic to plant and micro-organisms but not to animals. This would 
create a new class of herbicides and/or antibacterial agents with a novel mode of action. 
As the lysine biosynthetic pathway in plants is analogous to that of bacteria, but not to 
that of fungi (fungi use a different pathway for the biosynthesis of (S)-lysine),10 bacterial 
amino acid biosynthetic pathway can be used as a model to find inhibitors which could act 
as herbicides. While there are already herbicides that act by inhibiting amino acid 
biosynthesis at the enzymatic level there are no such antibacterial agents. The 
biosynthesis of (S)-lysine is an appropriate field for the search of herbicides and/or 
antibacterial agents since, as yet, no potent inhibitors have been found. Thus, the field of 
research is unbiased and further the biosynthetic genes have been well mapped in 
Escherichia coli (E. coli), enabling a means of isolation of these enzymes. ll 
(S)- Lysine biosynthesis 
The aspartate family of amino acids ((S)-methionine, (S)-threonine, (S)-isoleucine, 
and (S)-lysine) are synthesised from (S)-aspartate, itself derived from oxaloacetate (8) 
from the citric acid cycle, see figure 1-3. Initially, (S)-aspartate (9) is phosphorylated by 
aspartokinase to give (S)-p-aspartyl phosphate (10), before being reduced to (S)-aspartate 
p-semialdehyde (11) by aspartate p-semialdehyde dehydrogenase. This is the branch 
point for the biosynthesis of the four aspartate derived amino acids, where (S )-aspartate 
p-semialdehyde (11) either enters the diamiopimelate (dap) pathway to produce (S)-lysine 
(12), or is reduced again to give (S)-homoserine (13), by homo serine dehydrogenase. 
(S)-Homoserine (13) is then used to produce (S)-methionine (14), (S)-threonine (15), 
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and (S)-isoleucine (16). Aspartokinase and homoserine dehydrogenase are the points of 
regulation in this pathway. In E. coli there are three isozymes of aspartokinase and two 
isozymes of homo serine dehydrogenase (the homoserine dehydrogenase activities being 
canied on the aspartokinase enzymes). (S)-Threonine (15) and (S)-isoleucine (16) 
regulate the expression of the aspartokinase-homoserine dehydrogenase I, and (S)-
threonine (15) inhibits both activites. (S)-Methionine (14) represses the synthesis of 
aspartokinase-homoserine dehydrogenase II, while (S)-lysine (12) inhibits the activity 
and represses the synthesis of aspartokinase m.12 
Figure /-3: Biosynthesis of the aspartate (9)fam.ily of amino acids 
Oxaloacetate (8) (S)-Aspartate (9) (S)-~-Aspartyl phosphate (10) 
NADPH+H+) A art t sp a e 
~-semialdehyde 
dehydrogenase 
NADP+ 
Homoserine 
dehydrogenase 
NADP+ NADPH + H+ 
(S)-Aspartate ~-semialdehyde (11) 
(S)-Methionine (14) 
+ 
H3N H 
(S)-Isoleucine (16) 
(S)-Lysine (12) 
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(S)-Lysine biosynthesis via the diaminopimelate pathway 
(S)-Lysine (12) is synthesised via the diaminopimelate (dap) pathway in bacteria and 
plants, but via the a-aminoadipate pathway in fungi.13 The genes of the enzymes of the 
diaminopimelate pathway have been well mapped in E. coli, II as have many other amino 
acid genes, providing a basis for the study ofthese enzymes.14,15 
This research is limited to the biosynthetic pathway of lysine (12) in bacteria and 
plants via the diaminopimelate pathway, see figure 1-4. The first committed step in the 
diaminopimelate pathway is the condensation of (S)-aspartate ~-semialdehyde «(S)-ASA) 
(11) with pyruvate (17) to form an unstable heterocyclic molecule, thought to be 
dihydrodipicolinate (DHDPA) (18). Dihydrodipicolinate synthase (DHDPS/6 is the 
enzyme that catalyses this reaction, and, as it undergoes feedback inhibition by the final 
product (S)-lysine (12), it is a key point in the regulation of (S)-lysine biosynthesis. 
DHDPS has been isolated from E. COli,16,17.18 as well as other bacteria19.20.21.22,23 and 
plane4,25,26.27,28 sources. Dihydrodipicolinate (18) is then reduced to tetrahydro-
dipicolinate (19), by dihydrodipicolinate reductase (DHDPR),29 with concomitant 
oxidation of NAD(P)H, Feedback regulation by (S)-lysine (12) has not been observed 
for this enzyme. DHDPR has been isolated from E. COli,29,30 other bacteria,31.32 and also 
a plant source.33 
The cyclic molecule, tetrahydrodipicolinate (19), is then ring opened via a 
succinylation to form an a-keto acid, succinyl-E-keto-a-aminopimelate (20), in a reaction 
catalysed by tetrahydrodipicolinate succinylase?4 Following this, succinyl-E-keto-a-
aminopimelate aminotransferase35 performs a transamination to form succinyl 
diaminopimelate (21), which is then desuccinylated by succinyl diaminopimelate 
desuccinylase36 to form (S,S)-diaminopimelate (22). Diaminopimelate epimerase37 
catalyses the epimerisation of (S,S)-diaminopimelate (22) to meso-diaminopimelate (23), 
which is then decarboxylated to yield (S)-lysine (12) by the enzyme, diaminopimelate 
decarboxylase.38 
It has been observed that some bacteria use acetate (-COCH3), rather than succinate 
(-C02CH2C02H), in the ring opening step of the diaminopimelate pathway, while others 
may use both. A direct shunt from tetrahydrodipicolinate (19) to meso-diaminopimelate 
(23) has also been observed.19 However, the extent to which this contributes to 
anabolism and/or catabolism is unclear. E. coli has been observed only to use succinate 
in the diaminopimelate pathway. 
Many of the (S)-lysine (12) biosynthetic genes, which encode for the various 
enzymes, are regulated in their expression by the total (S)-lysine (12) pool. For example 
dap B, dap D, dap E, and lys A are regulated in this fashion,39 however dap A is not. At 
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the enzymatic level only DHDPS, and the earlier enzyme aspartokinase, are feedback 
regulated by (S)-lysine (12).40 
Figure 1-4: The diaminopimelate pathway 
Pyruvate (17) 
Dihydro-
dipicolinate 
synthase 
BC 4.2.1.52 
dapA 
(S)-Aspartate 
~-semia1dehyde (11) 
Dihydrodipicolinate (18) 
(S)-Lysine (12) 
Diaminopimelate 
decarboxylase 
EC 4.1.1.20 
lys A 
meso-Diaminopimelate (23) 
Dihydro-
dipicolinate 
reductase 
EC 1.3.1.26 
NAD(P)H+ H+ ----- NAD(P)+ 
dapB 
(': -O~N~CO-
2 H H 2 
Tetrahydrodipicolinate (19) 
Diamino-
pimelate 
dehydrogenase 
BC 1.4.Ll6 
ddh 
NAD(P)H + NH4+ 
Tetrahydro-
dipicolinate 
succinylase 
Succinyl CoA 
dapD 
Diaminopimelate 
epimerase 
EC 5.1.1.17 
dapF 
(S,S)-Diaminopimelate (22) 
Succinyl 
diarninopimelate 
desucciny lase 
BC 3.5.1.18 Succinyl-E-keto-
a-aminopimelate 
aminotransferase dap E 
NHSuc 0 BC 2 6 1 17 ~ ... NHSuc H HIiIi'1/ dapC ~+ 
-0 C CO -n HIlI/iI. """ NH3 
2 2 -02C C02 
Succinyl-E-keto-a-
. . Succinyl 
ammoplmelate (20) Glutamate a-Ketoglutarate diaminopimelate (21) 
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Although the diaminopimelate pathway generally leads to the production of (S)-lysine 
(12), it is also important as a source of meso-diaminopimelate (23), and as a source of 
dipicolinate (from dihydrodipicolinate (18» in some organisms. meso-Diaminopimelate 
(23) is used in the peptidoglycan cell wall of Gram negative (G) bacteria, while Gram 
positive (G+) bacteria use (S)-lysine (12).4! Either meso-diaminopimelate (23) or (S)-
lysine (12) is utilised in forming the cross links in the peptidoglycan, giving the cell wall 
its strength. Calcium dipicolinate is used in bacteria that produce endospores,42,43 giving 
the spore cortex its heat resistance, while meso-diaminopimelate (23) is also present in the 
spores. 
By blocking the (S)-lysine (12) biosynthetic pathway there are potentially three ways 
of producing antibacterial agents: by a lack of (S)-lysine (12) causing nutritional 
deficiency and leaving G+ bacteria with an inferior cell wall leading to susceptibility to 
osmotic shock; by lack of meso-diaminopimelate (23) leaving G bacteria with an inferior 
cell wall leading to susceptibility to osmotic shock; and in certain organisms by lack of 
dipicolinate preventing spore formation. 
Targets for inhibition44 
In the search for enzyme inhibitors of (S)-lysine (12) biosynthesis we chose to 
concentrate our efforts on the first two enzymes specific to (S)-lysine (12) biosynthesis, 
that is DHDPS and the succeeding enzyme of the diaminopimelate pathway DHDPR. A 
study of DHDPS and DHDPR requires a rigorous examination of the chemical nature of 
the substrates and products, as well as the enzymes themselves. Inhibitors of enzymes of 
the diaminopimelate pathway are also being investigated by other groups. For example 
inhibitors of diaminopimelate epimerase,9,45,46.47,48 diaminopimelate decarboxy lase,9,45.49 
succinyl-E-keto-a-aminopimelate aminotransferase,5o and diaminopimelate 
dehydrogenase45,47 are being studied. 
Ongoing research on DHDPS 
Genetics and enzymology 
The dap A locus, which encodes for DHDPS, has been mapped to 53 minutes on the 
E. coli chromosome l ! and subsequently cloned5! and sequenced.39 It encodes a 292 
amino acid polypeptide of Mr 31 372. The dap A gene has also been cloned from other 
bacteria and plants, for example Corynebacterium glutamicU111,52,53 Bacillus sub til is, 54 
Brevibacterium lacto!ermentum,55 poplar56 maize,57 soybean,58 wheat,59 and Nicotiana 
sylvestris (tobacco).60 Unlike some of the subsequent enzymes in the pathway the 
expression of E. coli DHDPS is constitutive,40 rather than inducible. This means the 
expression of E. coli DHDPS is not regulated by the total (S)-lysine (12) pool. 
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DHDPS has been isolated and partially purified from a variety of 
bacteriaI16,17,18,19,20,21,22,23 and plant sources.24,25,26,27,28 During the course of these studies 
coli DHDPS was crystallised,61 as well as being studied by electro spray mass 
spectrometry.18 The E. coli enzyme is a homotetramer with a Mr of 134000 as 
determined by gel filtration. 62 The published E. coli dap A sequence predicts a 
polypeptide of 292 amino acids with a Mr of 31 372.63 The electro spray mass 
spectrometry gives a Mr of 31 346; 18 this was used to identify an error in the amino acid 
sequence predicted from the gene sequence. Cloned wheat and maize DHDPS also exist 
as homotetramers with the Mr of the monomers being 35 77626 and 35 85464 respectively, 
while pea DHDPS is a trimer.28 A high level of homology at the amino acid level has 
been established between the DHDPS obtained from different sources,65 for example 
30% identity between wheat (Triticum aestvum) and E. coli enzymes,59 33% identity 
between Brevibacterium lactofermentum and E. coli,55 and 87% identity between wheat 
and maize genes.57,59 
The chemical nature of the substrate (S)·aspartate f3.semialdehyde 
Although the exact nature of (S)-aspartate ~-semialdehyde (11) has not been 
determined in the literature it is always assumed to exist as the aldehyde, as suggested by 
the name.65 Preliminary work in this area has suggested that (S)-aspartate ~-semi­
aldehyde (11) may not exist as the aldehyde (lla) but rather as a hydrate (lIb) or even as 
a cyclic lactol (11c),66 see figure 1-5. 
Figure /-5: (S)-Aspartate f3-semialdehyde (11), possible structures 
0 OR 
+1. tOH +1IOH R3N= ~ CO2. H3N ~ H3N § CO2 H H 0 
Aldehyde (lla) Hydrate (Ub) Cyclic lactol (Hc) 
The chemical nature of the product dihydrodipicolinate 
The literature usually reports the product of the DHDPS catalysed reaction as a 2,3-
dihydropyridine.65 However, as well as 2,3-dihydrodipicolinate (18) two other 
structures have been hypothesised for the product, namely 2,5-dihydrodipicolinate (27) 
and 4-hydroxy-2,3,4,5-tetrahydrodipicolinate (28).62 In theory, there are five isomeric 
dihydropyridines (1,2-, 1,4-,2,3-,3,4-,2,5- )67 depending on the position of the double 
bonds in relation to the heteroatom nitrogen. Altogether this gives six different structures 
as possible products of the DHDPS catalysed reaction, see figure 1-6. 
Figure /-6: Possible products of the DHDPS catalysed reaction 
1,2-Dihydrodipicolinate (24) 1,4-Dihydrodipicolinate (25) 
~ ::::::,...+ -·0 N ~ CO· 2 H H 2 
3,4-Dihydrodipicolinate (26) 2,5-Dihydrodipicolinate (27) 
Mechanism of the DHDPS catalysed reaction 
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2,3-Dihydrodipicolinate (18) 
4-Hydroxy-2,3,4,5-
tetrahydrodipicolinate (28) 
The first step in the catalysis of (S )-aspartate ~-semialdehyde (11) and pyruvate (17), 
to give dihydrodipicolinate (18), is the binding of pyruvate (17) with the loss of water, 
followed by the binding and reaction of (S)-aspartate ~-sernialdehyde (11). The pyruvate 
(17) binds to form a Schiff base with the c-arnino group of the active site lysine 161 Y 
Lysine 161 is conserved in all known DHDPS sequences and the Schiff base can be 
trapped with sodium borohydride, see figure 1-7. 
Figure /-7: Sodium borohydride trapping of the Schiff base 
NH2 ~ 
Enzyme Pyruvate (17) 
I NaBH4 
·0 cA ~ (Inhibits enzy;e) 
2 ~ 
Enzyme 
-OC~NH 
2 ~ 
Enzyme 
At the onset of this work little was known about the reaction mechanism of DHDPS, 
other than the initial binding of pyruvate (17) to form a Schiff base. How the molecule 
cyc1ises and generates the pyridine derivative was unknown, and this was also 
complicated by the lack of knowledge on the structure of the substrate (S)-aspartate ~­
semialdehyde (11), see figure 1-8. Work since 1995, in parallel with the results reported 
in this thesis, using X-ray crystallography,61 electrospray mass spectometry/8 NMR 
spectroscopy,68 and kinetic studies,69 has greatly increased our knowledge of the 
mechanism of DHDPS. 
Introduction 16 
Figure 1-8: Reaction catalysed by DHDPS, as hypothesised at the onset of this work. 
I ~ 
-OcA~H 
2 ~ 
Enzyme 
(S)-Aspartate 
~-semialdehyde (11) 
OH 
~N! CO2-
SH +NH3 
Enzyme 
Dihydrodipicolinate (18) 
Kinetic studies on DHDPS, including inhibition studies 
A number of kinetic studies on DHDPS have been reported. The enzyme displays 
high specificity for both substrates with Michaelis-Menten constants (Km values) ranging 
between 0.4 and 3.1 mM for (S)-aspartate ~-semialdehyde (11), and between 0.5 and 
11.8 mM for pyruvate (17).65 
0) Pyruvate analogues 
Bromopyruvate (29i8,21 and ethyl bromopyruvate (30)28 irreversibly inactivate 
DHDPS, presumably by alkylation, and inhibition is competitive with respect to pyruvate 
(17), but noncompetitive with respect to (S)-aspartate ~-semialdehyde (11), see figure 1-9 
and 1-10. In a review on the diaminopimelate pathway by Cox, published in 1996,65 it 
was stated that analogues of pyruvate such as phosphoenolpyruvate, phenylpyruvate, a-
ketobutyrate, a-ketoglutarate, oxaloacetate, and fluoropyruvate were not recognised by 
DHDPS. 
Figure 1-9: Pyruvate analogues 
Pyruvate (17) Bromopyruvate (29) Ethyl bromopyruvate (30) 
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Figure I-I0: Mode of inactivation by bromopyruvate (29) 
Br) iYC02 _ .. DHDPS 
.. 
Bromopyruvate (29) 
H-Nu 
\ 
+NH 
I 
ENZYME 
Adjacent nucleophile 
attacks the Schiff base 
releasing Br-. 
(ii) (S)-aspartate ~-semialdehyde analogues 
DHDPS is irreversibly 
inactivated. 
Five membered ring heterocycles, based on a possible cyclic form of the substrate 
(S)-aspartate ~-semialdehyde (llc), have been found to show some inhibition.66 In 
preliminary studies, the best inhibitor of this type was found to be (S )-homoserine lactone 
(31) ((S)-2-amino-4-butyrolactone), see figure 1-11. In the review on the diamino-
pimelate pathway by Cox, published in 1996,65 it was reported that some linear (S)-
aspartate ~-semialdehyde analogues were not recognised by DHDPS. Those tested 
included (S)-glutamate semi aldehyde, N-acetyl (S)-aspartate ~-semialdehyde, and 
succinic semialdehyde, as well as (R)-aspartate ~-semialdehyde. 
Figure I-II: (S)-Aspartate f3-semialdehyde analogues 
(S)-Aspartate 
~-semialdehyde (11a) 
o 
Cyclic lactol (11 c) 
(iii) (S)-Lysine (l2) and (S)-lysine analogues 
(S)-Homoserine lactone (31) 
DHDPS enzymes can be classified into three categories: those from sporulating 
bacteria, these show no feedback inhibition by (S)-lysine (12); those from other bacteria, 
these show inhibition by (S)-lysine (12) only at high concentrations; and those from 
plants, these show potent inhibition by (S)-lysine (12). E. coli DHDPS is moderately 
inhibited by (S)-lysine (12), IC50 = 1 mM.1S (S)-Lysine analogues, for example (2-
aminoethyl)-(R)-cysteine (32) and threo-~-hydroxy-(S)-lysine (33) (see figure 1-12), 
show similar inhibition but are less effective than (S)-lysine (12).17 
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Figure 1-12: (S)-Lysine (12) and (S)-Iysine (12) analogues 
(S)-Lysine (12) (2-Aminoethyl)-
(R)-cysteine (32) 
threo-4-Hydroxy-
(S)-lysine (33) 
(iv) Combined substrate and/or reaction intermediate inhibitors 
Diketopimelic acid (34) inhibits DHDPS and has been suggested to mimic both 
substrates, or an intermediate in the reaction, since it contains structural elements of both 
substrates, and shows competitive inhibition with respect to both substrates.66 Recent 
work published by Karsten, in 1995,70 shows acetopyruvate (35) is also a combined 
substrate inhibitor of DHDPS (where Kj is 5 11M). Both examples are shown in figure 
1-13. 
Figure 1-13: Combined substrate inhibitors 
JJyo 
o 
Diketopimelic acid (34) Acetopyruvate (35) 
(v) Product inhibitors 
Molecules designed to mimic the product dihydrodipicolinate (18), such as 
dipicolinic acid (36), have been found to inhibit the E. coli enzyme17 (E. coli does not 
produce dipicolinate (36), unlike sporulating bacteria). A systematic investigation of 
heterocycles by Couper et al. 71 at the onset of this work found substituted pyridines (37) 
and piperidines (38) to be only moderate inhibitors ofDHDPS, see figure 1-14. 
Figure 1-14: Product inhibitors 
n H02C N C02H ~ XANAX 
Dipicolinic Acid (36) Pyridines (37) Piperidines (38) 
Introduction 19 
Assay systems to measure the kinetics of DHDPS 
Three assays have been reported for DHDPS.62 Formation of a purple adduct with 
o-aminobenzaldehyde, which can give semi-quantitative measurements at 540 nm, has 
been noted. The product of the DHDPS catalysed reaction is reported to react with 
imidazole buffer and the product of this reaction can be detected at 270 nm. An extremely 
accurate quantitative assay, which couples the activity of DHDPS to DHDPR, has also 
been reported. This reaction is followed by monitoring the DHDPR utilisation of 
NADPH at 340 nm. While this third assay is extremely accurate it has been little used 
due to the difficulty in obtaining the enzymes required. Thus, the first two assays have 
been more widely used despite the lack of characterisation of the species being measured. 
Ongoing research on DHDPR 
Genetics and enzymology 
The dap B gene, which has been mapped to 0.5 min on the coli chromosome, 
encodes for DHDPR. 11 ,n It has been cloned and sequenced. Unlike the dap A gene, its 
expression is repressed by (S)-lysine (12).72 
DHDPR has been isolated and purified from E. coli,29,3o Bacillus cereus,31 B. 
megaterium,31 B. subtilis/2 and maize.33 Activity has also been detected in soybean, 
tobacco, and com.73 All of these enzymes cause the reduction of dihydrodipicolinate (18) 
to tetrahydrodipicolinate (19), utilising either NADPH or NADH. The E. coli enzyme is 
a homotetramer of Mr 110000 as determined by gel filtration chromatography,29 The dap 
B gene predicts the monomer to contain 273 amino acids, with a Mr of 28798.74 The Mr 
has also been determined, from an overexpressed E. coli gene, to be 28 758 ± 8 by 
electrospray mass spectrometry. 30 This matches the value of 28757 calculated from the 
DNA sequence (from PCR).74 The discrepancy between the predicted Mr from the dap B 
gene, and the Mr from the PCR prediction is due to a glycine residue, erroneously 
assigned as a valine residue, in the dap B sequence leading to a predicted Mr 42 greater 
than the actual value.74 
The maize enzyme has a Mr of -80 000 and is similar to the E. coli enzyme. 
However, DHDPR isolated from Bacillus sp. are very different. Bacillus sp. DHDPR31 
have a much higher Mr ~ 150000 and are inhibited, noncompetitively, by dipicolinate. 
This indicates a role in the regulation of dipicolinate (36) biosynthesis used in spore 
formation. The B. subtilis form of DHDPR is a homotetramer, with a subunit of 
Mr -18500. While it may use NADPH or NADH it also requires FMN.32 
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The chemical nature of the product tetrahydrodipicolinate 
The chemical synthesis of the potassium salt of 2,3,4,5-tetrahydrodipicolinate (19) 
was published in 1995 by Chrystal et al.75 It exists in solution in equilibrium with the 
en amine (39) and an open chain form (40), see figure 1-15. 
Figure 1-15: Tetrahydrodipicolinate (19) 
Enamine (39) 2,3,4,5-Tetrahydrodipicolinate (19) Open chain form (40) 
The mechanism of the DHDPR catalysed reaction 
Since the onset of this work, when there was very little published research on 
DHDPR, the X-ray structure of E. coli DHDPR has been resolved to 2.2 A by Scapin et 
ai.,76 mechanistic studies have been performed by Reddy et ai.,3°,77 and electrospray mass 
spectrometry has been performed by Wang et al.,78 enhancing the knowledge of the 
mechanism of this enzyme. For the reaction of DHDPR see figure 1-16. 
Figure 1-16: Reaction of DHDPR 
-02~C02---/--;O--=:::--~--~ ~co 
H- (\ 2 HH 2 
H NAD(P)H + H+ .NAD(P? 
Dihydrodipicolinate (18) Tetrahydrodipicolinate (19) 
Kinetic studies on DHDPR, including inhibition studies 
Michaelis-Menten constants have been determined for E. coli DHDPR with respect to 
the substrate dihydrodipicolinate (18), Km was found to be 50 ± 12 ~M,30 9.0 ~M,29 and 
190 ~.74 The enzyme is unusual in that either NADPH or NADH are accepted as 
cofactors.29,77 Often in metabolism NAD+/NADH is concerned with oxidative breakdown 
of substrates to provide electrons for energy producing systems, whereas 
NADP+/NADPH serve as donors of H+/H- for reductive biosynthesis. This allows the 
two pools to remain distinct.79,8o It was noted that, with NADH as the cofactor, Vmax was 
approximately half that for NADPH. However, values for VlK show that NADH is a 
more efficient substrate by a factor of two, because of its four fold lower value of Km. 30 
In a review by Cox, published in 1996,65 various substrate analogues had been 
shown to inhibit DHDPR. Dipicolinate (36) is a competitive inhibitor of E. coli DHDPR 
with respect to the substrate (Kj is 26 ± 6 ~M), but inhibits uncompetitively against the 
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cofactor NADPH (~ is 350 ± 5 JlM).30 Much weaker inhibition has been observed for 
other substrate analogues, for example isophthalic acid (41) (ICso ~2 mM). Compounds 
with only one carboxylate group, such a<; picolinic acid (42) and pipecolic acid (43), are 
very poor inhibitors (ICso >20 mm). Piperidine dicarboxylic acids (44) do not inhibit. 
Product inhibition by NADPH was also observed, being competitive with respect to 
NADPH (~ is 190 ± 35 JlM), and noncompetitive versus the substrate (Kj is 700 ± 200 
JlM). The stlUctures of these inhibitors are shown in figure I -17. 
Figure 1-17: Inhibitors 
H02CMC'hH H02CDC'hH 
Dipicolinic acid (36) Isophthalic acid (41) Picolinic acid (42) 
(lco~ 
H 
Pipecolic acid (43) 
H02~C02H 
H 
Piperidine dicarboxylic acids (44) 
Assay systems to measure the kinetics of DHDPR 
An assay measuring the activity of DHDPR has been described; this utilises reduction 
of dihydrodipicolinate (18), either from substrate produced enzymatically in situ from 
DHDPS, or from chemically synthesised substrate.29 However, if the substrate is 
chemically synthesised a mixture of compounds and isomers result. This is problematic 
as the stlUcture of the substrate is unknown, and the species produced in the chemical 
synthesis have been ill-characterised. The assay then quantifies activity by monitoring the 
oxidation of NADPH at 340 nm. 
Conclusions; aims of this thesis 
The primary aim of this research was to build up a more complete picture of the 
enzymology of (S)-lysine (12) biosynthesis using E. coli as a model. Preliminary work 
involved over-expressing the E. coli dap A gene to obtain supplies of DHDPS which 
were then purified. The dap B gene was also over-expressed to obtain supplies of 
DHDPR, which were then purified. An accurate time dependent assay was developed, 
using these purified enzymes. This enabled detailed kinetic studies of both DHDPS and 
DHDPR to be performed. 
Detailed kinetic studies were carried out on DHDPS and ~n and Vrnax parameters will 
be reported. (S)-Aspartate ~-semialdehyde (11), a substrate of DHDPS, was synthesised 
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optically pure from (S)-allylglycine. Kinetic studies were also carried out on DHDPR, 
and the Krn and Vrnax parameters will be reported for the substrate and both cofactors, 
NADPH and NADH. 
Inhibition studies on DHDPS were carried out involving the inhibition by high 
substrate concentrations of (S)-aspartate ~-semialdehyde (11) and the feedback inhibition 
by (S)-lysine (12). From inhibition studies using (S)-aspartate ~-semialdehyde (11) 
analogues along with structural studies on (S)-aspartate ~-semialdehyde (11) the solution 
structure of this substrate is reported. NMR studies on the DHDPS catalysed reaction, 
along with inhibition studies on product analogues of DHDPS and substrate analogues of 
DHDPR, have enabled the mechanisms of both enzymes to be more fully understood, 
and the product of the DHDPS catalysed reaction to be better characterised. 
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Results and Discussion Chapter One 
The Production of Required Enzymes and Substrates 
Background work 
To study the DHDPS and DHDPR enzyme-catalysed reactions, both the enzymes 
and substrates of these reactions were required. DHDPS catalyses the condensation of 
(S)-aspartate p-semialdehyde (11) and pyruvate (17) to form an unstable heterocyclic 
product. For detailed kinetic analysis pure (S)-aspartat€ p-semialdehyde (11) and 
pyruvate (17) were required. Pyruvate (17) is available commercially while there are 
several reported syntheses of (S)-aspartate p-semialdehyde (11) in the literature. 1,2,3,4 The 
gene encoding for E. coli DHDPS (dap A) was available on a multicopy plasmid.2 This 
provided a ready source of this enzyme. In the second reaction DHDPR catalyses the 
reduction of the DHDPS product to tetrahydrodipicolinate (19). Because of the ease of 
synthesising the product of the DHDPS reaction enzymatically, as opposed to chemical 
synthesis where multiple compounds and isomers form (and it is unknown which 
compound is the substrate of DHDPR), this was the method of choice for synthesising 
this substrate. The gene encoding for E. coli DHDPR (dap B) was also available on a 
multicopy plasmid,5 providing a source of this enzyme. The first part of this chapter 
deals with the synthesis of pure (S)-aspartate p-semialdehyde (11), as modified from 
literature procedures. While the second part of this chapter describes the production and 
purification of both DHDPS and DHDPR, again as modified from literature procedures. 
Part A Synthesis of (S)-Aspartate f3-Semialdehyde 
Introduction 
Previous syntheses of (S)-aspartate p-semialdehyde (11) in the literature1,2 are based 
on the method of Black and Wrighe which requires the ozonolysis of (S)-allylglycine 
(49). The four methods in the literature are: the original ozonolysis of (S)-allylglycine 
(49),3 the oxidation of (S)-allylglycine (49) using catalytic osmium tetroxide with sodium 
periodate2 (known as a Lemieux-Johnson reaction6,7), ozonolysis of diprotected (S)-
allylglycine (49)/ and hydrolysis of an enol ether derivative of (S)-aspartate p-semi-
aldehyde (11).4 It was decided to synthesise (S)-aspartate p-semialdehyde (11) by 
oxidation of diprotected (S)-allylglycine (49) as reported by Tudor et al./ but instead of 
performing the oxidation by ozonolysis, the method using catalytic osmium tetroxide with 
sodium periodate2,6,7 was employed. 
Synthetic route to (S)-allylglycine 
To synthesise (S)-aspartate p-semialdehyde (11) by oxidative cleavage of (S)-
allylglycine (49) optically pure (S)-allylglycine (49) was required. The method of 
Gerrard2 was followed with only minor changes to the first step (the formation of diethyl 
allylacetamidomalonate (46». This synthesis used an enzymatic resolution to effect 
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stereo-control. Diethyl acetamidomalonate (45) underwent an allylation reaction using 
allyl bromide to yield diethyl allylacetamidomalonate (46).8 This was then followed by a 
base catalysed hydrolysis, to yieldN-acetyl allylglycine (48). The (S)-enantiomer was 
then selectively de-acetylated by the enzyme porcine kidney acylase (EC 3.5.1.14) to 
yield (S)-allylglycine (49), see figure 1-1. 
Figure 1-1: Synthesis of optically pure (S)-allylglycine (49) 
Diethyl acetamidomalonate (45) 
(Diethyl 2-ethanamidopropanedioate) 
N-Acetyl allylglycine (48) 
(2-Ethanamido-4-pentenoic acid) 
.. 
j Porcine Kidney Acylase EC 3.5.1.14 
(S)-Allylglycine (49) 
«(S)-2-Amino-4-pentenoic acid) 
+ 
(R)-N-Acetyl allyl glycine (48) 
(i) Na+-OEtJEtOH 
(ii)~Br 
NaOH 
NaOH 
.. 
Diethyl allylacetamidomalonate (46) 
(DiethyI2-ethanamido-2-
(2-propenyl )propanedioate) 
N-Acetyl allylglycine ethyl ester (47) 
(Ethyl 2-ethanamido-4-pentenoate) 
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The allylation of diethyl acetamidomalonate (45) to give diethyl allylacetamido-
malonate (46) was modified from the method of Gerrard.2 It was shown that fewer side 
reactions occurred and a better yield was obtained if 1.5 equivalents of sodium ethoxide 
and allyl bromide were used. On prolonged heating under reflux, using less than 1.5 
equivalents of both the sodium ethoxide and the allyl bromide, the reaction proceeded to 
give the product N-acetyl allylglycine ethyl ester (47). This compound is presumably 
formed by an SN2 type dealkylation of diethyl allylacetamidomalonate (46) followed by 
decarboxylation in situ, see figure 1-2. This side reaction was not observed when the 
reaction time was decreased and the amount of sodium ethoxide and allyl bromide was 
increased to 1.5 equivalents. The diethyl allylacetamidomalonate (46) was obtained as a 
clear yellow oil, which crystallised on standing overnight, in a yield of 74%. 
Figure 1-2: 5;2 type dealkylationfollowed by decarboxylation 
Diethyl acetamidomalonate (46) 
(DiethyI2-ethanamido-2-
(2-propeny l)propanedioate) 
N-Acetyl allyl glycine 
ethyl ester (47) 
(EthyI2-Ethanamido-
4-pentenoate) 
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N-Acetyl allylglycine (48) was formed by base hydrolysis and decarboxylation of 
diethyl allylacetamidomalonate (46), using sodium hydroxide in aqueous ethanol.2 The 
reaction was heated under reflux until no starting material could be detected by IH NMR. 
The product (as recrystallised from hot propanone) gave N-acetyl allylglycine (48) as 
clear chunky crystals in 55% yield. 
Acetolysis and optical resolution were carried out in aqueous solution by incubation 
of N-acetyl allylglycine (48) with porcine kidney acylase Ee 3.5.1.14,z This enzyme 
selectively removes the acetyl group from the (S)-enantiomer, yielding (S)-allylglycine 
(49), but has negligible effect on the (R)-enantiomer.9 Thus, the reaction was complete 
when half the N-acetyl allylglycine (48) remained (as monitored by IH NMR). (S)-Allyl-
glycine (49) and (R)-N-acetyl allyl glycine (48) were then separated by ion exchange 
chromatography. The latter eluted at pH 7, whilst the required compound was eluted 
with aqueous ammonia. (S)-Allylglycine (49) was obtained as a white semi-crystalline 
solid of in 36% yield (the theoretical maximum yield was 50%). 
Synthetic route to pure (S)-aspartate ~-semialdehyde 
(S)-Aspartate ~-semialdehyde (11) was synthesised by oxidation of diprotected (S)-
allyl glycine (49) as reported by Tudor et al./ but the oxidation was performed using a 
Lemieux-Johnson reaction6•7 (which employs catalytic osmium tetroxide with sodium 
periodate) rather than using ozonolysis, see figure 1-3. The use of diprotected (S)-
allylglycine (52) minimised the formation of unwanted side products. Thus, the (S)-
aspartate ~-semialdehyde (11) obtained was of higher purity and therefore greater 
stability. 
(R,S)-Aspartate ~-semialdehyde (11) was synthesised from (R,S)-allylglycine (49) 
also using this method. 
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Figure 1-3: Synthesis of (S)-aspartate f3-semialdehyde (11) 
(S)-Allylglycine (49) 
((S )-2-Amino-4-pentenoic acid) 
o 
I 
O~OCH3 
o 
(S )-N-tert-Butoxycarbonylaspartate 
~-semialdehyde p-methoxybenzyl ester (53) 
(4-Methoxybenzyl-( S )-N-tert-butoxycarbonyl-
2-amino-4-oxobutanoate) 
(S)-Aspartate ~-semialdehyde (11 b) 
((S )-2-Amino-4-oxobutanoate acid) 
Potassium (S )-N-tert-butoxycarbonyl-
allylglycine (50) 
(Potassium (S )-N-tert-butoxycarbony 1-
2-amino-4-pentenoate) 
Cl~OCH3 
p-Methoxybenzyl 
Chloride (51) 
O~OCH3 
o 
(S)-N-tert- Butoxycarbonylallylglycine 
p-methoxybenzyl ester (52) 
(4-Methoxybenzyl- (S )-N-tert-butoxy-
carbony 1-2-amino-4-pentenoate ) 
(S)-Allylglycine (49) was N-protected by a tertiary butyl group in quantitative yield 
using the reagent di-tert-butylpyrocarbonate.1 This reaction was performed in base, with 
dioxane present, at room temperature. The product was obtained as a white oily solid 
which was purified to a white powder by washing with methanol. 
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C-Protection was as ap-methoxybenzyl ester.! p-Methoxybenzyl chloride (51), the 
protecting agent of choice, was synthesised from p-methoxybenzyl alcohol (anis alcohol) 
(54) by bubbling dry hydrochloride gas through the alcohol dissolved in ether,t° see 
figure 1-4. 
Figure 1-4: Synthesis of p-methoxybenzyl chloride!O 
H3CO~OH 
p-Methoxybenzyl alcohol (54) 
(Anis alcohol) 
p-Methoxybenzyl chloride (51) 
A slight excess of p-methoxybenzyl chloride (54) was reacted with the (S)-N-tert-
butoxycarbonylallylglycine (50) in DMF. The crude product contained a mixture of 
products due to the high reactivity of p-methoxybenzyl chloride (51) and its ability to 
polymerise. The desired product was obtained pure by chromatography as a clear yellow 
oil in a yield of 61 %. 
The alkene group of the diprotected (S)-allylglycine (52) was oxidised overnight at 
room temperature by a Lemieux-Johnson reaction using catalytic osmium tetroxide and 
three equivalents of sodium periodate, see figure 1_5,2.6,7 rather than by ozonolysis,t to 
give the desired aldehyde. The major advantage of the Lemieux-Johnson reaction is the 
ease of reaction and the purity of the resulting product. In the synthesis of the diprotected 
(S)-aspartate ~-semialdehyde (53) a relatively clean mixture of products was obtained, 
from this the desired product could be obtained pure as a clear oil by chromatography in 
76% yield. The major impurity in this reaction was unreacted starting material, not the 
range of oxidised side products that commonly form in the ozonolysis of (S)-allylglycine 
(49). 
Figure 1-5: Mechanism o/the Lemieux-Johnson reaction 
j 
~O~hO I~O\ 
0-
O~I~O ~I:I" 
y~ 
o 0 
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+ H20 
Deprotection of the diprotected (S)-aspartate ~-semialdehyde (53) was performed in 
trifluoroacetic acid in dry dichloromethane, yielding the (S)-asparate ~-semialdehyde (11) 
as the hydrate (11b) and the trifluoroacetate salt.! The product was obtained as a clear oil, 
in 90% yield. The optical rotation was measured confirming that the (S)-aspartate ~­
semialdehyde (11) synthesised was the (S) isomer and was of high optical purity. The 
rotation, as measured at the sodium D line, was + 3.1 T when measured at a 
concentration of 1.5 g/lOO ml in water, this agrees well with the literature.! Attempts to 
crystallise this oil proved fruitless (see Chapter Three). 
Summary 
Pure (S)-aspartate ~-semialdehyde (11) was synthesised from diprotected (S)-
allylglycine (52) as described by Tudor et al.,! except periodate-osmium tetroxide was 
used as the oxidising agent rather than ozone. The (S)-allylglycine (49) used in this 
synthesis was synthesised by the method of Gerrard,2 with only minor changes to the 
reaction conditions in the first step where diethyl acetamidomalonate (45) undergoes an 
allylation to diethyl allylacetamidomalonate (46). 
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Part B Production of the DHDPS and DHDPR Enzymes 
Introduction 
Given the reported similarity in the properties and inhibition patterns of the E. coli 
and other bacterial enzymes it was decided to concentrate on the E. coli DHDPS and 
DHDPR enzymes. Ample supplies of the purified enzymes were required. Both the dap 
A gene (which encodes for DHDPS) and the dap B gene (which encodes for DHDPR) 
were available on multicopy plasmids,2.5 thus, allowing their over-expression in E. coli. 
Crude enzyme extracts were then obtained which could be purified by standard 
biochemical procedures. 
Over-expression of the dap A gene and purification of the DHDPS enzyme 
The E. coli dap A gene had been cloned into pBluescript (a high copy number 
plasmid present at a level of 500 - 700 copies per cell) by Gerrard2 to give pJG001, see 
figures 1-6 and 1-7. Since synthesis of DHDPS is constitutive,!! incorporation of the 
dap A gene in a high copy number plasmid provided a simple and convenient means of 
over-expreSSIOn. 
Figure 1-6: pJG001 
AmpR pJGOOl 
4108 bp 
~l 
~UlCZ 
T7 promoter 
DapA insert 
(not to scale) 
Figure 1-7: Dap A insert from pJGOOl with surrounding restriction sites 
EcoRI Sma I BamHI Pst I Hind III 
BamHI Pst I DapA insert CIa I XhoI 
Sma I Sma I 
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E. coli XL-Blue was transfoffiled with pJOOO J using the calcium chloride method 12 
and successful transformants were identified by conferred ampicillin resistance. 
Verification that the plasmid pJOOO .J had been inselted in the E. coli was achieved by 
standard plasmid preparation via alkaline lysisl2 (derived from Birnboim and Doily) 
followed by restriction digests. DNA gel electrophoresis lJ was then performed to 
identify the plasmid DNA fragments . The plasmid was identified by a linear fragment of 
4100 bp from a single restriction digest, and by two fragments of 3000 and 1100 bp from 
a double digest, see figure 1-8. 
Figure /-8: DNA agarose gels of the pJGOO 1 plasmid digests 
2036 
1636 
2 3 4 5 6 7 
Lane I: I kbp ladder: 1018, 1636,2036,3054,4072 bp. 
Lane 2: plOOO l uncut. 
Lane 3: pJOOO I Xho I digest, 4100 bp, and uncut plOOOl. 
Lane 4: pJOOO I BamH I digest, 4100 bp, and uncut pJOOO I. 
Lane 5 : pJOOO 1 Xho I and BamH I double digest, 3000 and 1100 bp. 
Lane 6: pJGOO 1 authentic sample uncut. 
Lane 7: pJ0001 authentic sample Xho I and BamH I double digest, 
3000 and 1100 bp. 
T he E. coli transformed with pJOOOl was then cultivated and purified. All 
purification procedures were monitored by the detection of DHDPS, with the o-amino-
benzaldehyde assay (see Chapter Three) which, although does not provide quantitative 
analysis of enzyme activity, does detect very low levels of enzyme activity. 
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Purification of DHDPS 
Purification of DHDPS was based on the method by Gerrard,2 which was modified 
from Yugari and Gilvarg,14 and Shedlarski. 15 Gerrard obtained a crude enzyme extract 
by freeze-thawing the E. coli cells which had over-expressed the dap A gene. The crude 
extract was then purified by DEAE fast flow Sepharose ion exchange chromatography 
followed by dialysis against dry Sephadex. The freeze-thaw cycles and ion exchange 
chromatography were slightly modified, see below, then dialysis and ion exchange 
chromatography on a high resolution column were performed. 
After a standard overnight (-16 hrs) incubation E. coli cells were harvested by 
centrifugation and washed with buffer. All manipulations were performed at 0 to 4 °C to 
retain maximum activity. As the DHDPS enzyme resides in the periplasmic space 
(between the cell wall and the cell membrane) gentle disruption of the cell allows selective 
release of all the periplasmic proteins, including DHDPS, but few other proteins present 
in the cell. Previous wor~ had achieved this by freeze thaw cycles, which required cells 
that had been washed in Tris buffer to be harvested by centrifugation. The cell pellet was 
then flash frozen in liquid nitrogen and slowly thawed over 24 hours at 0 0c. Successive 
freeze thaw cycles produced more activity and it was found that between five and eight 
cycles was optimal; further cycles resulted in the release of significant amounts of other 
enzymes from the cell. A procedure involving seven freeze-thaw cycles was adopted as 
the general method. The crude extract was obtained by centrifugation, where it was either 
frozen for later work or purified. By SDS-PAGE it appeared a protein with Mr of -31 
kDa was the major component; this corresponds to DHDPS, see figure 1-9. 
Other workers16 had performed a heat shock on the crude DHDPS extract. However, 
it was found that a heat shock at 70°C for 2 minutes destroyed DHDPS activity; when the 
precipitated proteins had been removed by centrifugation less specific activity (activity per 
miligram of protein) remained than was initially present. It was concluded that DHDPS 
was heat sensitive although it may be protected by pyruvate (this was not investigated). 
A Q-Sepharose anion exchange column was used for the charge-based purification rather 
than DEAE Sepharose. The proteins were eluted using a 0 to 1.0 M sodium chloride 
gradient, in buffer, and DHDPS was found to elute at between 0.4 and 0.6 M salt 
concentration. Active fractions were then pooled and dialysed against 20 rnM Tris pH 
8.0 at 4°C containing 1 rnM EDTA, 1 rnM ~-mercaptoethanol, and 1 % ammonium 
sulfate. 
Gel filtration, as an alternative to dialysis, was also investigated as a method of size-
based purification. Gel filtration was performed on Sephacryl SAOO HR; however, it 
was found that the DHDPS, which exists as a native homotetramer (Mr -125 600), 
dissociated into the trimer (Mf -94 200), dimer (Mf -62 800), and monomer (Mf -31400) 
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during chromatography. Thus, the DHDPS activity was spread over a large molecular 
weight range making isolation difficult with little increase in the purity of the enzyme, see 
figure 1-9. 
The final step was a further charge-based purification performed on Q-Sepharose. 
This was used to purify and further concentrate the enzyme. Material to be used for 
DHDPS enzyme kinetic studies was purified, in batches, on a 1 ml Resource Q-
Sepharose Column that gave high resolution. Whereas, material that was to be used for 
DHDPR enzyme kinetic studies was purified on the large Q-Sepharose column used for 
the initial purification. The use of the Resource Q-Sepharose column (which has a more 
uniform bead size than normal Q-Sepharose) greatly increased the purity of the DHDPS 
enzyme and was a crucial step in this fast purification procedure. Material purified on the 
Resource Q column had a specific activity of 4.7 x 10-1 Ilmol·s-Img-I, whereas material 
purified on the Q-Sepharose column had a lower specific activity, 2.0 x 10-1 
Ilmol·s-Img-I, see figure 1-9. 
During the course of the DHDPS enzyme studies an alternative purification of E. coli 
DHDPS was reported. 16 This purification gave crystalline material. In this case 
ultrasonication was used to obtain the crude extract, followed by a heat shock, this 
differed from the above procedure. However, multiple chromatography was performed 
(DEAE-Sepharose, Phenyl-Sepharose, Q-Sepharose) which was similar to the procedure 
developed here. The main advantage of the purification described in this thesis was that it 
gave a quick and simple method for obtaining a homogeneous solution of DHDPS 
appropriate for kinetic studies. The final DHDPS had been purified to a specific activity 
of 4.7 x 10-1 Ilmol·s-Img-I of protein. This monomer was present as a single band on 
SDS-PAGE stained with Coomassie Brilliant Blue, its electrophoresis mobility 
corresponded to a monomer of molecular mass -31 kDa, see figure 1-9. 
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Figure 1-9: SDS-PAGE of DHDPS protein purification 
- 97.4 
66 
45 
31 
21.5 
14.5 kDa. 
2 3 4 5 6 7 8 9 --~~--~----------------
Lane 1 DHDPS crude supernatant. 
Lane 2 DHDPS heat shock supernatant. 
Lane 3 DHDPS ion exchange. 
Lane 4 DHDPS gel filtration. 
Lane 5 DHDPS second ion exchange. 
Lane 6 DHDPS ion exchange. 
Lane 7 DHDPS gel filtration. 
Lane 8 DHDPS second ion exchange. 
Lane 9 Molecular weight markers: 14.5, 2l.5, 31, 45, 66, 97.4 kDa. 
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Over-expression of the dap B gene and purification of the DHDPR enzyme 
The dap B gene had been cloned into pBluescript by Kraunsoe5 to give the plasmid 
pJKOOl, see figures 1-10 and 1-11. E. coli XL-Blue was transformed with pJKOOI 
using the calcium chloride method l ! and successful transformants were identified by 
conferred ampicillin resistance. 
Figure 1-10: Restriction Map of pJKOO 1 
AvaIl 
HpaI 
pIKOOl CIa I 
Xho I CIa I BsaA IlEeoR V (destroyed) 
Figure 1-11: Dap B insert with surrounding r.estriction enzyme sites 
Hpa I CIa I Hpa I BgI II Hine II CIa I 
I I I I I I 
933 1101 1256 1846 2523 
DapB 
Standard plasmid preparation was performed by alkaline lysis12 (derived from 
Birnboim and Doily) followed by restriction digests to verify that pJKOOl was present in 
the transformants. DNA gel electrophoresis13 was performed to identify the plasmid 
DNA fragments. XhoH I and BamH I double digest gave two fragments, 3000 bp and 
2300 bp long, confirming the plasmid was pJKOOl, see figure 1-12. 
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Figure 1-12: DNA agarose gel ojpJK001 plasmid digests 
'2 345 6 7 
Lane I: I kbp ladder: 1018, 1636, 2036, 3054,4072 bp. 
Lane 2: pJKOO 1 Xho I and BamH I double digest, 3000 and 2300 bp. 
Lane 3: pJKOOI Xho I and BamH I double digest, 3000 and 2300 bp. 
Lane 4: pJKOOI Xho I and BamH I double digest, 3000 and 2300 bp. 
Lane 5: pJKOOl Xho I and BamH I double digest, 3000 and 2300 bp. 
Lane 6: pJKOOI authentic sample Xho I and BamH I double digest, 
3000 and 2300 bp. 
Lane 7: pJKOOl authentic sample uncut. 
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Purification of DHDPR 
The purification of DHDPR from E. coli XL-l pJKOO 1 was based on the method of 
Tamir and Gilvarg,17 as modified by Kraunsoe.s This purification used ultrasonication to 
release the DHDPR enzyme, followed by an ammonium sulfate precipitation. Dialysis 
and ion exchange chromatography were then performed, and finally a heat shock to 
remove any contaminating NADPH utilising enzymes. Modifications to this reported 
procedure were made, as discussed below. 
E. coli XL-I Blue pJKOOl was cultured overnight, after which the cells were 
harvested by centrifugation, washed with buffer, and then resuspended in buffer. 
DHDPR is present in the cell body, not in the periplasmic space as with DHDPS, so 
ultrasonication (ultrasound treatment is known to disrupt bacterial cell walls18) was used 
to disrupt the cell contents. 
Crude preparations of DHDPR contain DHDPS and other enzymes which consume 
NADPH and interfere with the coupled assay,I9 this assay was used to follow the 
purification of DHDPR (see Chapter Three). However, DHDPR is unusually heat 
resistane9 and can withstand treatment at 70°C for 3 minutes without undue loss of 
activity; such treatment was employed to destroy contaminating enzyme activity of 
homoserine dehydrogenase and NADPH oxidase. Immediately after the ultrasonication 
the heat shock was performed, thus, removing the contaminating NADPH utilising 
enzymes as early as possible. This varies from the reported purification where the heat 
shock was performed as the final step.s 
A 20 - 60% ammonium sulfate precipitation was then performed, this was found to 
contain more DHDPS enzyme than the 48 - 65% precipitation used by Kraunsoe.s The 
precipitated proteins were harvested by centrifugation. The pellet of cells was redissolved 
in buffer and dialysed to remove any excess ammonium sulfate so that ion exchange 
could be performed. A Q-Sepharose anion exchange column (rather than DE-52 cellulose 
as reported previouslys) was then used to effect ion exchange chromatography and elution 
was performed using a buffered sodium chloride gradient, DHDPR eluted between 0.6 
and 0.9 M sodium chloride concentration and the active fractions were pooled. 
DHDPR was purified to a specific activity of 2.25 ~mol·s-lmg-l of protein. The 
purified enzyme was homogeneous as judged by SDS-PAGE, stained with Coomassie 
Brilliant Blue. Its electrophoretic mobility corresponded to a monomer of molecular mass 
~ 29 kDa (DHDPR exists as a homotetramer in its native form) see figure 1-13. 
Figure 1-13: SDS-PAGE of DHDPR purified enzyme 
2 3 4 5 6 
Lane 1 DHDPR crude extract. 
Lane 2 DHDPR heat shock supernatant. 
Lane 3 DHDPR 20 - 60% ammonium sulfate cut. 
Lane 4 DHDPR dialysed sample. 
Lane 5 DHDPR ion exchange. 
Lane 6 DHDPR ion exchange. 
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97.4 
66 
45 
31 
21.5 
14.5 kDa. 
Lane 7 Molecular weight markers: 14.5,21.5,31,45,66,97.4 kDa. 
During the course of these studies E. coli DHDPR was crystallised by Scapin et a/?o 
Their purification21 used a French press to obtain the crude extract of cells. This extract 
was treated with streptomycin sulfate, then dialysed, following which Q-Sepharose and 
gel filtration chromatography were performed. Ion exchange chromatography on a high 
performance anion exchange column was performed as the final step. This purification 
was more involved than the above procedure, although the fundamental steps of charge-
based purification and sized-based purification are COllilllon to both procedures. 
Although their purification is complicated, it does yield very high quality enzyme that was 
able to be crystallised, whereas the purification developed above is fast and simple and 
yields protein that is suitable for enzyme kinetic studies. 
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Summary 
Both the DHDPS and DHDPR enzymes were able to be over-expressed in E. coli 
and purified for use in enzyme kinetic studies. The purification of DHDPS was based on 
previous purifications.2,14,15 however, it was optimised to give a fast and efficient 
purification. The purity of the DHDPS was greatly enhanced by the use of a Resource Q-
Sepharose column; DHDPS was purified to an activity of 4.7 x 10-1 j.tmol·s-lmg-l. The 
purification of DHDPR was also modified from existing procedures,5,1? again providing a 
fast and efficient purification of the enzyme. Purified DHDPR had a specific activity of 
2.25 j.tmol·s-1mg-1• As both enzymes were obtained in high purity (-90%), they were 
appropriate for use in enzyme kinetic studies. 
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Results and Discussion Chapter Two 
DHDPS and DHDPR kinetics 
Introduction 
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In order to study the kinetic properties of the two enzymes DHDPS and DHDPR a 
quantitative assay was required. This assay could then be used to undertake systematic 
kinetic studies on the two enzymes. The parameters of immediate interest were Km and 
Vmax values for both substrates ofDHDPS, that is (S)-aspartate ~-semialdehyde (11) and 
pyruvate (17), and for the substrate of DHDPR. In the case of DHDPR the parameters 
for the two possible cofactors, NADPH and NADH, were also required. 
Assay methods 
To obtain quantitative results the assay had to be capable of accmately measuring the . 
initial rate of the enzyme catalysed reaction. The kinetics of both DHDPS and DHDPR 
were being studied, therefore, either two separate assays were required, or an assay that 
could be adapted to measure the activity of both of these enzymes. For DHDPS there are 
three assays in the literatme: the imidazole buffer assay,! the o-aminobenzaldehyde 
assay,l and a coupled assayY The o-aminobenzaldehyde assay yields qualitative results 
while both the imidazole buffer assay and the coupled assay have previously been used to 
obtain quantitative results. The coupled assay is also capable of measuring the kinetics of 
DHDPR. 
The imidazole buffer assay for DHDPS activity 
The imidazole buffer assay involves monitoring a rise in absorption at 270 nm on 
incubation of the DHDPS enzyme and its substrates ((S)-aspartate ~-semialdehyde (11) 
and pyruvate (17)) in imidazole buffer. l Despite the fact that this assay seems relatively 
simple, some major problems are encountered; thus, making it unsuitable for generating 
detailed, readily interpretable, quantitative kinetic measurements. The exact nature of the 
chromophore formed from the imidazole buffer reacting with the enzymatic product is 
unknown. There is also a lag phase before the absorbance at 270 nm increases. While 
this assay assumes that the rate of the DHDPS enzyme catalysed reaction is rate 
determining this lag phase suggests that the formation of the chromophore detected at 270 
nm may be the rate determining step. Thus, it is questionable whether the rate measured 
is actually the initial rate of the DHDPS catalysed reaction. However, since it is easy to 
perform, this assay continues to be used by other workers. 3 
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The o-aminobenzaldehyde assay for DHDPS activity 
The addition of o-aminobenzaldehyde (55) (as synthesised from o-nitrobenzaldehyde 
by the method of Smith and Opie4) to a solution containing the DHDPS catalysed reaction 
(the DHDPS enzyme and both substrates, (S)-aspartate ~-semialdehyde (11) and 
pyruvate (17)) immediately results in a yellow solution which slowly develops a deep 
purple chromophore during the enzyme catalysed reaction; the latter colour fades over 
time. The formation of the purple chromophore can be enhanced, after the enzyme-
catalysed reaction, by treatment with acid, such as 10% trichloroacetic acid. This assay is 
an extremely useful qualitative tool that was used to follow DHDPS protein purification; 
as it is both highly specific and extremely sensitive, detecting low levels of DHDPS 
present in crude extracts. 
However, again there are several problems with this assay which limits its 
effectiveness for quantitative work. The nature of the purple chromophore has yet to be 
determined, although it has been estimated that the extinction coefficient (£) is 1.224 x 
10-3 M-1cm-1 at 540 nm at pH 8.5.5 It is assumed that the rate of formation of the product, 
rather than the rate of complex formation, is the rate determining step. As with the 
imidazole buffer assay, a lag period, of at least 10 minutes, is associated with the 
generation of the measured chromophore. After the absorbance reaches its maximum it 
then slowly decreases over approximately two hours. To avoid the problem of a lag 
phase most workers leave the reaction for a specified period of time, generally 30 
minutes, before recording the rate.6 Thus, it is not clear which rate, that of the enzyme 
catalysed reaction or that of the purple complex formation, is being measured. 
It has been hypothesised that the product of the enzymatic reaction is oxidised to 
dipicolinate (36),3 which then reacts with o-aminobenzaldehyde (55) to form the purple 
chromophore, see figure 2-1. However, we found addition of o-aminobenzaldehyde (55) 
to dipicolinic acid (36) solutions does not result in the formation of a purple adduct, even 
under the exact conditions of the assay where acid is added. 
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Figure 2-1: Oxidation ofdihydrodipicolinate (18) to dipicolinate (36) 
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Gerrard7 hypothesised that the product of the DHDPS catalysed reaction initially 
forms a yellow dihydroquinazolium salt (56) (o-aminobenzaldehyde is known to form a 
yellow chromophore with irninesL-this has been used to test for irnines present in other 
biosynthetic pathways9). This dihydroquinazolium salt (56) may undergo further 
changes on standing which are enhanced by acid treatment, to generate the purple 
dihydroquinazolium salt (57}-detected at 540 nm, see figure 2-2. However, due to the 
instability of the purple complex, there is little. evidence to support either of these 
hypothesised structural changes. 
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Figure 2-2: Possible reaction of dihydrodipicolinate with o-aminobenzaldehyde to form 
the purple chromophore as suggested by Gerrard7 
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It is obvious that, while the o-aminobenzaldehyde assay can be used for qualitative 
measurements, it is not suitable for quantitative work. Clearly, the product of the 
DHDPS catalysed reaction forms a purple complex in the presence of o-amino-
benzaldehyde (55), the intensity of which is increased by acid treatment. The 
concentration of this adduct can be estimated by monitoring the absorbance at 540 nm. 
Anything further than this is conjecture. The o-aminobenzaldehyde assay was used 
during all stages of the purification of the DHDPS enzyme, but it was not used for kinetic 
studies. 
The coupled assay for DHDPS and DHDPR activity 
A coupled enzyme assay typically refers to following the activity of an enzyme by 
monitoring the activity of another enzyme that utilises the product of the first enzyme. If 
the second enzyme is present in excess, then the rate of reaction will depend entirely on 
the rate of the first reaction. This method is usually employed if the enzyme of interest is 
difficult to monitor but an enzyme catalysing a reaction of the product is relatively easy to 
monitor--say, by the reduction or oxidation of a nicotinamide cofactor. The DHDPS-
DHDPR coupled assay involves following the activity of DHDPS by monitoring the 
activity of the following enzyme DHDPR, which is a NADPH dependent enzyme. Thus, 
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the activity can be measured by following the decrease in absorbance at 340 nm 
corresponding to the oxidation of NADPH to NADP+, I see figure 2-3. This is easily 
quantifiable because, while NADPH has a strong absorbance at 340 nm (the extinction 
coefficient, £340' is 6.3 X 103 M-Icm-I) NADP+ exhibits negligible absorbance at this 
wavelength,lo,11 see figure 2-4. This assay is able to measure DHDPS kinetics if 
DHDPR is present in excess, since under these conditions DHDPS becomes rate limiting. 
DHDPR kinetics can also be measured, if DHDPS is present in excess, as then DHDPR 
becomes rate limiting. 
Figure 2-3: The coupled assay 
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DHDPR activity can also be measured using this assay by following the decrease in 
absorbance at 340 nm, due to the conversion ofNADPH to NADP+. Since the use of 
chemically synthesised substrate is problematic (a mixture of compounds and isomers 
results and it is not known which is utilised by DHDPR)12 DHDPS provided a convenient 
means of generating the substrate for DHDPR in situ. 
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Although the coupled assay was originally used by Yugari and Gilvarg in 1965,1 it 
was little used until recently. With the ease of obtaining large (milligram) quantities of 
DHDPS and DHDPR, using molecular biological techniques, there has been a resurgence 
in the use of this assay.13 This assay is ideal, giving sensitive and quantitative 
measurements of initial enzymatic rates of both the DHDPS and the DHDPR catalysed 
reactions. 
Modifications to the coupled assay 
The coupled assay was used to measure the kinetics of DHDPS and DHDPR since 
plentiful supplies of purified DHDPS and DHDPR, and (S)-aspartate ~-semialdehyde 
(11) were available (see Chapter One). It was however optimised to make it most 
effective for the range of kinetic investigations under scrutiny. 
The pH optimum of DHDPS is 8.4,1 but it is advantageous to run the assay at near 
physiological pH, to best mimic the true biological situation. The original coupled assay 
measuring DHDPS activity used Tris buffer at pH 7.4.1 However, due to the inadequate 
capacity of Tris to buffer near physiological pH (pH 7) an alternative buffer was sought. 
The buffering capacities of Hepes, Mops, Bis-Tris, and Mes are well known. Mops 
gives superior buffering capacity to Tris at pH 7.5 and below. At pH 7.5 Tris did not 
have significant buffering action to counteract the addition of (S)-aspartate ~-semi­
aldehyde as the trifluoroacetate salt, and consistent kinetics could not be obtained, as 
analysed by the Michaelis-Menten model and plotted on a Lineweaver-Burk (lIRate 
versus lI[Substrate]) plot (see the Appendix for the mathematical analysis of the 
Michaelis-Menten model and the Lineweaver-Burk plot, including a note on the units of 
activity used). Mops was found to buffer the assay adequately at pH 7.2, and consistent 
kinetics were obtained allowing Km and Vmax to be calculated. Using Mops buffer the pH 
of the assay mixture could be reduced to 6.8 and Michaelis-Menten kinetics were 
maintained, however, the Km and Vmax values did decrease significantly with the lowering 
of the pH. Since the substrate (S)-aspartate ~-semialdehyde (11) is more stable at lower 
pH, as are some of the possible inhibitors that we wished to test we opted for Mops 
buffer at pH 7.2 as the best compromise for the coupled assay, this was close to 
physiological pH and still maintained reasonable enzyme activity. Table 2-1 shows the 
results of the kinetic studies while varying the buffer and pH, while figure 2-5 shows the 
Lineweaver-Burk plot of the DHDPS kinetics in Mops buffer at pH 7.2. 
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Table 2 -1: DHDPS kinetic parameters while altering the buffer and pH, using (R,S)-
aspartate (3-semialdehyde (11) 
Buffer and pH at 25 DC Krn Vrnax 
x 1O-4 M X 10-1 ~rnol.s-1rng -1 
Tris pH 7.5 - -
Mops pH 7.5 5.11 1l.4 
Mops pH 7.4 2.63 7.46 
Mops pH 7.3 2.73 6.98 
Mops pH 7.2 2.67 3.67 
Mops pH 7.1 l.66 4.91 
Mops pH 7.0 l.78 3.87 
Mops pH 6.9 l.30 2.98 
Mops pH 6.8 l.12 2.24 
Figure 2-5: Lineweaver-Burk plots of the results of the DHDPS assay utilising Mops 
buffer at pH 7.2 
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Enzyme kinetics of DHDPS 
Enzyme kinetics ofDHDPS, with respect to (S)-aspartate ~-semialdehyde (11), were 
measured using the coupled assay with DHDPR present in an approximate 10-fold 
excess, and pyruvate (17) present in excess at 40 rnM. The concentration of (S)-aspartate 
~-semialdehyde (11) was varied between 0.06 and 0.25 rnM. Readings were taken in 
duplicate and the experiment was repeated until consistent kinetics were obtained. The 
results were interpreted in terms of the Michaelis-Menten model, analysing initial rates of 
reaction by Lineweaver-Burk (lIRate versus lI[Substrate]), Eadie Hofstee (Rate versus 
Rate/[Substrate]), and direct linear (Rate versus -[Substrate]) plots (detailed mathematical 
analysis of these three types of plots described are given in the Appendix). 14 
All three plots (Lineweaver-Burk, Eadie Hofstee, and direct linear) were used as each 
estimates the kinetic parameters Krn and Vrnax by slightly different mathematical 
approximations. The Lineweaver-Burk plot uses the reciprocal of both the rate and the 
concentration. This can lead to grouping of points distorting the appearance of any 
experimental error in the rate, making it difficult to judge which points are most accurate 
when plotting a straight line through the set of points. The Eadie-Hofstee plot does not 
have this same inherent problem, as the reciprocal of the concentration is modulated by 
being multiplied by the rate. With the direct linear plot a set of all possible Krn and Vrnax 
values are obtained for each rate measured at the various concentrations. This gives a 
range of values of which the median is taken to be the most accurate combination of Krn 
and Vrnax' The median is used as some pairs of lines may be nearly parallel and therefore 
some of the intersection points may be far from the correct values; such widely inaccurate 
estimates have a serious effect on the calculation of the mean, but hardly any effect on the 
median. 
The three plots gave comparable values of Krn and Vrnax' see table 2-2 and figure 2-6. 
The Lineweaver-Burk plot does not suffer undue distortion as the values representing the 
inverse of the substrate concentration are evenly spaced. The data points are tightly 
grouped on either side of the line of best fit, thus, this plot gives an accurate estimate of 
Km and Vrnax' The Eadie-Hofstee plot also has well spaced data points, again accurately 
estimating Krn and Vrnax' The direct linear plot has a small range of Krn and Vrnax values, 
this reflects the high accuracy of the data, and the median agrees well with the values 
from the two other plots. 
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Table 2-2: DHDPS kinetic parameters with respect to (S)-aspartate ~semia ldehyde (11) 
Type of plot Km Vmax 
x 1O-4 M X 10-1 jlmol's-1mg-1 
Lineweaver-Burk 1.24 7.08 
Eadie-Hofstee 1.03 6.50 
Direct linear 1.38 7.23 
Figure 2-6: Kinetic plots of DHDPS activity with respect to (S)-aspartate {3-semi-
aldehyde (11) 
(i) Lineweaver-Burk plot 
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Iii) Eadie-HoJ,tee plot 
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The range of the Km for IS)-aspartate ~-semialdehyde (l l), from the plots above, 
wus found to be (1.0 - 1.4) x 10'" M and the range of V,,,,, was found to be (6.5 - 7.2) x 
10-' ~mo l · s - ' mg" ' . These values are similar to those obta ined by Yugari and Gilvarg' 
who also used the coupled assay. At pH 7.4, at 25 °C, they found the Km to be 1.3 x 
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10-4 M. Karsten l3 reports a Km of (1.7 ± 0.1) x 10-4 M using the coupled assay. All 
these three values are considerably lower than those obtained using the imidazole buffer 
assay. For example, Couper et al. 3 report the Km to be 2.3 x 10-4 M, while Laber et al. 15 
report the Km to be 5.5 x 10-4 M, although this last value is probably twice the true value 
as racemic aspartate ~-semialdehyde (11) was used. 
DHDPS from other bacterial sources are reported to have Km values for (S)-aspartate 
~-semialdehyde (11) in the millimolar range, approximately 10 fold larger than that 
determined here for the E. coli enzyme. For example the Bacillus subtilis Km was 3.13 x 
10-3 M,"'16 the B. licheniformis Km was 2.6 x 10-3 M,l7 the B. sphaericus Km was 5.1 x 
10-3 M,m and the Corynebacterium glutamicum Km was 6.2 x 10-3 M."'19 While 
sporulating B. megaterium had a Km for aspartate ~-semialdehyde (11) comparable to that. 
calculated for E. coli, this Km was 4.6 x 10-4 M."'20 (Where'" values were measured using 
racemic aspartate ~-semialdehyde (11).) 
DHDPS from various plant sources are reported to have Km values for (S)-aspartate 
~-semialdehyde (11) in the millimolar and 10 fold lower range, for example the pea Km is 
4.0 X 10-4 M,"'21 the maize Km is 6.0 X 10-4 M,m the wheat Km is 1.6 X 10-3 M,m and the 
spinach leaf Km is 1.4 X 10-3 M."'24 
The kinetic parameters of DHDPS with respect to pyruvate (17) were also 
determined. In this case (S)-aspartate ~-semialdehyde (11) was present in excess at 2.5 
mM, while pyruvate (17) was varied between 0.05 and 0.5 mM. Again all three plots 
(Lineweaver-Burk, Eadie-Hofstee, and direct linear plots) were used and gave 
comparable Km and Vmax values, see table 2-3. In this case the Lineweaver-Burk plot 
reflects the high quality of the data where the data points are well spaced and close to the 
line of best fit, see figure 2-7. 
Table 2-3: DHDPS kinetic parameters with respect to pyruvate (17) 
Type of plot Km Vmax 
x 1O-4M X 10-1 rtmol·s-Img-I 
Lineweaver-Burk 1.14 4.76 
Eadie-Hofstee 1.12 4.85 
Direct linear 1.34 5.49 
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Figure 2 -7: Kinetics plot of DHDPR activity with respect to pyruvate (17) 
(i) Lineweaver-Burk plot 
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The range of Km (for pyruvate), from the above plots, was found to be (1.1 - 1.3) x 
10"4 M and the range of Vmax was found to be (4.8 - 5.5) x 10-1 Ilmol's"lmg"l. Again, 
these values are much closer to those obtained using the coupled assay by Yugari and 
Gilvarg/ who report a Km of 2.5 x lOA M, and by Karsten,13 where Km was reported as 
(1.7 ± 0.3) x lOA M (at pH 8), than those obtained using the imidazole buffer, for 
example Laber et al., 15 report a Km of 5.7 x 10"4 M. 
DHDPS Km values for pyruvate (17) can be compared with those from a range of 
different sources, for example the Bacillus subtilis Km is 1.07 X 10-3 M,16 the B. 
lichenifonnis Km is 5.3 X 10-3 M,17 the B. sphaericus Km is 9.0 X 10-3 M,t8 and the B. 
megaterium Km is 5.0 X 10-3 M.20 DHDPS from plant sources had similar Km values, for 
example the pea Km is 1.7 X 10-3 M,21 the maize Km is 2.1 X 10-3 M,22 and the wheat Km is 
1.18 X 10-2 M.23 Again the Km values were 10 fold larger, in the millimolar range. 
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Possible inhibition of DHDPS by high substrate concentrations of (S)-
aspartate f3-semialdehyde 
Previous literature has reported that substrate inhibition occurs at (S)-aspartate ~­
semialdehyde (11) concentrations greater than 2 ruM for wheat DHDPS;24 spinach 
DHDPS,2S maize DHDPS,22 and the B. lichenifarmis enzyme26 also showed inhibition, 
although it was uncertain if this was true inhibition or an artefact of the assay.24 No 
substrate inhibition by (S)-aspartate ~-semialdehyde (11) has been reported for E. calilS 
or pea DHDPS.21 No inhibition was observed on increasing the (S)-aspartate ~­
semialdehyde (11) concentration up to 2.5 ruM, with pyruvate (17) at 10.0 mM or 5.0 
ruM. However, as pyruvate (17) is present at a reasonably high concentration this may 
protect against inhibition by (S)-aspartate ~-semialdehyde (11). At pyruvate (17) 
concentrations of 1.0 ruM and 5.0 ruM, increasing the (S)-aspartate ~-semialdehyde (11) . 
concentration from 1.0 ruM to 10 ruM increased rather than decreased the rate, even 
though again pyruvate (17) should have been rate limiting. Thus, no evidence of 
inhibition by high concentrations of (S)-aspartate ~-semialdehyde (11) was observed. 
Feedback inhibition of (S)-lysine on DHDPS 
DHDPS is a branch point enzyme in the synthesis of the aspartate family of amino 
acids. It is the first enzyme in the diaminopimelate pathway, thus, it is the first enzyme 
committed to (S)-lysine (12) biosynthesis. It is important that cells produce amino acids 
as required, otherwise costly metabolic products and energy are wasted. Thus, the 
synthesis of (S)-lysine (12) is regulated by the enzyme DHDPS in some organisms. In 
these organisms, DHDPS is feedback inhibited by (S)-lysine (12). As such, if high 
levels of (S)-lysine (12) are present in the cell; the DHDPS enzyme is inhibited and no 
further (S)-lysine (12) is synthesised. 
Inhibition kinetics were run at a range of inhibitor and substrate concentrations, and 
kinetics were plotted on Lineweaver-Burk plots to estimate Krn and Vrnax' see table 2-4. 
Kinetics were also plotted as Dixon (l/Rate versus [Inhibitor]) and modified Dixon 
([Substrate]lRate versus [Inhibitor]) plots to determine the type of inhibition (competitive, 
noncompetitive, uncompetitive, or mixed) and to estimate the inhibition constant Ki (see 
the Appendix for detailed analysis of these plots). Inhibition of (S)-lysine (12) on 
DHDPS, with respect to (S)-aspartate ~-semialdehyde (11), was shown to be 
uncompetitive as the Dixon plot comprises of a series of nearly parallel lines while the 
modified Dixon plot has a series of lines with a common intercept at a positive substrate 
concentration upon rate value. The K/ was found to be in the range of (3.4 - 3.9) x 10-4 
M, as determined from the modified Dixon plot, see figure 2-8. 
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Tahle 2-4: Kinetic parameters of the feedback inhibition of (S)-lysine (12) on DHDPS 
activity with respect to (S)-aspartate /3-semialdehyde ( 11) 
[(S)-Lysinel KOl VOlax 
mM x 10-4 M X 10- 1 ~mol·s-Img-I 
0 1.19 6.03 
0.25 1.34 4.59 
0.50 1.13 3.70 
0.75 0.916 3.16 
Figure 2-8: Kinetic plots of the feedhack inhibition of (S)-lysine (12) on DHDPS activity 
with respect to (S)-aspartate f3-semialdehyde (11) 
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The inhibition of (S)-lysine (12) on DHDPS with respect to pyruvate (17) was also 
uncompetitive with a K;' in the range of (3.1 - 3.8) x 10-4 M, again this value was 
determined from the modified Dixon plot, see table 2-5 and figure 2-9. These results 
suggest that the (S)-lysine (12) binding site is allosteric, that is at a site remote to the 
active site. However, because early results suggested there may be mixed inhibition, it is 
possible that the (S)-lysine (12) binding site may slightly overlap with the (S)-aspartate ~­
semialdehyde (11) binding site. 
Recentll7.2S the allosteric binding site for (S)-Iysine (12) has been localised by X-ray 
crystallography, where it was found to be at the dimer interface (DHDPS is a 
homotetramer made up of a dimer of dimers). It should also be noted that the word 
'allosteric' implies a cooperativity effect, however, often the terms allosteric inhibitor and 
allosteric binding site are used when cooperativity has not been proven. Thus, they are 
often used to simply describe binding at a remote site as opposed to at the active site. 
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Table 2-5: Kinetic parameters of the fe edback inhibition of(S)-lysine (12) on DHDPS 
["'f) . h tt t (17) ac IVl 'wlt respec 0 oyruva e 
[(S)-Lysine] Km Vmnx 
mM X lOA M X 10. 1 )lmo1·s- 1mg- 1 
0 1.22 6.58 
0.25 1.34 6.19 
0.50 0.615 3.89 
0.75 0.531 3.02 
Figure 2-9: Kinetic plots of the feedback inhibition of(S)-lysine (12) on DHDPS activity 
with respect to pyruvate (17) 
(i) Dixon plot 
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(ii) Modified Dixon plot 
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It has been reported29 that feedback inhibition by (S)-lysine (12) on bacterial enzymes 
is not as significant as on plant enzymes. These results support this assertion. Typically 
the lC50 value for (S)-lysine (12) is 0.01 to 0.05 mM for DHDPS from plant$,2I.2221.2E'i 
but the lCso value of bacterial DHDPS is around 1.0 mM.IS Because of the weaker 
inhibition of (S)-lysine (12) on bacterial DHDPS than plant DHDPS, it is possible that 
introduction of bacterial DHDPS into plants might result in more nutritious crops. 
Transgenic crops such as wheat supplement with E. coli DHDPS are being studied with 
this in mind. Other crops under scrutiny include potato plants expressing E. coli DHDPS 
in their chloroplasts,' o and tobacco plants expressing E. coli DHDPS. ' I 
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Enzyme kinetics of DHDPR 
The kinetic studies of DHDPR were measured using the coupled assay following the 
oxidation of NADPH at 340 nm. The substrate of the DHDPR catalysed reaction was 
synthesised in situ from (S)-aspartate ~-semialdehyde (11) by DHDPS. Since this 
product may be unstable (dihydropyridines are prone to oxidation in the air32) the (S)-
aspartate ~-sernialdehyde (11) was added to the reaction cuvette as the penultimate 
ingredient of the assay, DHDPR being added last to initiate the enzymatic reaction. 
However, the (S)-aspartate ~-sernialdehyde (11) did have to be added at least five 
minutes before the assay was started, or the formation of the DHDPS product (rather 
than its utilisation) was rate-limiting and bi-phasic kinetics were observed over the five 
minutes of the assay, see figure 2-10. 
Figure 2-10: DHDPR kinetics 
If (S)-aspartate ~-semialdehyde is added 
immediately before DHDPR the rate 
limiting step is the formation of the 
unstable heterocycle (by DHDPS), rather 
than its utilisation (by DHDPR). 
______ DHDPR catalysed reaction 
Time 
If (S)-aspartate ~-semialdehyde is added at 
least five minutes prior to the assay 
biphasic kinetics are no longer obtained. 
~ DHDPR catalysed reaction 
Time 
The Krn and Vrnax values of DHDPR with respect to the substrate were measured. 
DHDPS was present in approximately 10 fold excess of DHDPR, and pyruvate (17) was 
present in excess at 40 mM in the cuvette. A range of substrate concentrations from 0.05 
to 0.30 mM were used, and NADPH was present at 0.162 mM. Readings were taken in 
duplicate and the experiment was repeated until consistent kinetics were obtained. The 
results were subject to Michaelis-Menten analysis using Lineweaver-Burk, Eadie-
Hofstee, and direct linear plots to determine the kinetic parameters. All three methods 
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gave consistent estimates of the enzyme parameters Km and Vmax' see table 2-6. The 
Lineweaver-Burk plot (where the data points hardly deviate from the line of best fit) and 
the direct linear plot show that the data is highly consistent and accurate, see figure 2-11. 
Table 2-6: DHDPR kinetic parameters with respect to the substrate 
Type of plot Km Vmax 
x 1O-4 M Jlmol·s-1mg-1 
Lineweaver-Burk 4.93 5.27 
Eadie-Hofstee 5.04 5.39 
Direct linear 5.29 5.71 
Figure 2-11: Kinetic plots of DHDPR activity with respect to the substrate 
(i) Lineweaver-Burk plot 
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(ii) Direct linear plot 
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For DHDPR, with respect to the substrate, Km was found to be in the range of (4.9 -
5.3) x 10-4 M, while VlIlax was found to be in the range of 5.3 - 5.7 ~mol·s-Img-I . A 
variety of Kill values have been reported, for example previous studies on E. coli DHDPR 
by Kraunsoe, :l generated a Km value of 1.90 x 10-4 M; which is comparable to the value 
given above. However, Tamir and Gilvarg l2 reported a much lower Km of 9.0 x 10-6 M 
(at pH 7.5 in Tris buffer) for E. coli DHDPR. More recent studies on E. coli DHDPR 
by Reddy et (/1 .'4 generated a Km value of (5.0 ± 1.2) x lO-s M. 
In spomlating bacteria, for example Bacillus sp., the Km of DHDPR with respect to 
substrate appears to vary very little. For B. subtilis Km is 7.7 X 10-4 M,:1S for B. cereus 
Km is 6.2 X 10-6 M,'6 and for B. megaterium Km is 5.9 X 10-6 M.36 In plants only maize 
DHDPR has been studied and this has a Km similar to that obtained for E. coli, 4.3 x 10-4 
M,37 however this value was obtained using chemically synthesised dihydrodipicolinate 
(L8) which exists as a mixture of compounds and isomers, not all of which can be utilised 
by DHDPR. Thus, this value may be artifical1y inflated . We expect DHDPR from the 
same source to have the same Km, however DHDPR from different sources is likely to 
have different kinetic parameters even if there is a high degree of homology. 
The Km and Villa, parameters of the cofactor, NADPH, of DHDPR were also 
detemlined. DHDPR is an unusual enzyme in that it can utilise NADPH or NADH; most 
nicotinamide dependent enzymes show a marked preference for one of these two 
cofactors."ux.w However, due to the greater stability towards acid hydrolysis of 
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NADPH (conferred by the phosphate group) this is normally the cofactor of choice in the 
assay. [[ The kinetics were more complicated for this system because NADPH utilisation 
is the method of monitoring the reaction, so when the NADPH is rate limiting there is 
only a very short period of enzyme reaction before all the NADPH has been used. The 
NADPH concentration was varied between 0.01 and 0.04 mM, while the substrate was 
present in excess due to the very high levels of (S)-aspartate ~-semialdehyde (11) (35 
rnM) and pyruvate (17) (40 mM) employed. Again the kinetics were analysed by the 
Michaelis-Menten model and plotted by the three different methods previously discussed, 
see table 2-7. Here the data showed slightly more deviation from the line of best fit in 
both the Lineweaver-Burk and Eadie-Hofstee plots. The direct linear plot gave the 
median values of the Kill and Vim" parameters, see figure 2-12. 
T, hi 2 7 DHDPR k · [" t ·th a e - me lC parame ers Wl re::,pec tt NADPH a 
Type of plot Km Vmax 
x 10-5 M ~mol"s - Img-I 
Lineweavcr-Burk 1.96 4.14 
Eadie-Hofstee 1.45 3.58 
Direct linear 1.65 3.63 
Figure 2-12: Kinetic plot of DHDPR activity with respect to NADPH 
(i) Direct linear plot 
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For DHDPR the Km, with respect to NADPH, was found to be in the range of (1.5-
2.0) x 10-5 M, while Vmax was found to be in the range of 3.6 - 4.1 Ilmol·s-lmg-l. The 
Km value is comparable to other reports for E. coli DHDPR. Tamir and Gilvarg12 found 
the Km to be less than 1.0 x 10-5 M in Tris buffer at pH 7.5, and Reddy et al. 34 found the 
Km to be (8 ± 2.5) x 10-6 M. These low Km values reflect the high affinity of the DHDPR 
enzyme for the cofactor NADPH. 
The Km of DHDPR with respect to NADPH in Bacillus sp. is also very low, for B. 
subtilis Km is 7.2 X 10-5 M,35 while for B. cereus Km is 8 X 10-6 M,36 and for B. 
megaterium Km is 1.3 X 10-5 M.36 This high affinity for the cofactor is also shown in 
plant sources of DHDPR, for example maize where the Km is 4.6 X 10-5 M.37 Inhibition 
of DHDPR by the cofactor product NADP+ has been observed in B. cereus and B. 
megaterium, with Kj being 5.5 x 10-5 M and 1.2 x 10-4 M, respectively.36 
DHDPR can also utilise NADH, however, the nicotinamide is quickly hydrolysed in 
acidic conditions and must be made up immediately prior to use. Some DHDPR kinetics 
were determined using NADH as the cofactor, these were plotted on Lineweaver-Burk, 
Eadie-Hofstee, and direct linear plots, see table 2-8. Here the Lineweaver-Burk plot gave 
the median value for Km; the Vmax being nearly identical to that obtained from the Eadie-
Hofstee plot, see figure 2-13. 
Table 2-8: DHDPR kinetics with respect to NADH 
Type of plot Km Vmax 
x 1O-6 M' Jlmol·s-1mg- 1 
Lineweaver-Burk 5.36 1.95 
Eadie-Hofstee 4.95 1.96 
Direct linear 6.56 2.36 
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Figure 2-13: Kinetic plot of DHDPR activity with respect to NADH 
(i) Lineweaver-Burk plot 
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The Km was found to be in the range of (5.0 - 6.6) x 10-6 M and Vmax was found to be 
in the range of 2.0 - 2.4llmol·s-lmtl. This Kmis lower than that ofNADPH, as is the 
V
max
' Studies by Reddy et al. 34 have found NADH to be a better cofactor than NADPH, 
as NADH exhibits a Km value of approximately four times lower than that for NADPH 
(showing NADH has a greater affinity for DHDPR than NADPH). Initial studies 
performed by Farkas and Gilvarg40 also reported that the rate of the DHDPR catalysed 
reaction mediated by NADPH is approximately half that found when NADH is used. 
However, as NADPH has greater chemical stability it is the cofactor of choice in the 
coupled assay. 
Summary 
In this chapter the kinetics of both DHDPS and DHDPR have been thoroughly 
investigated using the coupled assay. DHDPS, at a pH 7.2, had a Km for (S)-aspartate p-
semialdehyde (11) in the range of (1.0 - 1.4) x 10-4 M and a Vmax in the range of (6.5 -
7.2) x 10-1 Ilmol's-lmg-t, while for pyruvate Km was in the range of (1.1 - 1.3) x 10-4 M 
and V
max 
was in the range of (4.8 - 5.5) x 1O-1Ilmol·s-lmg-l. High concentrations of the 
substrate (S)-aspartate p-semialdehyde (11) did not cause inhibition of E. coli DHDPS, 
but E .coli DHDPS was found to be feedback inhibited by (S)-lysine (12). Inhibition of 
DHDPS by (S)-lysine (12) was shown to be uncompetitive with respect to (S)-aspartate 
p-semialdehyde (11) with a K/ in the range of (3.4 - 3.9) x 10-4 M. Inhibition with 
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respect to pyruvate (17) was also uncompetitive with a K/ in the range of (3.1 - 3.8) x 
1O-4 M. 
The kinetic parameters of DHDPR with respect to its substrate and the two possible 
cofactors, NADPH and NADH, were also measured. For DHDPR, at pH 7.2, with 
respect to the substrate, Km was found to be in the range of (4.9 - 5.3) x 10-4 M, while 
~nax was in the range of 5.3 - 5.7 flmol·s-lmg-l. The Km , with respect to NADPH, was 
found to be in the range of (1.5 - 2.0) x 10-5 M, while V max was found to be in the range 
of 3.6 - 4.1 flmol-s-lmg-l. The K
m
, with respect to NADH, was found to be in the range 
of (5.0 - 6.6) x 10-6 M and ~nax was found to be in the range of 2.0 - 2.4 flmol·s-lmg-l. 
As the Km for NADH is considerably lower than that for NADPH, NADH is a more 
efficient cofactor. 
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Results and Discussion Chapter Three 
The Structure of (S)-Aspartate f3-Semialdehyde 
Introduction 
Although (S)-aspartate ~-semialdehyde (11) had been prepared in previous studies, 
the biologically relevant structure was unknown. It could possibly exist in solution as an 
aldehyde (lla), a hydrate (llb), or a cyclic lactol (11c), see figure 3-1. While the 
literature had always assumed (S)-aspartate ~-semialdehyde (11) existed as the aldehyde 
(11a) there was no evidence for this. The question of whether cyclic or acyclic forms of 
(S)-aspartate ~-semialdehyde (11) predominate in aqueous solution, and what form of 
(S)-aspartate ~-semialdehyde (11) the enzyme DHDPS recognises, were key issues 
addressed in this research. 
Figure 3-1: Possible structures of (S)-aspartate f3-semialdehyde (11) 
HO OH 
H H 
0- 0-
o o 
Linear aldehyde (lla) Linear hydrate (Ub) Cyclic laetol (Ue) 
In previous literature reports, (S)-aspartate ~-semialdehyde (11) has always been 
assumed to exist as an aldehyde.! However, this seemed unlikely on examination of the 
chemical properties of (S)-aspartate ~-semialdehyde (11). In the original report of the 
synthesis of (S)-aspartate ~-semialdehyde (11) by Black and Wright it was noted that: 
'the usual aldehyde derivatives did not readily form with this substance'.2 Recent work 
by Tudor et al.3 concluded, from spectral data, that the molecule exists predominantly as 
the hydrate (1ib). While a study on succinic semi aldehyde derivatives, which are 
structurally similar to (S)-aspartate ~-semialdehyde (11), by Salmon-Legagneur,4 
concluded that the acyclic form (58) is a minor component of an equilibrium which 
favours a five-membered cyclic lactol (59), see figure 3-2. 
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Figure 3-2: Equilibrium of the aldehyde with the cyclic lactol 
o 
Acyclic form (58) 
?9
0H 
Rl 
o 
R2 
o 
Cyclic lactol (59) 
In the literature5•6 it was further noted that some aspartate ~-semialdehyde derivatives 
were reported in the lactol form (for example 60 and 61 in figure 3-3), although little data 
is available on these compounds. 
Figure 3-3: Derivatives of aspartate f3-semialdehyde (11) reported as lactols 
(60) (61) 
Previous work by Gerrard? had shown that (S)-homoserine lactone (31) ((S)-2-
amino-4-butyrolactone), a five membered cyclic molecule, inhibited the enzyme DHDPS, 
see figure 3-4. This result suggested that the substrate (S)-aspartate ~-semialdehyde (11) 
of the DHDPS catalysed reaction, may exist as the cyclic lactol (Uc). 
Figure 3-4: (S)-Homoserine lactone (31) 
(S)-Homoserine lactone (31) 
(( S )-2-Arnino-4-butyrolactone) 
Studies were undertaken to determine the exact structure of (S)-aspartate ~­
semialdehyde (11) as recognised by the DHDPS enzyme. This work involved DHDPS 
inhibition studies, using a variety of compounds that mimicked the different hypothesised 
structures of (S)-aspartate ~-semialdehyde (11). Structural studies on (S)-aspartate ~­
semi aldehyde (11) were also performed, these utilised NMR (including two-dimensional 
NMR) and infra-red spectroscopy. 
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Analogues of a possible cyclic lactol form of (S)-aspartate ~-semialdehyde 
(S)-Homoserine lactone (31) had been shown to inhibit DHDPS. It is possible that it 
acts as a substrate analogue if (S)-aspartate ~-semialdehyde (11) binds to DHDPS as a 
cyclic lactol (11c).? Alternatively, it may act as an inhibitor while binding at a remote site 
(that is, not at the active site). For example homo serine lactone (31) derivatives have 
been hypothesised to act as global starvation signals in cells.8 Thus, the type of inhibition 
that homo serine lactone (31) has on DHDPS needed to be determined. This would then 
clarify the structure of (S )-aspartate ~-semialdehyde (11) as recognised by the enzyme. If 
homoserine lactone (31) is acting as a substrate analogue then inhibition of DHDPS 
should be competitive with respect to (S)-aspartate ~-semialdehyde (11). However, if 
homoserine lactone (31) inhibits DHDPS by binding at a remote site either uncompetitive 
or noncompetitive inhibition should result. In either case, homo serine lactone (31) may 
be an important drug lead, as potent inhibitors of DHDPS are potentially of interest as 
antibacterial and/or herbicidal agents. Modification of homo serine lactone (31) is one 
way to develop such inhibitors. 
Samples of both racemic homoserine lactone (31) and (S)-homoserine lactone (31) 
were tested for inhibition ofDHDPS. Two other cyclic analogues were investigated, (S)-
3-aminopyrrolid-2-one (62) and 2-aminocyclopentanone (63), see figure 3-5. (S)-3-
Aminopyrrolid-2-one (62), which is a lactam (cyclic amide), is more stable towards 
hydrolysis than homoserine lactone (31), which is a lactol (cyclic ester), while 2-amino-
cyclopentanone (63) is stable to hydrolysis. (S)-3-Aminopyrrolid-2-one (62) was 
synthesised from the enantiomerically pure (S)-u,y-diaminobutyrate (65).9 The other 
analogue, 2-aminocyclopentanone (67), was synthesised, as the racemate, from 
cyclopentanone (67).10 
Figure 3-5: Homoserine lactone (31) and analogues 
CIH3i1~ 
o 
(S )-Homoserine lactone (31) (S)-3-Aminopyrrolid-2-one (62) 2-Aminocyc1opentanone (63) 
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Stability studies on homoserine lactone 
Homoserine lactone (31) (2-amino-4-butyrolactone) is known to hydrolyse to 
homo serine (64) (2-amino-4-hydroxybutanoic acid) see figures 3-6 and 3-7. 
Figure 3-6: Hydrolysis homoserine lactone (31) 
Homoserine lactone (31) 
(2-Amino-4-butyrolactone) 
Hydrolysis 
OH 
o 
Homoserine (64) 
(2-Amino-4-hydroxybutanoic acid) 
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Figure 3-7: NMR of homoserine lactone (31) hydrolysis to homoserine (64) 
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The hydrolytic stability of homoserine lactone (31) under the enzyme assay 
conditions is important in interpreting inhibition data. A study of the stability of 
homoserine lactone (31) with respect to pH was undertaken. Initial stability studies on 
homoserine lactone (31) were performed by following the IH NMR in phosphate buffer 
(KH2P04~HP04-which is NMR silent). Homoserine lactone (31) had a half-life of 
approximately 120 minutes, at pH S.O, showing -10% decomposition in 30 minutes. At 
pH 7.0 slightly less decomposition occurred, whereas at pH 1 less then 10% decomposed 
over 24 hours. Thus, it was found that homoserine lactone (31) was quickly hydrolysed 
in basic conditions, but was relatively stable in acid. As the coupled assay had been 
modified to run at pH 7.2 over five minutes (see Chapter Two) it was feasible to run 
kinetics measuring the effect of homoserine lactone (31) on DHDPS using this assay with 
minimal decomposition of the lactone. To minimise the hydrolysis of homo serine lactone 
(31) it was freshly prepared in Mops buffer at pH 3.5, before addition to the assay. 
Effect of homoserine lactone on DHDPS kinetics 
DHDPS activity was inhibited by homoserine lactone (31) at a range of 
concentrations. Dixon and modified Dixon plots were used to determine the exact nature 
of inhibition (competitive, noncompetitive, uncompetitive, or mixed) and to the calculate 
Ki values. The inhibition was found to be reversible and noncompetitive with respect to 
both substrates, as both the Dixon and modified Dixon plots show a series of straight 
lines that have a common intercept on the x-axis (which in both cases represents inhibitor 
concentration), see tables 3-1 and 3-2, and figures 3-S and 3-9. ~,from the Dixon and 
modified Dixon plots, was found to be in the range of (1.2 - 2.2) x 10.2 M with respect to 
(S)-aspartate ~-semialdehyde (11), and in the'range of (O.S 1.5}x 10.2 M with respect to 
pyruvate (17). This reversible noncompetitive inhibition is consistent with the inhibition 
occurring at an allosteric site, and is compatible with the hypothesis that the molecule is 
acting in its capacity as a global starvation signal in E. coli.s 
Table 3-1: Kinetic parameters of the inhibition of homo serine lactone (31) on DHDPS 
. h (S) f3' ld h d (11) actlVtty w~t respect to -aspartate -semza eye 
[Homo serine lactone] Krn Vrnax 
mM X 10-4 M X 10.1 Jlmol·s-1mg-1 
0 1.24 7.0S 
40 LOS 2.94 
60 0.S03 1.63 
80 0.S53 1.22 
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Figure 3-8: Kinetic plots of the inhibition of homoserine lactone (31) on DHDPS activity 
with respect to (S)-a.spartate f3-semialdehyde ( 11) 
(i) Dixonplot 
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(ii) Modified Dixon plot 
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Table 3-2: Kinetic parameters afthe inhibition of homoserine lactone (31) on DHDPS 
actil'it)l with respect to pvruvate ( 17) 
~ 
[Homoscrine lactone] Kill Vma x 
mM x lOA M X 10- 1 ~mol·s-Img-I 
0 l.14 4.76 
40 0.973 l.80 
60 0.624 l.17 
80 0.796 l.22 
Figure 3-9: Kinetic plots of the inhibition of homo serine lactone (31) on DHDPS activity 
with respect to pyruvate (17) 
(i) Dixon plot 
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(ii) Modified Dixon plot 
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Inhibition by homoserine lactone (31) with respect to (S)-aspartate ~-semialdehyde 
(11) was repeated using optically pure (S)- homoserine lactone (31) , to determine if the 
enzyme was specifically inhibited by the (S)-isomer. The results, however, were 
inconclusive. Inhibition was still noncompetitive and Kj , as determined from the Dixon 
and modified Dixon plots, was found to be in the range of (3.2 - 3.7) x 10-2 M. This 
increase in K j probably reflects the decrease in the quality of data, rather than a decrease 
in the affinity of the inhibitor for DHDPS when only the (S)-isomer is present, see table 
3-3 and figure 3-10. 
Table 3-3: Kinetic parameters of the inhibition of(S)-homoserine lactone (31) on 
DHDPS activity with re~pect to (S)-aspartate f3-semialdehyde (11) 
[(S)-Homoserine Km VOla, 
lactone] x 10-4 M X 10-1 !1mol·s- lmg- 1 
mM 
0 1.13 7.57 
40 0.425 2.48 
60 l.65 3.79 
70 0.674 1.92 
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Figure 3-10: Kinetic plots of the inhibition of (S)-homoserine lactone (31) on DHDPS 
activity with re.\pect to (S )-aspartate /3-semialdehyde (11) 
(i) Dixon plot 
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(S)-3-Aminopyrrolid-2-one 
(S)-3-Amino-pyrrolid-2-one (66),9 which is more stable towards hydrolysis than 
homo serine lactone (31), was synthesised as an analogue of (S)-homoserine lactone (31) 
from the enantiomerically pure (S)-a,y-diaminobutyrate (65), see figure 3-11. 
(S)-a,~-Diaminobutyrate 
hydrochloride (65) 
Ethyl (S)-a,~-diaminobutyrate 
dihydrochloride (66) 
(S)-3-Aminopyrrolid-2-one (62) 
(S)-a,y-Diaminobutyrate hydrochloride (65) was converted to the ethyl ester 
dihydrochloride (66) by Akabori and Nimano's methodll (a Fischer esterification). The 
free ester, on liberation at 0 DC, cyclised to give (S)-3-aminopyrrolid-2-one (62).9 
Although this esterification did not go to completion, re-reacting the reaction mixture 
increased the ratio of product to starting material. Care had to be taken on purification of 
the product that hydrolysis to the starting material did not occur. The ethyl (S)-a,y-
diaminobutyrate dihydrochloride (66) was obtained as a white sticky solid in a yield of 
86%. Attempts to crystallise the resinous mass with ethanol-toluene failed. However, as 
the material was pure by IH NMR the second 'cyclisatibn step was performed on the 
unpurified product. The cyc1isation of ethyl (S)-a,y-diaminobutyrate dihydrochloride 
(66), to yield (S)-3-aminopyrrolid-2-one (62), was performed in sodium ethoxide at 
_5°C. The product was obtained as a yellow-brown solid in 32% yield, compared to a 
literature value of 97%.9 There was difficulty in getting the ester to cyclise, and in 
removing the sodium chloride by-product. Cyclisation was acheived in low yield after 
initial attempts resulted in the conversion of the starting material (ethyl (S)-a,y-diamino-
butyrate dihydrochloride (66)) to the diamine. 
The effect of 3-aminopyrrolid-2-one (62) on the activity of DHDPS was then tested; 
no inhibition of DHDPS activity was observed with this molecule, showing that 
replacement of the ring oxygen with nitrogen decreased binding to the enzyme. 
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2-Aminocyclopentanone 
2-Aminocyclopentanone (63), which is related to homo serine lactone (31) by 
exchange of the ring oxygen with a carbon, is unable to undergo hydrolytic ring opening. 
It was synthesised and tested for inhibition of DHDPS. For the synthetic scheme see 
figure 3-12. 
Figure 3-12: Synthetic scheme 
.. 
Cyclopentanone (67) Cyclopentanone oxime (68) 
.. 
2-Aminocyclopentanone (63) 
Aminocyclopentane 
(Cyclopentylamine) (69) 
tert-Butyl j X 
hypochlorite 
(70) OCI 
Cyclopentanone oxime (68) was prepared, as pure white micro-crystals, from 
cyclopentanone (67)12,13 in a yield of 66%. When the material was left to slowly 
crystallise, large white needle crystals formed (~2mm x ~2mm thick by up to 40 mm 
long). The oxime was converted to aminocyclopentane (69)14 by treatment with sodium 
ethoxide in ethanol. 15 The amine was purified by fractionally distillation under reduced 
pressure, and obtained as a clear, faintly yellow, oil in a yield of 39%. 
2-Aminocyclopentanone (63) was then synthesised from the aminocyc1opentane (69) 
via an elaborate one pot cyclisation procedure. 10 The first step involved adding tert-butyl 
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hypochlorite (70) in dry toluene, dropwise, to a solution of the aminocyc1opentane (69) in 
dry toluene, while maintaining the temperature below 1O"C. The tert-butyl hypochlorite 
(70) was synthesised from tert-butyl alcohol (71) in acidic conditions with sodium 
hypochlorite (6.75%),16 see figure 3-13. 
Figure 3-13: Production oftert-butyl hypochlorite (74) 
tert-Butyl alcohol (71) tert-Butyl hypochlorite (70) 
The aminocyc1opentane (69) and tert-butyl hypochlorite (70) were reacted with 
sodium methoxide until all the imine species (=NCl) had been converted to the amine 
(-NH-). The 2-aminocyc1opentanone (63» was readily purified by recrystallisation from 
hot isopropyl alcohol yielding of 11 % of the product. 
2-Aminocyclopentanone (63) was tested for inhibition ofDHDPS, and it was found 
to be a reversible noncompetitive inhibitor as the Dixon and modified Dixon plots, which 
showed a series of lines that had a common intercept with the x -axis (on which inhibitor 
concentration was plotted), were almost identicaL The inhibition constant, ~ (again 
calculated from the Dixon and modified Dixon plots), with respect to (S)-aspartate ~­
semialdehyde (11), was in the range of (1.2 - 2.4) x 10-1 M, see table 3-4 and figure 
3-14. This Kj value is greatly increased relatiye to that of homoserine lactone (31), thus, 
showing a greatly decreased affinity for the remote site with the removal of the ring 
oxygen. 
Table 3-4: Kinetic parameters of the inhibition of2-aminocyclopentanone (63) on 
DHDPS activity with respect to (S)-aspartate (3-semialdehyde (11) 
[2-aminocyc10- Km Vmax 
pentanone] x 1O-4 M x 10-1 flmol·s-Img-I 
mM 
0 0.706 5.16 
60 1.02 4.81 
80 1.21 3.86 
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Figure 3-14: Kinetic plots ojthe inhibition oj2-aminocyclopentanone (63) on DHDPS 
activity with respect to (S)-aspartate (3-semialdehyde (11) 
(i) Dixon plot 
14 
12 
10 
8 
6 
4 
2 
0 
-160 -120 -80 - 4 0 0 
12-A llliIlOl:yciopenlallont: I 
(M) ( 1/1 noO) 
• 
40 80 
(ii) Mod!jied Dixon plot 
12,-------------------------------------~ 
10 
8 
6 
4 
2 
O~~~~~_,--~~--r_~~--~_r_,r_~~ 
-160 -120 -80 -40 o 40 
[2-AminocyclopenLanone) 
(M ) (111000) 
80 120 
~ (S)-ASA 0.250 mM 
• (S)-ASAO.125mM 
• (S)-ASA 0.085 mM 
<> (S)-ASA 0.065 mM 
~ (S)-ASA 0.250 mM 
• (S)-ASA 0.125 mM 
• (S)-ASA 0.085 mM 
o (S)-ASA 0.065 mM 
Results and Discussion 85 
As neither homo serine lactone (31) nor 2-aminocyclopentanone inhibit DRDPS 
competitively it can be assumed that they do not bind at the active site, thus, they do not 
mimic the biologically significant structure of (S)-aspartate ~-semialdehyde (11). This 
provides evidence that (S)-aspartate ~-semialdehyde (11) does not bind to DHDPS as the 
cyclic lactol (l1c). 
Structural studies on (S)-aspartate ~wsemialdehyde 
Structural studies were then performed on (S)-aspartate ~-semialdehyde (11). These 
initially involved attempts to crystallise (S )-aspartate ~-semialdehyde (11), using different 
counter ions. Later the work involved spectroscopic studies, using mainly NMR 
spectroscopy (including two-dimensional NMR), and infra-red spectroscopy. 
Attempts to prepare crystalline derivatives of (S)-aspartate /3-
semialdehyde 
Attempts were made to crystallise salts of (S)-aspartate ~-semialdehyde (11) with a 
variety of counter ions. The trifluoroacetate salt originally prepared did not yield any 
crystals. Picryl sulfonic acid (75), then, was investigated as it forms highly crystalline 
salts. Picryl sulfonic acid (75)17,18 was synthesised by the aromatic nitration of l-chloro-
2,4-dinitrobenzene (72) followed by nucleophilic substitution of the chloro substitutent 
by a sulfonic group, see figure 3-15. 
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Figure 3-15: Synthesis of picryisuljonic acid (75) 17.18 
CI Cl 
NOz 
Nitration 
NOz 
l-Chloro-2,4-dinitrobenzene (72) 
NOz 
cRCl 
Picrylsulfonic acid (75) 
NOz 
NOz 
Picryl chloride (73) 
(1-Chloro-2,4,6-trinitrobenzene) 
NOz 
Sodium picrylsulfonate (74) 
The aromatic nitration of l-chloro-2,4-dinitrobenzene (72), to give picryl chloride 
(73), was performed using concentrated sulfur:ic acid and fuming concentrated nitric acid. 
The product fOlmed as a yellow solid in 93% yield. The picryl chloride (73) was then 
converted to sodium picrylsulfonate (74) by the addition of sodium bisulfitc in ethanol 
and heating under reflux. Recrystallisation gave the sodium picrylsulfonate (74) as fine 
yellow crystals in 8.8% yield. The sodium picrylsulfonate (74) was converted to the acid 
with concentrated hydrochloric acid, this was then crystallised from acidic aqueous 
ethanol as pale yellow needle crystals in 38% yield. 
Diprotected (S)-aspartate ~-semialdehyde (53) was deprotected by picrylsulfonic acid 
(75). The reaction was perfOlmed in water, with anisole present as a scavenger, and 
monitored by IH NMR. The solvent was removed in vacuo, resulting in a white fluffy 
solid. The product was confirmed by IH NMR as being the picryl sulfonate salt of (S)-
aspartate ~-semialdehyde (11). Attempts to crystallise this solid in water, water/dioxane, 
water/acetonitrite, ethanol, and diethyl ether all failed. 
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Spectroscopic work 
Spectroscopic and structural studies were performed on (S)-aspartate ~-semialdehyde 
(11), at pH 7. By IH NMR a slight trace of aldehyde was present, as indicated by the 
presence of a low intensity resonance at 0H 9.61 ppm, see figure 3-16. Attempts to 
derivatise the aldehyde were unsuccessful; standard aldehyde tests with semi-carbazide, 
2,4-dinitrophenylhydrazine, hydroxylamine, benzaldehyde, and dimedone all proved 
negative. 
Figure 3-16: NMR of (S)-aspartate f3-semialdehyde (11 ) 
(i) IH NMR of(S)-aspartate f3-semialdehyde (11) at pH 1 
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(iii) 1 H NMR of (S)-aspartate f3-semialdehyde (11) at pH 7, showing the aldehyde peak 
present at OH 9.61 pprn 
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Heteronuclear multibond coupling (HNlBC) NMR experiments were peclormed to 
distinguish between the cyclic form of (S)-aspartate p-semialdehyde (11) and acyclic 
species (specifically to distinguish between the cyclic lactol form (11c) and the linear 
hydrate form (lIb». Experiments peclormed on homoserine lactone (31) (analogous to 
the proposed cyclic (S )-aspartate p-semialdehyde (11) structure) showed clear coupling 
between the carbonyl carbon and the a-proton, the pro-S p-proton (the stereochemistry 
was assigned on the basis ofnOe measurements), and both the y-protons. Comparison 
experiments performed on (S)-aspartate p-semialdehyde (11), showed coupling between 
the carbonyl carbon and the a and p protons, but no evidence of coupling between the 
carbonyl carbon and the y-proton. Coupling between the carbonyl carbon and the y-
proton would be expected if (S)-aspartate p-semialdehyde (11) was predominantly cyclic, 
see figures 3-17 and 3-18. 
This evidence suggested that a cyclic form of (S)-aspartate p-semialdehyde (11) was 
not present at detectable levels. Infra-red spectra of both (S)-aspartate p-semialdehyde 
(11) and homo serine lactone (31) were also peclormed. While infra-red spectra of 
aqueous solutions of (S)-aspartate p-semialdehyde (11) and homoserine lactone (31) 
were not well resolved, some structural information could be obtained. Homoserine 
lactone (31), in a potassium bromide disc, absorbs strongly at 1774 cm-1 and in aqueous 
solution at 1784 cm-1, corresponding to the y-Iactone absorbance. For (S)-aspartate p-
semialdehyde (11), however, no y-Iactone absorbance was observed. These results 
further support the notion that (S)-aspartate p-semialdehyde (11), in solution, at 
physiological pH, does not exist significantly in a cyclic form, but rather exists 
predominantly as the linear hydrate (11b). 
Figure 3-17: Coupling inHMBC NMR experiments 
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Figure 3-18: HMBC NMR experiments 
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Solution properties of (S)-aspartate f3-semialdehyde as a function of time 
and pH 
The IH NMR properties of (S)-aspartate ~-semialdehyde (11) were studied as a 
function of time and pH to provide information about the structure equilibria in solution. 
It was found that (S)-aspartate ~-semialdehyde (11) was stable in deuterium oxide (D20) 
for greater than 96 hours (-4 days). It was observed that the resonances due to the ~ 
protons decreased in intensity over this time due to exchange with deuterium oxide, see 
figure 3-19. 
Figure 3-19: Exchange of f3 protons in deuterium oxide 
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At pH 1 and 4 no aldehyde peak was present; at pH 7 a peak appeared at ()H 9.61 
ppm, corresponding to an aldehyde moiety, started to appear (this had been observed in 
the initial1HNMR studies performed), see figures 3-20 and 3-16 (iii). This was slightly 
more pronounced at pH 9. This showed that, while a small amount of the free aldehyde 
was present above pH 7, it was not a significant species in aqueous solutions of (S)-
aspartate ~-semialdehyde (11). 
Figure 3 -20: Aldehyde formation in (S)-asparate f3-semialdehyde (11) 
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The structural studies on (S )-aspartate ~-semialdehyde (11) strongly suggest that, in 
aqueous solution, (S )-aspartate ~-semialdehyde (11) exists predominantly as the linear 
hydrate (11b). This correlates with the enzymological studies which suggest that DHDPS 
recognises a linear form of (S)-aspartate ~-semialdehyde (11). 
Analogues of the hydrate form of (S)-aspartate ~-semialdehyde 
Since (S )-aspartate ~-semialdehyde (11) appears to exist predominantly as a linear 
hydrate (11 b) in aqueous solutions, analogues of this structure were tested as possible 
inhibitors of DHDPS. S-Methyl-(R)-cysteine (76) and the corresponding sulfoxide (77) 
and sulfone (78), together with (R)-cysteine sulfinic acid (79) were tested for inhibition 
of DHDPS. Finally other amino acids, namely (S)-aspartic acid (9), (S)-asparagine (80), 
and (S)-glutamic acid (81), were tested. The chemical structures of these analogues are 
shown in figure 3-21. 
Figure 3-21: Structure of(S)-aspartate {J-semialdehyde hydrate (lJb) and analogues 
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S-M ethyl- (R)-cysteine 
Inhibition studies on DHDPS showed S-methyl-(R)-cysteine (76) did not inhibit at 
concentrations up to 50 mM. 
S-Methyl-(R)-cysteine sulfoxide 
Hydrogen peroxide was used to oxidise S-methyl-(R)-cysteine (76) to the 
corresponding sulfoxide (77),19 see figure 3-22. This sulfoxide precipitated out of 
solution on addition of methanol and acetone. The reaction proceeded in an unoptimised 
yield of 23%. The sulfoxide was produced as a mixture of two diastereoisomers. 
Identification of the product was by IH NMR and l3C NMR comparing the spectra from 
the product with that of the starting material and then comparing both of these to 
methionine and methionine sulfoxide.20 The -SCH3 resonance moved from OR 2.08 in the 
sulfide, to OR 2.75 in the sulfoxide (compared to methionine OR 2.15 and methionine 
sulfoxide OH 2.80). The -CH2- peaks also moved down field as did the a proton, OR 3.86 
(in the sulfide) to OR 4.11 - 4.21 (in the sulfoxide). Mass spectra confirmed the sulfoxide 
was present as the corresponding protonated molecular ion was observed, and infra-red 
spectra indicated a distinctive sulfoxide stretch at 1022 cm-I. 
Figure 3-22: Synthetic scheme l9 
Oxidation 
S-Methyl-(R)-cysteine (76) 
~ 
i s-.. CH3 + = H3N ~ CO2-
H 
S-Methyl-(R)-cysteine sulfoxide (77) 
(Two diastereoisomers) 
Inhibition studies on DHDPS showed S-methyl-(R)-cysteine sulfoxide (77), like S-
methyl-CRY-cysteine (76), did not inhibit at concentrations up to 50 mM. 
S-Methyl-(R)-cysteine SUlfone 
The two step oxidation was performed with ammonium molybdate and perchloric 
acid, followed by hydrogen peroxide,21 see figure 3-23. Mass spectra was consistent 
with sulfone generation. Sulfone absorbances were identified in the infra-red spectra at 
1410 and 1387 cm-I. NMR spectra were also obtained and showed that no starting 
material or sulfoxide was present. 
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Figure 3-23: Synthetic scheme21 
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.. 
S-Methyl-(R)-cysteine sulfone (78) 
Inhibition studies on S-methyl-(R)-cysteine sulfone (78), again like S-methyl-(R)-
cysteine (76) and the sulfoxide (77), did not show any inhibition at concentrations up to 
50mM. 
(R)-Cysteine sulfinic acid 
(R)-Cysteine sulfinic acid (79) was tested as a possible inhibitor of DHDPS. It was 
found to be a moderate inhibitor; at 10 mM there was 37% inhibition, while at 50 mM 
there was 89% inhibition. Detailed kinetics were, therefore, run and it was found that 
this compound was a moderately strong reversible uncompetitive inhibitor, with respect 
to (S)-aspartate ~-semialdehyde (11), as the Dixon plot consists of a series of nearly 
parallel lines, while the modified Dixon plot has a series of lines that have a common 
intercept at a positive substrate concentration upon rate value. K;' (calculated from the 
modified Dixon plot) was in the range of (6.1 - 8.6) x 10-3 M, see table 3-5 and figure 
3-24. 
Table 3-5: Kinetic parameters of the inhibition of(R)-cysteine sulfinic acid (79) on 
DHDPS activity with respect to (S)-aspartate {3-semialdehyde (11) 
[( R)-cysteine Krn Vrnax 
sulfinic acid] x 1O-4 M x 10-1 I-lmol·s-1mg-1 
mM 
0 1.92 7.37 
10 0.547 3.30 
20 0.679 2.66 
30 0.543 1.49 
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Figure 3-24: Kinetic plots of the inhibition of (R)-cysteine sulfinic acid (79) on DHDPS 
activity Wilh respect to (S)-asparrate f3-semialdehyde ( J J) 
(i) Dixon plot 
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Effect of (S)-aspartic acid on DHDPS kinetics 
As (R)-cysteine sulfinic acid (79) inhibits DHDPS it was hypothesised that related 
amino acids may also inhibit DHDPS. (S)-Aspartic acid (9) was also tested as an 
inhibitor ofDHDPS. This amino acid is similar to (R)-cysteine sulfinic acid (79), it has 
the same length carbon backbone but a carboxylic acid moiety as opposed to the sulfinic 
acid group. (S)-AsPaItic acid (9) was found to be a mixed inhibitor ofDHDPS, with 
respect to (S )-aspartate ~-semialdehyde (11), as the Dixon plot shows a series of lines 
that have common intercept at a positive inverse rate value, while the modified Dixon plot 
comprises of a series of straight lines with a common intercept at a negative value of 
substrate concentration upon rate. K j (calculated from the Dixon plot) was in the range of 
(0.9 1.4) x 10-2 M and~' (calculated from the modified Dixon plot) was in the range of 
(2.1 3.9) x 10'2 M, see table 3-6 and figure 3-25. One interpretation of the observation 
that (S)-aspartic acid is a mixed inhibitor (it has properties of both uncompetitive and 
competitive inhibition) is that the (S)-lysine (12) feedback inhibition allosteric site and the 
(S)-aspartate ~-semialdehyde hydrate (lIb) active site, of DHDPS, may overlap and that 
(S)-aspartic acid (9) binds there. 
Table 3-6: Kinetic parameters of the inhibition of(S)-aspartic acid (9) on DHDPS activity 
with respect to (S)-aspartate {3-semialdehyde (11) 
[(S)-aspartic acid] Km Vmal' 
mM x lO'4M X 10,1 Ilmo1's,lmg,l 
0 1.48 6.40 
10 1.37 5.38 
20 0.586 2.46 
30 2.50 3.67 
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Figure ]-25: Kinetic plots (~fthe inhihition oj (S)-aspartic acid (9) on DHDPS activity 
with respect to (S)-u.')partute J3-semiuldehyde (11) 
(i) Dixon plot 
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(S)-Asparagine (80), which is analogous to (S)-aspartic acid (9) with an amide group 
rather than a carboxylic acid group, was tested for inhibition ofDHDPS. However, it did 
not show inhibition at concentrations up to 50 mM. 
Effect of (S)-glutamic acid on DHDPS kinetics 
(S)-Glutamic acid (81), which contains a carbon backbone one unit larger than (S)-
aspartic acid (9), was tested as an inhibitor ofDHDPS. (S)-Glutamic acid (81) was 
found to be an uncompetitive inhibitor of DHDPS, with respect to (S)-aspartate ~-semi­
aldehyde (11), like (R)-cysteine sulfinic acid (79), the Dixon plot gave a series of almost 
parallel lines, where the modified Dixon plot gave a series of lines with a common 
intercept at a positive substrate concentration upon rate value. ~' (calculated from the 
modified Dixon plot) was in the range of (0.9 1.6) x 10-2 M, see table 3-7 and figure 
3-26. 
Table 3-7: Kinetic parameters of the inhibition of (S)-glutamic acid (81) onDHDPS 
activity with respect to (S)-aspartate {3-semialdeh vde (11) 
[(S)-glutamic acid] Km Vmax 
rnM x 1O-4 M X 10-1 Ilmol·s-'mg-
' 
0 1.91 6.43 
10 6.09 4.93 
20 1.05 3.05 
30 2.20 0.997 
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Figure 3-26: Kinetic plots of the inhibition of (S)-glutamic acid (81) on DHDPS activity 
with respect to (S)-aspartate f3-semialdehyde ( 11) 
(i) Dixon plot 
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Summary 
Analogues of the hypothesised cyclic lactol structure of (S)-aspartate ~-semialdehyde 
(11) were tested for inhibition against DHDPS. These analogues included homo serine 
lactone (31), (S)-3-aminopyrrolid-2-one (62), and 2-aminocyclopentanone (63). 
Homoserine lactone (31) was found to be a reversible noncompetitive inhibitor of 
DHDPS with respect to both substrates, ~ with respect to (S)-aspartate ~-semialdehyde 
(11) was in the range of (1.2 - 2.2) x 10-2 M, and Kj with respect to pyruvate (17) was in 
the range of (0.8 - 1.5) x 10-2 M. 2-Aminocyclopentanone (63) also showed reversible 
noncompetitive inhibition with respect to (S)-aspartate ~-semialdehyde (11), but K j was 
greatly increased, and found to be in the range of (1.2 - 2.4) x 10-1 M. (S)-3-
Aminopyrrolid-2-one (62) did not inhibit DHDPS. Since these cyclic molecules do not 
competitively inhibit DHDPS it is unlikely that the substrate (S)-aspartate ~-semialdehyde 
(11) binds to the enzyme in a cyclic form. 
The solution structure of (S)-aspartate ~-semialdehyde (11) was determined by 
spectroscopic means, including NMR and infra-red spectroscopy, to be the linear hydrate 
(11 b). No cyclic lactol (11c) was observed at physiological pH and only traces of free 
aldehyde (11a) were present. 
Analogues of the hydrate form of (S)-aspartate ~-semialdehyde (lIb) were then 
tested as inhibitors of DHDPS. These included S-methyl-(R)-cysteine (76) and the 
corresponding sulfoxide (77) and sulfone (78), (R)-cysteine sulfinic acid (79), (S)-
aspartic acid (9), (S)-asparagine (80), and (S)-glutamic acid (81). (R)-Cysteine sulfinic 
acid (76), and (S)-glutamic acid (81) were uncompetitive inhibitors of DHDPS, with 
respect to (S)-aspartate ~-semialdehyde (11), (R)-cysteine sulfinic acid (79) had a~' in 
the range of (6.1 - 8.6) x 10-3 M, while (S)-glutamic acid (81) had a K;' in the range of 
(0.9 - 1.6) x 10-2 M. (S)-Aspartic acid (9) was a mixed type inhibitor of DHDPS, with 
respect to (S)-aspartate ~-semialdehyde (11), where K j was in the range of (0.9 - 1.4) x 
10-2 M, and K;' was in the range of (2.1 - 3.9) x 10-2 M. It is suggested that these 
inhibitors bind to the (S)-lysine (12) feedback inhibition site, as they do not compete with 
the substrate for the active site. 
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Results and Discussion Chapter Four 
Analogues of Dipicolinate Species 
Introduction 
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The enzyme DHDPS catalyses the condensation of (S)-aspartate ~-sernialdehyde (11) 
and pyruvate (17), the product (normally formulated as dihydrodipicolinate (18» is then 
reduced by DHDPR, to yield tetrahydrodipicolinate (19), see figure 4-1. The 
condensation reaction presumably generates a reduced pyridine derivative, but, at the 
onset of this work, there was uncertainty about the exact nature of this heterocycle. It 
was not known whether the product was a dihydropyridine or a hydroxytetrahydro-
pyridine which could be subsequently dehydrated to give a dihydropyridine. The 
literature usually reports the product of the DHDPS catalysed reaction as 2,3-dihydro-
dipicolinate (18), although both 2,5-dihydrodipicolinate (27) and 4-hydroxy-2,3,4,5,-
tetrahydrodipicolinate (28) have also been hypothesised,! see figure 4-2. Work on 
isolating or synthesising these compounds is difficult due to the ring instability, so stable 
analogues of these three possible intermediates, hydroxytetrahydrodipicolinate (28), 
dihydrodipicolinate (18), and tetrahydrodipicolinate (19), were investigated in an effort to 
obtain fmther information about the DHDPS and DHDPR catalysed reactions and the 
substrates and products concerned. 
Figure 4-1: Possible scheme for the DHDPS catalysed condensation of(S)-aspartate IJ 
semialdehyde (11) and pyruvate (17), followed by the DHDPR catalysed reaction 
o 
~C02 + 
Pyruvate (17) 
(S )-Aspartate 
~-semialdehyde (11) 
OH 
C02 ~ " %+ -·0 N ~ CO· 2 H H 2 
Hydroxytetrahydro- Dihydrodipicolinate (18) 
dipicolinate (28) NAD(P)H + ~ 
DHDPR 
NAD(P)+ 
(: -0~~0co-
2 H H 2 
Tetrahydrodipicolinate (19) 
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Figure 4-2: Hypothesised structures of the product of the DHDPS catalysed reaction 
2,3-Dihydrodipicolinate (18) 2,5-Dihydrodipicolinate (27) 
OH 
4-Hydroxy-2,3,4,5-
tetrahydrodipicolinate (28) 
If the initially formed product is a hydroxytetrahydropyridine it is most likely to be 4-
hydroxy-2,3,4,5-tetrahydrodipicolinate (28); this retains the chirality of (S)-aspartate ~­
semi aldehyde (11). If a dihydropyridine is formed, either from the DHDPS catalysed 
reaction or from a subsequent dehydration, there are theoretically five possible 
isomers--depending on the position of the double bonds in relation to the ring nitrogen,2 
see figure 4-3. 
Figure 4-3: Thefive isomeric dihydropyridines 
0 
N 
() 
N 
0 
N 
0 
N 
0 N 
H H 
1,2- 1,4- 2,3- 3,4- 2,5-
(82) (83) (84) (85) (86) 
A 2,5-dihydropyridine (86) seems unlikely as the 1t electrons are not conjugated. 
Both 2,3- and 3,4-dihydropyridines (84 and 85 respectively) allow conjugation of 
electrons over three carbons and the nitrogen. However, 2,3-dihydropyridines (84) are 
extremely unstable3 so this structure is also unlikely. 1,2- and 1,4-dihydropyridines (82 
and 83 respectively) are more stable as they allow conjugation of electrons over four 
carbon atoms and the nitrogen. It may be noted that in the reduction of dihydro-
dipicolinate (18) to tetrahydrodipicolinate (19), by DHDPR, NAD(P)H is employed, an 
example of a stable l,4-dihydropyridine (83). Since the stereochemistry of the chiral 
centre is unchanged during the biosynthesis of (S)-lysine (12) the 1,2-dihydropyridine 
(82) structure seems intrinsically most likely. Thus, if the product initially formed by the 
DHDPS catalysed reaction is a dihydropyridine it is most probably 1,2-dihydro-
dipicolinate (24). An alternative intermediacy of a dihydropyridine might involve 
generation of 2,3-dihydrodipicolinate (18), as a reactive intermediate, by dehydra60n of 
4-hydroxy-2,3,4,5-tetrahydrodipicolinate (28) at the active site of DHDPR. The 
alterna6ve structures for the product of the DHDPS catalysed reaction are shown in figure 
4-4. 
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Figure 4-4: Alternative structures of dihydrodipicolinate or hydroxytetrahydrodipicolinate 
1,2-Dihydrodipicolinate (24) 
Retains stereochemistry, 
and allows conjugation of 
electrons over four carbons 
and the nitrogen. 
3,4-Dihydrodipicolinate (26) 
Allows conjugation of 
electrons over three carbons 
and the nitrogen. 
1,4-Dihydrodipicolinate (25) 
Allows conjugation of 
electrons over four carbons 
and the nitrogen. 
2,5-Dihydrodipicolinate (27) 
Retains stereochemistry. 
~ ~+ = -0 N 2 co-2 R H 2 
2,3-Dihydrodipicolinate (18) 
Retains stereochemistry, 
and allows conjugation of 
electrons over three carbons 
and the nitrogen. 
OR 
4-Rydroxy-2,3,4,5-
tetrahydro-(2S )-
dipicolinate (28) 
Retains stereochemistry. 
Work on dihydropyridines reported in the literature focusses on l,4-dihydro-
pyridines (83),4 and 1,2-dihydropyridines (82),5 Dihydropyridines are useful 
intermediates in organic synthesis, and have been successfully used in alkaloid 
synthesis.6 They undertake stereospecific hydride transfers/ and have also been used in 
the pharmaceutical industry for the treatment of angina8 and as anti-hypertension drugs.9 
Studies aimed at providing information about the structure of the product of the 
DHDPS enzyme catalysed reaction have been of two types: NMR studies of the DHDPS 
enzymatic reaction, and DHDPS and DHDPR inhibition studies using mimics of the 
possible cyclic intermediates. 
NMR studies on the DHDPS catalysed reaction to determine the structure 
of the product 
Work on determining the structure of the product of the DHDPS enzymatic reaction 
involved following the reaction by NMR, in conjunction with a literature search on 
dihydropyridines and their NMR data. Figure 4-5 shows the chemical shifts of various 
dihydropyridines, 10,11 
Figure 4-5: NMR resonances of various dihydropyridines10,1l 
0e 125,19 
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DC 22.3 
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/'" N 
DC 128.62 H 
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1,4-
(83) 
2,3-
(84) 
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.----""'~ "" DC 160.13 N DC 45.5 
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In the IH NMR studies resonances due to the substrates, (S)-aspartate p-serni-
aldehyde (11) and pyruvate (17), were well resolved in deuterium oxide (buffered at pH 
7.2) with -15% aqueous present (the enzyme was introduced in this aqueous solution). 
As many dibydropyridines are relatively unstable the experiments were performed on a 
short time scale in an inert environment. (S)-Aspartate p-sernialdehyde (11) and pyruvate 
(17) were relatively stable in these conditions, and did not form detectable amounts of the 
corresponding Schiff base. High buffer concentrations (1 M) were required as (S)-
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aspartate ~-semialdehyde (11), present in high concentration, was introduced as the 
trifiuoroacetate salt. Phosphate buffer (K2HPOJKH2P04), at pH 7.2, was used rather 
than Mops buffer as this is IH NMR silent. Kinetics performed on the two buffers 
showed they gave comparable Km and Vmax values for (S)-aspartate ~-semialdehyde, thus, 
phosphate does not significantly affect catalysis by DHDPS. The Km and Vmax values 
were calculated from Lineweaver Burk plots, see table 4-1 and figure 4-6. 
Table 4-1: DHDPS kinetic parameters comparing the buffering ability of Mops to 
h h . h DHDPS I d p asp ate m t e couple assay 
Buffer and pH at 25°C Km Vrnax 
x 104 M X 10-1 Ilmol·s-lmg-l 
Mops pH 7.2 1.24 7.08 
Phosphate pH 7.2 1.41 8.11 
Figure 4-6: Lineweaver Burk plots comparing the buffering ability of Mops to phosphate 
in the DHDPS coupled assay 
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6 
5 
4 
c-
o 
8 
8 3 t) 
"8 
B'iil 
~ on 
-$ 2 
o 5 10 
1/[(S)-ASA] 
(lIM) (x 1000) 
15 20 
(ii) 200 mM Phosphate buffer at pH 7.2 
~ 
S 
8 
u 
'6 
0--
.... en 
~ oil ~8 
,...; '--' 
6 
5 
4 
3 
2 
o 4 8 12 
l/[(S)-ASAJ 
(lIM) (x 1000) 
Results and Discussion 107 
16 20 
A chemical change, assumed to be due to enzyme catalysis, was observed as the 
substrates diminished over time (-2 hours). Peaks in the regions of OH 1.6 2.6,3.4-
4.4, 7.5 - 8.6 ppm appeared but the product could not be resolved, see figure 4-7. These 
peaks were absent from the control ((S)-aspartate ~-semialdehyde (11) and pyruvate (17) 
without the DHDPS enzyme). However, it did appear that no vinylic proton was present, 
this suggested the structure could be the 4-hydroxy-2,3,4,5-tetrahydrodipicolinate (28). 
Comparison with the IH NMR data of synthesised 2,3,4,5-tetrahydrodipicolinate 
(19),12,13 which exists in equilibrium with an enamine form (39) and an open chain form 
(40), supports this, see figure 4-8. 2,3,4,5-Tetrahydrodipicolinate (19) (with no vinylic 
proton) has all of its 'H NMR resonances in the regions of OH 1.55 - 1.72, 2.25, and 
4.30 ppm. However, the enamine (39) contains a vinylic proton as a doublet of doublets 
at OH 5.20 ppm. The literature also notes that, in samples of 2,3,4,5-tetrahydro-
dipicolinate (19) that had been left for some time trace formation of dipicolinic acid was 
detected by the appearance of a 'H NMR resonance at OH 8.34 ppm. 12,13 
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Figure 4-7: IH NMR resonance of(S)-aspartate f3-semialdehyde (11) and pyruvate (17) 
IHNMR 
OH 4.01 - 4.05 
Pyruvate (17) (S)-Aspartate 
~-semialdehyde (lIb) 
DHDPS 
OH , 
, 
, 
Product 
OH 1.6 -2.6, 3.4-
4.4, 7.5 - 8.6 ppm. 
Figure 4-8: IH NMR oftetrahydrodipicolinate (19) 12,13 
OH 5.20 (dd) ppm 
Enamine (39) Potassium salt of 2,3,4,5-
tetrahydrodipicolinate (19) 
OH 1.55 - 1.72 (8H, m), 
2.25 (4H, m), 4.30 (2H,m) ppm. 
Open chain form (40) 
Work published this year,14 using isotopically labelled metabolites and two 
dimensional NMR, has demonstrated that (4S)-4-hydroxy-2,3,4,5-tetrahydro-(2S)-
dipicolinate (28) is, in fact, produced by DHDPS catalysis (at pH 8). It is not clear 
whether the (4S)-4-hydroxy-2,3,4,5-tetrahydro-(2S)-dipicolinate (28) undergoes 
DHDPR induced reduction directly or if, prior to reduction, the material undergoes a 
dehydration to a species such as 2,3-dihydrodipicolinate (18). Since 2,3-dihydro-
Results and Discussion 109 
pyridines are unstable3 the presence of such a species would be difficult to detect. A 
mechanism for the biosynthesis of (4S)-4-hydroxy-2,3,4,5-tetrahydro-(2S)-dipicolinate 
(28), based on this NMR work and X-ray crystallography, has been hypothesised.14 The 
NMR results obtained above are consistent with those published, see figures 4-9 and 
4-10. 
Figure 4-9: Reported NMR of (4S)-4-hydroxy-2,3,4, 5-tetrahydro-(2S) 
-dipicolinate (28) 14 
: } 8H 1.28 ppm 
8H 4.0ppm 
(4S )-4-Hydroxy-2,3 ,4,5-tetrahydro-(2S )-dipicolinate (28) 
Figure 4-10: IH NMR results obtained in this study 
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4-Hydroxy-2,3,4,5-tetrahydrodipicolinate (28) 
It was also noted that a red coloured complex formed in both the experiment and the 
control ((S)-aspartate ~-sernialdehyde (11) and pyruvate (17) without the DHDPS 
enzyme) suggesting that a non-enzymatic process was also occurring. It has been 
documented that dipicolinate (36) forms non-enzymatically from (S)-aspartate ~­
sernialdehyde (11) and pyruvate (17) under very vigorous conditions: an equimolar ratio 
of sodium pyruvate (17) (in 11 M potassium hydroxide) and aspartate ~-sernialdehyde 
(11) (in 2 M hydrochloric acid)/5 see figure 4-11. 
Figure 4-11: Non-enzymatic synthesis of dipicolinate (36yt5 
o 
Pyruvate (17) 
+ { 
+ -
H3N § C02-
H 
(S)-Aspartate 
~-senrialdehyde (11) 
J 
o 
H 
J 
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Dipicolinate (36) 
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Mechanism of DHDPS 
From these results and those published in the literature the information on the 
DHDPS catalysed reaction can be summarised. The first step in the condensation of (S)-
aspartate ~-semialdehyde (11) and pyruvate (17) to give dihydrodipicolinate (18) is the 
binding of pyruvate (17). A "ping-pong" mechanism has been postulated16 where one 
equivalent of pyruvate (17) binds per subunit (DHDPS is a homotetramer), with the loss 
of water, followed by binding and reaction of (S)-aspartate ~-semialdehyde (11). The 
pyruvate (17) binds to form a Schiff base with the E-amino group in the active site lysine 
161P An imine is formed and this has been observed by electrospray mass 
spectroscopy.18.19 Lysine 161 has been found to be the only conserved lysine in all 
known DHDPS sequences, and the imine formed with this residue is easily trapped by 
sodium borohydride, see figure 4-12. 
Figure 4-12: Sodium borohydride trapping of the Schiffbase 
H20 
~oc~~ 
2 ~ "02C~ 0 + V"2 
Enzyme 
(Inhibits enzyme) 
Pyruvate (17) Enzyme 
"OC~NH 
2 ~ 
Enzyme 
In 1995, the crystal structure of E. coli DHDPS at 2.5 A resolution was publishedP 
DHDPS is a homotetramer where each monomer is active. Each monomer is composed 
of two domains: an eight-fold a/~ barrel and a C-terminal a-helical domain (residues 224 
to 292). The active site lysine 161 is located in the a/~ barrel and has access via two 
entrances from the C-terminal side of the barrel. There are adjacent aspartate residues, 
aspartate 187 and aspartate 188, which form an entrance for the substrates and may have 
a mechanistic role. As well as Schiff base formation an aldol type condensation and a 
cyclisation have to occur. 
The product of the DHDPS enzyme catalysed reaction is (4S)-hydroxy-2,3,4,5-
tetrahydro-(2S)-dipicolinate (28)/4 rather than a dihydrodipicolinate isomer as previously 
assumed. 17,18,20,21 The proposed mechanism resulting in the formation of (4S)-hydroxy-
2,3,4,5-tetrahydro-(2S)-dipicolinate14 is shown in figure 4-13, 
Results and Discussion 112 
Figure 4-13: Mechanism ojDHDPS resulting in (4S)-hydroxy-2,3,4,5-tetrahydro-
dipicolinate (28)jormation I4 
Lys 161 
NH2 
o~ 
H3C ~ _ 
HOo- Tyr 133 
Pyruvate (17) I 
\\\\ 
HO"" 
Lys 161 
Lys 161 
(4S )-4-hydroxy-2,3 ,4,5-tetra-
hydro-(2S )-dipicolinic acid (28) 
COO-
Hoo-1 Tyr 133 
Lys 161 
· 
· 
· 
Lys 161 
Lys 161 
(NH 
tilzC>l COo-
Schiff Base 
Enarnine 
Hy~ 
XNH3 Hoo-1 Tyr 133 
-OOC H 
(S)-Aspartate 
~-semia1dehyde (lIb) 
I 
: 
DHDPS has been classified as a type I aldolase, that is its reversible reaction is 
catalysed through a Schiff base intermediate between the active site lysine and a carbonyl 
carbon of the substrate. Unlike type II aldolases, a metal ion is not required for catalysis. 
DHDPS is similar to the type I aldolase fructose-1,6-bisphosphate22 which cleaves 
fructose 1,6-bisphosphate into dihydroxyacetone phosphate and glyceraldehyde 3-
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phosphate (this enzyme catalysis is a key step in glycolysis). DHDPS also shows 
considerable homology with the type I aldolase N-acetylneuraminate lyase which converts 
N-acetylneuraminic acid (sialic acid) (87) to pyruvate (17) and N-acetyl-D-mannosamine 
(88) via Schiff base formation with an active site lysine residue followed by a retro-aldol 
reacti on, see figure 4_14.23.24 
Figure 4-14: N-Acetyl neuraminate lyase/rom E. coli23,24 
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Mechanistic studies have also been published on DHDPR,25 and E. coli DHDPR has 
recently been crystallised,26 enhancing the knowledge of the mechanism of this enzyme. 
X-Ray crystallography shows the enzyme has two domains. A dinucleotide binding 
domain is present, this has a central seven stranded parallel ~-sheet surrounded by four 
a-helices, and the NAD(P)H cofactor binds to the C-terminal end of the ~-sheet. There 
is also a substrate binding domain consisting of a ~-sandwich of four ~-strands and two 
a-helices. By X-ray crystallography it has been determined that the cofactor donates its 
4-pro-R hydride in the formation of tetrahydrodipicolinate (19). From these X-ray 
crystallography results and the results above on the mechanism of DHDPS it is 
hypothesised that 4-hydroxy-2,3,4,5-tetrahydrodipicolinate (28) undergoes a 
dehydration, in situ, to form 2,3-dihyrodipicolinate (18) prior to the reduction forming 
tetrahydrodipicolinate (19), see figure 4-15. 
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Figure 4-15: Modification of the mechanism proposed by Reddy et al. in 199525 
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Stable analogues of the proposed intermediates in the biosynthetic reactions were 
investigated in an effort to obtain further structural information about the DHDPS and 
DHDPR catalysed reactions and provide new types of inhibitors. Initially a range of 
commercially available cyclic compounds were tested as inhibitors of both DHDPS and 
DHDPR. Most of these compounds were aromatic and were derivatives of either 
pyridine or benzene, however, the nonaromatic cyclic compounds piperidine and 
morpholine were also tested. Further inhibition studies were then performed using 
partially reduced aromatic compounds, tetrahydrodipicolinic acid mimics, in an effort to 
gain more information. 
The cyclic compounds were tested for inhibition of DHDPS and DHDPR. 
Previously results obtained in this area used the imidazole buffer assay to measure 
DHDPS enzyme activity, however, due to the uncertainties in this assay it is difficult to 
quantify the inhibition accurately. An extensive study of the inhibition of E. coli DHDPS 
by pyridine and piperidine derivatives has been completed by Couper et ai. 21 These 
results are based on the imidazole buffer assay and so the data is not definitive. They 
report that the most potent inhibitors in their study are the N-oxide of dipicolinic acid and 
the di-imidate of dimethyl pyridine-2,6-dicarboxylate (both have ICso values of -0.2 
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mM). Dipicolinate (36) was found to be a competitive inhibitor of DHDPS, IC50 = 4 X 
10-4 M. However, this data is in conflict with the IC50 value of 1.2 x 10-
3 M reported by 
Laber et al., 27 again using the imidazole buffer assay. Tamil' and Gilvarg28 found E. coli 
DHDPR was inhibited by dipicolinate (36), with a ~ of 1 x 10-3 M, and isophthalic acid 
(41), with a ~ of 1.5 x 10-2 M.28 Reddy and Blanchard25 found dipicolinic acid (36) 
inhibited DHDPR competitively with respect to dihydrodipicolinate (18), ~ was 2.6 ± 
0.6 x 10-5 M, and uncompetitively with respect to NADPH, Kj was 3.3 ± 0.5 x 10-4 M. 
While picolinic acid (42) and pipecolic acid (43) had shown inhibition of maize 
DHDPR,29 
The cyclic compounds were tested for inhibition of DHDPS and DHDPR, where the 
concentration of (S )-aspartate p-semialdehyde (11) was 0.25 mM, and pyruvate (17) was 
present in vast excess at 40 mM. Most compounds were tested in aqueous solutions at 
concentrations up to 100 ruM or to the limit of their solubility. Some compounds had 
considerably greater solubility in methanol: in these cases the assay was run in 10% 
methanol. (10% Methanol decreased the enzyme rate by approximately 20%, but 
inhibition could still be clearly quantified.) Initially an introductory survey of the cyclic 
compounds was performed to determine which compounds were strong inhibitors. 
Detailed kinetic studies were then performed on these inhibitors. 
Initially pyridine (89) and pyridine (89) derivatives were tested for inhibition of 
DHDPS and DHDPR, these compounds contained the heteroatom nitrogen, see figure 
4-16 and table 4-2. 
Figure 4-16: Pyridine and pyridine derivatives 
0 Q Q 
N ~N CR3 ~N C02R 
Pyridine (89) 2-Methyl pyridine (90) Picolinic acid (42) 
CRO 
Nicotinic acid (91) Dipicolinic acid (36) Pyridoxal 5-phosphate (92) 
Table 4-2: Inhibition by pyridine (89) derivatives 
(i) DHDPS 
Compound 
Pyridine (89) 
2-Methyl pyridine (90) 
Picolinic acid (42) 
Nicotinic acid (91) 
Dipicolinic acid (36) 
Pyridoxal 5-phosphate (92) 
(ii) DHDPR 
Compound 
Pyridine (89) 
2-Methyl pyridine (90) 
Picolinic acid (42) 
Nicotinic acid (91) 
Dipicolinic acid (36) 
Pyridoxal 5-phosphate (92) 
Results and Discussion 116 
Concentration Inhibition 
ruM % 
100 0 
100 0 
1.0 0 
10 5 
50 80 
100 91 
10 0 
50 86 
1.0 2 
2.5 16 
0.1 0 
Concentration Inhibition 
ruM % 
100 0 
100 0 
10 0 
50 22 
100 60 
1.0 0 
10 22 
50 55 
0.01 0 
0.1 10 
1.0 75 
2.5 80 
0.1 0 
Pyridine (89) itself did not inhibit either enzyme, nor did 2-methyl pyridine (90). 
Pyridine carboxylic acids, for example picolinic acid (42), nicotinic acid (91), and 
dipicolinic acid (36) were found to be inhibitors of both enzymes. Picolinic acid (42), 
which has the carboxylic acid group in the two position on the ring was a weak: inhibitor 
ofDHDPS and DHDPR. Nicotinic acid (91), where the carboxylic acid group is in the 
three position on the ring, also gave weak inhibition ofDHDPS. However, for DHDPR 
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the inhibition of nicotinic acid (91) was stronger than that for picolinic acid (42). This 
result for DHDPR is unexpected as groups in the 2- position on the ring more closely 
resemble the reaction intermediates than when they are in the 3- position. Dipicolinic acid 
(36), which contains two carboxylic acid groups, in the 2- and 6- positions on the ring, 
appeared to be a moderate inhibitor of DHDPS, it was not a potent inhibitor as suggested 
by Couper et al. 21 and Laber et al. 27 For DHDPR dipicolinic acid (36) appeared to be a 
strong inhibitor, IC50 of ~5 x 10-4 M. 
Pyridoxal 5-phosphate (92), which is a coenzyme in many biological systems, 
contains an acidic group at the three position like nicotinic acid (91), and was tested for 
inhibition. However, it has a strong absorbance at 340 nm which interfered with the 
absorbance change monitored in the assay. Thus, only low concentrations gave 
interpretable data. No inhibition of either DHDPS or DHDPR was observed at 0.1 mM, 
thus, pyridoxal 5-phosphate (92) is not a potent inhibitor of these enzymes. 
Benzene derivatives were also tested as inhibitors of DHDPS and DHDPR, see 
figure 4-17 and table 4-3. 
Figure 4-17: Benzene derivatives 
Q 
Benzoic acid (93) 
Isophthalic acid (41) 
NH2 
2-Aminoacetophenone (94) 
(') 
~C02H 
C02H 
Phthalic acid (96) 
Phthalimide (95) 
Table 4-3: Inhibition by benzene derivatives 
(i) DHDPS 
Compound 
Benzoic acid (93) 
2-Amino acetophenone (94) 
Phthalimide (95) 
Isophthalic acid (41) 
Phthalic acid (96) 
(ii) DHDPR 
Compound 
Benzoic acid (93) 
2-Aminoacetophenone (94) 
Phthalimide (95) 
Isophthalic acid (41) 
Phthalic acid (96) 
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Concentration Inhibition 
mM % 
1.0 5 
10 39 
50 85 
0.1 7 
0.1 12 
1.0 33 
5.0 5 
10 17 
1.0 0 
10 70 
12.5 95 
Concentration Inhibition 
mM % 
10 0 
50 100 
0.1 0 
1.0 0 
1.0 0 
2.5 21 
0.1 0 
1.0 30 
10 71 
Benzoic acid (93), analogous to picolinic acid (42) but lacking nitrogen, showed 
weak inhibition of DHDPS and DHDPR. This inhibition may be in part due to a pH 
effect even though the assay is buffered at pH 7.2. 2-Aminoacetophenone (94), like 
pyridoxal 5-phosphate (92), has a strong absorbance at 340 nm limiting the range of 
concentrations which could be evaluated accurately. Kinetic data was inaccurate at 1 mM, 
and no significant inhibition of either enzyme was observed at 0.1 mM. Phthalimide (95) 
was a moderate inhibitor ofDHDPS, but it did not inhibit DHDPR. Isophthalic acid (41) 
which is analogous in structure to dipicolinic acid (36), but without the nitrogen, was a 
moderate inhibitor of DHDPS and a strong inhibitor of DHDPR. Phthalic acid (96), 
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where the two carboxylic acid groups are side by side, gave moderate inhibition for 
DHDPS and DHDPR. 
Piperidine (97) and morpholine (98) were also tested as inhibitors of DHDPS and 
DHDPR, see figure 4-18 and Table 4-4. Piperidine (97) inhibited DHDPS and DHDPR 
at high concentrations. Whereas, morpholine (98) did not show any inhibition of 
DHDPS at concentrations up to 100 mM, but showed weak inhibition of DHDPR. 
Figure 4-18: Piperidine and morpholine 
o 
H 
Piperidine (97) 
() 
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H 
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Table 4-4: Inhibition by piperidine (97) and morpholine (98) 
(i) DHDPS 
Compound Concentration 
mM 
Piperidine (97) 10 
100 
Morpholine (98) 100 
(ii) DHDPR 
Compound Concentration 
mM 
Piperidine (97) 1.0 
10 
50 
100 
MorphoHne (98) 1.0 
25 
50 
100 
Inhibition 
% 
0 
100 
0 
Inhibition 
% 
0 
46 
88 
100 
0 
23 
45 
84 
From these results it can be concluded that for DHDPS dipicolinic acid (36), 
phthalimide (95), isophthalic acid (41), and phthalic acid (96) are moderate inhibitors, 
while picolinic acid (42), nicotinic acid (91), benzoic acid (93), and piperidine (97) are 
weak inhibitors. No potent product inhibitors of DHDPS were discovered. While the 
most potent inhibitors of DHDPR, were dipicolinic acid (36) and isophthalic acid (41). 
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Phthalic acid (96) was a moderate inhibitor of DHDPR, but picolinic acid (42), nicotinic 
acid (91), benzoic acid (93), piperidine (97), and morpho line (98) were all only weak 
inhibitors. Thus, it was decided to undertake detailed kinetic studies on the inhibition of 
DHDPR by dipicolinic acid (36) and isophthalic acid (41). It was noted that all the cyclic 
compounds tested showed greater inhibition of DHDPR than of DHDPS. This possibly 
reflects a stronger binding of the substrate than the product, and highlights the increased 
difficulty in finding product inhibitors rather than substrate inhibitors. The cyclic diacids 
mimic both the substrate and product of the DHDPR catalysed reaction, whereas they 
only mimic the product (not the substrate) of the DHDPS catalysed reaction. 
Inhibition of DHDPR by dipicolinic acid 
In the literature dipicolinic acid (36) is reported to be an inhibitor of E. coli DHDPR. 
Reddy and Blanchard25 found dipicolinic acid (36) inhibited DHDPR competitively with 
respect to the substrate, Kj was (2.6 ± 0.6) x 10-5 M, and uncompetitively with respect to 
NADPH, K j was (3.3 ± 0.5) x 10-4 M. Tamir and Gilvarg28 found that dipicolinic acid 
(36) competitively inhibited DHDPR with respect to the substrate where Kj was 1 xlO-3 
M. The preliminary studies suggested an IC50 value of -5 x 10-
4 M. 
Some studies had also been performed on DHDPR from other sources. In maize 
dipicolinic acid (36) also competitively inhibited DHDPR with respect to the substrate 
dipicolinate (18), Kj was reported to be 9 x 10-4 M.29 For sporulating bacteria the pattern 
of inhibition changes to noncompetitive indicating the dipicolinic acid (36) binds at an 
allosteric site, this is most likely to be a feedback inhibtion site as these organisms use 
dipicolinic acid (36) in spore formation. The literature30 cites Bacillus cereus, and B. 
lnegaterium as being inhibited noncompetitively by dipicolinate (36) with respect to the 
substrate, with Kj being 8.5 x 10-5 M,and 1.4 x 10-4 M respectively. B. subtilis is also 
inhibited by dipicolinic acid (36), here inhibition is noncompetitive at 0.1 mM, then 
uncompetitive at 1.0 mM.31,32 
Dixon and modified Dixon plots were used to determine ~ and the nature of the 
inhibition of DHDPR by dipicolinic acid (36). The inhibition was found to be reversible 
and competitive with respect to the substrate as the Dixon plots shows a series of lines 
with a common intercept at a positive inverse rate value and the modified Dixon plot 
shows a series of nearly parallel lines, see table 4-5 and figure 4-19. Kj (from the Dixon 
plot) was found to be in the range of (4.3 - 4.4) x 10-4 M. Thus, dipicolinic acid is a 
strong inhibitor ofDHDPR and as it inhibits competitively (binding at the active site) it 
closely resembles the substrate. It was found that the quality of the data obtained in the 
detailed inhibition studies on DHDPR was poorer than that obtained in the DHDPS 
inhibition studies reported in Chapter Three. One factor which compromised these 
studies is the absorbance of the inhibitor at 340nm interfering with the assay. There was 
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also the problem that the cyclic molecules inhihit both of the enzymes of the assay. 
However, DHDPR was still found to be rate limiting in these DHDPR inhibition studies. 
The Dixon and modified Dixon pilots were used as an indicator of the type of inhibition 
obtained, rather than the trend in the Kill and VOlax values obtained from the Lineweaver-
Bl:.lfk plot. as the latter method is more prone to individual inacurracies. The K; value of 
(4.3 - 4.4) x 10-4 M falls between the two reported values for E. coli DHDPR. 
Table 4-5: Kinetic parameters of the inhibition of dipicolinic acid (36) on DHDPR 
activity with re.\pecf to the substrate 
[Dipicolinate] Km Vm:Jx 
mM X 10-4 M llmol·s-'mg-
' 
0 0.837 2.26 
0.10 6.14 6 .54 
0.50 28.3 41.7 
1.0 6_13 3.85 
Figure 4-J9: Kinetic plots of the inhibition of dip icolin ic acid (36) on DHDPR activity 
with respect to the suhstrate 
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(ii) Modified Dixon plot 
01) 0 
c;:jO 
e::-~>< 
«:.:: 
~'fo 
:r: E 
8-0. 
3.0...,.---------------------. 
2.5 
2.0 
1.5 
1.0 
0.5 
0.0 -f"---"'-r-~---r-........_____r-........_____r-........_____r-..______r_-----I 
-1 . 2 -0.8 -0 .4 00 
lDipicolinalej 
(M) (111000) 
0 .4 0 .8 1.2 
Inhibition of DHDPR by isophthalic acid 
Il IDHDPAI 0.25 mM 
• [DHDPAl 0.15 mM 
• [DHDPAIO.IOmM 
• [DHDPA I 0.075 mVl 
The inhibition of DHDPR by isophthalic acid (41) was also found to be reversible 
and competitive with respect to the substrate, again the Dixon plots shows a series of 
lines with a common intercept at a positive inverse rate value and the modified Dixon plot 
shows a series of nearly parallel lines (althogh the data is not as consistent as in the above 
case with dipicolinc acid (36)), see table 4-6 and figure 4-20. Ki (again calculated from 
the Dixon plot) was found to be in the range of (5.4 - 5.6) x 10-] M. Thus, while 
isophthalic acid (41) hinds at the active site like dipicolinic acid (36), it is a weaker 
inhibitor, hy about a factor of ten. The only stmctural difference between isophthalic acid 
(41) and dipicolinic acid (36) is the removal of the heterocycle nitrogen, thus, this 
nitrogen appears to be important to binding. 
Table 4-6: Kinetic parameters of the inhihition of isophthalic acid (41) on DHDPR 
. I I I II b t actlVI(Y wit 1. respec 0 7e su stra e 
[Isophthalate] Kill Vmax 
nM x 10-4 M jlmol·s-'mg-
' 
0 11.0 15.6 
2.5 8.86 9.23 
5.0 3.71 : 5.08 
7.5 8.36 7.49 
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Fi/{ure 4-20: Kinetic plots ()f the inhibition of isophthalic acid (41) all DHDPR activity 
with respect to the substrate 
(i) Dixon plot 
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In the literature28 E. coli DRDPR is reported to be competitively inhibited by 
isophthalic acid (41) with respect to the substrate, K. was found to be 1.5 x10-2 M, this 
value is higher than that found above. This report also found the inhibition by dipicolinic 
acid (36) to have a higher Ki value than that obtained in this research. 
Inhibition of DRDPS and DHDPR by tetrahydrodipicolinate mimics 
Mimics of the 4-hydroxy-2,3,4,5-tetrahydrodipicolinate were synthesised as possible 
inhibitors of DRDPS and DRDPR. As noted previously 2,3,4,5-tetrahydrodipicolinate 
(19) (~2_ species) is in equilibrium with the enamine (39) (~3_ species) and an open chain 
form (40) generated by hydrolysis,12,13 see figure 4-21. This complex chemistry will 
affect any tetrahydropyridine of this type. It was decided to concentrate inhibition studies 
on reduced isophthalic acids which are more stable than the corresponding reduced 
dipicolinic acids. ~3 - Tetrahydroisophthalic acid (99) and ~2 -tetrahydroisophthalic acid 
(100) were synthesised and tested for inhibition of both DRDPS and DRDPR. 
Figure 4-21: 2,3,4,5-Tetrahydrodipicolinate (19) 
Enamine (39) 2,3,4,5-Tetrahydrodipicolinate (19) Open chain form (40) 
It was hypothesised that ~2-tetrahydroisophthalic acid (100) may be a stronger 
inhibitor of DRDPS and DRDPR than the ~3 -tetrahydroisophthalic acid (99) as this 
mimics the imine (19). A~ ~3-tetrahydroisophthalic acid (99) mimics the enamine (39) 
inhibition may depend on the extent of the tautomerism to this form. 
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Reduction of isophthalic acid to ,13.tetrahydroisophtlzalic acid 
The method of Perkin and Pickles33 was used to synthesise /13 -tetrahydroisophthalic 
acid (99). Isophthalic acid (41) was reduced in aqueous solution, at 70 °C, by sodium 
amalgam, see figure 4-22. The reaction did not go to completion and some starting 
material was recovered. However, some /13 -tetrahydroisophthalic acid (99) was 
obtained. The yield of the reaction was low (4.7%), as the reaction gave a mixture of 
different products; the extraction of /13 -tetrahydroisophthalic acid (99) was tedious due to 
this mixture of products formed, but was successfully achieved by repeated fractional 
crystallisation. 
Figure 4-22: Reduction ofisophthalic acid at 70 °C33 
Isophthalic acid (41) 113 -Tetrahydroisophthalic acid (99) 
Reduction of isophthalic acid to ,12., ,13., ,14 -tetrahydroisophthalic acids 
The reaction conditions used to synthesise /13-tetrahydroisophthalic acid (99) can be 
modified to make a mixture of /12_, /13_, and /14-tetrahydroisophthalic acids (100,99, and 
101 respectively). Since it has been reported33 that these can be separated it was decided 
to try these as a route to /12_ and /14-tetrahydroisophthalic acids (100 and 101 
respectively). The reaction above was performed at 45°C under a constant stream of 
carbon dioxide,33 see figure 4-23. In the report by Perkin and Pickles33 it was stated that 
this method synthesised all three isomers, and that these could be separated by fractional 
crystallisation. A reasonable amount of material was obtained at the end of the reaction, 
however this material could not be separated into unreacted starting material, and the 
various reaction products-not only are there the three possible tetrahydroisophthalic 
acids (100, 99, and 101) but also possible dihydroisophthalic acids. Repeated attempts at 
fractional crystallisation in both water and methanol/diethyl ether were fruitless, probably 
due to the very low solubilites of this material in these solvents. The material could not 
be purified effectively by chromatography. 
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Figure 4-23: Reduction ofisophthalic acid at 45°C under carbon dioxide33 
NaHg/C02 
Isophthalic acid (41) /12_ Tetrahydroisophthalic acid (100) 
H02~C02H 
/13 -Tetrahydroisophthalic acid (99) 
H02~CChH 
/14_ Tetrahydroisophthalic acid (10 1) 
(cis- and trans- ) 
Synthesis of 112.tetrahydroisophthalic acid from cyclohexanone 
In view of the difficulty in separating a mixture of ,'!l?-, !j,?-, and L14-tetrahydro-
isophthalic acids (lOa, 99, and 101 respectively) a synthesis that produced only L12_ 
tetrahydroisophthalic acid (100) was required; There were two such syntheses in the 
literature, both reported in the same paper.34 Kon and Nandi34 reported that L12-tetra-
hydroisophthalic acid (lOa) could be synthesised from cyclohexanone (l02) or from 1,3-
dibromopropane (l08) and diethyl malonate (109). The synthesis of L12-tetrahydro-
isophthalic acid (lOa) was first attempted from cyclohexanone (102), see figure 4-24. 
Figure 4-24: Synthetic sche111e34 
Cyclohexanone (102) 
H3CH2C02CMcOC02CH2CH3 
Ethyl-3-carbethoxy-/12-
cyc1o-hexeneglyoxalate (107) 
/12 -Tetrahydroisophthalic acid (100) 
Cyclohexanone 
cyanohydrin (103) 
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Initially cyclohexanone cyanohydrin (103) was synthesised from cyclohexanone 
(102) by the method of Ruzika and Brugger.35 This involved producing hydrogen 
cyanide in situ to add a cyano group to the carbonyl carbon. The reaction gave a 
reasonable yield of the cyanohydrin (103), 66.3%. The next step involved a dehydration, 
using thionyl chloride, to form the ring double bond. While the reaction itself proved to 
be straightforward, difficulties were encounted in removing the thionyl chloride, and 
extracting the product from the reaction mixture--this was achieved by repeated fractional 
distilJation yielding pure 2-cyano-1-cyclohexene (104) in 19% yield. 
The synthesis of ethyl tetrahydrobenzoate (105)36 was performed in acidic ethanol at 
120 The esterification occured in reasonable yield (56.7 %), and no further 
purification was required, however, the compound was unstable and hydrolysis to the 
acid was observed to occur relatively rapidly even at -20°C. Unfortunately, 
condensation of ethyl tetrahydrobenzoate (l05) with diethyl oxalate (106) as reported by 
Kon and Nande4 was problematic. This route was not pursued further due to success 
with the alternative route from 1,3-dibromopropane (108) and diethyl malonate (109). 
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Synthesis of iJ.2-tetrahydroisophthalic acid from 1,3.dibromopropane and 
diethyl malonate 
~2_ Tetrahydroisophthalic acid (100) was synthesised from 1,3-dibromopropane 
(108) and diethyl malonate (109), as reported by Kon and Nandi34 with minor 
modifications, see figure 4-25. 
Figure 4-25: Synthetic scheme34 
1,3-Dibromopropane (108) 
Br~Br 
R = -C02CH2CH3 
Diethyl malonate (109) 
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dicarboxylate (112) j SOCI,tpyrid;n, 
Ethyl cyclohexanone-
2,6-dicarboxylate (111) 
r'1 Hydrolysis.. r"I 
H3CH2C02C~C02CH2CH3 H02~C02H 
Ethyl Ll2-tetrahydro- Ll2_ Tetrahydroisophthalic acid (100) 
isophthalic acid (113) 
Ethyl dicarboxypimelate (110) was synthesised from 1,3-dibromopropane (108) and 
diethyl malonate (109) via Uschakov's method as reported by Kon and Nandi34 and 
modified according to the method of Adams and Kamm.37 The product was purified by 
fractional distillation, and unreacted diethyl malonate was also recovered in the 
distillation. Ethyl dicarboxypimelate (110) was then cyclised to give the ketonic ester, 
ethyl cyclohexanone-2,6-dicarboxylate (111).34 Two portions of sodium ethoxide (each 
1.9 equivalents) were required to drive this reaction to completion. A yield of 37.5% was 
obtained after purification by chromatography, this was a slight increase over literature 
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reports (31.0%34). The NMR of this compound was complex due to enol formation, 
however, with the use of two dimensional NMR (COSY--proton proton coupling, and 
HSQC--proton carbon coupling) the two tautomers could be assigned; for these reasons 
two dimensional NMR was used throughout this synthesis of A2-tetrahydroisophthalic 
acid (100) to assign NMR spectra. Mass spectra confirmed the ketone (111) had been 
obtained, and a distinct carbonyl stretch, corresponding to the ketone, was also seen in 
the infra-red spectrum at 1657 cm-I (the carboxylic acid carbonyl peak occurred at 1730 
cm- I ). 
Ethyl cyclohexanol-2,6-dicarboxylic acid (112) was synthesised by the reduction of 
the ketone moiety to a hydroxy group using Adam's catalyst (platinum oxide) and ferrous 
chloride under a hydrogen atmosphere.34 The product was obtained in high yield 
(92.4%) by chromatography (literature yield of 67.4%33). A broad singlet at OR 4.63 
ppm was observed in the IH NMR from the proton next to the hydroxy group. Two 
molecular ions of rnJz 244 were also observed by GCMS, which was able to separate the 
two stereoisomers. The dehydration of this compound to give ethyl A2-tetrahydro-
isophthalic acid (113) was performed using thionyl chloride in pyridine. Initial attempts 
using the conditions as quoted by Kon and Nandi,34 thionyl chloride (1.3 equivalents) in 
pyridine (2.4 equivalents) for 20 hours, gave only a small amount of product and a large 
proportion of side products. To counteract the side product formation and to increase the 
amount of product the conditions were altered to increased amounts of thionyl chloride 
(44 equivalents) and pyridine (98 equivalents) but with a shOlter time of reaction (90 
minutes).38 The product was purified by chromatography and obtained in a yield of 
35.7%. The vinylic proton was observed as a broad singlet at 0H7.00 ppm in the lH 
NMR, in the l3C NMR the two vinylic carbons were observed at Oc 132.4 and 135.2 
ppm. Again a molecular ion of rnJz 226 was observed by GCMS, verifying the identify 
of the compound. 
Hydrolysis of ethyl A2-tetrahydroisophthalic acid (113) to A2-tetrahydroisophthalic 
acid (100) was carried out by the methodology of Abell et al.39 This involved heating 
under reflux the ethyl A2-tetrahydroisophthalic acid (113) with potassium carbonate (2.0 
equivalents) in 10% aqueous methanol for 20 hours. The product was obtained as a 
white solid of reasonable purity after multiple extractions. 
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Inhibition of DHDPS and DHDPR by ,12.tetrahydroisophthalic acid and ,13. 
tetrahydroisophthalic acid 
L~?-Tetrahydroisophthalic acid (100) did not show potent inhibtion ofDHDPS, there 
was 15% inhibition at 5 mM, yet this did not greatly increase with increasing inhibitor 
concentration, there was 13% inhibition at 10 mM, 17% at 20 mM, and 23% at 40 mM. 
L~? -Tetrahydroisophthalic acid (100) did not show potent inhibition of DHDPR, there was 
9% inhibition at 10 mM, and again this did not greatly increase with increasing 
concentration of the analogue, at 20 mM there was 16% inhibition, and at 40 mM there 
was 21 % inhibition. 
113 - Tetrahydroisophthalic acid (99) showed significant inhibition of DHDPS with 
22% inhibition at 5 mM, 38% at 10 mM, and 91 % at 30 mM, giving an IC50 value of 
-1.5 x 10-2 M. 113_ Tetrahydroisophthalic acid (99) showed stronger inhibition of DHDPR 
with 58% inhibition at 5 mM, 66% at 10 mM, and 84% at 30 mM, giving an IC50 value 
of -4 x 10-3 M. Thus, 113 -tetrahydroisophthalic acid (99) shows similar inhibition to 
isophthalic acid, whereas, 112-tetrahydroisophthalic acid (100) shows only slight 
inhibition. 
These results are contrary to what we had originally expected. It was hypothesised 
that 112 -tetrahydroisophthalic acid (100) would be a stronger inhibitor of DHDPS and 
DHDPR than the 113-tetrahydroisophthalic acid (99) as the double bond in the 112 position 
more closely resembles 4-hydroxy-2,3,4,5-tetrahydrodipicolinate (28) (the imine). The 
results obtained, where 113 -tetrahydroisophthalic acid (99) is a stronger inhibitor than 112_ 
tetrahydroisophthalic acid (l00), suggest that significant tautomerism of the imine (28) to 
the enamine (39) (where the double bond is in the 113 position) may occur. Other 
rearrangements, such as dehydration, may also occur, giving rise to a new species 
Alternatively, the alteration of the mimic to exclude a nitrogen atom in the ring sufficiently 
alters binding so as to remove any relationship between the site of the double bond and 
inhibition. 
Summary 
NMR studies performed on the DHDPS enzymatic reaction gave results that were 
consistent with the product being 4-hydroxy-2,3,4,5-tetrahydrodipicolinate (28), rather 
than 2,3-dihydrodipicolinate (18). A variety of cyclic compounds (mainly aromatic) were 
tested as product inhibitors of DHDPS, and substrate inhibitors of DHDPR. Of these the 
best inhibitors of DHDPR were dipicolinic acid (36) and isophthalic acid (41). 
Dipicolinic acid (36) was determined to be a competitive inhibitor of DHDPS with respect 
to the substrate, Kj was in the range of (4.3 - 4.4) x 10-4 M. Similarly isophthalic acid 
(41) was also a competitive inhibitor ofDHDPS with respect to the substrate, Kj was in 
the range of (5.4 - 5.6) x 10-3 M. 
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Isomers of tetrahydroisophthalic acid were then synthesised and tested for inhibition 
of DHDPS and DHDPR 82-Tetrahydroisophthalic acid (100) did not show potent 
inhibition ofDHDPS or DHDPR. However, 8 3-tetrahydroisophthalic acid (99) was a 
moderate inhibitor of DHDPS, ICso was -1.5 x 10-2 M, and a stronger inhibitor of 
DHDPR, ICso was -4 x 10-
3 M. Thus, it is hypothesised that the 4-hydroxy-2,3,4,5-
tetrahydrodipicolinate (28) tautomerises to give the enamine (39). 
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Results and Discussion Conclusion 
Chemically and optically pure (S)-aspartate ~-semialdehyde (11) was synthesised 
from diprotected (S)-allylglycine (52), where the oxidation was performed using a 
Lemieux-Johnson reaction. Both the dap A and dap B genes were over-expressed in E. 
coli. to produce milligram quantities of the corresponding enzymes, DHDPS and DHDPR 
via large growth cultures. These enzymes were purified to high levels for use in kinetic 
studies. 
A coupled assay, using both DHDPS and DHDPR, and following the utilisation of 
NADPH (at 340 nm) by DHDPR, was optimised to run in Mops buffer at pH 7.2, and 
was used for kinetic studies on the two enzymes. Quantitative kinetics of DHDPS were 
obtained when DHDPR was present in excess, and quantitative kinetics of DHDPR were 
obtained when DHDPS was present in excess. DHDPS was found to have a Krn for (S)-
aspartate ~-semialdehyde (11) in the range of (1.0 - 1.1) x 10-4 M with a V max in the range 
of (6.5 -7.2) x 10-1 flmol·s-Img-I, while Krn for pyruvate (17) was in the range of (1.1-
1.3) x 10-4 M and Vrnax was in the range of (4.8 - 5.5) x 10-1 flmol·s-Img-I. Feedback 
inhibition on DHDPS occurred in the presence of moderate to high levels of (S)-lysine 
(12), as expected for bacterial DHDPS enzymes. Inhibition was reversible and 
uncompetitive with respect to (S)-aspartate ~-semialdehyde (11), where K;' was in the 
range of (3.4 - 3.9) x 10-4 M. Inhibition was also reversible and uncompetitive with 
respect to pyruvate (17), with a K;' in the range of (3.1 - 3.8) X 10-4 M. 
DHDPR was determined to have a Km for its substrate in the range of (4.9 - 5.3) x 
10-4 M with a V
max 
in the range of 5.3 - 5.7 flmol·s-Img-I. The Michaelis-Menten 
constant, Km , for NADPH was in the range of (1.5 - 2.0) x 10-5 M and Vmax was in the 
range of 3.6 - 4.1 flmol·s-Img-I. NADH also acts as a cofactor for DHDPR, with a Km 
in the range of (5.0 - 6.6) x 10-6 M and V max in the range of 2.0 - 2.4 flmol·s-Img-I. 
NADH is a better cofactor than NADPH as it has a considerably lower Km' 
Analogues of a possible cyclic lactol structure of (S)-aspartate ~-semialdehyde (1Ic) 
were tested as potential inhibitors of DHDPS. These mimics included homo serine lactone 
(31), (S)-3-aminopyrrolid-2-one (62), and 2-aminocyclopentanone (63). Homoserine 
lactone (31) was found to be a reversible noncompetitive inhibitor of DHDPS with 
respect to both substrates, K; with respect to (S)-aspartate ~-semialdehyde (11) was in the 
range of (1.2 - 2.2) x 10-2 M, and K; with respect to pyruvate (17) was in the range of 
(0.8 - 1.5) x 10-2 M. 2-Aminocyclopentanone (63) also showed reversible non-
competitive inhibition with respect to (S)-aspartate ~-semialdehyde (11), but K; was 
greatly increased to be in the range of (1.2 - 2.4) x 10-1 M. However, (S)-3-amino-
pyrrolid-2-one (62) did not inhibit DHDPS. Since these cyclic molecules do not inhibit 
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DHDPS competitively it is unlikely that the substrate (S)-aspartate p-semialdehyde (11) 
binds to the enzyme in a cyclic form. 
The solution structure of (S)-aspartate p-semialdehyde (11) was determined by 
spectroscopic means, including NMR, and infra-red spectroscopy, to be predominately 
the linear hydrate (llb). No cyclic lactol (11c) was observed at physiological pH and 
only traces of free aldehyde were present, and these could not be derivatised efficiently. 
Analogues of the hydrate form of (S)-aspartate p-semialdehyde (11b) were tested as 
inhibitors ofDHDPS. These included S-methyl-(R)-cysteine (76) and the corresponding 
sulfoxide (77) and sulfone (78), (R)-cysteine sulfinic acid (79), (S)-aspartic acid (9), (S)-
asparagine (80), and (S)-glutamic acid (81). (R)-Cysteine sulfinic acid (79), and (S)-
glutamic acid (81) were reversible uncompetitive inhibitors of DHDPS, where K;' for 
(R)-cysteine sulfinic acid (79) was in the range of (6.1 - 8.6) x 10-3 M, while K/ for (S)-
glutamic acid (81) was in the range of (0.9 - 1.6) x 10-2 M. (S)-Aspartic acid (9) was a 
reversible mixed type inhibitor with a Ki in the range of (0.9 - 1.4) x 10-2 M, and a K/ in 
the range of (2.1 - 3.9) x 10-2 M. It was suggested that these inhibitors may bind to the 
(S)-lysine (12) allosteric site. 
NMR studies were consistent with the hypothesis that the structure of the DHDPS 
enzymatic reaction product is 4-hydroxy-2,3,4,S-tetrahydrodipicolinate (28), rather than 
2,3-dihydrodipicolinate (18). 
A range of cyclic compounds were tested- as product inhibitors of DHDPS, and 
substrate inhibitors of DHDPR. The most potent inhibitors of DHDPR were dipicolinic 
acid (36) and isophthalic acid. Dipicolinic acid (36) was found to be a reversible 
competitive inhibitor of DHDPR with respect to the substrate, with a K; in the range of 
(4.3 - 4.4) x 10-4 M. Isophthalic acid (41) was a slightly weaker inhibitor of DHDPR. 
Inhibition was again reversible and competitive with respect to the substrate, with a Ki in 
the range of (S.4 - S.6) x 10-3 M. ~2-Tetrahydroisophthalic acid (100) was found to give 
only slight inhibition of DHDPS and DHDPR. Whereas, ~3 -tetrahydroisophthalic acid 
(99) was a moderate inhibitor of the two enzymes, ICso (DHDPS) ~ 1.S x 10-2 M, and 
ICso (DHDPR) ~4 x 10-3 M. These different inhibition properties of ~2_ and ~3_ 
tetrahydroisophthalic acid might be indicative of the tautomerism equilibria of enzyme-
bound tetrahydrodipicolinate (19). 
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Experimental 
Equipment and Suppliers 
Chemicals were generally purchased from Aldrich Chemicals, Sigma Chemical Company 
Ltd., or BDH Laboratory Supplies; media for bacterial cultures was purchased from Life 
Technologies Ltd. 
pH measurements were made using a standard meter fitted with a Russell Combination 
(Tris compatible) Electrode type no. TRlCMAW 7111TB. 
Centrifugation was performed in an Eppendorf Centrifuge 5403, on a small scale (.$.1.5 
ml) at up to 15 000 rpm using a 16 F24-11 rotor,· and on a large scale (.$.50 ml) at up to 
5000 rpm using a 16A4-44 rotor, at 4°C. 
Agarose gels were routinely run on a Hoefer Horizontal Submarine Unit using a Bio-Rad 
300 power pack. 
Q-Sepharose and Sephacryl media were purchased from Pharmacia, and Phrumacia 
XK-26 columns were run using Gilson Minipuls M312 peristaltic pumps and a Gilson 
FC-203B fraction collector. 
Polyacrylamide gel electrophoresis (PAGE) were routinely run on a Hoefer Sturdier Slab 
Gel Electrophoresis Unit SE 400, using a Bio-Rad 300 Power Pack. 
Ultra-violet (UV) spectroscopy was performed on a Hewlett Packard 8452A Diode Array 
Spectrophotometer. 
Thin layer chromatography (TLC) was performed on Merck DC-Plastikfolien Kiesegel 60 
F254 20 x 20 cm plastic backed plates, and visualisation was afforded by ultra-violet light 
and/or iodine staining. 
Radial chromatography was performed on a chromatotron (a centrifugally accelerated 
radial thin layer chromatograph) (Harrison Research Inc.) using a 1 mm, 2 mm, or 4 mm 
silica plate, and an elution gradient of 100% petroleum ether (50170) to 100% diethyl 
ether. The plate was washed and reactivated with methanol. Visualisation of non-
coloured compounds was achieved using an ultra-violet lamp. 
Melting points (mp) less than 200°C were recorded on a Reichert Hotstage microscope 
and ru'e uncorrected. Melting points greater than 200 °C were measured using an 
Electrothermal melting point apparatus and are uncorrected. 
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Nuclear magnetic resonances (NMR) CH: 300 MHz and 13C: 75 MHz) were performed 
on a Varian Unity 300 instrument, or on a Varian XL 300 instument, and peaks are 
quoted in ppm. Multiplicities are denoted as singlet (s), broad singlet (bs), doublet (d), 
broad doublet (bd), triplet (t), quartet (q), quintet (qu), doublet of doublets (dd), doublet 
of triplets (dt), or multiplet (m). For IH NMR the spectra were referenced to tetramethyl-
silane (TMS), if run in deuterated chloroform (CDCI3). For samples run in deuterium 
oxide (D20) the spectra was referenced to the residual protonated solvent at 4.70 ppm, 
and for samples run in deuterated methanol (CD30D) the spectra was referenced to the 
residual protonated solvent at 3.30 ppm. For 13C NMRrun in deuterated chloroform 
(CDCI3) the spectra was referenced to the residual protonated solvent at 77.0 ppm, and 
for samples run in deuterated methanol (CD30D) the spectra was referenced to the 
residual protonated solvent at 49.3 ppm. 
Infra-red (IR) spectroscopy was performed on a Perkin Elmer 1600 FTIR Spectro-
photometer or on a Shimadzu FTIR-8201 PC Spectrophotometer. Maxima are recorded 
in wave numbers (cm-I) and denoted weak (w), medium (m), or strong (s). 
Mass spectroscopy (MS), electron ionisation (EI), chemical ionisation (CI), and fast atom 
bombardment (FAB)--using glycerol (gly), nitrobenzyl alcohol (NOBA), or thioglycerol 
(thio), were recorded on a Kratos MS80RFA magnetic sector double focussing mass 
spectrometer operating a 4 kV accelerating voltage. Where possible the high resolution 
mass of the parent ion is compared with the expected calculated value. The relative 
intensities of the fragment ions are quoted as a percentage. 
Optical rotation dispersion (ORD) spectroscopy were recorded using a Jasco J-2OC 
Recording Spectropolarimeter. [a]Dt is the specific rotation at t °C as measured at the 
sodium D line (589.3 nm), and the concentration is given in gllOO mI. 
Solvents were purified by routine means: 
Dichloromethane was dried over calcium chloride. 
Diethyl ether was distilled from concentrated sulfuric acid (50 mB- I ), and stored over 
sodium wire. For dry diethyl ether, the solvent was distilled from sodium in the presence 
of benzophenone, immediately prior to use. 
Ethanol (dry) was distilled from magnesium ethoxide immediately prior to use. 
Methanol (dry) was distilled from magnesium methoxide immediately prior to use. 
Petroleum ether (50170) was distilled from phosphorous pentoxide. 
Tetrahydrofuran was distilled from sodium in the presence of benzophenone. 
Toluene was dried over calcium chloride, and stored over sodium wire. 
Moisture sensitive reactions were performed under dry nitrogen. 
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Experimental Part I 
The Production of Required Enzymes and Enzyme Substrates 
Part A Synthesis of (S)-Aspartate f3-Semialdehyde 
Diethyl allylacetamidomalonate (46) (diethyl 2-ethanamido-2-(2-propenyl)-
propanedioate )1,2 
Sodium ethoxide was prepared by adding sodium wire (0.66g, 28.7 mrnol) to 
freshly distilled dry ethanol (20 m1), and allowing it to react under a calcium chloride 
drying tube. Diethyl acetamidomalonate (45) (4.126 g, 18.9 mrnol) was added to the 
solution of sodium ethoxide, followed by freshly distilled allyl bromide (l-bromo-2-
propene) (2.46 ml, 3.43 g, 28.4 mrnol). The solution was then heated under reflux on an 
oil bath (bath temperature 122°C) for 18 hours after which time no starting material 
remained (TLC (diethyl ether) Rf O.35 (starting material), 0.51 (product), visualised by 
iodine). The reaction mixture was cooled to room temperature, and the solvent removed 
in vacuo. The resulting residue was resuspended in distilled water (10 m1), forming a 
heterogeneous mixture. The mixture was extracted with chloroform (3 x 10 ml), the 
combined organic layers were dried over magnesium sulfate, and the solvent removed in 
vacuo to yield the diethyl allylacetarnidomalonate (46) as a yellow oil which crystallised 
on standing overnight. A small sample was recrystallised from benzene to yield a white 
solid. 
The yield of diethyl allylacetamidomalonate (46) was 3.60g (14.0 mrnol, 74.1 %). 
Mp 44 - 46 DC, literature 46 0c.2 
IH NMR (300 MHz, CDCI3) OH 1.26 (6H, t, -J = 7.4 Hz, 2 x -CH2CH3), 2.04 (3H, s, 
-NHCOCH3), 3.08 (2H, d, J = 7.4 Hz, -CH2CH=CH2), 4.25 (4H, q, J = 7.4 Hz, 2 x 
-CH2CH3), 5.09 - 5.16 (2H, m, -CH=CHz), 5.51 - 5.65 (1H, m, -CH=CH2), 6.77 
(IH, bs, -NH-) ppm. 
IR (KEr disc) 'Umax 3417 (N-H (m», 2985 (C-H (w», 1738 (C=O (s», 1680 (C=O (s», 
1500 (s), 1308 (m), 1232 (m) cm- I . 
MS rnJz (El) 257 (M+, 48%),198 (MH-2(CllzcH3t"55%), 184 (M-C02CH2CH3+, 
69%), 174 (92%),142 (100%), 68 (53%),43 (CH3CO+, 98%). 
N-Acetyl allylglycine ethyl ester (47) (ethyl 2-ethanamido-4-pentenoate) 
Sodium ethoxide was prepared by adding sodium wire (1.34 g, 58.3 mrnol) to 
freshly distilled dry ethanol (30 m1), and allowing it to react under a calcium chloride 
drying tube. Diethyl acetamidomalonate (45) (12.7 g, 58.3 mrnol) was added to the 
solution of sodium ethoxide, followed by freshly distilled allyl bromide (l-bromo-2-
propene) (6.3 mI, 61 mrnol). The solution was heated under reflux for 19 hours on an oil 
bath (bath temperature 120°C). The solvent was removed in vacuo after the reaction was 
cooled to room temperature, and the resulting mixture was resuspended in distilled water 
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(25 ml). The mixture was extracted with chloroform (3 x 25 ml) and dried over 
magnesium sulfate. The solvent was removed in vacuo to yield a yellow oil which was 
analysed by IH NMR and shown to contain starting material. The material was 
redissolved in ethanol (30 ml), and sodium (0.35 g, 15.2 mmol) was added followed by 
allyl bromide (1.6 ml, 15.5 mmol). The reaction mixture was heated under reflux for a 
further 18 hours whereupon a deep red colour formed. The solvent was removed in 
vacuo to give a red oil, this was resuspended in distilled water (30 ml), acidified (pH <4) 
with glacial acetic acid (0.5 ml), and extracted with chloroform (3 x 30 ml). The 
combined organic layers were dried over magnesium sulfate, and the solvent again 
removed in vacuo to yield N-acetyl allylglycine ethyl ester (47) as a red oil. 
The yield of N-acetyl allylglycine ethyl ester (47) was 7.30 g (39 mmol, 66.9%). 
TLC (diethyl ether) Rf O.26, visualised by iodine. 
lH NMR (300 MHz, CDCI3) OR 1.22 (3H, t, J = 7.3 Hz, -CH2CH3), 1.96 (3H, s, 
-NHCOCH3), 2.41 - 2.53 (2H, m, -CH2CH=CH2), 4.10 - 4.18 (2H, m, -OCH2CH3), 
4.60 - 4.64 (1H, m, -NHCHCOOCH2CH3), 5.02 - 5.08 (2H, m, -CH=CH2), 5.54 -
5.66 (lH, m, -CH=CH2), 6.13 (lH, bs, -NH-) ppm. 
IR (CHCI3 solution) u max 3433 (N-H (w)), 3034 (C-H (m)), 1734 (C=O (s)), 1676 (C=O 
(s)), 1509(s), 1377 (w), 1236 (m), 1196 (w) cm-I. 
MS mJz (E.!.) 185 (M+, 40%), 144 (M-CH2CH=CH/, 75%), 112 (M-C02CH2CH3+, 
75%), 102 (H2NCHC02CH2CH/, 85%), 70 (H3CCONHC+, 85%), 43 (CH3CO, 
100%). 
N-Acetyl allylglycine (48) (2-ethanamido-4-pentenoic acid)1,3 
Diethyl allylacetamidomalonate (46) (31.2g, 122 mmol), was dissolved water and 
ethanol (1:1) (210 ml). Sodium hydroxide (4.90 g, 122 mmol) was added and the 
reaction was heated under reflux for 72 hours. The disappearance of starting material 
was monitored by TLC. The reaction had not gone to completion. A 1.0 ml aliquot was 
removed, the solvent was removed in vacuo, the residue was washed with ethyl acetate, 
and the aqueous layer acidified with concentrated hydrochloric acid to pH 1 before being 
extracted into ethyl acetate. The organic layer was dried over magnesium sulfate and the 
solvent removed in vacuo. The residue was analysed by lH NMR (300 MHz, D 20) 
showing the reaction had gone to 90% conversion. Sodium hydroxide (2.45 g, 61.2 
mmol) was added and the reaction was heated under reflux for a further 18 hours. The 
reaction was cooled and concentrated in vacuo to 105 ml, then washed with ethyl acetate 
(2 x 140 ml) to remove any remaining starting material. The aqueous layer was acidified 
to pH 1 with concentrated hydrochloric acid. The product was extracted into ethyl acetate 
(3 x 140 ml), dried with magnesium sulfate, and the solvent removed in vacuo. 
Recrystallisation in hot propanone yielded the N-acetyl allylglycine (48) as pure clear 
chunky crystals. 
The yield of N-acetyl allyl glycine (48) was 10.8 g (67.8 mmol, 55.4%). 
Mp 116 - 118 DC ( literature 118 DCI). 
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IH NMR (300 MHz, D20) OH 1.90 (3H, s, -NHCOCH3), 2.32 - 2.54 (2H, m, 
-CH2CH=CH2), 4.28 - 4.32 (1H, m, -NHCHCOOH), 5.01 -5.10 (2H, m, -CH=CH2), 
5.60 - 5.74 (IH, m, -CH=CH2 ) ppm. 
IR (KBr disc) umax 3341 (N-H (s», 2934 (C-H (w», 2454 (b), 1928 (b), 1722 (HOC=O 
(s», 1541 (HNC=O (s», 1231 (m) cm-I. 
MS rn/z (El) 139 (55%), 116 (M-CH2CH=CH/, 62%),74 (H2NCHC02H+, 77%), 70 
(H3CCONHC+, 72%), 43 (CH3CO+, 100%). 
(S)-Allylglycine (49) ((S)-2-amino-4-pentenoic acid)l,4 
N-Acetyl allylglycine (48) (10.21 g, 62.12 mmol) was placed in a conical flask and 
dissolved in water (300 ml), the solution was then brought to pH 7.5 by the addition of 
1 M NH3 (aq). Porcine kidney acylase EC 3.5.1.14 (-16 mg, -2.3 x 104 units) was then 
added, and the reaction incubated at 37 DC, with shaking at 180 rpm, for 20 hours. The 
reaction was monitored by removing 1.0 ml aliquots from the reaction, removing the 
solvent in vacuo and then analysing the residue by IH NMR (300 MHz, D20). When 
50% of the starting material remained, the enzyme was denatured by heating the solution 
under reflux, and then removed by filtration. The filtrate was acidified with concentrated 
hydrochloric acid and then washed with ethyl acetate (3 x 150 ml). The aqueous layer 
was evaporated in vacuo to yield a yellow-white solid which was purified by ion 
exchange chromatography (Dowex 50W-X8(H) 16 - 40 mesh cation exchanger). The 
Dowex column was acidified with 2 M hydrochloric acid and then washed with distilled 
water until the elutant was neutral, before loading the material on to the column. (R)-N-
Acetyl allylglycine (48) was eluted first with water. (S)-Allylglycine (49) was eluted 
with 1 M NHiaq), the solvent was then removed in vacuo to yield the titled product as a 
white semi-crystalline solid. 
The yield of (S)-allylglycine (49) was 2.66 g (23.1 mmol, 36.0%). 
Mp (decomposition) 210 DC (literature 180 DC,I 251 - 253 DC5). 
IH NMR (300 MHz, D20) OH 2.44-2.59 (2H, m, -CH2CH=CH2), 3.68-3.72 (1H, m, 
-CHCH2CH= CH2), 5.14-5.20 (2H, m, -CH=CH2), 5.60-5.74 (1H, m, -CH=CH2) 
ppm. 
lR (KBr disc) u
max 3433 (N-H (w», 2934 (C-H (s», 1587 (C=O, (s», 1513 (s), 1405 
(s) cm- I . 
MS rn/z (Cl (C4H lO» 116 (MH+, 100%),74 (M-CH2CH=CH2+, 80%), 70 (M-C02H+, 
67%). 
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Potassium (S)-N-tert-butoxycarbonylallylglycine (50) (potassium (S)-N-tert-
butoxycarbony 1-2-amino-4-pentenoate)6 
To a solution of (S)-allylglycine (49) (602 mg, 5.23 mmol) in water (15.0 rnl) was 
added dioxane (7.2 rnl), KHC03 (575 mg, 5.75 mmol) and di-tert-butyl pyrocarbonate 
(1.14 g, 5.23 mmol) with continuous stirring at room temperature for 20 hours. The 
solvents were removed by azeotroping with ethanol (-50 rnl) in vacuo, yielding a white 
oily solid. The solid was washed with methanol (-10 rnl) which was then removed in 
vacuo to yield the product as a white powdery solid. 
The yield of the potassium (S)-N-tert-butoxycarbonylallylglycine (50) was 1.36 g (5.38 
mmol, quantitative). 
Mp >230 DC. 
IH NMR (300 MHz, D20) 8H 1.35 (9H, s, 3 x -CH3), 2.31-2.41 (2H, m, 
-CH2CH=CH2), 3.91 (lH, m, -CHCH2CH=CH2), 5.04 - 5.23 (2H, m, =CH), 5.66 -
5.75 (1H, m, -CH=CH2) ppm. 
IR (KEr disc) 'U
max 3416 (C-H (s)), 1686 (w), 1618 (C=O (s)), 1384 (C-O (s)), 1173 (m) 
cm- I • 
MS mlz (FAB(thio)) 292 (MK/, 5%), 255 (MHK+, 10%), 185 (12%), 147 (100%). 
p-Methoxybenzyl chloride (51)7 
p-Methoxybenzyl alcohol (54) (55.0 rnl, 60.9 g, 0.441 mol) in dry diethyl ether (250 
ml) was saturated with dry hydrogen chloride gas at 0 DC for 5.5 hours. The reaction 
vessel was then stoppered and stored at -20 DC for 40 hours. Removal of the excess 
hydrogen chloride was afforded by distillatiori over a water bath at 32 - 38 DC at 
atmospheric pressure. The residual p-methoxybenzyl chloride was distilled under 
reduced pressure, bp 94 - 98 DC (-1.5 mm Hg), to give a clear liquid. The product was 
then stored at -20 DC, stabilised with potassium carbonate. 
The yield of p-methoxybenzyl chloride (51) was 45.0 ml (51.9 g, 0.332 mol, 75.3%). 
Bp 94 - 98 DC (-1.5 mm Hg). 
IH NMR 8H (300 MHz, CDC13) 3.76 (3H, s, -OCH3), 4.53 (2H, s, -CH2Cl), 6.85 (2H, 
d, J = 8.8 Hz, aryl), 7.28 (2H, d, J = 8.8 Hz, aryl) ppm. 
lR (thin film) 'U
max 
2959 (C-H (w)), 2836 (w), 1611 (C=C aryl, (s)), 1514 (C=C aryl, 
(s)), 1304 (m), 1249 (C-O (s)), 1176 (m), 1033 (m) cm-I. 
MS rn/z (El) 156 (M+, 28%), 121 (M-Cl+, 100%),77 (Ph+, 10%). 
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(8)-N-tert-Butoxycarbonylallylglycine p-methoxybenzyl ester (52) 
(4-methoxybenzy I (S)-N-tert-butoxycarbony 1-2-amino-4-pentenoate)6 
To a solution of potassium (S)-N-tert-butoxycarbonylallylglycine (50) (0.504 g, 
1.99 mmol) in DMF (3.5 ml) was added p-methoxybenzyl chloride (51) (0.331 ml, 2,44 
mmol). The mixture was stirred continuously for 48 hours. The solvent was then 
removed by azeotroping with xylene in vacuo. The crude product was analysed by TLC 
«diethyl ether and pet ether (1: 1» Rf 0.15,0.34 (product), 0.68). The crude product was 
purified by radial chromatography (4 mm silica plate). The (S)-N-tert-butoxycarbonyl-
allylglycine p-methoxybenzyl ester (52) was obtained as a brown oil. 
The yield of (S)-N-tert-butoxycarbonylallylglycine p-methoxybenzyl ester (52) was 408 
mg (1.22 mmol, 61.3%). 
IH NMR (300MHz, CDCI3) bH 1.44 (9H, s, 3 x -CH3), 2,46 - 2.50 (2H, m, 
-CH2CH=CHz)' 3.82 (3H, s, -OCH3), 4.38 4,42 (lH, m, -CHCHzCH=CH2), 5.05 -
5.17 (5H, m, =CH2, -CH2 aryl, -NH-), 5.60 - 5.69 (lH, m, -CH=CHz)' 6.87 - 6.91 
and 7.26 7.31 (4H, m, aryl) ppm. 
IR (CDCI3) urnax 3439 (N-H (s», 2982 (C-H (m», 1710 (C=O (s», 1614 (m), 1515 (s), 
1249 (m), 1174 (m) cm-I. 
MS rnIz (EI) 335 (M+, 10%),279 (M-tBu+, 54%), 121 (CH30C6H4CH/, 100%), 70 
(82%). 
(8 )-N-tert-Butoxycarbonylaspartate ~-semialdehyde p-methoxybenzyl 
ester (53) (4-methoxybenzyl (S )-N-tert-butoxycarbonyl-2-amino-4-oxobutanoate)I 
(S)-N-tert-Butoxycarbonylallylglycine p-inethoxybenzyl ester (52) (105 mg, 0:313 
mmol) was dissolved in water and dioxan (3:1) (9.0 ml). A catalytic amount of osmium 
tetroxide (OS04) « 1 mg) was added to this mixture. The mixture was stirred at room 
temperature for 30 minutes during which time a blue-black colour appeared. Sodium 
periodate (NaI04) (0.250 g, 1.17 mmol) was then added slowly over 30 minutes. The 
reaction was then stirred for 16 hours. The mixture was partitioned between ethyl acetate 
(7 ml) and water (7 ml). The organic layer was washed with water (2 x 7 ml), then 
evaporated in vacuo to yield a yellow black oil (TLC (diethyl ether and pet ether (3: 1» 
Rf O.76 (starting material), 0.53, 0,40 (product). The yellow-black product was 
dissolved in diethyl ether and passed\hrough a silica plug to remove any last traces of 
osmium tetroxide The product was purified by ramal chromatography (4 mm silica 
plate). The solvent was removed in vacuo to yield the (S)-N-tert-butoxycarbonylaspartate 
~-semialdehyde p-methoxybenzyl ester (53) as a clear oil. 
The yield of (S)-N-tert-butoxycarbonylaspartate ~-semialdehyde p-methoxybenzyl ester 
(53) was 79.8 mg (0.237 mmol, 75.7%). 
lH NMR (300 MHz, CDC13) bH 1.42 (9H, s, 3 x -CH3), 3.02 - 3.06 (2H, m, 
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-CH2-CHO), 3.81 (3H, s, -OCH3), 4.57 - 4.63 (lH, m, -CHCH2CHO), 5.11 (2H, s, 
-CH2 aryl), 5.42 (IH, bd, -NH-), 6.89 and 7.26 (4H, m, almost A2B2, aryl), 9.71 (lH, 
s, -CHO) ppm. 
IR (CDCI3) 'Umax 3436 (N-H (w», 2981 (C-H (w», 1715 (C=O (s», 1516 (s), 1501 (m), 
1250 (s), 1174 (s) em-I. 
MS mlz (EI) 337 (M+, 10%),281 (27%),202 (32%),137 (CH30PhCH20+, 65%), 121 
(CH30PhCH/, 100%),72 (70%). 
(S)-Aspartate ~-semialdehyde hydrate trifluoroacetate (lIb) «(S)-2-amino-4-
oxobutanoate )6 
(S)-N-tert-butoxycarbonylaspartate ~-semialdehyde p-methoxybenzyl ester (53) 
(72.0 mg, 0.214 mmol) was dissolved in dry dichloromethane (1.5 ml). The reaction 
was stined under nitrogen and trifluoroacetic acid (1.5 ml) was added via a syringe. The 
reaction was stirred for two hours, going a deep red colour. The solvent was then 
removed in vacuo to give a brown oily residue, which was partitioned between water (7.0 
ml) and ethyl acetate (3 x 7.0 ml). The aqueous layer was then concentrated to yield the 
(S)-aspartate ~-semialdehyde hydrate trifluoroacetate(11b) as a pale yellow oil. 
The yield of (S)-aspartate ~-semia1dehyde hydrate trifluoroacetate (lIb) was 47.2 mg 
(0.190 mmol, 89.6%). 
IH NMR (300 MHz D20) OR 1.97 - 2.21 (2H, m, -CH2CHNH2), 4.01 -4.05 (lH, m, 
-CHNHJ, 5.21 (JH, t, J = 5.9 Hz, -CH(OH)2) ppm. 
13C NMR (75 MHz DzO) Oc 36.2 (-CH2CHNH2), 49.7 (-CHNH2), 87.7 (-CH(OH)2)' 
118.0 (-CCF3), 162 (-CCF3), 171.2 (-C=O): 
HMBc8 OR ca. 2.1 coupling to Oc 49.7, 87.7, and 171.2; OR ca. 4.0 coupling to Oc 36.2, 
87.7, and 171.2; OR ca. 5.2 coupling to Oc 36.2, and 49.7. 
[aJ D23 = + 3.170 (c = 1.5, H20). 
IR (KBr disc) 'Umax 3414 (O-H (s», 1678 (C=O (s», 1522 (w), 1437 (m), 1201 (s), 1143 
(s) em-I. 
MS mlz (FAB (gly» 136 (M+, 15%), 118 (28%), 93 (100%),77 (Ph+,75%). 
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Part B Production of the DHDPS and DHDPR enzymes 
A. Standard Microbiology and Molecular Biology Methods 
Main sources 
J.I-1. Miller 'A short course in bacterial genetics: a lab manual and handbookfor E. coli 
and related bacteria' Cold Spring Harbor, New York (1992). 
F.M. Ausubel (Ed.) 'Short Protocols in Molecular Biology' Wiley Interscience, New 
York (1989). 
T. Maniatis, E.F. Fritsch., 1. Sambrook 'Molecular Cloning: A Laboratory Manual' 2nd 
ed., Cold Spring Harbor, N. Y. (1990). 
G.D. Fasman 'CRC Practical Handbook of Biochemistry and Molecular Biology' CRC 
Press, Florida (1989). 
Bacterial cultures 
All E. coli cultures were grown under sterile conditions. All media and equipment 
were either autoclaved at 121 DC for 20 minutes, filtered through a 0.2 micron acrodisc 
(Gellman Sciences), or purchased sterile. Solutions were made up in sterile deionised 
water. During the transfer of cultures all equipment was flamed, and manipUlations were 
carried out in a laminar flow hood. Each experiment was accompanied by an appropriate 
control to monitor for contamination. 
Media 
(Plus 15g select agar for plates, pH 7.0.) 
Luria-Bertani medium (LB broth) 
Per litre of medium: 
Bactotryptone (casein hydrolysate) 109 
Yeast extract 5 g 
Sodium chloride (NaCl) 10 g 
adjusted to pH 7.0 with 5 M NaOH (optional), autoclaved 20 minutes at 121 DC. 
Antibiotics 
Stock solutions (1000 x) of antibiotics were stored at -20°C, The following 
concentrations were used for selection: 
Ampicillin 
Tetracycline 
Added through an acrodisc to sterile media at <48°C, 
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E. coli XLI-Blue 
E. coli XLI-Blue can be obtained from Stratgene; it was a kind gift from Jane 
Lancaster (Crop and Food Research Ltd, Christchurch, New Zealand), and was selected 
and maintained on tetracycline plates. 
Preparation of glycerol freezes 
1.0 ml of an overnight culture was added to 0.25 rnl of sterile 80% glycerol (propan-
1,2,3,-uiol) in deionised water in a screw top eppendorf. The tube was gently vortexed 
before being frozen in liquid nitrogen (-196°C) for long term storage. 
Plate preparation 
Plates were poured, in a laminar flow hood and/or in close proximity to a flame, at 
~50 DC, directly into sterile petri dishes. 30 - 35 rnl of media per plate was adequate for 
overnight growth on LB media. Any bubbles were removed by quickly flaming the 
smface before the agar had hardened. The plates were allowed to set overnight before 
use. The plates could be stored for several weeks if sealed with parafilm and kept at 
4 DC. 
Incubation of colonies 
Agar plates were streaked with E. coli XL-I Blue (from a glycerol freeze, an 
overnight culture, or a single colony on an agar plate) using a flamed sterilised nichrome 
wire; the concentration was successively decreased across the plate to allow for selection 
of single colonies. The plates were incubated, inverted, overnight at 37°C, Individual 
colonies were selected out with a wire loop, or wire stab, and used to innoculate 5ml of 
liquid medium. These starter cultures were grown overnight in a shaker incubator 
(37°C, 180 rpm) and subsequently used to innoculate larger quantities of media. 
Single colonies remained viable on an agar plate for approximately three to four 
weeks if stored at 4°C, with the plate sealed with parafilm. The bacteria were restreaked 
if the plate had been stored for more than two days. 
Transformation by the calcium chloride method 
Day one: 
0.2 ml of overnight culture was grown in 10 mi ofLB broth (37°C, 310 rpm) for two 
hours. 
The cells were chilled on ice, then centrifuged (8000 rpm, 5 minutes), and the supernatant 
was decanted off. 
Experimental 146 
The pellet was resuspended in 5 m! of 10 mM NaCI and chilled on ice for 20 minutes 
before recentrifuging (8000 rpm, 5 minutes). 
The pellet was resuspended in 2.5 m1 of 100 mM CaC12 and chilled on ice for 20 minutes 
before recentrifuging (8000 rpm, 5 minutes). 
The pellet was finally resuspended in 0.6 ml of 100 mM CaC12 and chilled on ice for 30 
minutes to give competent cells. 
Day two: 
2 ).11 of plasmid DNA and 0.1 m1 of competent cells, prepared earlier, were added to an 
eppendorf and incubated on ice for 30 minutes then heat shocked for 2 minutes at 42°C, 
and chilled on ice for a further 2 minutes. 
The cells were then transferred to a flask containing 5 m1 of LB broth and incubated 
(37°C, 250 rpm) for 2 hours. 
0.2 rn1 of the cells was plated out on the appropriate antibiotic plate, while 3 ml was 
centrifuged (8000 rpm, 5 minutes) and the pellet spread on an appropriate antibiotic plate. 
Standard plasmid preparation by alkaline lysis 
(Derived from Birnboim and Doily) 
Solution I (4°C) 50 mM Glucose 
lOmMEDTApH8.0· 
25 mM Tris.HCI pH 8.0 
Solution II (R.T.) 
Solution ill (4°C) 
TE buffer 
0.2mMNaOH 
1% SDS 
3 M Sodium acetate pH 4.8 
10 mM Tris.HCI pH 8.0 
1 mMEDTA 
A single bacterial colony was used to innoculate 5 ml of LB broth containing appropriate 
antibiotics and incubated overnight (37°C, 180 rpm). 
1.5 rn1 of culture was then transferred to an eppendotf and centrifuged (760 rpm, 
2 minutes). 
The supernatant was removed by aspiration and the pellet resuspended in 100).11 of ice 
cold solution I and chilled on ice for 10 minutes. 
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200 III of freshly prepared solution II was added slowly and mixed by gentle rotation, 
and chilled on ice for 5 minutes. 
150 III of ice-cold solution III was added and gently mixed until the viscosity decreased 
and a white precipitate formed; this mixture was chilled on ice for 20 minutes. 
The tube was centrifuged (12000 rpm, 5 minutes), the supernatant was decanted off and 
strained into a fresh tube. 
250 III of isopropyl alcohol was added to the supernatant, mixed and stored on ice for 20 
minutes. 
The tube was centrifuged (12 000 rpm, 5 minutes) and then the supernatant was carefully 
removed. 
The pellet was rinsed with 1 ml of ethanol at 4°C, centrifuged (12 000 rpm, 1 minute), 
and the supernatant aspirated out. 
The pellet was dissolved in 200 III of 0.3 M sodium acetate and vortexed briefly. 
400 III of 100% ethanol (ice-cold) was added and mixed, and the solution stored on ice 
for 10 minutes. 
The tube was then centrifuged (12 000 rpm, Sminutes), and supernatant was aspirated 
out. 
The pellet was dried in a vacuum dessicator for 5 minutes, and then dissolved in 20 III of 
buffer by vortexing briefly. 
Restriction digests 
1 % Agarose gel 0.3 g Agarose 
30 ml T AE buffer 
TAB buffer 0.80 mM Tris.HCI pH 8.0 
0.40 mM Glacial acetic acid 
0.02mMEDTA 
Loading dye 30% Glycerol 
0.25% Bromophenol blue 
0.25% Xylene cyanol 
RNAse was added to a final concentration of 10 mgml-1. 
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Restriction digests were typically performed in 15 III volumes. 1.5 III of the 
manufacturer's lOx restriction enzyme buffer was used and digests were incubated at the 
appropriate temperature for one to four hours. 
For example: Double digest of pJG001 with BamH I and Xho I 
10 III dH20 
2.0 III DNA solution from standard plasmid preparation 
1.5 III React 3 Buffer 
1.0 III Xho I 
0.5 U1BamHI 
15 III Total 
Incubated four hours 37°C 
1.0 III Loading buffer was added and mixed immediately prior to the 
running of the DNA gel. 
Agarose gel electrophoresis 
Restriction fragments were mapped on a 1 % (w/v) agarose gel against a one kb 
ladder. 30 ml of boiling 1 % agarose gel was cooled to ~50 DC and poured into a gel 
casting tray and the well comb inserted. The gel was allowed to set completely (about 30 
minutes) before the comb was removed. The casting tray was then transferred into a gel 
tank containing electrophoresis TAE buffer. The gel was loaded with DNA samples (15 
Ill) mixed with loading dye (1 Ill) containing DNA free RNAse. A DNA ladder was also 
loaded; 5 III of the one kb ladder (Bio Rad; 4072, 3054, 2036, 1636, 1018). The gel was 
run at 60 V for two to three hours until the bromophenol blue band was nearing the end 
of the gel. The gel was stained with ethidium'bromide (0.5 mgml- l ), and the DNA 
fragments were visualised on a UV transiluminator with a wavelength of 302 nm. The 
gel was then photographed under UV light. 
B. Overexpression of the dap A gene 
Transformation of pJGOOl into E. coli XL·l Blue 
E. coli XL-I Blue were transformed with pJGOOl (derived from pBluescript by 
Grerrard l ). Successful transform ants were identified by conferred ampicillin resistance. 
Restriction digest of pJGOOl 
Plasmid preparation was carried out by the alkaline lysis method. Successful 
isolation of pJGOOl was confirmed by restriction mapping: 4100 bp (Xho I), 4100 bp 
(BamH I), 3000 and 1100 bp (Xho I and BamH I double digest), and 3000 and 1100 bp 
(EcoR I and Hind III double digest). 
C. Overexpression of the dap B gene 
Transformation of pJKOOl into E.coli XL-l Blue 
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E. coli XL-I Blue were transformed with pJKOOl (derived from pBluescript by 
Kraunsoe9). Successful transformants were identified by conferred ampicillin resistance. 
Restriction digest of pJKOOl 
Plasmid preparation was carried out by the alkaline lysis method. Successful 
isolation of pJKOOl was confirmed by restricion mapping: 3000 and 2300 bp (Xho I and 
BamH I double digest). 
D. Biochemistry standard methods 
Main Sources 
RK. Scopes 'Protein Purification. Principles and Practice' 3rd ed., Springer Verlag, 
New York (1994). 
E.L. Harris, S. Angal (Eds) 'Protein Purification. A practical approach' IRL Press, 
Oxford (1989). 
T.E. Creighton (Ed.) 'Protein Function. A practical approach' IRL Press, Oxford 
(1989). 
G.D. Fasman 'CRC Practical Handbook of Biochemistry and Molecular Biology' CRC 
Press, Florida (1989). 
Ion exchange 
Pharmacia Product Information: 'Ion Exchange. Principles and Methods' 3rd ed., 
Pharmacia LKB Biotechnology, Sweden (1991). 
Gel Filtration 
Pharmacia Product Information: 'Gel Filtration. Principles and Methods' 5th ed., 
Pharmacia LKB Biotechnology, Sweden (1991). 
Polyacrylamide Gel Electrophoresis (PAGE) 
U.K. Laemmli Nature 227,680 (1970). 
Product information Hoefer Scientific Sturdier Slab Gel Electrophoresis Unit. 
B.D. Hames, D. Rickwood (Eds) 'Gel electrophoresis of proteins. Apractical 
approach' IRL Press, London (1981). 
Ultrafiltra tion 
Lida Ultrafiltration Product Information. 
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Preparation of Bradford ReagentI° 
Coomassie Brilliant Blue (100 mg) was dissolved in 95% (v/v) ethanol (50 ml) with 
vigorous agitation, then mixed with 85% (w/v) phosphoric acid (100 rnI). The mixture 
was diluted to 1 litre with distilled water and filtered to remove the undissolved dye. The 
solution was stable at room temperature for several weeks. Each batch of Bradford 
reagent was calibrated against a series of Bovine Serum Albumin (BSA) standards of 
known concentration. A range of protein concentrations from 0.2 - 2.0 mgml-1 was 
assayed and plotted on a graph to produce a calibration curve. Each measurement was 
peliormed in duplicate. 
Standard Bradford assayll,12 
The protein solution (0.05 ml) was added to the Bradford reagent (2.50 rnI) and 
mixed thoroughly. The solution was allowed to stand for exactly 10 minutes, before the 
absorbance was measured at 595 nm against a blank solution (sample buffer (0.05 rnI) 
and Bradford reagent (2.5 ml)). Protein concentrations were obtained from the 
calibration curve; however, since individual proteins interact with Coomassie Brillant 
Blue dye in a slightly different manner according to the amino acid compostion, only 
approximate protein concentrations were obtained. 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
Stock solutions 
Monomer solution 
Resolving gel buffer 
Stacking gel buffer 
Electrophoresis tank buffer 
30% (w/v) Acrylamide 
2.7% (w/v) Bis-acrylamide 
Stored ih a dark container at 4 DC 
1.5 M Tris.HCI pH 8.8 
0.5 M Tris.HCI pH 6.8 
0.125 M Tris.HCI pH 6.8 
200 mM Glycine 
4%SDS 
1 % Coomassie Brilliant Blue Stain 1% (w/v) Coomassie Brilliant Blue G 250 
Stirred vigorously and filtered 
Coomassie Brilliant Blue Stain 0.125% 1 % Stain stock 
50% Methanol 
10% Glacial acetic acid 
Destain I 50% Methanol 
10% Glacial acetic acid 
Destain II 5% Methanol 
7% Acetic acid 
12.5 % Resolving gel 
Acrylamide monomer 
Resolving gel buffer 
Distilled water 
12.5 ml 
7.5 ml 
9.5 ml 
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Degassed by swirling for 15 minutes under a water pump at room temperature 
10% SDS 300 ~LI 
10% Ammonium persulfate 100 J..lI 
TEMED (tetramethylethylenediamine) 25 ~l 
The acrylamide mixture was poured into the assembled slab gel plates which had 
been cleaned and dried thoroughly. Any air bubbles were removed by a heated nichrome 
wire. The surface of the gel was carefully overlayed with n-butanol to prevent drying 
out. The gel was allowed to set overnight. 
4 % Stacking gel 
Acrylamide monomer 
Stacking gel bufer 
Distilled water 
1.33 ml 
2.5 ml 
6.1 ml 
Degassed by swirling for 15 minutes under a water pump at room temperature 
10% SDS 100 ~l 
10% Ammonium persulfate 50 ~LI 
TEMED (tetramethylethylenediamine) 5 ~l 
n-Butanol was poured off the gel, and the' stacking gel was then poured on. The gel 
comb was inserted on an angle to prevent the introduction of any air bubbles. The gel 
was allowed to set for about two hours before removing the comb, where it was then 
used immediately. 
Running the gel 
Samples were diluted to an approximate concentration (to allow the loading of 
-20 ~g of total protein) with TE buffer and then mixed with an equal volume of 2 x 
treatment buffer. 
TE buffer 10 mM Tris.HCI pH 8.0 
1mMEDTA 
2 x Treatment buffer 0.125 M Tris.HCI pH 8.6 
4%SDS 
20% Glycerol 
10% 2-Mercaptoethanol 
0.25% Bromophenol blue 
Stored at -20 DC 
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The samples were centrifuged briefly and boiled for -3 minutes before loading into 
the wells of the gel using a duckbill tip. A marker was also added, either 67, 60, 53, 46, 
40, 34, 27, 15, 6.5 kDa; or 97.4,66,45, 31,21.5, 14.5 kDa. The gel was 
electrophoresed at 4 DC at constant current (30 rnA) through the stacking gel, then the 
amp age was increased to 40 rnA until the bromophenol blue had run out the bottom of the 
resolving gel. The gel was then stained overnight, washed with destain I for -4 hours, 
then washed with destain II overnight. 
Preparation of dialysis tubing 
Visking tubing was boiled for 10 minutes in a 2% (w/v) solution of sodium 
bicarbonate and 0.05% (w/v) EDTA. Care had to be taken to ensure the tubing remained 
submerged at all times. The tubing was then boiled for a further 10 minutes in deionised 
water, this was then repeated. The solution was cooled and the tubing stored at 4 DC in 
0.1 % (w/v) sodium azide for up to three months. 
E. Overexpression and Purification of DHDPS 
Growth of E. coli XL~l Blue pJGOOl 
E. coli XL-1 Blue pJGOOl glycerol freeze was streaked out on LB agar and grown 
overnight at 37 DC. A single colony was selected and restreaked on LB agar, containing 
standard concentrations of both ampicillin and tetracycline, and incubated overnight at 
37°C. A single colony was then selected and used to innoculate 5 rnl of LB broth, 
containing standard concentrations of both ampicillin and tetracycline, and incubated 
overnight (37°C, 180 rpm). 1.0 ml of overnight culture was used to innoculate 200 ml 
of LB broth containing both ampicillin and tetracycline, and incubated overnight as 
above. The cells were chilled on ice for 30 minutes, then harvested by centrifugation 
(5000 rpm, 10 minutes). 10 I of LB broth gave -50 g wet weight of cells. 
Preparation of a crude cell free extract 
Cells were harvested, as above, and washed by resuspending in 20 ruM Tris.HCI pH 
8.0 at 4°C (30 ml), then gently pipetting the buffer and the cell pellet together. The cell 
suspension was centrifuged for (5000 rpm, 10 minutes). The supernatant was discarded 
and the cell pellet was resupended in an equal volume of 20 mM Tris.HCI pH 8.0 at 4 DC. 
The sample was then flash frozen in liquid nitrogen and stored at -20 DC. 
To obtain the crude enzyme extract the cells were subjected to seven freeze thaw 
cycles; each cycle involved flash freezing the cells in liquid nitrogen (-196 DC) followed 
by slowly thawing on ice at 4 DC overnight. The crude extract was then obtained by 
centrifugation (5000 rpm, 10 minutes) to remove all the cell debris, the supernatant was 
collected (70 ml). 
Purification 
Ion exchange 
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The crude supernatant (35 ml) was loaded on to a Q-Sepharose ion exchange column 
(bed volume 70 ml, 15 x 2.6 cm) that had been pre-equilibrated with three bed volumes 
of 20 rnM Tris.HCI pH 8.0 at 4 DC. The column was then washed with five bed volumes 
of the start buffer (20 rnM Tris.HCI pH 8.0 at 4 DC) and the DHDPS was then eluted with 
a 0 to 1 M NaCI salt gradient in 20 rnM Tris.HCI pH 8.0 at 4 DC. The column was then 
washed with three bed volumes of regeneration buffer (1 M NaCI in 20 rnM Tris.HCI pH 
8.0 at 4 DC). The eluted fractions were tested for DHDPS activity using the o-amino-
benzaldehyde micro assay (see Part II). Active fractions eluted between 0.4 and 0.6 M 
NaCl, and were pooled (110 ml). 
Dialysis 
Dialysis buffer 20 mM Tris.HCl pH 8.0 at 4 DC 
1 mMEDTA 
1mM 2-Mercaptoethanol 
1 % Ammonium sulfate 
Pooled material from the ion exchange (110 ml) was dialysed overnight in dialysis 
buffer (2 x 21). Dialysed sample was collected (100 ml). 
Second ion exchange 
(a) Small scale 
A 1 ml Resource Q-Sepharose column (Pharmacia) was used in the final ion 
exchange step. 1.0 ml batches of dialysed sample were charged onto the 1 ml column, 
the column was then washed with five bed volumes of 20 mM Tris.HCl pH 8.0 at 4 DC. 
The column was then eluted with a linear gradient of 0 to 1 M NaCI in 20 rnM Tris.HCl 
pH 8.0 at 4 DC. DHDPS eluted between 0.4 and 0.6 M NaCl; active fractions were 
pooled (5.0 ml). 
(b) Large scale 
For large amounts of DHDPS required for the coupled assay to measure the activity 
of DHDPR the second ion exchange was performed in an analogous way to the first ion 
exchange column. The supernatant (70 ml) was loaded on to a Q-Sepharose ion 
exchange column (bed volume 70 ml, 15 x 2.6 cm) that had been pre-equilibrated with 
three bed volumes of 20 rnM Tris.HCl pH 8.0 at 4 DC. The column was then washed 
with five bed volumes of the start buffer (20 rnM Tris.HCl pH 8.0 at 4 DC) and the 
DHDPS was then eluted with a 0 to 1 M NaCI salt gradient in 20 mM Tris.HCl pH 8.0 at 
4 DC. The column was then washed with three bed volumes of regeneration buffer (1 M 
NaCI in 20 rnM Tris.HCl pH 8.0 at 4 DC). The eluted fractions were tested for DHDPS 
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activity using the o-aminobenzaldehyde micro assay (see Part II). Active fractions eluted 
between 0.4 and 0.6 M NaCl, and were pooled (132 ml). 
Purification 
Purification step Total protein Activity 
(mgml-1) (Ilmol·s-lml-l) 
Crude supernatant 10.2 1.73 x 10-1 
Ion exchange 2.4 1.35 x 10-2 
Dialysis 1.6 5.18 x 10-2 
Second ion exchange 
-Resource Q-Sepharose 4.0 x 10-2 1.18 X 10-3 
Second ion exchange 
-Q-Sepharose 8.0 x 10-2 1.60 X 10-3 
Attempted modifications to the DHDPS purification 
Heat shock on the crude extract6 
Specific activity 
(Ilmol·s-lmg-l) 
1.70 X 10-2 
1.35 X 10-2 
3.24 X 10-2 
4.70 X 10-1 
2.00 X 10-1 
The crude supernatant (3.0 ml) was heat shocked at 70°C for two minutes. 
Precipitated proteins were removed by centrifugation (5000 rpm, 10 minutes). The 
supernatant (2.5 ml) showed decreased DHDPS activity. 
Gel filtration 
A Sephacryl S-400 HR (bed volume 68 ml, 2.6 x 30 cm) column pre-equilibrated 
with 20 mM Tris.HCl pH 8.0 at 4°C, was eluted at 2mlmin-l. An ion exchanged sample 
(4.2 ml) was loaded onto the column and eluted (104 ml), the bands were too diffuse for 
gel filtration to be of any practical use. 
F: Over-Expression and Purification of DHDPR 
Growth of E. coli XL-l Blue pJKOOl 
E. coli XL-1 Blue pJKOO 1 glycerol freeze was streaked out on LB agar and grown 
overnight at 37°C, A single colony was selected and restreaked on LB agar containing 
standard concentrations of both ampicillin and tetracycline, incubated overnight at 37°C, 
A single colony was selected and used to innoculate 5 ml of LB broth containing both 
ampicillin and tetracycline, incubated overnight at 37°C, 180 rpm. 1 ml of saturated 
overnight culture was used to innoculate 200 ml of LB broth containing both ampicillin 
and tetracycline, and incubated as above. The cells were chilled on ice for 30 minutes, 
then harvested by centrifugation (5000 rpm, 10 minutes). 
Preparation of a crude cell free extract 
Cells were harvested as above and washed by resuspending in 20 mM Tris.HCl pH 
8.0 at 4°C (30 ml), gently pipetting the buffer and the cell pellet together. The cell 
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suspension was centrifuged (5000 rpm, 10 minutes). The supernatant was discarded and 
the cell pellet resuspended in an equal volume of 20 mM Tris.HCl pH 8.0 at 4°C, then 
flash frozen in liquid nitrogen and stored at -20°C. 
To obtain the crude extract the frozen cells were slowly thawed on ice at 4 °C 
overnight. The suspension was then ultrasonicated on ice, 4 microns, for 4 minutes in 15 
second bursts with 15 seconds between each burst. The supernatant was then collected 
by centrifugation (5000 rpm, 10 minutes). 
Purification 
Heat shock 
The supernatant was heat shocked in 1.0 ml aliquots at 70°C for three minutes, 
followed immediately by cooling on ice. The precipitated proteins were removed by 
centrifugation (10 minutes, 5000 rpm), and the supernatant was collected (65 ml). 
Ammonium sulfate precipitation 
Solid ammonium sulfate was added to the supernatant, resulting from ultrasonication 
treatment, until 20% saturation was achieved (100% saturation of ammonium sulfate = 70 
g/lOO ml) and stirring was continued for 30 minutes. The mixture was centrifuged (10 
minutes, 15000 rpm). The supernatant was transferred to a fresh tube, solid ammonium 
sulfate was then added until 60% saturation was achieved, stirring was continued for 30 
minutes. The supernatant was discarded, as was the first precipitate, while the second 
precipitate was dissolved in a volume of 20 mM Tris.HCl pH 8.0 at 4 °C equal to the 
volume of the crude extract. 
Dialysis 
Dialysis buffer 20 mM Tris.HCl pH 8.0 at 4 °C 
1mMEDTA 
1mM 2-Mercaptoethanol 
1 % Ammonium sulfate 
The ammonium sulfate precipitate was dialysed against and 50 volumes of dialysis 
buffer overnight at 4 0C. 
Ion exchange 
The dialysed sample was loaded on to a Q-Sepharose ion exchange column (bed 
volume 70 ml, 15 x 2.6 cm) that had been pre-equilibrated with three bed volumes of 20 
mM Tris.HCl pH 8.0 at 4 0C. The column was then washed with five bed volumes of 
the start buffer (20 mM Tris.HCl pH 8.0 at 4 0c) and the DHDPS was then eluted with a 
o to 1.0 M NaCl salt gradient in 20 mM Tris.HCl pH 8.0 at 4°C. The column was then 
washed with three bed volumes of regeneration buffer (1 M NaCl in 20 mM Tris.HCl pH 
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8.0 at 4°C). The eluted fractions were tested for DHDPR activity using the coupled 
assay. Active fractions eluted between 0.6 and 0.9 M NaCl, and were pooled. 
Purification 
Purification step Total protein Activity Specific activity 
(mgml- I ) (Ilmol·s-1ml-1) (Ilmol·s-1mg- l ) 
Crude supematant 9.0 7.10 x 10-3 7.89 X 10-4 
Heat shocked 
supematant 3.4 3.88 x 10-4 1.14 X 10-4 
Ammonium sulfate 
precipiate 4.2 1.34 x 10-3 3.18 X 10-4 
Dialysis 3.0 1.34 x 10-3 4.45 X 10-4 
Ion exchange 1.0 x 10-2 2.25 X 10-2 2.25 
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Experimental Part II 
DHDPS and DHDPR Kinetics 
o-Aminobenzaldehyde (55)1 
Water (350 ml), ferrous sulfate heptahydrate (210 g), concentrated hydrochloric acid 
(1.0 ml), and o-nitrobenzaldehyde (12.0 g, 72.7 mmol) were added to a three-necked two 
litre round bottom flask. The mixture was stirred and heated under reflux. When the 
temperature reached 90°C one portion of concentrated ammonia solution (50 ml) was 
added, followed by, at two minute intervals, two further portions (2 x 20 ml). 
Immediately after the addition of the last portion of ammonia solution heating under reflux 
was discontinued and the product was steam distilled. One 500 ml fraction of distillate 
was collected on ice (5°C) and saturated with sodium chloride until precipitation appeared 
to be complete. The yellow solid was then dried under vacuum. The collected yellow 
crystalline solid was o-aminobenzaldehyde (55) with some dimerised material present. 
The yield of o-aminobenzaldehyde (55) was 3.843 g (31.7 mmol, 39.6%) 
Mp (decomposition) 38 - 40°C, literature 38 - 40 0c.2 
lH NMR oR(CDC13, 300 MHz) 6.12 (2H, bs, -NH2), 6.66 (lH, d, J = 8.3 Hz, 
-CH=CNH2), 6.75 (1H, t, J = 7.4 Hz, -CH=CHCCHO), 7.29 - 7.35 (lH, m, 
-CHCH=CNH2), 7.49 (1H, d, J = 7.9 Hz, =CH-C-CHO), 9.88 (lH, s, -CHO) ppm. 
IR (CDCI3 solution) u max 3504 (N-H (m», 3363 (N-H (m», 1668 (CH=O (s», 1619 (s), 
1593 (m), 1557 (m), 1206 (m), 1159 (m) cm-I . 
MS m/z (EI) 224.1 (dimer), 121.0 (M+, 60%), 93.0 (MH-CHO+' 50%), 77.0 (Ph+, 
62%). 
The o-aminobenzaldehyde assay (qualitative assay for DHDPS activity)3 
Standard assay, semi-quantitative 
Buffer (200 mM Tris.HCl pH 8.5 at 25°C, 80 mM pyruvate) 
o-Aminobenzaldehyde (55) (50 mgml- I in ethanol) 
Test solution 
(S)-Aspartate ~-semialdehyde (11) (0.01 M) (added last) 
500 ~l 
10 ~l 
290 ~l 
200 ).11 
1.00 ml 
The mixture was incubated 30°C for 30 minutes, then quenched by the addition of 
10% (w/v) trichloroacetic acid (500 ~l). (S)-Aspartate ~-semialdehyde (11) was omitted 
from the blank; a control containing no enzyme was also included. A deep purple colour 
indicated the presence of DHDPS activity, in the absence of DHDPS a yellow colour 
resulted. Semi-quantitative measurements were made by measuring the increase in 
absorbance of the solution at 540 nm compared to the blank containing no (S)-aspartate 
~-semialdehyde (11). 
Mini assay, semi-quantitative 
Buffer (200 mM Tris.HCl pH 8.5 at 25°C, 80 mM pyruvate) 
o-Aminobenzaldehyde (55) (50 mgml"' in ethanol) 
Test solution 
(S)-Aspartate ~-semialdehyde (11) (0.01 M) (added last) 
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500 III 
10 III 
29 III 
20 ~l 
559 !ll 
The mixture was incubated 30°C for 30 minutes, then quenched by the addition of 
10% (w/v) trichloroacetic acid (500 Ill). (S)-Aspartate ~-semialdehyde (11) was omitted 
from the blank; a control containing no enzyme was also included. A deep purple colour 
indicated the presence ofDHDPS activity, in the absence of DHDPS a yellow colour 
resulted. Semi-quantitative measurements were made by measuring the increase in 
absorbance of the solution at 540 nm compared to the blank containing no (S)-aspartate 
~-semialdehyde (11). 
Micro assay, qualitative only 
Buffer (200 mM Tris.HCl pH 8.5 at 25°C, 80 mM pyruvate) 
o-Aminobenzaldehyde (55) (50 mgml-l in ethanol) 
Test solution 
(S)-Aspartate ~-semialdehyde (11) (0.01 M) (added last) 
10 III 
0.5 !ll 
5 !ll 
iJJl 
20.5 !ll 
The mixture was incubated 30°C for 30 minutes, then quenched by the addition of 
10% (w/v) trichloroacetic acid (10 Ill). (S)-Aspartate~-semialdehyde (11) was omitted 
from the blank; a control containing no enzyme was also included. A deep purple colour 
indicated the presence of DHDPS activity, in the absence of DHDPS a yellow colour 
resulted. 
Test of whether dipicolinic acid (36) forms a purple complex with 
o-amino~benzaldehyde (55) 
Standard assay 
Buffer (200 mM Tris.HCl pH 8.5 at 25°C, 80 mM pyruvate) 
o-Aminobenzaldehyde (55) (50 mgml-1 in ethanol) 
Test solution (dipicolinic acid (36) 4.1 mM) 
500 III 
10 III 
490 ~l 
1.00 ml 
The mixture was incubated 30°C for 30 minutes, then quenched by the addition of 
10% (w/v) trichloroacetic acid (500 !ll). No colour changes were observed after 30 
minutes, nor after the addition of 10% trichloroacetic acid (500 Ill). 
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Mixtures of dipicolinic acid (36) (1 mM) and o-aminobenzaldehyde (55) (1 mM) 
(1.00 ml) were tested for the formation of a purple chromophore. Solutions were 
incubated at 30°C for minutes. No colour changes were observed after this time nor after 
the addition of 0.50 rnl of 10% trichloroacetic acid. 
Dipicolinic acid o-Amino- Colour 
"-max Absorbance 
(1 mM) benzaldehyde (nm) (blanked 
(ImM) against dH2O) 
99% 1% clear 270 1.47 
98% 2% clear 214 0.14 
270 1.43 
90% 10% clear 258 1.54 
80% 20% clear 260 1.74 
364 0.21 
50% 50% yellow 264 2.23 
368 1.05 
20% 80% yellow 266 2.33 
370 2.24 
10% 90% yellow 266 2.38 
370 2.56 
2% 98% yellow 266 2.39 
370 2.74 
1% 99% yellow 266 2.39 
368 2.75 
Original quantitative DHDPS/DHDPR coupled assay (from Shedlarski and 
Gilvarg4 and modified by Gerrard5) 
To test for DHDPS activity: 
NADPH (54 mM in dH20) 
Buffer (1M Tris.HCI pH 8.5 at 25°C, 80 mM pyruvate (17)) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5 mM) 
Enzyme activity: 1 Unit = ~[NADPH] = 1 J-lmol·ml-1s-1 
500 ~l 
337 ~l 
10 J-ll 
100 J-ll 
50 !-tl 
1.00 ml 
(Using 0.25 mM (S)-aspartate ~-semialdehyde (11) at 30°C, pH 7.2.) 
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The NADPH solution was viscous, requiring it to be added to the buffer and distilled 
water with vigorous mixing. The reaction was initiated in the cuvette by addition of 
freshly prepared (S)-aspartate ~-semialdehyde (11), mixed by inversion of the cuvettte. 
~A340 was measured over 300 seconds at 30 DC, blanked against dH20. The control 
experiment contained no aspartate ~-semialdehyde (11). 
To test for DHDPR activity: 
NADPH (54 mM in dH20) 
Buffer (1M Tris.HCl pH 8.5 at 25 DC, 80 mM pyruvate (17» 
dH20 
DHDPS (10 fold excess) 
(S)-ASA (11) (5 mM) 
DHDPR (2.25 x 10-4 U, 1.0 x 10-4 mg) 
Enzyme activity: 1 Unit (U) = ~[NADPH] = 1 Jlmol·mr1s-1 
(Using 0.25 mM (S)-aspartate ~-semialdehyde (11), which converts to 
dihydrodipicolinate (18), at 30 DC, pH 7.2.) 
3 JlI 
500 JlI 
337 JlI 
100 JlI 
50 JlI 
lQ-!!l 
1.00 rn1 
The NADPH solution was viscous, requiring it to be added to the buffer and distilled 
water with vigorous mixing. The (S)-aspartate ~-semialdehyde was added prior to 
initiation of the reaction to form the substrate. The reaction was then initiated in the 
cuvette by addition of DHDPR, mixed by inversion of the cuvettte. ~A340 was measured 
over 300 seconds at 30 DC, blanked against dH20. The control experiment contained no 
aspartate ~-semialdehyde (11). 
During purification of the DHDPR the coupled assay was used to assess which 
fractions were active, thus containing DHDPR. This, at times, involved altering the 
volumes of reagents used, such as increasing the volume of DHDPR solution used. 
Enzyme kinetics 
Major sources 
A. Cornish-Bowden Biochem. 1. 137, 143 (1974). 
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A. Cornish-Bowden, C.W. Wharton 'Enzyme Kinetics' IRL Press, Oxford (1988). 
M. Dixon Biochem. 1. 55, 170 (1953) 
M. Dixon, E.c. Webb 'Enzymes' 3rd edn, Academic Press (1979). 
R. Eisenthal, M.l Danson (Eds) 'Enzyme Assays. A practical approach' IRL Press, 
Oxford (1992). 
In the kinetic readings an outlier is denoted by an asterisk (*), and is then excluded 
from the calculations of Km and Vmax' 
Buffer dependence of the coupled assay 
Buffer 
Tris 
Tris(hydroxymethy1)methylamine 
Hepes 
N-2-hydroxyethy1piperazine-N' -2-ethane-sulfonic acid 
Mops 
3-(N-Morpholino )propanesu1fonic acid 
Bis-Tris 
Bis(2-hydroxyethyl)iminotris(hydroxymethyl)methane 
Mes 
2-(N-Morpholino )ethanesulfonic acid 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 ruNI buffer, pyruvate (17) 80 mM) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(R,S)-ASA (11) (10.0 mM to 2.6 mM in dH20) 
pKa at 25 DC 
8.1 
7.5 
7.2 
6.5 
6.2 (20 DC) 
buffering 
region6 
7.0 - 9.2 
6.8 - 8.2 
6.4 - 7.9 
5.8 - 7.2 
5.5 - 6.8 
3.0 fll 
500 fll 
337 fll 
10 J.11 
100 fll 
50 b1J 
1.00 ml 
The reaction was initiated in the cuvette by addition of freshly prepared (S)-aspartate 
~-semialdehyde (11), mixed by inversion of the cuvettte. ~A34o was measured over 300 
seconds at 30 DC, blanked against dH20. 
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DHDPS kinetics using 200 mM Tris pH 7.5 at 25°C 
[(R,S)-ASA] lI[(R,S)-ASA] Rate lIRate 
Mx 104 M-1 X 103 I-Lmol's-Img-l x 10-1 mg's'l-Lmol- 1 
5.00 2.00 2.00 4.99 
5,00 2.00 2.75 3.64 
2,50 4.00 2.17 4.60 
2.50 4.00 1.88 5.31 
1.70 5.88 1.84 5.44 
1.70 5.88 1.94 5.15 
1.30 7.69 1.82 5.50 
1.30 7.69 1.77 5.64 
Vmax and Km could not be estimated. 
DHDPS kinetics using 200 mM Mops pH 7.5 at 25°C 
[(R,S)-ASA] 1![(R,S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 Ilmol·s-1mg-1 x 10-1 mg,s'llmol-1 
5.00 2.00 5.00 2.00 
5.00 2.00 5.83 1.72 
2.50 4.00 3.75 2.67 
2.50 4.00 4.68 2.14 
1.70 5.88 2.82 3.55 
1.70 5.88 2.47 4.05 
1.30 7,69 2,20 4,54 
1.30 7.69 2,55 3.92 
Lineweaver-Burk plot 
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DHDPS k' t' me lCS usmg 200mMM ops PJ a 
[(R,S)-ASA] lI[(R,S)-ASA] Rate lIRate 
Mx 10'4 M,I X 103 J,.Lmol·s-1mg,1 x 10-1 mg,s·J,.Lmol- 1 
5.00 2.00 4.66 2.14 
5.00 2.00 5.55 1.80 
2.50 4.00 3.33 3.00 
2.50 4.00 3.61 2.77 
1.70 5.88 3.00 3.33 
1.70 5.88 2.92 3.42 
1.30 7.69 2.39 4.18 
1.30 7.69 2.58 3.88 
Lineweaver-Burk plot 
DHDPSk' metlcs usmg 200mMM OpSPJ at 
[(R,S)-ASA] lI[(R,S)-ASA] Rate lIRate 
Mx 10'4 M-I X 103 J,.Lmol.s-lmg,1 x 10'1 mg·s·J,.Lmol- 1 
5.00 2.00 4.20 2.38 
5.00 2.00 4.87 2.05 
2.50 4.00 3.18 3.14 
2.50 4.00 3.41 2.93 
1.70 5.88 2.78 3.59 
1.70 5.88 2.68 3.74 
1.30 7.69 2.25 4.45 
1.30 7.69 2.22 4.51 
Lineweaver-Burk plot 
Experimental 164 
DHDPSk' metics usmE 200rnMM OpSPJ at 
[(R,S)-ASA] lI[(R,S)-ASA] Rate lIRate 
Mx 10-4 M-I X 103 Ilmol·s-1mg-1 x 10-1 mg·s'jlmo 1-1 
5.00 2.00 4.28 2.34 
5.00 2.00 4.29 2.33 
2.50 4.00 3.42 2.93 
2.50 4.00 4.33 2.31 
1.70 5.88 2.86 3.50 
1.70 5.88 2.45 4.08 
1.30 7.69 1.60 6.24 
1.30 7.69 1.44 6.93 
Lineweaver-Burk plot 
DHDPS k' ( me lCS usmg 200rnMM opsp. a 
[(R,S)-ASA] lI[(R,S)-ASA] Rate lIRate 
M x lOA M-I X 103 jlmoI·s-lmg-1 x 10-1 mg,s'!1ffioI- 1 
5.00 2.00 3.52 2.84 
5.00 2.00 3.90 2.57 
2.50 4.00 3.02 3.31 
2.50 4.00 2.94 3.41 
1.70 5.88 2.38 4.20 
1.70 5.88 2.46 4.06 
1.30 7.69 2.19 4.56 
1.30 7.69 2.17 4.61 
Lineweaver-Burk plot 
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DHDPS k' metlcs usm§ 200mMM ops PJ at 
[(R,S)-ASA] lI[(R,S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 IJ,mol·s-1mg-1 x 10-1 mg,s'lJ,mol- 1 
5.00 2.00 3.05 3.28 
5.00 2.00 2.43 4.12 
2.50 4.00 2.62 3.82 
2.50 4.00 2.12 4.72 
1.70 5.88 2.01 4.97 
1.70 5.88 1.99 5.02 
1.30 7.69 1.62 6.19 
1.30 7.69 1.52 6.56 
Lineweaver-Burk plot ~nax = 3.87 X 10-1 IJ,mol·s-1mg-1 Km = 1.78 X 10-4 M 
DHDPS kinetics using 200 mM Mops pH 6.9 at 25 DC 
[(R,S)-ASA] lI[(R,S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 !J,mol's-1mg-1 x 10-1 mg,s'lJ,mol- 1 
5.00 2.00 2.15 4.64 
5.00 2.00 2.58 3.87 
2.50 4.00 2.19 4.56 
2.50 4.00 1.84 5.44 
1.70 5.88 1.64 6.09 
1.70 5.88 1.67 6.00 
1.30 7.69 1.48 6.76 
1.30 7.69 1.53 6.56 
Lineweaver-Burk plot 
Experimental 166 
DHDPS ki r ne lCS usmg 200mMM OpSPJ at 
[(R,S)-ASA] l/[(R,S)-ASA] Rate llRate 
M x 10-4 M-1 X 103 Ilmol·s-1mg-1 x 10-1 mg,s'llmol-1 
5.00 2.00 1.68 5.95 
5.00 2.00 1.90 5.26 
2.50 4.00 1.65 6.06 
2.50 4.00 1.58 6.33 
1.70 5.88 1.28 7.82 
1.70 5.88 1.38 7.26 
1.30 7.69 1.24 8.05 
1.30 7.69 1.16 8.60 
Lineweaver-Burk plot Vmax = 2.33 X 10-1 Ilmol·s-1mg-
1 Km = 1.18 X 10-4 M 
Enzyme kinetics of DHDPS 
Kinetics of DHDPS with respect to (S)-aspartate f3-semialdehyde (11) 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC, pyruvate (17) 80 mM) 
dH20 
DHDPS (2.0 x 10-4 D, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 mM to 1.2 mM in dH20) 
3.0 III 
500 III 
337 III 
10 III 
100 III 
50 III 
1.00 m1 
The reaction was initiated in the cuvette by addition of freshly prepared (S )-aspartate 
~-semialdehyde (11), mixed by inversion of the cuvettte. ~A340 was measured over 300 
seconds at 30 DC, blanked against dH20. 
Experimental 167 
Run 1: 
[(S)-ASA] l/[(S)-ASA] Rate lIRate Rate/[( S)-ASA] 
Mx 10-4 
2.50 
2.50 
1.50 
1.50 
1.00 
1.00 
0.80 
0.80 
0.60 
0.60 
Lineweaver-Burk plot 
Eadie-Hofstee plot 
Direct linear plot 
Run 2: 
M-I X 103 ~mol·s-Img-I mg·s·~mo I-I l·s-Img-I x 10-3 
4.00 
4.00 
6.67 
6.67 
10.0 
10.0 
12.5 
12.5 
16.7 
16.7 
x 10-1 
4.17 2.40 1.67 
4.71 2.12 1.88 
3.86 2.59 2.57 
2.50 4.00 1.67 
3.03 3.30 3.03 
2.91 3.44 2.91 
2.52 3.97 3.15 
2.55 3.92 3.19 
2.06 4.85 3.44 
2.10 4.76 3.51 
Vrnax = 5.85 X 10-1 ~mol·s-Img-I Krn = 1.07 X 10-4 M 
Vrnax = 5.42 X 10-1 ~mol·s-Img-I Krn = 0.882 X 10-4 M 
Vrnax = 6.92 X 10-1 ~mol·s-Img-I Krn = 1.40 X 10-4 M 
[(S)-ASA] l/[(S)-ASA] Rate 1 IRate Rate/[ (S)-ASA] 
M x 10-4 
2.50 
2.50 
1.50 
1.50 
1.00 
1.00 
0.80 
0.80 
0.60 
0.60 
Lineweaver-Burk plot 
Eadie-Hofstee plot 
Direct linear plot 
M-I X 103 ~mol·s-Img-I mg·s·~mo tl l·s-Img-I x 10-3 
4.00 
4.00 
6.67 
6.67 
10.0 
10.0 
12.5 
12.5 
16.7 
16.7 
x 10-1 
4.16 2.40 1.66 
5.14 1.95 2.06 
4.33 2.31 2.89 
4.31 2.32 2.87 
2.78 3.62 2.78 
3.28 3.04 3.28 
2.74 3.65 3.42 
2.53 3.95 3.16 
2.31 4.33 3.86 
2.47 4.05 4.12 
Vrnax = 7.08 X 10-1 ~mol·s-Img-I Krn = 1.24 X 10-4 M 
Vrnax = 6.50 X 10-1 ~mol·s-Img-I Krn = 1.03 X 10-4 M 
Vrnax = 7.23 X 10-1 ~mol·s-Img-I Krn = 1.38 X 10-4 M 
Kinetics of DHDPS with respect to pyruvate (17) 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC) 
dH20 
DHDPS (2.0 x 10-4 D, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
Pyruvate (17) (2.0 mM to 0.20 mM in dH20) 
(S)-ASA (11) (50 mM in dH20) 
Experimental 168 
3.0 ~l 
500 ~l 
87 ~l 
10 ~l 
100 ~l 
250 ~l 
50 LLI 
1.00 ml 
The reaction was initiated in the cuvette by addition of freshly prepared (S)-aspartate 
~-semialdehyde (11), mixed by inversion of the cuvettte. LlA340 was measured over 300 
seconds at 30 DC, blanked against dH20. 
Run 1: 
[Pyruvate] 1 /[Pyruvate] Rate 1 IRate Rate/[Pyruvate] 
Mx 10-4 
5.00 
5.00 
1.25 
1.25 
0.70 
0.70 
0.50 
0.50 
Lineweaver-Burk plot 
Eadie-Hofstee plot 
Direct linear plot 
M-I X 103 ~mol·s-Img-I mg·s·~mo I-I l·s·lmg-1 x 10-3 
2.00 
2.00 
8.00 
8.00 
14.3 
14.3 
20.0 
20.0 
x 10-1 
3.41 2.93 0.682 
3.62 2.76 0.724 
1.99 5.03 
2.02 4.95 
1.32 7.58 
1.56 6.41 
0.795 12.6 
1.11 9.01 
Vmax = 5.99 X 10-1 ~mol·s-Img-I Km = 2.56 X 10-4 M 
Vmax = 4.35 X 10-1 J.lmol·s-Img-
I Km = 1.51 X 10-4 M 
Vmax = 4.59 X 10-1 ~mol·s-Img-I Km = 1.53 X 10-4 M 
1.59 
1.61 
1.89 
2.23 
1.59 
2.22 
Experimental 169 
Run 2: 
[Pyruvate] I/[Pyruvate] Rate lIRate Rate/[Pyruvate] 
M x 10-4 M-1 X 103 Ilmol·s-lmg-l mg,s'llmot1 l·s-Img-I x 10-3 
x 10-1 
5.00 2.00 3.80 2.63 0.760 
5.00 2.00 4.86 2.06 0.972 
1.25 8.00 1.97 5.08 1.58 
1.25 8.00 2.70 3.70 2.16 
0.70 14.3 1.97 5.08 2.82 
0.70 14.3 1.72 5.81 2.46 
0.50 20.0 1.33 7.52 2.66 
0.50 20.0 1.65 6.06 3.30 
Lineweaver-Burk plot 
Eadie-Hofstee plot 
Direct linear plot 
Vrnax = 4.76 X 10-1 Ilmol·s-Img-I Krn = 1.14 X 10-4 M 
Vrnax = 4.85 X 10-1 Ilmol·s-Img-I Krn = 1.12 X 10-4 M 
Vrnax = 5.49 X 10-1 Ilmol·s-Img-I Krn = 1.34 X 10-4 M 
Effect of high (S)-aspartate f3-semialdehyde (11) concentration on DHDPS 
kinetics 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25°C) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (200 mM to 2.5 mM in dH20) 
Pyruvate (17) (400 mM to 12.5 mM in dH20) 
3.0 III 
500 III 
237 III 
10 III 
100 III 
50 III 
150 yl 
1.00 ml 
The reaction was initiated in the cuvette by addition of freshly prepared (S )-aspartate 
~-semialdehyde (11), mixed by inversion of the cuvettte. M 340 was measured over 300 
seconds at 30°C, blanked against dH20. 
Experimental 170 
Run 1: 
[Pyruvate (17)] = 40 mM 
[(S)-ASA] Rate 
Mx 10-3 J..lmol·s-Img-1 x 10-1 
0.25 4.85 
0.25 4.21 
0.50 6.38 
0.50 7.39 
0.75 6.14 
0.75 6.50 
1.00 7.27 
1.00 8.01 
1.25 6.76 
1.25 8.85 
1.50 8.21 
1.50 8.05 
Run 2: 
[Pyruvate (17)] == 5.0 mM 
[(S)-ASA] Rate 
Mx 10-3 J..lmol·s-1mg-1 x 10-1 
1.00 6.27 
1.00 4.54 
1.50 6.82 
1.50 6.27 
2.00 7.66 
2.00 5.46 
2.50 6.58 
2.50 7.46 
Experimental 171 
Run 3: 
[Pyruvate (17)] = 10.0 mM 
[(S)-ASAJ Rate 
M x 10-3 Ilmol·s-'mg-I x 10-1 
1.00 7.89 
1.00 6.65 
1.50 7.78 
1.50 6.81 
2.00 7.53 
2.00 7.01 
2.50 7.68 
Run 4: 
[P t (17)] 125 mM 'yruva e = 
[(S)-ASAJ Rate 
M x 10-3 Ilmol·s-1mg-1 x 10-1 
0.125 2.72 
0.125 2.39 
0.250 2.61 
0.250 2.56 
0.500 2.84 
0.500 3.91 
1.00 4.13 
1.00 4.62 
1.50 4.14 
1.50 3.93 
2.00 4.42 
2.00 4.22 
Experimental 172 
Run 5: 
[Pyruvate (17)] = 1.25 mM 
[(S)-ASA] Rate 
M x 10-3 Jlmol·s-1mg-1 x 10-1 
1.00 4.56 
1.00 4.96 
2.50 8.17 
2.50 10.0 
5.00 11.4 
6.00 11.6 
10.0 9.92 
10.0 12.1 
Effect of (S)-lysine (12) on DHDPS kinetics with respect to (S)-aspartate 
fJ-semialdehyde (11) 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25°C, pyruvate (17) 80 mM) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 mM to 1.3 mM in dH20) 
(S)-Lysine (12) (10.0 mM to 1.0 mM in dH20) 
3.0 JlI 
500 JlI 
237 JlI 
10 JlI 
100 JlI 
50 JlI 
100 yJ 
1.00 ml 
The reaction was initiated in the cuvette by addition of freshly prepared (S)-aspartate 
~-semialdehyde (11), mixed by inversion of the cuvettte. LlA340 was measured over 300 
seconds at 30°C, blanked against dH20. 
Experimental 173 
Run 1: 
[(S)-Lysine (12)] = 0 mM 
[(S)-ASA] 1/[( S)-ASA] Rate lIRate 
Mx 10-4 M-1 X 103 !lmol·s-1mg-1 x 10-1 mg,s·!..lmo 1-1 
2.50 4.00 4.04 2.48 
2.50 4.00 4.19 2.39 
1.25 8.00 4.13 2.42 
1.25 8.00 4.30 2.32 
0.85 11.8 3.35 2.98 
0.85 11.8 3.59 2.79 
0.65 15.4 2.70 3.70 
0.65 15.4 2.80 3.60 
Lineweaver-Burk plot 
[(S)-Lysine (12)] = 0.10 mM 
[(S)-ASA] 1/[(S)-ASA] Rate lIRate 
Mx 10-4 M-1 X 103 !..lmol·s-1mg-1 x 10-1 mg,s·J.!mol- 1 
2.50 4.00 5.46 1.83 
2.50 4.00 5.07 1.97 
1.25 8.00 4.37 2.29 
1.25 8.00 4.46 2.24 
0.85 11.8 3.45 2.90 
0.85 11.8 3.43 2.91 
0.65 15.4 2.97 3.36 
0.65 15.4 2.98 3.36 
Lineweaver-Burk plot 
Experimental 174 
[(S)-Lysine (12)] = 0.50 mM 
[(S)-ASA] l/[(S)-ASA] Rate 1IRate 
M x 10-4 M-1 X 103 j..lmol·s-1mg-1 x 10-1 mg,s·j..lmol- 1 
2.50 4.00 3.00 3.33 
2.50 4.00 3.01 3.32 
1.25 8.00 2.44 4.10 
1.25 8.00 2.49 4.02 
0.85 11.8 1.73 5.76 
0.85 11.8 1.83 5.45 
0.65 15.4 1.18 8.44 
0.65 15.4 1.40 7.14 
Lineweaver-Burk plot 
[(S)-Lysine (12)] = 1.0 mM 
[(S)-ASA] l/[(S)-ASA] Rate 1IRate 
M x 10-4 M-1 X 103 j..lmol.s-1mg-1 x 10-1 mg,s·j..lmol- 1 
2.50 4.00 1.82 5.51 
2.50 4.00 1.24 8.08 
1.25 8.00 1.10 9.11 
1.25 8.00 1.36 7.33 
0.85 11.8 0.904 11.1 
0.85 11.8 1.02 9.81 
0.65 15.4 0.903 11.1 
0.65 15.4 0.987 10.1 
Lineweaver-Burk plot 
Determination of K;: 
[(S)-ASA] [(S)-Lysine] 
Mx 10-4 M X 10-3 
2.50 0 
2.50 0.10 
2.50 0.50 
2.50 1.0 
1.25 0 
1.25 0.10 
1.25 0.50 
1.25 1.0 
0.85 0 
0.85 0.10 
0.85 0.50 
fI.85 1.0 
0.65 0 
0.65 0.10 
0.65 0.50 
0.65 1.0 
Uncompetitive or mixed inhibition. 
Assuming uncompetitive inhibition: 
K;' (Modified Dixon) 3.25 x 10-4 M 
3.37 X 10-4 M 
Assuming mixed inhibition: 
K; (Dixon) 1.90 x 10-4 M 
2.97 X 10-4 M 
Experimental 175 
lIRate [(S)-ASA]/Rate 
mg·s· ~mol-l s·mg·t J x 102 
2.48 
1.83 
3.33 
5.51 
2.42 
2.29 
4.10 
9.11 
2.98 
2.90 
5.76 
11.1 
3.70 
12.1 
8.44 
11.1 
2.39 6.20 
1.97 4.58 
3.32 8.33 
8.08 13.8 
2.32 3.03 
2.24 2.86 
4.02 5.13 
7.33 11.4 
2.79 2.53 
2.91 2.47 
5.45 4.90 
9.81 9.44 
3.60 2.41 
7.71 2.18 
7.14 5.49 
10.1 7.22 
K;' (Modified Dixon) 4.85 x 10-4 M 
5.20 X 10-4 M 
5.98 
4.93 
8.30 
20.2 
2.90 
2.80 
5.03 
9.16 
2.37 
2.47 
4.63 
8.34 
2.34 
2.18 
4.64 
6.57 
Experimental 176 
Run 2: 
[(S)-Lysine (12)] = 0 mM 
[(S)-ASA] 1/[(S)-ASA] Rate 1 IRate 
M x 10-4 M-1 X 103 !!mol's-1mg-1 x 10-1 mg·s·!!mol- 1 
2.50 4.00 4.86 2.08 
2.50 4.00 4.22 2.37 
1.25 8.00 4.13 2.42 
1.25 8.00 4.55 2.20 
0.85 11.8 1.73 5.80 
0.85 11.8 3.77 2.66 
0.65 15.4 2.87 3.49 
0.65 15.4 3.15 3.18 
Lineweaver-Burk plot 
[(S)-Lysine(l2)] = 0.25 mM 
[(S)-ASA] 1/[(S)-ASA] Rate 1 IRate 
Mx 10-4 M-1 X 103 !!mol's-1mg-1 x 10-1 mg,s'!-lmol- 1 
2.50 4.00 4.42 2.26 
2.50 4.00 4.68 2.14 
1.25 8.00 3.23 3.10 
1.25 8.00 1.54 6.51 
0.85 11.8 2.99 3.34 
0.85 11.8 2.98 3.36 
0.65 15.4 2.34 4.28 
0.65 15.4 1.94 5.16 
Lineweaver-Burk plot 
Experimental 177 
[(S)-Lysine (12)] = 0.50 mM 
[(S)-ASA] 1/[(S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 Ilmol·s-1mg-1 x 10-1 mg,s'llmol-1 
2.50 4.00 2.87 3.48 
2.50 4.00 1.43* 6.99* 
1.25 8.00 2.06 4.86 
1.25 8.00 2.17 4.61 
0.85 11.8 1.85 5.41 
0.85 11.8 1.77 5.64 
0.65 15.4 1.52 6.59 
0.65 15.4 1.66 6.04 
Lineweaver-Burk plot 
[(S)-Lysine (12)] = 0.75 mM 
[(S)-ASA] 1/[(S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 J.Lmol·s-1mg- t x 10-1 mg,s·J.Lmol- 1 
2.50 4.00 2.36 4.24 
2.50 4.00 2.03 4.93 
1.25 8.00 1.62 6.19 
1.25 8.00 1.75 5.71 
0.85 11.8 1.40 7.15 
0.85 11.8 1.43 7.01 
0.65 15.4 1.19 8.40 
0.65 15.4 1.14 8.78 
Lineweaver-Burk plot 
Detennination of K;: 
[(S)-ASA] [(S)-Lysine] 
M x lOA Mx 10-3 
2.50 0 
2.50 0.25 
2.50 0.50 
""~ 0.75 ":'.JV 
1.25 0 
1.25 0.25 
1.25 0.50 
1.25 0.75 
0.85 0 
0.85 0.25 
0.85 0.50 
0.85 0.75 
0.65 0 o.6sH 
0.65 r. 
0.65 0.75 
Uncompetitive inhibition: 
K,' (Modified Dixon) 3.43 x 10-4 M 
3.73 X 10-4 M 
3.91 X 10-4 M 
Experimental 178 
lIRate [(S)-ASA]lRate 
mg·s· Llmol- 1 s·mg·}"l x 102 
2.08 2.37 5.20 5.93 
2.26 2.14 5.65 5.35 
3.48 .99* 8.70 1.75* 
4.24 .93 10.6 1.23 
2.42 2.20 3.03 2.75 
3.10 6.51 3.88 8.14 
4.86 4.61 6.08 5.76 
6.19 5.71 7.74 7.14 
5.80 2.66 4.93 2.26 
3.34 3.36 2.84 2.86 
5.41 4.60 4.79 
7.15 6.08 5.96 
3.49 2.27 2.07 
4.28 5.16 2.78 3.35 
6.59 6.04 4.28 3.93 
8.40 8.78 5.46 5.71 
Effect of (S)-lysine (12) 011 DHDPS kinetics with respect to pyruvate (17) 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25°C) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
Pyruvate (17) (2.0 mM to 0.20 mM in dH20) 
(S)-ASA (11) (50 mM in dH20) 
(S)-Lysine (12) (10 mM to 3.33 mM in dH20) 
3.0 1-11 
5001-11 
12 1-11 
10 1-11 
1001-11 
2501-11 
501-11 
7511I 
1.00mI 
Experimental 179 
The reaction was initiated in the cuvette by addition of freshly prepared (S)-aspartate 
~-semia1dehyde (11), mixed by inversion of the cuvettte. ~A340 was measured over 300 
seconds at 30°C, blanked against dH20. 
Run 1: 
[(S)-Lysine (12)] = 0 ruM 
[Pyruvate] l/[Pyru vate] Rate 1 IRate 
M x 10-4 M-I X 103 f..lmo1·s-lmg-1 x 10-1 mg,s·f..lmo I-I 
5.00 2.00 5.31 1.88 
5.00 2.00 6.74 1.48 
1.25 8.00 3.12 3.20 
1.25 8.00 3.30 3.03 
0.70 14.3 1.94 5.16 
0.70 14.3 1.98 5.06 
0.50 20.0 1.44 6.96 
0.50 20.0 1.67 5.99 
Lineweaver-Burk plot 
[(S)-Lysine (12)] = 0.25 ruM 
[Pyruvate] l/[Pyru vate] Rate 1 IRate 
Mx 10-4 M-I X 103 f..lmo1·s-lmg-1 x 10-1 mg,s·J.!mo1- 1 
5.00 2.00 4.50 2.22 
5.00 2.00 5.34 1.87 
1.25 8.00 2.86 3.49 
1.25 8.00 2.64 3.79 
0.70 14.3 2.02 4.96 
0.70 14.3 2.08 4.81 
0.50 20.0 1.67 6.00 
0.50 20.0 1.56 6.42 
Lineweaver-Burk plot 
Experimental 180 
[(S)-Lysine (12)] = 0.50 mM 
[Pyruvate] l/[Pyruvate] Rate lIRate 
M x 10-4 M-1 X 103 ~mol·s-Img-I x 10-1 mg,s'J!mol- 1 
5.00 2.00 4.07 2.45 
5.00 2.00 3.77 2.65 
1.25 8.00 2.82 3.55 
1.25 8.00 2.30 4.35 
0.70 14.3 1.75 5.71 
0.70 14.3 1.75 5.72 
0.50 20.0 1.54 6.48 
0.50 20.0 1.46 6.85 
Lineweaver-Burk plot Vrnax = 4.71 X 10-1 ~mol·s-Img-I Krn = 0.906 X 10-4 M 
[(S)-Lysine (12)] = 0.75 mM 
[Pyruvate] l/[Pyruvate] Rate lIRate 
M x 10-4 M-1 X 103 Ilmol·s-Img-I x 10-1 mg,s'J!mol- 1 
5.00 2.00 3.33 3.00 
5.00 2.00 2.84 3.53 
1.25 8.00 2.35 4.26 
1.25 8.00 2.46 4.06 
0.70 14.3 1.74 5.76 
0.70 14.3 1.51 6.60 
0.50 20.0 1.48 6.78 
0.50 20.0 1.48 6.78 
Lineweaver-Burk plot 
Determination of K' 
[Pyruvate] [(S)-Lysine] lIRate 
M x 10-4 Mx 10-3 mg,s'!lmol- 1 
5.00 0 1.88 1.48 
5.00 0.25 2.22 1.87 
5.00 0.50 2.45 2.65 
5.00 0.75 3.00 3.53 
1.25 0 3.20 3.03 
1.25 0.25 3.49 3.79 
1.25 0.50 3.55 4.35 
1.25 0.75 4.26 4.06 
0.70 0 5.16 5.06 
0.70 0.25 4.96 4.81 
0.70 0.50 5.71 5.72 
0.70 0.75 5.76 6.60 
0.50 0 6.96 5.99 
0.50 0.25 6.00 6.42 
0.50 0.50 ·6.48 6.85 
0.50 0.75 
Uncompetitive inhibition: 
K,' (Modified Dixon) 4.50 x 10-4 M 
4.68 X 10-4 M 
4.85 X 10-4 M 
5.73 X 10-4 M 
6.78 6.78 
Experimental 181 
[( S)-ASA ] IRate 
s·mg·fl x 102 
9.40 7.40 
11.1 9.35 
12.3 13.3 
15.0 17.7 
4.00 3.79 
4.36 4.74 
4.44 5.44 
5.33 5.08 
3.61 3.54 
3.47 3.37 
4.00 4.00 
4.03 4.62 
3.48 3.00 
3.00 3.21 
3.24 3.43 
3.39 3.39 
Experimental 182 
Run 2: 
[(S)-Lysine (12)] = 0 mM 
[Pyruvate] 1/[Pyruvate] Rate llRate 
M x 10-4 M-! X 103 /-lmol·s-1mg-1 x 10-1 mg,s'/-lmol-! 
5.00 2.00 4.17 2.40 
5.00 2.00 5.64 1.77 
1.25 8.00 3.66 2.73 
1.25 8.00 3.68 2.72 
0.70 14.3 2.32 4.32 
0.70 14.3 2.51 3.99 
0.50 20.0 1.93 5.19 
0.50 20.0 1.82 5.49 
Lineweaver-Burk plot 
[(S) L . (12)] 025 mM - _ysme = 
[Pyruvate] 1/[Pyruvate] Rate 1 IRate 
Mx 10-4 M-1 X 103 Ilmol·s-1mg-1 x 10-1 mg· S' !-Lmol-! 
5.00 2.00 4.60 2.17 
5.00 2.00 5.33 1.88 
1.25 8.00 2.75 3.64 
1.25 8.00 3.05 3.28 
0.70 14.3 2.36 4.23 
0.70 14.3 2.03 4.94 
0.50 20.0 1.69 5.90 
0.50 20.0 1.63 6.15 
Lineweaver-Burk plot 
Experimental 183 
[(S)-Lysine (12)] = 0.50 mM 
[Pyruvate] 11 [Pyruvate ] Rate lIRate 
M x 10-4 M-1 X 103 Ilmol·s-lmg-l x 10-1 mg,sj..lmol- 1 
5.00 2.00 2.99 3.35 
5.00 2.00 3.56 2.81 
1.25 8.00 2.68 3.73 
1.25 8.00 2.76 3.63 
0.70 14.3 2.20 4.54 
0.70 14.3 2.18 4.59 
0.50 20.0 1.69 5.92 
0.50 20.0 1.66 6.03 
Lineweaver-Burk plot V
max 
= 3.89 X 10-1 /-lmol·s-1mg-1 Km = 0.615 X 10-4 M 
[(S)-Lysine (12)] = 0.75 mM 
[Pyruvate] 1/[Pyruvate] Rate lIRate 
M x 10-4 M-1 X 103 /-lmol·s-1mg-1 x 10-1 mg,s'/-lmol- I 
5.00 2.00 2.91 3.44 
5.00 2.00 2.60 3.84 
1.25 8.00 2.19 4.56 
1.25 8.00 2.07 4.83 
0.70 14.3 1.77 5.64 
0.70 14.3 1.60 6.25 
0.50 20.0 1.48 6.76 
0.50 20.0 1.48 6.75 
Lineweaver-Burk plot 
Determination of K' 
[Pyruvate] [(S)-Lysine] 
M x 10-4 M X 10-3 
5.00 0 
5.00 0.25 
5.00 0.50 
5.00 0.75 
1.25 0 
1.25 0.25 
1.25 0.50 
1.25 0.75 
0.70 0 
0.70 0.25 
0.70 0.50 
0.70 0.75 
0.50 0 
0.50 0.25 
0.50 0.50 
0.50 0.75 
Uncompetitive inhibition: 
K,.' (Modified Dixon) 3.13 x 10-4 M 
3.81 X 10-4 M 
DHDPR enzyme kinetics 
lIRate 
mg,s'!J,mo 1-1 
2.40 1.77 
2.17 1.88 
3.35 2.81 
3.44 3.84 
2.73 2.72 
3.64 3.28 
3.73 3.63 
4.56 4.83 
4.32 3.99 
4.23 4.94 
4.54 4.59 
5.64 6.25 
5.19 5.49 
5.90 6.15 
5.92 6.03 
6.76 6.75 
Kinetics of DHDPR with respect to the substrate 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC, pyruvate (17) 80 mM) 
dH20 
DHDPS (10 fold excess) 
(S)-ASA (11) (6.0 mM to 1.0 mM in dH20) 
DHDPR (2.25 x 10-4 U, 1.0 X 10-4 mg) 
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[(S)-ASA]lRate 
s·mg·l-1 x 102 
12.0 
10.9 
16.8 
17.2 
3.41 
4.55 
4.66 
5.70 
3.02 
2.96 
3.18 
3.95 
2.60 
2.95 
2.96 
3.38 
3.0 !J,l 
500 !J,l 
337 !J,1 
100 !J,1 
50 !J,l 
1J2.)JJ. 
1.00 m1 
8.35 
9.40 
14.1 
19.2 
3.40 
4.10 
4.54 
6.04 
2.79 
3.46 
3.21 
4.38 
2.75 
3.08 
3.02 
3.38 
The (S )-aspartate ~-semia1dehyde was added prior to initiation of the reaction to form 
the substrate. The reaction was then initiated in the cuvette by addition of DHDPR, 
mixed by inversion of the cuvettte. ~A340 was measured over 300 seconds at 30 DC, 
blanked against dH20. 
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Run 1: 
[DHDPA] 1/[DHDPA] Rate lIRate 
Mx 10,4 M'I X 103 flmol's,lmg,1 mg·s·flmol,1 
2.50 
2.50 
1.50 
1.50 
1.00 
1.00 
0.65 
0.65 
0.50 
Lineweaver-Burke plot 
Eadie-Hofstee plot 
Direct linear plot 
Run 2: 
4.00 
4.00 
6.67 
6.67 
10.0 
10.0 
15.4 
15.4 
20.0 
1.60 0.627 
1.99 0.503 
1.30 0.766 
1.32 0.758 
0.851 1.18 
0.845 1.18 
0.621 1.61 
0.551 1.81 
0.420 2.38 
Vrnax = 11.6 flmol's,lmg,1 Krn = 7.85 X 10'4 M 
Vrnax = 4.12 flmol's,lmg,1 Krn = 3.71 X 10'4 M 
Vrnax = 6.52 flmol's,lmg,1 Krn = 6.59 X 10'4 M 
[DHDPA] lI[DHDPA] Rate lIRate 
Mx 10'4 
3.00 
3.00 
2.50 
2.50 
2.00 
2.00 
1.50 
1.50 
1.00 
1.00 
0.50 
0.50 
Lineweaver-Burk plot 
Eadie-Hofstee plot 
Direct linear plot 
M'I X 103 flmol's,lmg,1 mg·s·flmol,1 
3.33 
3.33 
4.00 
4.00 
5.00 
5.00 
6.66 
6.66 
10.0 
10.0 
20.0 
20.0 
1.97 0.507 
2.12 0.471 
1.94 0.517 
1.83 0.546 
1.55 0.646 
1.46 0.685 
1.27 0.787 
1.25 0.798 
0.825 1.21 
0.823 1.21 
0.486 2.06 
0.499 2.00 
Vrnax = 5.27 flmol's,lmg,1 Krn = 4.93 X 10'4 M 
Vrnax = 5.39 flmol's,lmg,1 Krn = 5.04 X 10'4 M 
Vrnax = 5.71 flmol's,lmg,1 Krn = 5.29 X 10,4 M 
Rate/[DHDPA] 
l·s'lmg'l x 10,4 
6.40 
7.96 
8.66 
8.13 
8.51 
8.45 
9.56 
8.49 
8.40 
Rate/[DHDPA] 
l·s'lmg'l x 10'4 
6.56 
7.06 
7.76 
7.32 
7.75 
7.30 
8.46 
8.33 
8.25 
8.23 
9.72 
9.98 
Kinetics of DHDPR with respect to the cofactor NADPH 
Assay: 
NADPH (13.5 to 3.43 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25°C, pyruvate (17) 80 mM) 
dH20 
DHDPS (10 fold excess) 
(S)-ASA (11) (5 mM in dH20) 
DHDPR (2.25 x 10-4 U, 1.0 X 10-4 mg) 
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3.0 III 
500 III 
337 III 
100 III 
50 III 
1.QJJJ. 
1.00 rnl 
The (S)-aspartate ~-semialdehyde was added prior to initiation of the reaction to form 
the substrate. The reaction was then initiated in the cuvette by addition of DHDPR, 
mixed by inversion of the cuvettte. ~A340 was measured over 300 seconds at 30 DC, 
blanked against dH20. 
Run 1: 
[NADPH] l![NADPH] Rate lIRate 
M x 10-5 
4.05 
4.05 
2.70 
2.70 
1.35 
1.35 
1.08 
1.08 
Lineweaver-Burk plot 
Eadie-Hofstee plot 
Direct linear plot 
M-1 X 104 Ilmol·s-1mg-1 mg·s'llmo 1-1 
2.47 
2.47 
3.70 
3.70 
7.41 
7.41 
9.26 
9.26 
x 10-1 
2.84 3.52 
2.87 3.48 
2.64 3.78 
2.70 3.70 
1.70 5.87 
1.25 7.99 
1.61 6.22 
1.68 5.94 
V
max 
= 4.34Ilmol·s-lmg-l Km = 2.10 X 10-5 M 
V max = 3.62Ilmol·s-lmg-1 Km = 1.35 X 10-5 M 
V
max 
= 3.90 Ilmol·s-1mg-1 Km = 1.49 X 10-5 M 
Rate/[NADPH] 
l·s-lmg-1 x 10-3 
7.02 
7.09 
9.77 
9.99 
12.6 
9.26 
14.9 
15.6 
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Run 2: 
[NADPH] 1 I [NADPH] Rate lIRate Rate/[NADPH] 
Mx 10-5 M-1 X 104 ~mol·s-lmg-l mg·s·~mo 1-1 l'S-lmg-l x 10-3 
x 10-1 
4.05 2.47 2.58 3.88 6.37 
2.00 4.00 2.23 4.49 8.92 
2.00 4.00 2.51 3.99 10.0 
1.35 7.41 1.77 5.65 13.1 
1.35 7.41 1.77 5.65 13.1 
1.03 9.71 1.28 7.82 12.4 
1.03 9.71 1.51 6.63 14.7 
Lineweaver-Burk plot 
Eadie-Hofstee plot 
Direct linear plot 
Vmax = 4.14 ~mol·s-lmg-l Km = 1.96 X 10-5 M 
Vmax = 3.58 ~mol·s-lmg-l Km = 1.45 X 10-5 M 
Vmax = 3.63 ~mol·s-lmg-l Km = 1.65 X 10-5 M 
Kinetics of DHDPR with respect to the cofactor NADH 
Assay: 
NADH (10.7 to 1.33 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC, pyruvate (17) 80 mM) 
dH20 
DHDPS (10 fold excess) 
(S)-ASA (11) (5 mM in dH20) 
DHDPR (2.25 x 10-4 U, 1.0 X 10-4 mg) 
3.0 ~l 
500 ~l 
337 ~l 
100 ~l 
50 ~l 
.l.QJ1l 
1.00 ml 
The (S )-aspartate ~-semialdehyde was added prior to initiation of the reaction toform 
the substrate. The reaction was then initiated in the cuvette by addition of DHDPR, 
mixed by inversion of the cuvettte. ~A340 was measured over 300 seconds at 30 DC, 
blanked against dH20. 
Run 1: 
[NADH] 
M x 10-5 
3.20 
3.20 
1.60 
1.60 
1.10 
1.10 
0.800 
Lineweaver-Burk plot 
Eadie-Hofstee plot 
Direct linear plot 
Run 2: 
[NADH] 
M x 10-5 
3.20 
3.20 
1.60 
1.60 
0.800 
0.800 
0.400 
0.400 
Lineweaver-Burk plot 
Eadie-Hofstee plot 
Direct linear plot 
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l/[NADH] Rate lIRate 
M-I X 104 Ilmol·s-Img-I mg,s'llmol-1 
3.13 
3.13 
6.25 
6.25 
9.09 
9.09 
12.5 
x 10-1 
1.52 6.59 
1.32 7.57 
1.55 6.47 
1.27 7.89 
1.27 7.86 
1.23 8.10 
0.985 10.2 
Vrnax = 1.74 Ilmol·s-Img-I Krn = 5.09 X 10-6 M 
Vrnax = 1.58 Ilmol·s-Img-I Krn = 3.21 X 10-6 M 
Vrnax = 1.96 Ilmol·s-Img-I Krn = 6.27 X 10-6 M 
l/[NADH] Rate lIRate 
M-I X 104 Ilmol·s-Img-I mg,s'llmol-1 
3.13 
3.13 
6.25 
6.25 
12.5 
12.5 
25.0 
25.0 
x 10-1 
2.11 4.74 
1.81 5.54 
1.55 6.44 
1.40 7.12 
1.21 8.30 
0.826 12.1 
1.00 9.97 
0.789 12.7 
Vrnax = 1.95 Ilmol·s-Img-I Krn = 5.36 X 10-6 M 
Vrnax = 1.96 Ilmol·s-Img-I Krn = 4.95 X 10-6 M 
Vrnax = 2.36 Ilmol·s-Img-I Krn = 6.56 X 10-6 M 
Rate/[NADH]] 
l·s-Img-I x 10-3 
4.76 
4.13 
9.69 
7.94 
11.5 
11.2 
12.3 
Rate/[NADH]] 
l·s-Img-I x 10-3 
6.60 
5.67 
9.69 
8.75 
15.1 
10.3 
25.0 
19.7 
Experimental 189 
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Experimental Part III 
The Structure of (S)-Aspartate f3-Semialdehyde 
Stability of homoserine lactone (31) (2-amino-4-butyrolactone) 
NMR studies, including HMBC and nOe experiments, were performed on 
homoserine lactone (31) (15 mg) in D20 at pH = 1. Infra-red studies were also 
performed, in aqueous solution and in potassium bromide. 
Homoserine lactone (31) 
IH NMR (300 MHz, D20) DH 2.l3 2.28 (1H, m, -CH2CHNH2 (pro-R); nOe to DH 4.2, 
4.4),2.51 - 2.61 (lH, m, -CH2CHNH2 (pro-S); nOe to DH 4.2), 4.16 - 4.26 (2H, m, 
-CH2CH2CHNH2), 4.33 - 4.40 (1H, m, -CHNH2) ppm. 
l3C NMR (75 MHz, D20) Dc 27.9 (t, -CH2CH20-), 46.9 (d, -CHNH3), 68.7 (t, 
-CH20-), 173 (-C=O). 
HMBC: I DH ca. 2.2, coupling to Dc 46.9, and 68.7; DH ca. 2.6, coupling to Dc 46.9, and 
173; DH ca. 4.2, coupling to Dc 27.9, and 173; DH ca. 4.4 coupling to Dc 27.9, 46.9, and 
173. 
IR (KEr disc) 'Umax 3448 (N-H (w», 2976 (C-H (s», 1774 (C=O (s», 1490 (w), 1216 
(w), 1188 (w), 1026 (w) em-I. 
IR (H20) 'Urnax 1748 em-I. 
Homoserine lactone (31) was found to hydrolyse to homoserine (64). 
Homoserine (64) 
IH NMR (300 MHz, D20) DH 1.88 - 2.03 (2H, m, -CH2CHNH2), 3.54 3.58 (2H, m, 
-CH2CH2CHNH2), 3.97 - 4.01 (1H, m, -CHNH2)ppm. 
Stability at pH 8.0 
Homoserine lactone (31) (1 mg) in phosphate buffer (KH2POJK2HP04), in D20, 
(150 Ill) followed by IH NMR. 
Homoserine lactone Homoserine Time 
(%) (%) 
100 0 o mins 
90 10 37 mins 
77 23 47 mins 
69 31 57 mins 
38 62 4 hrs 
0 100 22 hrs 
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Stability at pH 7.5 
Homoserine lactone (31) (1 mg) in phosphate buffer, in D20, (150 J..tl) followed by 
lH NMR. 
Homoserine lactone Homo serine Time 
(%) (%) 
100 0 Omins 
80 20 36 mins 
75 25 42 mins 
0 100 22hrs 
Stability at pH 7.0 
Homoserine lactone (31) (1 mg) in phosphate buffer, in D20, (150 J..tl) followed by 
lH NMR. 
Homoserine lactone Homoserine Time 
(%) (%) 
100 0 Omins 
87 13 39 mins 
83 17 44 mins 
75 25 53 mins 
0 100 22 hrs 
Stability in Mops buffer at pH 7.2 
Homoserine lactone (31) (1 mg) in 200 mM Mops buffer, pH 7.2 at 25°C in D20, 
(150 J..tl) followed by lH NMR. 
Homoserine lactone Homoserine Time 
(%) (%) 
100 0 Omins 
93.9 6.1 6mins 
89.4 10.6 13 mins 
86.6 13.4 22 mins 
81.0 19.0 30 mins 
71.1 28.9 40mins 
66.2 33.8 49 mins 
0 100 24 hrs 
Experimental 192 
Effect of homo serine lactone (31) on DHDPS kinetics respect to 
(S)-aspartate ~-semialdehyde (11) 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25°C, pyruvate (17) 80 mM) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 mM to 1.2 mM in dH20) 
Homoserine lactone (31) 
(1.0 M to 0.5 M in 0.5 M Mops pH 3.5 at 25 DC) 
3.0 III 
500 III 
257 III 
10 III 
100 III 
50 III 
80y,1 
1.00 ml 
The reaction was initiated in the cuvette by the addition of freshly prepared (S)-
aspartate ~-semialdehyde (11), mixed by inversion of the cuvette. AA340 was measured 
over 300 seconds at 30°C, blanked against dH20. 
Run 1: 
[Homoserine lactone (31)] = 0 mM 
[(S)-ASA] lI[(S)-ASA] Rate 1 IRate 
Mx 10-4 M-1 X 103 Ilmol·s-1mg-1 x 10-1 mg,s'll-mot i 
2.50 4.00 4.17 2.40 
2.50 4.00 4.71 2.12 
1.50 6.67 3.86 2.59 
1.50 6.67 2.50 4.00 
1.00 10.0 3.03 3.30 
1.00 10.0 2.91 3.44 
0.80 12.5 3.03 3.97 
0.80 12.5 2.55 3.92 
0.60 16.7 2.06 4.85 
0.60 16.7 2.10 4.76 
Lineweaver-Burk plot 
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[Homo serine lactone (31)] = 40 mM 
[(S)-ASA] 1/[(S)-ASA] Rate 1IRate 
Mx 104 M-I X 103 Ilmo}·s·lmg·1 x 10-1 mg,s·J.!mol·1 
2.50 4.00 2.16 4.63 
2.50 4.00 1.84 5.42 
1.50 6.67 1.47 6.78 
1.50 6.67 1.63 6.14 
1.00 10.0 1.36 7.38 
1.00 10.0 1.32 7.60 
0.80 12.5 1.18 8.46 
0.80 12.5 1.20 8.33 
0.60 16.7 1.00 10.0 
0.60 16.7 1.07 9.37 
Lineweaver-Burk plot 
[Homo serine 1 actone (31)] = 60 mM 
[(S)-ASA] 1/[(S)-ASA] Rate 1 IRate 
M x 104 M·I X 103 Ilmol·s·lmg- I x 10'1 mg,s'llmol,l 
2.50 4.00 1.25 7.97 
2.50 4.00 1.25 7.99 
1.50 6.67 1.22 8.22 
1.50 6.67 1.45 6.90 
1.00 10.0 0.846 11.8 
1.00 10.0 0.801 12.5 
0.80 12.5 0.770 13.0 
0.80 12.5 0.800 12.5 
0.60 16.7 0.616 16.2 
0.60 16.7 0.743 13.5 
Lineweaver-Burk plot 
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[Homoserine lactone (31)J = 80 mM 
[(S)-ASA] l/[(S)-ASAJ Rate lIRate 
Mx 10-4 M-1 X 103 j..Lmol·s-1mg-1 x 10-1 mg,s·j..Lmof 1 
2.50 4.00 0.901 11.1 
2.50 4.00 0.910 11.0 
1.50 6.67 0.741 13.4 
1.50 6.67 0.769 13.0 
1.00 10.0 0.668 15.0 
1.00 10.0 0.542 18.5 
0.80 12.5 0.388 25.8 
0.80 12.5 0.537 18.6 
0.60 16.7 0.496 20.2 
0.60 16.7 0.503 19.9 
Lineweaver-Burk plot 
Determination of K' 
[(S)-ASA] [Homo serine 
M x 10-4 lactone] 
Mx 10-3 
2.50 0 
2.50 40 
2.50 60 
2.50 80 
1.50 0 
1.50 40 
1.50 60 
1.50 80 
1.00 0 
1.00 40 
1.00 60 
1.00 80 
0.80 0 
0.80 40 
0.80 60 
0.80 80 
0.60 0 
0.60 40 
0.60 60 
0.60 80 
Noncompetitive inhibition: 
Ki (Dixon) 1.03 x 10-2 M 
1.50 X 10-2 M 
1.56 X 10-2 M 
2.05 X 10-2 M 
2.26 X 1O~2 M 
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1IRate [(S)-ASA]lRate 
mg·s·~mo 1-1 s·mg·1-1 x 102 
2.40 2.12 6.00 
4.63 5.42 11.6 
7.97 7.99 20.0 
11.1 11.0 27.7 
2.59 4.00 3.89 
6.78 6.14 10.2 
8.22 6.90 12.3 
13.4 13.0 20.2 
3.30 3.44 3.30 
7.38 7.60 7.38 
11.8 12.5 11.8 
15.0 18.5 15.0 
3.97 3.92 3.17 
8.46 8.33 6.78 
13.0 12.5 10.4 
25.8 18.6 20.6 
4.85 4.76 2.91 
10.0 9.37 6.00 
16.2 13.5 9.74 
20.2 19.9 12.1 
K;' (Modified Dixon) 1.03 x 10-2 M 
1.50 X 10-2 M 
1.57 X 10-2 M 
2.06 X 10-2 M 
2.25 X 10-2 M 
5.31 
13.6 
20.0 
27.5 
6.00 
9.20 
10.3 
19.5 
3.44 
7.60 
12.5 
18.5 
3.14 
6.67 
10.0 
14.9 
2.86 
5.61 
8.08 
11.9 
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Run 2: 
[Homoserine lactone (31)] = 0 mM 
[(S)-ASA] lI[(S)-ASA] Rate lIRate 
Mx 10-4 M-1 X 103 /-Lmol's-1mg-1 x 10-1 mg,s'/-Lmol"l 
2.50 4.00 4.16 2.40 
2.50 4.00 5.14 1.95 
1.50 6.67 4.33 2.31 
1.50 6.67 4.3] 2.32 
1.00 10.0 2.78 3.62 
1.00 10.0 3.28 3.05 
0.80 12.5 2.74 3.65 
0.80 12.5 2.53 3.95 
0.60 16.7 2.31 4.33 
0.60 16.7 2.47 4.05 
Lineweaver-Burk plot 
[Homoserine lactone (31)] = 40 mM 
[(S)-ASA] lI[(S)-ASA] Rate lIRate 
M x 10-4 M- I X 103 /-Lmol·s-1mg-1 x 10-1 mg,s·J..lmol- 1 
2.50 4.00 1.90 5.26 
2.50 4.00 2.07 4.83 
1.50 6.67 1.84 5.43 
1.50 6.67 1.56 6.41 
1.00 10.0 1.75 5.71 
1.00 10.0 1.36 7.35 
0.80 12.5 1.19 8.40 
0.60 16.7 1.05 9.52 
0.60 16.7 1.02 9.80 
Lineweaver-Burk plot 
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[Homoserine lactone (31)] = 60 mM 
[(S)-ASA] l/[(S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 Ilmol·s-lmg-l x 10-1 mg,s'llmo I-I 
2.50 4.00 1.23 8.15 
2.50 4.00 1.34 7.45 
1.50 6.67 1.12 8.93 
1.50 6.67 1.05 9.54 
1.00 10.0 0.872 11.5 
1.00 10.0 0.870 11.5 
0.80 12.5 0.803 12.5 
0.80 12.5 0.708 14.1 
0.60 16.7 0.766 13.0 
0.60 16.7 0.701 14.3 
Lineweaver-Burk plot 
[Homo serine lactone (31)] = 80 mM 
[(S)-ASA] l/[(S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 Ilmol·s-Img-I x 10-1 mg,s'llmol-1 
2.50 4.00 0.929 10.8 
2.50 4.00 0.942 10.6 
1.50 6.67 0.911 11.0 
1.50 6.67 0.772 13.0 
1.00 10.0 0.586 17.1 
1.00 10.0 0.569 17.6 
0.80 12.5 0.579 17.3 
0.80 12.5 0.649 15.0 
0.60 16.7 0.456 21.9 
0.60 16.7 0.587 17.0 
Lineweaver-Burk plot v = 1.22 X 10-1 "mol·s-1mg-1 Km = 0.853 X 10-4 M max ~ 
Determination of K: 
[(S)-ASA] [Homo serine 
M x 10-4 lactone] 
Mx 10-3 
2.50 0 
2.50 40 
2.50 60 
2.50 80 
1.50 0 
1.50 40 
1.50 60 
1.50 80 
1.00 0 
1.00 40 
1.00 60 
1.00 80 
0.80 0 
0.80 40 
0.80 60 
0.80 80 
0.60 0 
0.60 40 
0.60 60 
0.60 80 
Noncompetitive inhibition: 
Kj (Dixon) 1.17 x 10-2 M 
1.57 X 10-2 M 
1.61 X 10-2 M 
1.83 X 10-2 M 
2.11 X 10-2 M 
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lIRate [(S)-AS A] IRate 
mg·s·~mo 1-1 s·mg·r 1 x 102 
2.40 1.95 6.01 
5.26 4.83 13.2 
8.15 7.45 20.3 
10.8 10.6 26.9 
2.31 2.32 3.46 
5.43 6.41 8.15 
8.93 9.54 13.4 
11.0 13.0 16.5 
3.62 3.04 3.60 
5.71 7.35 5.71 
11.5 11.5 11.5 
17.1 17.6 17.1 
3.65 3.95 2.92 
8.40 6.72 
12.5 14.1 10.0 
17.3 15.0 13.8 
4.33 4.05 2.60 
9.52 9.80 5.71 
13.0 14.3 7.83 
21.9 17.0 13.2 
K/ (Modified Dixon) 1.17 x 10-2 M 
1.58 X 10-2 M 
1.62 X 10-2 M 
1.82 X 10-2 M 
2.22 X 10-2 M 
4.86 
12.1 
18.7 
26.5 
3.48 
9.62 
14.3 
19.4 
3.05 
7.35 
11.5 
17.6 
3.16 
11.3 
12.3 
2.43 
5.88 
8.56 
10.2 
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Effect of homoserine lactone (31) on DHDPS kinetics with respect to 
pyruvate (17) 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25°C) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
Pyruvate (17) (2.0 mM to 0.20 mM in dH20) 
(S)-ASA (11) (50 mM in dH20) 
Homoserine lactone (31) 
(1.0 M to 0.50 M in 0.5 M Mops pH 3.5 at 25°C) 
3.0 ~l 
500 ~l 
7 ~l 
10 ~l 
100 ~l 
250~1 
50 ~l 
80 !1J 
1.00 ml 
The reaction was initiated in the cuvette by the addition of freshly prepared (S)-
aspartate ~-semialdehyde (11), mixed by inversion of the cuvette. LlA340 was measured 
over 300 seconds at 30°C, blanked against dH20. 
Run 1: 
[Homoserine lactone (31)] = 0 mM 
[Pymvate] I/[Pymvate] Rate lIRate 
Mx 104 M-1 X 103 Ilmol·s-1mg-1 x 10-1 mg·g·jlmol-1 
5.00 2.00 3.41 2.93 
5.00 2.00 3.62 2.76 
1.25 8.00 1.99 5.03 
1.25 8.00 2.02 4.95 
0.70 14.3 1.32 7.58 
0.70 14.3 1.56 6.41 
0.50 20.0 0.795 12.6 
0.50 20.0 1.11 9.01 
Lineweaver-Burk plot 
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[Homoserine lactone (31)] = 40 ruM 
[Pyruvate] 11 [Pyru vate] Rate lIRate 
Mx 10"4 M-1 X 103 J.Lmol.s"'mg-1 x 10-1 mg,s·J.Lmol- 1 
5.00 2.00 1.93 5.18 
5.00 2.00 2.24 4.47 
1.25 8.00 1.18 8.45 
1.25 8.00 1.16 8.59 
0.70 14.3 0.775 12.9 
0.70 14.3 0.498 20.1 
0.50 20.0 0.666 15.0 
0.50 20.0 0.605 16.5 
Lineweaver-Burk plot 
[Homo serine lactone (31)J = 60 ruM 
[Pyruvate] lI[Pyruvate] Rate lIRate 
Mx 10-4 M-1 X 103 1..l.,ffiol·s-lmg-1 x 10-1 mg·s'J.Lmol- 1 
5.00 2.00 1.39 7.20 
5.00 2.00 1.60 6.26 
1.25 8.00 0.790 12.7 
1.25 8.00 0.859 11.6 
0.70 14.3 0.603 16.6 
0.70 14.3 0.584 17~1 
0.50 20.0 0.459 21.8 
0.50 20.0 0.430 23.2 
Lineweaver-Burk plot 
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[Homoserine lactone (31)] = 80 mM 
[Pyruvate] I/[Pyruvate] Rate 1 IRate 
M x 10-4 M-l X 103 !lmol·s-1mg-1 x 10-1 mg,s'!lmol- l 
1.25 
1.25 
0.70 
0.70 
0.50 
Lineweaver-Burk plot 
Determination of K' '. 
[Pyruvate] [Homo serine 
M x 10-4 lactone] 
Mx 10-3 
5.00 0 
5.00 40 
5.00 60 
1.25 0 
1.25 40 
1.25 60 
1.25 80 
0.70 0 
0.70 40 
0.70 60 
0.70 80 
0.50 0 
0.50 40 
0.50 60 
0.50 80 
Noncompetitive inhibition: 
Ki (Dixon) 3.48 x 10-2 M 
3.73 X 10-2 M 
4.34 X 10-2 M 
8.00 
8.00 
14.3 
14.3 
20.0 
0.375 26.1 
0.552 18.1 
0.409 24.4 
0.440 22.7 
0.289 34.6 
lIRate [Pyruvate ]lRate 
mg,s'!lmol- l s·mg·t l x 102 
2.93 2.76 14.7 13.8 
5.18 4.47 25.9 22.3 
7.20 6.26 36.0 31.3 
5.03 4.95 6.28 6.34 
8.45 8.59 10.6 10.8 
12.7 11.6 15.8 14.6 
26.6 18.1 ~ 22.6 7.58 6.41 4.49 12.9 i 20.1 14.1 16.6 I 17.1 12.0 
24.4 22.7 +. 1..}.7 12.6 9.01 4.50 
15.0 16.5 7.51 8.26 
21.8 23.2 10.9 Fl1.6 
34.6 17.3 
K/ (Modified Dixon) 3.47 x 10-2 M 
3.72 X 10-2 M 
4.36 X 10-2 M 
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Run 2: 
[Homo serine lactone (31)] = 0 mM 
[Pyruvate] 1/[Pyruvate] Rate lIRate 
M x 10-4 M-1 X 103 Ilmol·s-1mg-1 x 10-1 mg,s'llmol- 1 
5.00 2.00 3.80 2.63 
5.00 2.00 4.86 2.06 
1.25 8.00 1.97 5.08 
1.25 8.00 2.70 3.70 
0.70 14.3 1.97 5.08 
0.70 14.3 1.72 5.81 
0.50 20.0 1.33 7.52 
0.50 20.0 1.65 6.06 
Lineweaver-Burk plot 
[Homoserine lactone (31)] = 40 mM 
[Pyruvate] 1/[Pyruvate] Rate lIRate 
M x 10-4 M- j X 103 Ilmol·s-1mg-1 x 10-1 mg,s'llmol- 1 
5.00 2.00 1.46 6.83 
5.00 2.00 1.63 6.12 
1.25 8.00 1.05 9.55 
1.25 8.00 1.02 9.78 
0.70 14.3 0.605 16.5 
0.70 14.3 0.709 14.1 
0.50 20.0 0.650 15.4 
0.50 20.0 0.604 16.6 
Lineweaver-Burk plot 
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[Homoserine lactone (31)] = 60 mM 
[Pyruvate] 1/[Pyruvate] Rate lIRate 
M x 10-4 M-1 X 103 Ilmol·s-1mg- 1 x 10-1 mg,s'llmol-
' 
5.00 2.00 1.43 6.99 
5.00 2.00 1.21 8.27 
1.25 8.00 0.710 14.1 
1.25 8.00 0.731 13.7 
0.70 14.3 0.596 16.8 
0.70 14.3 0.427 23.4 
0.50 20.0 0.642 15.6 
0.50 20.0 0.599 16.7 
Lineweaver-Burk plot 
[Homoserine lactone (31)] = 80 mM 
[Pyruvate] 1![Pyruvate] Rate lIRate 
M x 10-4 M-1 X 103 Ilmol.s-lmg-I x 10-1 mg,s'llmol-
' 
5.00 2.00 0.611 16.4 
5.00 2.00 0.696 14.4 
1.25 8.00 0.141* 71.1 * 
1.25 8.00 0.418 23.9 
0.70 14.3 0.389 25.7 
0.70 14.3 ·0.215 46.6 
0.50 20.0 0.221 45.2 
0.50 20.0 0.255 39.2 
Lineweaver-Burk plot 
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Detennination of K' 
[Pyruvate] [Homoserine lIRate [Pyruvate ]lRate 
Mx 10-4 lactone] mg·s·~mo I-I s·mg·t l x 102 
Mx 10-3 
5.00 0 RO 40 5.00 60 
.0 60 
1.25 0 
1.25 40 
1.25 60 
1.25 80 
0.70 0 
0.70 40 
0.70 60 
0.70 80 
0 
0.50 40 
60 
0.50 80 
N oncompetiti ve inhibition: 
Kj (Dixon) 8.23 x 10-3 M 
9.06 X 10-3 M 
9.10 X 10-3 M 
15.0 X 10-3 M 
2. k 'l 6 13.8 
6.83 6.12 34.2 
6.99 8.27 35.0 
16.4 14.4 81.8 
5.08 3.70 6.35 
9.55 9.78 11.9 
14.1 13.7 17.6 
71.1 * 23.4 88.7* 
5.08 5.81 3.55 
16.5 14.1 11.6 
16.8 23.4 11.7 
25.7 5.6T 18.0 
7.52 6.06 3.76 
15.4 16.6 7.69 
15.6 16.7 7.79 
45.2 39.2 22.6 
Ki' (Modified Dixon) 8.21 x 10-3 M 
9.13 X 10-3 M 
9.59 X 10-3 M 
15.0 X 10-3 M 
10.3 
3.07 
41.3 
71.8 
4.63 
12.3 
17.1 
29.9 
4.07 
9.87 
16.4 
32.6 
3.03 
8.28 
8.35 
19.6 
Effect of (S)-homoserine lactone (31) on DHDPS kinetics with respect to 
(S)-aspartate p-semialdehyde (11) 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25°C, pyruvate (17) 80 mM) 
dH20 
DHDPS (2.0 x 10-4 D, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 mM to 1.3 mM in dH20) 
(S)-Homoserine lactone (31) 
(0.875 M to 0.5 Min 0.5 M Mops pH 3.5 at 25°C) 
3.0 ~l 
500~1 
257 ~l 
10 ~l 
100 ~l 
50 JlI 
80 !ll 
1.00 ml 
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The reaction was initiated in the cuvette by the addition of freshly prepared (S)-
aspartate p-semialdehyde (11), mixed by inversion of the cuvette. M 340 was measured 
over 300 seconds at 30°C, blanked against dH20. 
[(S)-Homoserine lactone (31)] = 0 mM 
[(S)-ASAJ l/[(S)-ASAJ Rate lIRate 
M x 10-4 M-1 X 103 j.1mol·s-1mg-1 x 10-1 mg,s'!-lmo I-I 
2.50 4.00 4.33 2.31 
2.50 4.00 5.64 1.77 
1.25 8.00 4.23 2.36 
1.25 8.00 4.27 2.34 
0.85 11.8 3.39 2.95 
0.85 11.8 3.19 3.13 
0.65 15.4 2.63 3.80 
0.65 15.4 2.76 3.62 
Lineweaver-Burk plot 
[(S)-Homoserine lactone (31)] = 40 mM 
[(S)-ASA] l/[(S)-ASA] Rate 1 IRate 
M x 10-4 M-1 X 103 j.1mol·s-Img-1 x 10-1 mg,s'!-lmol- 1 
2.50 4.00 1.11 * 8.98* 
2.50 4.00 2.00 5.00 
1.25 8.00 0.970* 10.3* 
1.25 8.00 1.92 5.20 
0.85 11.8 1.80 5.56 
0.85 11.8 1.64 6.10 
0.65 15.4 ].40 7.12 
0.65 ] 5.4 1.51 6.62 
Lineweaver-Burk plot 
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[( S)-Homo serine lactone (31)] = 60 mM 
[(S)-ASAJ lI[(S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 !J.mo]·s-1mg-1 x 10-1 mg ,s·!J.mol-1 
2.50 4.00 2.16 4.63 
2.50 4.00 2.34 4.27 
1.25 8.00 1.55 6.45 
1.25 8.00 1.70 5.88 
0.85 11.8 1.38 7.25 
0.85 11.8 1.30 7.69 
0.65 15.4 1.00 10.0 
0.65 15.4 1.10 9.09 
Lineweaver-Burk plot 
[(S)-Homoserine lactone (31)] = 70 mM 
[(S)-ASA] lI[(S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 jlmol·s·1mg-1 x 10-1 mg,s'/-lmol-1 
2.50 4.00 1.60 6.26 
2.50 4.00 1.46 6.86 
1.25 8.00 1.27 7.88 
1.25 8.00 0.627* 14.9* 
0.85 11.8 1.04 9.63 
0.85 11.8 1.05 9.51 
0.65 15.4 0.899 11.1 
0.65 15.4 1.02 9.79 
Lineweaver-Burk plot 
Determination of K . '. 
[(S)-ASA] [(S)-Homo-
Mx 10-4 serine lactone] 
M x 10-3 
2.50 0 
2.50 40 
2.50 60 
2.50 70 
1.25 0 
1.25 40 
1.25 60 
1.25 70 
0.85 0 
0.85 40 
0.85 60 
0.85 70 
0.65 0 
0.65 40 
0.65 60 
0.65 70 
Noncompetitive inhibition: 
Ki (Dixon) 3.20 x 10-2 M 
3.27 X 10-2 M 
3.61 X 10-2 M 
3.70 X 10-2 M 
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URate [(S)-ASA]lRate 
mg,s'llmo I-I s·mg·l- I x 102 
2.31 1.77 5.77 
8.98* 5.00 22.5* 
4.63 4.27 11.6 
6.26 6.86 15.6 
2.36 2.34 2.96 
10.3* 5.20 12.9* 
6.45 5.88 8.06 
7.88 14.9* 9.84 
2.95 3.13 2.51 
5.56 6.10 4.72 
7.25 7.69 6.16 
9.63 9.51 8.17 
3.80 3.62 2.47 
7.12 6.62 4.64 
10.0 9.09 6.50 
11.1 9.79 7.23 
~' (Modified Dixon) 3.19 x 10-2 M 
3.28 X 10-2 M 
3.61 X 10-2 M 
3.71 X 10-2 M 
4.43 
12.5 
10.7 
17.1 
2.93 
6.51 
7.35 
18.6* 
2.66 
5.18 
6.54 
8.10 
2.36 
4.30 
5.91 
6.37 
Ethyl (S)-a;y-diaminobutyrate dihydrochloride (66)2,3 
(S)-a,,¥-Diaminobutyric acid hydrochloride (65) (99.8 mg, 0.646 mmol) was 
suspended in dry ethanol (6.0 rnI). Dry hydrogen chloride gas was passed through the 
mixture, while being heated under reflux, until a clear solution was obtained (two to three 
hours). The solution was then heated under reflux overnight to remove any excess 
dissolved hydrogen chloride gas. The ethanol was then removed in vacuo, and any 
remaining residual solvent was removed by azeotroping with ethanol (2.0 ml) and toluene 
(1.0 rnI). IH NMR showed there was a mixture of product (two parts) and starting 
material (one part). The material was re-reacted in dry ethanol (6.0 ml). Dry hydrogen 
chloride gas was passed through the solution, while being heated under reflux, for two 
hours. The ethanol was removed in vacuo and any residual solvents were removed by 
azeotroping with ethanol (2.0 rnI) and toluene (1.0 ml), the solvents were removed in 
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vauo. Ethyl (S)-a;y-diaminobutyrate dihydrochloride (66) was obtained as a white 
viscous solid. 
The yield of ethyl (S)-a,y-diaminobutyrate dihydrochloride (66) was 121 mg (0.554 mol, 
85.8%). 
Mp (decomposition) 170°C (literature 172 °C3). 
IH NMR (300 MHz, D20) ()H 1.21 (3H, t, J = 7.3 Hz, -OCH2CH3), 2.07 - 2.34 (2H, m, 
-CH2CH2NH2), 3.05 - 3.23 (2H, m, -CH2NH2), 4.l2 - 4.17 (lH, m, -CHNH2), 4.24 
(2H, q, J = 6.9 Hz, -OCH2CH3) ppm. 
IR (KEr disc) u max 3426 (C-H (m», 3001 (m), 1742 (C=O (s», 1618 (m), 1501 (m), 
1237 (m) em-I. 
MS rnJz (FAB (gly» 147 (MH+, 100%), 132 (MH-CH3+, 100%),93 (100%), 75 
(100%). 
(S)~3-Aminopyrrolid.2-one (62)2,3 
Ethyl (S)-a,y-diaminobutyrate dihydrochloride (66) (92.8 mg, 0.423 mmol) was 
dissolved in dry ethanol (0.66 ml) and cooled to -5°C, in an atmosphere of dry nitrogen. 
A solution of sodium ethoxide, sodium (19 mg, 0.826 mmol) in dry ethanol (0.33 ml), 
was added with vigorous stirring. After two minutes the mixture was diluted with dry 
diethyl ether (1.99 ml). Sodium chloride immediately precipitated out and was removed 
by centrifugation (5 minutes, 15000 rpm). The yellow supernatant was evaporated in 
vacuo to give (S)-3-aminopyrrolid-2-one (62) as a brownish yellow solid. 
The yield of (S)-3-aminopyrrolid-2-one (62Ywas 18.5 mg (0.136 mmol, 32.2%). 
Mp 95 - 97°C (literature 98 - 99 OC3). 
lH NMR (300 MHz, D20) ()H 1.55 - 1.80 (m), 2.31 - 2.41 (2H, m, -CH2NH-) 2.56 -
2.61 (m), 3.15 - 3.27 (2H, m, -CH2CH2NH-), 3.45 - 3.47 (1H, m, -CHCH2CH2NH-) 
ppm. 
IR (KBr disc) u max 3196 (N-H (s», 2878 (C-H (s», 1682 (C=O (s», 1574 (s), 1408 
(w), 1294 (w), 1051 (w) em-I. 
MS rnJz (FAB (gly» 101 (M+, 22%). 
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Effect of (S)-3-aminopyrrolid-2-one (62) on DHDPS kinetics with respect 
to (S)-aspartate p-semialdehyde (11) 
Assay: 
NADPH (54 rnM in dH20) 
Buffer (200 rnM Mops pH 7.2 at 25 DC, pyruvate (17) 80 rnM) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 rnM) 
(S)-3-Aminopyrrolid-2-one (62) (0.525 M to 0.25 M in dH20) 
3.0 III 
500 III 
257 III 
10 III 
100 III 
50 III 
80 yJ 
1.00 rn1 
The reaction was initiated in the cuvette by the addition offreshly prepared (S)-
aspartate p-semialdehyde (11), mixed by inversion of the cuvette. M 340 was measured 
over 300 seconds at 30 DC, blanked against dH20. (S)-Aspartate p-semialdehyde (11) 
was present at a concentration of 0.25 rnM. The activity is the rate of reaction with 
inhibitor present relative to the rate of reaction in the absence of the inhibitor. 
Compound Concentration Activity 
ruM % 
(S)-3-aminopyrrolid-2-one 20 100 
(62) 40 85.0 
42 100 
Cyclopentanone oxime (68)4,5 
Cyc1opentanone (67) (8.88 mI, 0.10 mol) was stirred in a 250 ml round bottom flask 
fitted with a double surface reflux condenser and a thermometer. A solution of 
hydroxylamine hydrochloride (8.7g, 0.125 mol) in water (15.0 ml) was added as the 
mixture was stirred vigorously. A solution of anhydrous sodium carbonate (6.7 g, 63.0 
rnrnol) in water (25.0 mI) was added dropwise, via a separating funnel fitted to the reflux 
condenser, at such a rate that the temperature did not rise above 45 DC. The reaction was 
stirred for a further hour. The oxime solidified out of the aqueous layer, and was 
recrystallised from warm (40 DC) water. The white crystals of the oxime were collected 
over a sintered glass funnel. 
The yield of cyc1opentanone oxime (68) was 6.58 g (66.4 rnrnol, 66.4%). 
Mp 55 - 56 DC. 
lH NMR (300 MHz, CDCI3) OR 1.70 - 1.83 (4H, m, 2x -CH2C=NOH), 2.34 - 2.39 
(2H, m, 2x -CH2CH2C=NOH), 2.43 - 2.48 (2H, m, 2x -CH2CH2C=NOH) ppm. 
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lR (CDCI3 solution) 'Umax 2962 (C-H (s», 2857 (w), 1540 (s), 1447 (s), 1261 (s), 1097 
(s), 1016 (s) cm-I. 
MS m/z (El) 99 (M+) 
Aminocyclopentane (69)4.6 
Cyclopentanone oxime (68) (6.0 g, 60.1 mmol) in dry ethanol (35 ml) was heated 
under reflux on a water bath whilst sodium metal (9.0 g, 0.39 mol) was added. 
Additional ethanol (60 ml) was added to maintain a vigorous reaction and ensure all of the 
sodium had dissolved. The reaction was cooled and water (30 ml) was added, this was 
distilled off, over an oil bath, until the boiling point reached 80 DC. Additional water (30 
ml) was added and distillation was continued until the boiling point reached 92 DC. Most 
of the amine remained as a layer in the strongly alkaline solution and was extracted with 
diethyl ether (lOOml, 2 x 50 ml). Some of the amine had distilled over into the ethanol 
layer; this was then fractionally distilled, the amine layer being extracted with diethyl ether 
(40 ml, 2 x 20ml). The ether layers were combined and dried over sodium hydroxide. 
The solvent was removed under vaccum and the residue was then fractionally distilled 
under reduced pressure (~20 mm Hg); aminocyclopentane (69) was collected at 23 -
29 DC as a yellow oil. 
The yield of aminocyclopentane (69) was 2.Olg (23.7 mmol, 38.9%). 
Bp 23 - 29 DC (~20 mm Hg). 
IH NMR (300 MHz, CDCI3) OR 1.24 (4H, t, J = 7.4 Hz, 2x -CH2CH2CHNH2), 1.54 
(2H, bs, -NH2), 1.60 - 1.75 (lH, m, -CH2CHNH2), 1.78 - 1.87 (lH, m, 
-CH2CHNH2), 3.32 (lH, qu, J = 6.4 Hz, -CHNH2),3.71 (2H,q, J = 7.3 Hz, 
-CH2CHNH2) ppm. 
lR (CDCI3 solution) 'Umax 3619 (N-H (m», 2960 (s), 2872 (w), 1602 (w), 1449 (w), 
1255 (w) cm-I. 
MS mlz (E.!.) 85 (M+, 8%), 69 (M-NH/, 9%), 56 (CH2CH2CH2CH/, 37%), 40 
(100%). 
tert-Butyl hypochlorite (70)7 
Sodium hypochlorite bleach solution (6.25%, 250 ml) was cooled to below 10 DC 
and a solution of tert-butyl alcohol (71) (l8.5 ml, 0.195 mol) and glacial acetic acid (l2.3 
ml, 0.215 mol) were added, in a dark environment, to the rapidly stirring solution. 
Stirring was then continued for a further three minutes. The aqueous layer was 
discarded, and the organic layer was washed with 10% aqueous sodium carbonate (25 
ml) followed by water (25 ml). The resulting tert-butyl hypochlorite (70) was dried over 
calcium chloride (0.5 g), and filtered. The tert-butyl hypochlorite (70) was collected as a 
yellow liquid, and stored over calcium chloride, away from light, at -20 DC. 
The yield of tert-butyl hypochlorite (70) was 12.1 g (0.112 mol, 60.5%). 
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2-Aminocyclopentanone (63)8,9 
In a dry 100 ml three necked flask fitted with a magnetic stirrer, a dropping funnel, a 
calcium chloride drying tube, and a thermometer was placed aminocyc1opentane (69) 
(1.00 ml, 0.857 g, 10.1 mmol) in dry toluene (2.5 ml). The solution was stirred and 
cooled to 5 DC in an ice-salt bath. A solution of tert-butyl hypochlorite (70) (2.53 ml, 
20.7 mmol) in dry toluene (2.5 ml) was added dropwise at such a rate so as to maintain 
the temperature below 10 DC. The reaction was then stirred for 2.5 hours at room 
temperature. The drying tube was replaced with a reflux condenser, again fitted with a 
drying tube. Freshly prepared sodium (0.697 g, 30.3 mmol) in anhydrous methanol (7.1 
ml), see note 1, was added to the toluene solution dropwise so as to maintain a gentle 
reflux. The reaction was then heated under reflux (bath temperature 94 DC) for one hour 
whereupon a test with starch-iodide paper was negative, see note 2. 
The reaction mixture was then cooled in an ice bath, and the precipitated sodium 
chloride was removed by filtration through a sintered glass funnel. The filter cake was 
washed with three portions of dry toluene (3 x 1.25 ml), and the combined filtrates were 
then added very slowly, with stirring, to 2 M hydrochloric acid (7.6 ml) in a 50 ml 
beaker. The organic layer was removed in vacuo, and the remaining aqueous layer was 
then extracted with diethyl ether (2 x 20 ml). The dark brown aquous layer was 
evaporated to dryness in vacuo at a temperature not greater than 40 DC. The residue, in a 
500 ml round bottom flask, was heated under reflux for 30 minutes in a solution of 
isopropyl alcohol, concentrated hydrochloric acid (99: 1) (20.2 ml), then filtered, hot, 
through a sintered glass funnel. The residual solid, mainly sodium chloride, was re-
extracted with a solution of isopropyl alcohol and concentrated hydrochloric acid (99: 1) 
(7.6 ml). The two extracts were cooled separately at room temperature and then placed at 
4 DC overnight. 
Black micro-crystals had formed overnight, these were collected over a Buchner 
funnel and washed with dry diethyl ether (2.5 ml each). Each of the filtrates were then 
diluted with an equal volume of dry diethyl ether (20.2 ml and 7.6 ml respectively) and 
placed at 4 DC overnight. Large brown fern-crystals formed, these were recrystallised 
from hot isopropyl alcohol. The 2-aminocyc1opentanone (63) was obtained as a 
brownish white crystalline product. 
The yield of 2-aminocyc1opentanone (63) was 151 mg (1.12 mmol, 11.0%). 
Mp 142 DC (literature 146 -147 DC8). 
IH NMR (300 MHz, D20) 8H 1.46 - 1.78 (4H, m, -CH2CH2CHNH/), 1.93 - 1.97 (2H, 
m, -CH2C=O), 3.52 - 3.59 (lH, m, -CHNH2) ppm. 
IR (thin film) 'Umax 3431(N-H (m)), 2937 (C-H (s)), 1751 (C=O (s)), 1597, 1491, 1153, 
1059 cm- I . 
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HRMS m/z (FAB(gly) 100.07601 (M+-, 100% (CSHlONO requires 100.07624)). 
MS m1z (FAB(gly) 100 (M+-, 100%),93 (22%),82 (10%), 73 (56%), 61 (36%),57 
(14%). 
Note I: Anhydrous methanol was prepared by refluxing methanol (100 ml) over 
magnesium (1.0 g) for four hours. Inverse addition procedure was used for the 
preparation of the sodium methoxide, that is methanol was added dropwise to the sodium 
metal. 
Note 2: To perform a starch-iodide test, starch-iodide paper is moistened with 2 M 
hydrochloric acid. A positive test is indicated by the immediate formation of a dark 
violet/black spot, while a faint beige colour is a negative result. 
Effect of 2-aminocyclopentanone (63) on DHDPS kinetics with respect to 
(S)-aspartate ~-semialdehyde (11) 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC, pyruvate (17) (80 mM) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 mM) 
2-Aminocyclopentanone (63) (1.0 M to 0.50 M in dH20) 
3.0 f..LI 
500 f..LI 
257 f..LI 
10 f..LI 
100 f..LI 
50 f..LI 
.8QJJJ 
1.00 ml 
The reaction was initiated in the cuvette by the addition of freshly prepared (S)-
aspartate ~-semialdehyde (11), mixed by inversion of the cuvette. M340 was measured 
over 300 seconds at 30 DC, blanked against dH20. 
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[2 A . I t - mmocyc open anone = (63)] 0 mM 
[(S)-ASA] lI[(S)-ASA] Rate llRate 
Mx 10-4 M-1 X 103 ""mol's-1mg-1 x 10-1 mg·s·""mol- I 
2.50 4.00 3.69 2.71 
2.50 4.00 4.13 2.42 
1.25 8.00 3.27 3.06 
1.25 8.00 2.53 2.83 
0.85 11.8 2.93 3.41 
0.85 11.8 1.48* 6.78* 
0.65 15.4 2.21 4.53 
0.65 15.4 2.69 3.72 
Lineweaver-Burk plot V
max 
= 5.16 X 10-1 ""mol·s-1mg-1 Km = 0.706 X 10-4 M 
[2-Aminocyc1opentanone (63)] = 40 mM 
[(S)-ASA] 1/[(S)-ASA] Rate llRate 
Mx 10-4 M-1 X 103 ""mol·s-1mg-1 x 10-1 mg,s'!lmol- I 
2.50 4.00 2.93 3.41 
2.50 4.00 5.45* 1.83* 
1.25 8.00 2.64 3.78 
1.25 8.00 2.35 4.26 
0.85 11.8 1.39 7.19 
0.85 11.8 1.11 8.97 
0.65 15.4 0.825 12.1 
0.65 15.4 1.30 7.71 
Lineweaver-Burk plot V max and Km were not able to be estimated accurately. 
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[2-Aminocyc1opentanone (63)] = 60 mM 
[(S)-ASA] lI[(S)-ASA] Rate 1IRate 
M x 10-4 M-I X 103 I!mol·s-Img-l x 10-1 mg,s'l!mol- 1 
2.50 4.00 3.20 3.13 
2.50 4.00 3.64 2.74 
1.25 8.00 2.65 3.77 
1.25 8.00 2.60 3.85 
0.85 11.8 2.05 4.88 
0.85 11.8 2.44 4.09 
0.65 15.4 1.78 5.60 
0.65 15.4 1.92 5.20 
Lineweaver-Burk plot 
[2 A . t - rmnocyc open anone = (63)] 80mM 
[(S)-ASA] lI[(S)-ASA] Rate 1 IRate 
Mx 10-4 M-I X 103 Ilmol·s-Img-J x 10-1 mg,s'l!mor l 
2.50 4.00 2.50 4.00 
2.50 4.00 2.58 3.88 
1.25 8.00 1.91 5.22 
1.25 8.00 2.02 4.96 
0.85 11.8 1.67 5.97 
0.85 11.8 1.64 6.09 
0.65 15.4 1.28 7.80 
Lineweaver-Burk plot 
Determination of K: 
[(S)-ASA] [2-Amino 
M x 10-4 cyclo-
pentanone] 
M x 10-3 
2.50 0 
2.50 40 
2.50 60 
2.50 80 
1.25 0 
1.25 40 
1.25 60 
1.25 80 
0.85 0 
0.85 40 
0.85 60 
0.85 80 
0.65 0 
0.65 40 
0.65 60 
0.65 80 
Noncompetitive inhibition: 
Kj (Dixon) 1.23 x 10'1 M 
1.49 X 10-1 M 
1.76 X 10-1 M 
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lIRate [(S)-ASA]lRate 
mg,s'J!mo 1'1 s·mg .1- 1 x 102 
2.71 6.78 6.05 
8.53 4.59* 
3.13 2.74 7.81 6.87 
4.00 3.88 10.0 9.69 
3.06 2.83 3.82 I 3.54 
3.78 4.26 4.73 5.32 
3.77 3.85 4.72 4.81 
5.22 4.96 6.54 6.19 
3.41 6.78* 2.90 5.74* 
7.19 8.97 6.12 7.66 
4.88 4.09 4.15 3.48 
5.97 6.09 5.09 5.18 
4.53 3.72 2.94 2.42 
12.1 7.71 7.88 5.00 
5.60 5.20 3.65 3.39 
7.80 3.96 
~' (Modified Dixon) 1.23 x 10-1 M 
1.77 X 10'1 M 
2.36 X 10-1 M 
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Picryl chloride (73) (1-chloro-2,4,6,-trinitrobenzene)2,1O,11 
1-Chloro-2,4-dinitrobenzene (72) (23.9 g, 0.118 mol) was dissolved in concentrated 
sulfuric acid (98%, 185 ml) and stirred for three hours in a 500 ml round bottomed flask 
stoppered with glass wooL Fuming concentrated nitric acid (30 ml) was then added 
dropwise, the solution became yellow brown in colour. The reaction was heated, in an 
oil bath, to 135°C with an air condenser attached, again stoppered with glass wool. The 
reaction turned a deep orange and was heated under reflux for 21 hours. The reaction 
was cooled for 15 minutes, turning a clear pale yellow, and added slowly to 2.0 lof 
distilled water in a 3 I beaker. A yellowish green liquid formed; this was left for 72 hours 
where upon a yellow precipitate had formed. The yellow 1-chloro-2,4,6, trinitrobenzene 
(73) was removed via suction through a sintered glass funnel. 
The yield of picryl chloride (73) was 27.3 g (0.110 mol, 93.3 %). 
Mp 75 -76°C. 
IH NMR (300 MHz, CDCI3) OH 8.86 (2H, s, aryl) ppm. 
lR (CDCI3 solution) umax 3092 (C-H (s», 1606 (s), 1546 (N-02 (s», 1340 (s) cm-I. 
MS mlz (El) 247 (M+, 100%), 149 (65%),109 (M-3N02+, 65%),74 (M-(3N02+CI)+, 
65%),40 (65%). 
Sodium picrylsulfonate (74)2,11,]2 
Sodium bisulfite (0.246 mol), were added to absolute ethanol (20 ml). This mixture 
was then added to picryl chloride (73) (25.1 g, 0.102 mol) suspended in absolute ethanol 
(300 ml) and heated under reflux for six hours (bath temperature 110 "c). The reaction 
was cooled to 0 "C where the crude sodium piCrylsulfonate (74) precipitated, this was 
filtered off and stirred into distilled water (50 ml). The aqueous suspension was heated 
under reflux until all the solid had dissolved, approximately ten hours. During this time 
the solution lightened from deep red to pale orange. The hot solution was filtered, and 
the filtrate cooled to 0 0c, The sodium picrylsulfonate (74) immediately crystallised, 
where it was recrystallised once from boiling water, and once from 50% ethanol in 50% 
water. The sodium picryl sulfonate (74) was collected as fine pale yellow crystals. 
The yield of sodium picrylsulfonate (74) was 2.83 g (9.05 mmol, 8.8%). 
Mp >215 "C. 
IH NMR (300 MHz, D20) 0H 8.82 (2H, s, aryl) ppm. 
lR (KBr disc) umax 3096 (C-H (s», 1542 (N-02 (s», 1355 (s), 1270 (s), 1236 (s) cm-I • 
Picrylsulfonic acid (75)2,11,12 
Sodium picrylsulfonate (74) (2.50 g, 7.99 mmol) was dissolved in propanone (25 
ml), and filtered through decolourising charcoaL Concentrated hydrochloric acid (1.25 
ml) was added to the filtrate and the precipitated sodium chloride was filtered off. The 
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filtrate was then concentrated in vacuo to 7.5 mI, and the further precipitated sodium 
chloride was filtered off. The filtrate was then concentrated to dryness, in vacuo, the 
residue being recrystallised from a hot solution of ethanol (2.5 ml), water (1.5 ml), and 
concentrated hydrochloric acid (3.5 ml). The picryl sulfonic acid (75) formed pale yellow 
crystals which were collected over a sintered glass funnel. 
The yield of picryl sulfonic acid (75) was 891 mg (3.04 mmol, 38.1 %). 
Mp (decomposition) 172 - 176°C, literature 190 °C. 13 
IH NMR (300 MHz, D20) OH 8.77 (2H, s, aryl) ppm. 
IR (KBr disc) u max 3489 (m), 3095 (C-H (w», 1652 (w), 1609 (w), 1550 (N-02, (s», 
1355 (s), 1271 (s), 1235 (s) cm-I. 
MS rn/z (E.I.) 293 (M+, 1%),213 (M-S03H+, 100%),167 (25%),120 (40%),75 
(90%). 
(S)~ Aspartate p-semialdehyde hydrate picrylsulfonate2 
Picrylsulfonic acid (75) (41.9 mg, 133 Ilmol, 2.3 equivalents) was dissolved in 
water (1.5 mI) and then added to the (S)-N-tert-butoxycarbonylaspartic acid p-
sernialdehyde p-methoxybenzyl ester (53) (19.6 mg, 58 Ilmol) and anisole (6.3 111,58 
Ilmol, 1.0 equivalent), flushed with nitrogen, and left to react for three hours. The water 
was removed in vacuo yielding an oily white solid. Further water (2 x 1.5 mI) was added 
and removed in vacuo yielding an impure sample of the above named product. Attempts 
to crystallise the above product in water, water and dioxane, water and acetonitrile, 
ethanol, and diethyl ether all failed. 
The yield of the impure (S)-aspartic acid p-semialdehyde hydrate picryl sulfonate was 
56.0 mg. 
IH NMR (300 MHz, D20) OH 2.06 - 2.15 (2H, m, -CH2CHNH2), 4.17 4.18 (1H, m, 
-CHNH2), 5.11 - 5.10 (1H, m, -CH(OH)2)' 8.81 (2H, s, aryl, picryl sulfonate) ppm. 
IR (thin film) u
max 3445(O-H, C-H (s», 1636 (w), 1542 (m), 1355 (m) cm- l • 
MS m/z (FAB(gly» 277 (20%), 185 (90%),93 (100%). 
Stability of (S)-aspartate J3-semialdehyde hydrate trifluoroacetate (lIb) at 
pH = 7 in D20. 
After 24 hours the signal at OH 1.97 - 2.21 (m, -CHzCHNH2) is reduced in intensity. 
After 96 hours this signal has disappeared. 
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IH NMR of (S)-aspartate f3-semialdehyde hydrate trifluoroacetate (lJb) as 
a function of pH. 
pH = 1. 
IH NMR (300 MHz D20) 0H 1.98 - 2.20 (2H, m, -CH2CHNH2), 4.00 -4.04 (lH, m, 
-CHNH2), 5.19 - 5.22 (1H, m, -CH(OH)2) ppm. 
pH =4. 
IH NMR (300 MHz D20) 0H 1.96 - 2.16 (2H, m, -CH2CHNH2), 3.85 - 3.89 (1H, m, 
-CHNH2), 5.16 - 5.20 (lH, m, -CH(OH)2) ppm. 
pH=7. 
IH NMR (300 MHz D20) 0H 1.91 (2H, m, -CH2CHNH2), 3.55 (1H, m, -CHNH2), 
5.12 (lH, m, -CH(OH)2) 9.58 (1H, s, -CHO) ppm. 
pH = 9. 
IH NMR (300 MHz D20) 0H 1.80 (2H, m, -CH2CHNH2), 3.39 (1H, m, -CHNH2), 
5.10 (1H, m, -CH(OH)2) 9.58 (1H, s, -CHO) ppm. 
Attempts to prepare aldehyde derivatives of (S)-aspartate ~-semialdehyde 
trifluoroacetate (11)4 
Using semi-carbazide 
Stock solution 1 g semi-carbazide hydrochloride 
1.5 g crystallised sodium acetate 
(S)-Aspartate ~-semialdehyde (11) (pH = 7, in phosphate buffer 
(KH2PO/K2HP04), 2 mg) and reagent (0.02 ml) gave no crystalline semi-carbazone. 
Using 2~4-dinitrophenylhydrazine 
Stock solution 0.25 g 2,4-dinitrophenylhydrazine suspended in 5.0 rn1 methanol 
0.5 rn1 concentrated sulfuric acid 
The solution was then filtered 
(S)-Aspartate ~-semialdehyde (11) (pH = 7, in phosphate buffer, 2 mg) and reagent 
(0.05 ml) gave no crystalline hydrazone. 
Using hydroxylamine 
Stock solution 1.0 g hydroxylamine hydrochloride 
2.0 g crystallised sodium acetate 
8 - 10 ml water 
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(S)-Aspartate ~-semialdehyde (11) (pH = 7, in phosphate buffer, 2 mg) and reagent 
(0.04 ml) heated on a water bath for 10 minutes failed to give a crystalline oxime. 
Using benzaldehyde 
(S)-Aspartate ~-semialdehyde (11) (pH = 7, in phosphate buffer, 2mg), 
benzaldehyde (2.1 mg, 2 ~l), ethanol (0.02 ml), and 5 M NaOH (1 ~l) gave no isolable 
derivative. 
Using dimedone 
Stock solution Saturated aqueous dimedone solution 
(S)-Aspartate ~-semialdehyde (11) (pH = 7, in phosphate buffer, 2 mg) added to 
reagent gave no isolable derivative. 
Preparation S-methyl (R)-cysteine sulfoxide (77)14 
30% Hydrogen peroxide (1.48 ml, approximately 14.8 mmol) was added dropwise 
to a stirred solution of S-methyl (R)-cysteine (76) (1.00 g, 7.40 mmol) in water (37 ml). 
After three hours at room temperature methanol (18.5 ml) and propanone (148 ml) were 
added and the solution was left overnight, during which time the sulfoxide (77) 
precipitated as a white solid (a mixture of the two diasteroisomers). 
The yield of S-methyl (R)-cysteine sulfoxide (77) was 260 mg (1.72 mmol, 23.2%). 
Mp (decomposition) 150 - 155°C. 
IH NMR (300 MHz, D20) ()H 2.75 (3H, s, -SCH3), 3.12 - 3.19 (1H, m, -CH2SCH3), 
3.29 - 3.45 (1H, m, -CH2SCH3), 4.11 - 4.21 (1H, m, -CHNH2) ppm. 
13C NMR (75 MHz, D20) ()e 39.33 (-SCH3); 40.27 (-SCH3); 52.30, 53.09, 54.23, and 
55.08 (2 x -CH2CHNH2), 118.24 (-C=O), 173.44 (-C=O) ppm. 
IR (KEr disc) umax 3431 (N-H (s)), 2918 (C-H (m)), 1630 (C=O (s)), l385 (m), 1022 
(S=O (s)) em-I. 
HRMS mJz (FAB (gly)) 152.03796 (MH+, 100% (C4HIO03N32S requires 152.03814)). 
MS mJz (FAB (gly)) 152 (MH+, 100%), l36 (M-CH3+, 46%), 119 (20%), 110 (20%). 
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Preparation of S-methyl (R)-cysteine sulfone (78)15 
Ammonium molybdate (91 mg, 73.6 !-Lmol) was added to water (2.7 ml), followed 
by the addition of 70% perchloric acid (0.63 ml, 73.0 !-Lmol). The solution was boiled 
for five minutes, then filtered and left to cool. S-Methyl (R)-cysteine (76) (1.00 g, 7.4 
mmol) was added to 0.738 ml of the solution prepared above in a 25 ml round bottom 
flask. Additional water (0.6 ml) was added and the resulting thick slurry was stirred at 
o DC. 30% Hydrogen peroxide solution (1.29 ml, 12.6 !-Lmol) was added in 0.1 ml 
portions while maintaining the reaction at 0 DC. After addition of the hydrogen peroxide 
was complete the temperature was allowed to rise, and the reaction was stirred overnight 
at room temperature. The product precipitated out as a yellow solid and was collected by 
filtration followed by washing with water (25 ml), ethanol (25 mI), and diethyl ether (25 
ml). The S-methyl (R)-cysteine sulfone (78) formed a yellowish white powder. 
The yield of S-methyl (R)-cysteine sulfone (78) was 349 mg (2.09 mmol, 28.2%). 
Mp 174 - 178 DC. 
IH NMR (300 MHz, D20) DR 3.17 (3H, s, -SCH3), 3.64 - 3.72 (2H, m, -CHNH2), 
3.90 (1H, d, J = 15.5 Hz, -CH2CHNH2), 4.23 (1H, d, J = 9.5 Hz, -CH2CHNH2) ppm. 
l3C NMR (75 MHz, D20) Dc 43.03 (-SCH3), 51.00 (-CH2-), 55.74 (-CH-), 172.43 
(-COOH) ppm. 
IR (KEr disc) 'Umax 3225 (N-H (w)), 2880 (C-H (m)), 1558 (C=O (s)), 1410 (S=O (m)) 
1387 (S=O (m)), 1356 (m), 1281 (m), 1207 (m), 1119 (m) cm-1• 
HRMS rn/z (FAB (gly)) 168.03270 (MH+, 78% (C4HloN0/2S requires 168.03306)). 
MS rn/z (FAB (gly)) 168 (MH+, 78%),122 (10%),110 (8%). 
Effect of (S)-aspartate ~-semialdehyde hydrate (l1b) mimics on DHDPS 
kinetics 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC, pyruvate (17) 80 mM) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 mM) 
Inhibitor (appropriate concentration) 
3.0/-ll 
500/-ll 
137/-ll 
10 /-ll 
100 !-Ll 
50/-ll 
200 III 
1.00 ml 
The reaction was initiated in the cuvette by the addition of freshly prepared (S)-
aspartate ~-semialdehyde (11), mixed by inversion of the cuvette. ilA340 was measured 
over 300 seconds at 30 DC, blanked against dH20. (S)-Aspartate ~-semialdehyde was 
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present at a concentration of 0.25 ruM. The activity is the rate of reaction with inhibitor 
present relative to the rate of reaction in the absence of the inhibitor. 
Compound Concentration Activity 
ruM % 
S-Methyl (R)-cysteine (76) 50 119 
S-Methyl (R)-cysteine 
sulfoxide (77) 50 112 
S-Methyl (R)-cysteine 
sulfone (78) 50 96.1 
(R)-Cysteine sulfinic acid 50 11.0 
(79) 10 62.8 
5.0 94.2 
(S)-Aspartic acid (9) 50 29.1 
30 45.2 
5.0 95.5 
ine (80) 50 109 
(S)-Glutamic acid (81) 50 12.4 
10 83.0 
5.0 119 
Effect of (R)-cysteine sulfinic acid (79) on DRDPS kinetics with respect 
to (S)-aspartate ~-semialdehyde (11) 
Assay: 
NADPH (54 ruM in dH20) 
Buffer (200 ruM Mops pH 7.2 at 25°C, pyruvate (17) 80 ruM) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 ruM to 1.30 mM in dH20) 
(R)-Cysteine sulfinic acid (79) (150 ruM to 40 ruM in dH20) 
3.0 III 
500 III 
l37 III 
10 III 
100 III 
50 III 
200 !AI 
1.00 ml 
The reaction was initiated in the cuvette by the addition of freshly prepared (S)-
aspartate ~-semialdehyde (11), mixed by inversion of the cuvette. AA340 was measured 
over 300 seconds at 30°C, blanked against dH20. 
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Run 1: 
[(R)-Cysteine sulfinic acid (79)] = 0 mM 
[(S)-ASA] 1/[(S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 !-lmol·s-1mg-1 x 10-1 mg,s·jl.mol- I 
2.50 4.00 3.66 2.73 
2.50 4.00 4.21 2.37 
1.25 8.00 2.96 3.38 
1.25 8.00 2.62 3.81 
0.85 11.8 2.35 4.25 
0.85 11.8 2.10 4.77 
0.65 15.4 1.73 5.78 
0.65 15.4 1.99 5.02 
Lineweaver-Burk plot 
[(R)-Cysteine sulfinic acid (79)] = 8 mM 
[(S)-ASA] 1/[(S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 !-lmol·s-1mg-1 x 10-1 mg,s'!-lmol- I 
2.50 4.00 3.53 2.83 
2.50 4.00 3.51 2.85 
1.25 8.00 2.72 3.68 
1.25 8.00 2.69 3.72 
0.85 11.8 2.00 5.01 
0.85 11.8 2.36 4.24 
0.65 15.4 2.01 4.98 
0.65 15.4 1.91 5.24 
Lineweaver-Burk plot 
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[(R)-Cysteine sulfinic acid (79)] = 15 rnM 
[(S)-ASA] l/[(S)-ASA] Rate lJRate 
M x 10-4 M-1 X 103 Ilmol's-Img-I x 10-1 mg,s'jlmo1-1 
2.50 4.00 2.90 3.45 
2.50 4.00 2.96 3.38 
1.25 8.00 1.78 5.60 
1.25 8.00 1.97 5.07 
0.85 11.8 1.91 5.23 
0.85 11.8 1.84 5.43 
0.65 15.4 1.32 7.56 
0.65 15.4 1.21 8.24 
Lineweaver-Burk plot 
[(R)-Cysteine sulfinic acid (79)] = 25 rnM 
[(S)-ASA] l/[(S)-ASA] Rate lIRate 
Mx 10-4 M-1 X 103 Ilmo1·s-lmg-1 x 10-1 mg· s· !lmo1-1 
2.50 4.00 1.65 6.05 
2.50 4.00 1.76 5.68 
1.25 8.00 1.15 8.72 
1.25 8.00 1.11 9.04 
0.85 11.8 1.08 9.28 
0.85 11.8 1.01 9.91 
0.65 15.4 0.928 10.8 
Lineweaver-Burk plot Vmax = 2.15 X 10-1 Ilmol·s-Img-I Km = 0.919 X 10-
4 M 
Determination of K' 
[(S)-ASA] [( R)-Cysteine 
Mx 10"4 sulfinic acid] 
Mx 10-3 
2.50 0 
2.50 8.0 
2.50 15 
2.50 25 
1.25 0 
1.25 8.0 
1.25 15 
1.25 25 
0.85 0 
0.85 8.0 
0.85 15 
0.85 25 
0.65 0 
0.65 8.0 
0.65 15 
0.65 25 
Uncompetitive inhibition: 
K/ (Modified Dixon) 2.62 x 10"3 M 
3.72 X 10-3 M 
4.04 X 10-3 M 
12.1 X 10"3 M 
13.9 X 10-3 M 
lIRate 
mg,s'Jlmo 
2.73 
2.83 
3.45 
6.05 
3.38 
3.68 
5.60 
8.72 
4.25 
5.01 
5.23 
9.28 
5.78 
4.98 
7.56 
10.8 
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[(S)-ASA]IRate 
I-I s·mg·t1 x 102 
2.37 6.83 5.93 
2.85 7.08 7.13 
3.38 8.63 8.45 
5.68 15.1 14.2 
3.81 4.23 4.76 
3.72 4.60 4.65 
).UI 00 6.34 
9.04 10.9 11.3 
4.77 3.61 4.0'-::: 
4.24 4.26 3.60 
5.43 4.45 4.62 
9.91 7.89 8.42 
5.02 3.76 3.26 
5.24 3.24 3.41 
8.24 4.91 5.36 
7.02 
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Run 2: 
[(R) Ct' - ;ys eme su If' 'd (79)] 0 mM mlC act = 
[(S)-ASA] 1/[(S)-ASAJ Rate lIRate 
Mx 104 M-I X 103 IlffioI·s-1mg-1 x 10-1 mg,sj-lmol- I 
2.50 4.00 3.66 2.73 
2.50 4.00 4.21 2.37 
1.25 8.00 2.96 3.38 
1.25 8.00 2.62 3.81 
0.85 11.8 2.35 4.25 
0.85 11.8 3.30 3.03 
0.65 15.4 1.73 5.78 
0.65 15.4 1.68 5.94 
Lineweaver-Burk plot 
[(R)-Cysteine sulfinic acid (79)] = 10 mM 
[(S)-ASAJ 1/[(S)-ASAJ Rate lIRate 
Mx 104 M- I X 103 Ilmol·s·1mg- 1 x 10-1 mg,s'llmo1 1 
2.50 4.00 2.64 3.78 
2.50 4.00 2.86 3.50 
1.25 8.00 0.810* 12.3 
1.25 8.00 2.14 4.67 
0.85 1l.8 1.91 5.23 
0.85 11.8 2.24 4.46 
0.65 15.4 1.88 5.32 
0.65 15.4 1.68 5.94 
Lineweaver-Burk plot 
Experimental 226 
[(R)-Cysteine sulfinic acid (79)] = 20 mM 
[(S)-ASA] lI[(S)-ASA] Rate lfRate 
Mx 10-4 M-1 X 103 llmol·s-1mg-1 x 10-1 mg,s'llmol- 1 
2.50 4.00 2.09 4.79 
2.50 4.00 2.02 4.95 
1.25 8.00 1.80 5.57 
1.25 8.00 1.50 6.66 
0.85 11.8 2.03 4.93 
0.85 11.8 1.48 6.75 
0.65 15.4 1.17 8.51 
0.65 15.4 1.26 7.92 
Lineweaver-Burk plot Vrnax = 2.66 X 10-1 llmoJ.s-1mg-1 Krn = 0.679 X 10-4 M 
[(R) C If" d (79)] 30 mM - :ysteme su Imc aCl = 
[(S)-ASA] 1/[(S)-ASA] Rate lIRate 
Mx 10-4 M-1 X 103 !1,ffiol·s-lmg-1 x 10-1 mg'SJlmOr l 
2.50 4.00 1.16 8.62 
2.50 4.00 1.36 7.37 
1.25 8.00 0.923 10.8 
1.25 8.00 1.30 7.70 
0.85 11.8 0.741 13.5 
0.85 11.8 0.894 11.2 
0.65 15.4 0.902 11.1 
0.65 15.4 0.831 12.0 
Lineweaver-Burk plot 
Determination of K' '. 
[(S)-ASA] [(R)-Cysteine 
Mx 10-4 sulfinic acid] 
Mx 10-3 
2.50 0 
2.50 10 
2.50 20 
2.50 30 
1.25 0 
1.25 10 
1.25 20 
1.25 30 
0.85 0 
0.85 10 
0.85 20 
0.85 30 
0.65 0 
0.65 10 
0.65 20 
0.65 30 
Dncompetitive inhibition 
K/ (Modified Dixon) 6.13 x 10-3 M 
6.84 X 10-3 M 
8.64 X 10-3 M 
Experimental 227 
lIRate [(S)-ASA]lRate 
mg,s'llmol-1 s·mg·l-1 x 102 
2.73 2.37 6.83 5.93 
3.78 3.50 9.45 8.75 
4.79 4.95 12.0 12.4 
8.62 7.37 21.6 18.4 
3.38 3.81 4.23 4.76 
12.3* 4.67 15.4* 5.84 
5.57 6.66 6.96 8.33 
10.8 7.70 13.5 9.63 
4.25 3.03 3.61 2.58 
5.23 4.46 4.44 3.79 
4.93 6.75 4.19 5.74 
13.5 11.2 11.5 9.52 
5.78 5.94 3.76 3.86 
5.32 5.94 3.46 3.86 
8.51 7.92 5.53 5.15 
11.1 12.0 7.22 7.80 
Effect of (S)-aspartic acid (9) on DHDPS kinetics with respect to (S)-
aspartate ~-semialdehyde (11) 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC, pyruvate (17) 80 mM) 
dH20 
DHDPS (2.0 x 10-4 D, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 mM to 1.30 mM in dH20) 
(S)-Aspartic acid (9) (150 mM to 50 mM in d~O) 
3.0 III 
500 III 
137 III 
10 III 
100 III 
50 III 
200 ~Ll 
1.00 m1 
Experimental 228 
The reaction was initiated in the cuvette by the addition of freshly prepared (S)-
aspartate ~-semialdehyde (11), mixed by inversion of the cuvette . .1A340 was measured 
over 300 seconds at 30 DC, blanked against dH20. 
Run 1: 
[(S)-Aspartic acid (9)] = 0 mM 
[(S)-ASA] l/[(S)-ASA] Rate lIRate 
M x 10-4 M-1 X 103 ~mol·s-lmg-l x 10-1 mg,s·J.!mol- 1 
2.50 4.00 3.60 2.78 
2.50 4.00 3.92 2.55 
1.25 8.00 2.27 4.41 
1.25 8.00 3.01 3.32 
0.85 11.8 2.22 4.51 
0.85 11.8 2.21 4.52 
0.65 15.4 1.88 5.32 
0.65 15.4 1.60 6.25 
Lineweaver-Burk plot 
[(S)-Aspartic acid (9)] = 10 mM 
[(S)-ASA] l/[(S)-ASA] Rate lIRate 
Mx 10-4 M-1 X 103 ~mol·s-Img-l x 10-1 mg,s'!-Lmol- 1 
2.50 4.00 1.95 5.12 
2.50 4.00 2.22 4.51 
1.25 8.00 1.57 6.39 
1.25 8.00 1.33 7.55 
0.85 11.8 1.84 5.43 
0.85 11.8 1.01 9.86 
0.65 15.4 0.943 10.6 
0.65 15.4 1.06 9.42 
Lineweaver-Burk plot 
Experimental 229 
[(S) A 'd (9)] 20 mM - spartlc aCl = 
[(S)-ASA] l/[(S)-ASA] Rate I IRate 
Mx 10-4 M-1 X 103 flmol·s-Img-I x 10-1 mg,s'flmol- I 
2.50 4.00 2.61 3.83 
2.50 4.00 2.71 3.68 
1.25 8.00 1.99 5.01 
1.25 8.00 1.32 7.59 
0.85 11.8 0.898 11.1 
0.85 11.8 0.727 13.8 
0.65 15.4 1.01 9.90 
0.65 15.4 0.765 13.1 
Lineweaver-Burk plot 
[(S)-Aspartic acid (9)] = 30 mM 
[(S)-ASA] l/[(S)-ASA] Rate 1 IRate 
Mx 10-4 M-1 X 103 flmol·s-Img-I x 10-1 mg,s'jlmol- I 
2.50 4.00 1.47 6.79 
2.50 4.00 2.39 4.19 
1.25 8.00 1.61 6.22 
1.25 8.00 1.51 6.62 
0.85 11.8 1.34 7.46 
0.85 11.8 0.855 11.7 
0.65 15.4 1.06 9.47 
0.65 15.4 0.805 12.4 
Lineweaver-Burk plot 
Experimental 230 
Determination of K' 
[(S)-ASA] [(S)-Aspartic lIRate [(S)-ASA]lRate 
M x 10-4 acid] mg,s'llmo I-I s·mg·1- 1 x 102 
Mx 10-3 
2.50 0 2.78 2.55 6.95 6.38 
2.50 10 5.12 4.51 12.8 11.3 
2.50 20 3.83 3.68 9.58 9.20 
2.50 30 6.79 4.19 17.0 10.5 
1.25 0 4.41 3.32 5.51 4.15 
1.25 10 6.39 7.55 7.99 9.44 
1.25 20 5.01 7.59 6.26 9.49 
1.25 30 6.22 6.62 7.78 8.29 
0.85 0 4.51 4.52 3.83 3.84 
0.85 10 5.43 9.89 4.62 8,41 
0.85 20 11.1 13.8 9.44 11.8 
0.85 30 7.46 11.7 6.34 9.95 
0.65 0 5.32 6.25 3.46 4.06 
0.65 10 10.6 9.42 6.89 6.12 
0.65 20 9.90 13.1 6.44 8.52 
0.65 30 9.47 12.4 6.16 8.06 
The type of inhibition could not be determined unambiguously. 
Experimental 231 
Run 2: 
[(S) A f 'd (9)] 0 mM - spar IC aCl = 
[(S)-ASA] 1/[(S)-ASA] Rate lIRate 
M x 10-4 M-l X 103 Jlmol·s-1mg-l x 10-1 mg,sjlmol- l 
2.50 4.00 3.93 2.55 
2.50 4.00 4.23 2.36 
1.25 8.00 3.01 3.32 
1.25 8.00 2.70 3.70 
0.85 11.8 2.41 4.15 
0.85 11.8 2.38 4.20 
0.65 15.4 1.99 5.03 
0.65 15.4 1.89 5.28 
Lineweaver-Burk plot 
[(S)-Aspartic acid (9)] = 10 mM 
[(S)-ASAJ l/[(S)-ASAJ Rate 1 IRate 
M x 10-4 M- l X 103 !!mol·s-1mg-1 x 10-1 mg,s'!!ffio1- 1 
2.50 4.00 3.12 3.21 
2.50 4.00 3.72 2.69 
1.25 8.00 2.72 3.68 
1.25 8.00 2.59 3.86 
0.85 11.8 1.97 5.07 
0.85 11.8 2.09 4.79 
0.65 15.4 1.88 5.33 
0.65 15.4 1.60 6.27 
Lineweaver-Burk plot 
Experimental 232 
[(S)-Aspartic acid (9)] = 20 mM 
[(S)-ASA] l/[(S)-ASA] Rate 1 IRate 
M x 10-4 M-1 X 103 !lmol·s-1mg-1 x 10-1 mg,s·J,.lmol- 1 
2.50 4.00 2.18 4.58 
2.50 4.00 2.41 4.16 
1.25 8.00 1.73 5.78 
1.25 8.00 1.19 8.43 
0.85 11.8 1.45 6.89 
0.85 11.8 1.57 6.39 
0.65 15.4 1.35 7.43 
0.65 15.4 1.32 7.60 
Lineweaver-Burk plot Vrnax = 2.46 X 10-1 /lmol·s-1mg-1 Krn = 0.586 X 10-4 M 
[(S)-Aspartic acid (9)] = 30 mM 
[(S)-ASA] l/[(S)-ASA] Rate 1 IRate 
M x 10-4 M-1 X 103 !lmol·s-1mg-1 x 10-1 mg,s'!lmol- 1 
2.50 4.00 1.84 5.43 
2.50 4.00 1.81 5.53 
1.25 8.00 1.33 7.53 
1.25 8.00 1.14 8.77 
0.85 11.8 0.895 11.2 
0.85 11.8 0.975 10.3 
0.65 15.4 0.766 13.1 
0.65 15.4 0.744 13.4 
Lineweaver-Burke plot 
Determination of K' 
[(S)-ASA] [(S)-Aspartic 
Mx 10-4 acid] 
Mx 10-3 
2.50 0 
2.50 10 
2.50 20 
2.50 30 
1.25 0 
1.25 10 
1.25 20 
1.25 30 
0.85 0 
0.85 10 
0.85 20 
0.85 30 
0.65 0 
0.65 10 
0.65 20 
0.65 30 
Mixed inhibition: 
Ki (Dixon) 0.868 x 10-2 M 
1.07 X 10-2 M 
1.13 X 10-2 M 
1.15 X 10-2 M 
1.19 X 10-2 M 
1.36 X 10-2 M 
I 
Experimental 233 
lIRate [(S)-ASA] IRate 
mg,s·J.lmo 1-' s·mg·t1 x 102 
2.55 2.36 I 6.38 
~ I ~ I 8.03 £.. I 4.16 11.5 
5.43 5.53 13.6 
3.32 3.70 4.15 
3.68 3.86 4.60 
5.78 8.43 7.23 
7.53 8.77 9.41 
4.15 4.20 3.53 
5.07 4.79 4.31 
6.89 6.39 5.86 
11.2 10.3 9.52 
5.03 5.28 3.27 
5.33 6.27 3.46 
7.43 7.60 4.83 
13.1 13.4 8.52 
K/ (Modified Dixon) 2.12 x 10-2 M 
2.53 X 10-2 M 
2.69 X 10-2 M 
3.20x 1O-2 M 
3.37 x 10-2 M 
3.87 X 10-2 M 
5.90 
6.73 
10.4 
13.8 
4.63 
4.83 
10.5 
11.0 
3.57 
4.07 
5.43 
8.76 
3.43 
4.08 
4.94 
8.71 
Experimental 234 
Effect of (S)-glutamic acid (81) on DHDPS kinetics with respect to (S)-
aspartate ~-semialdehyde (11) 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC, pyruvate (17) 80 mM) 
dH20 
DHDPS (2.0 x 10-4 D, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 mM to 1.30 mM in dH20) 
(S)-Glutarnic acid (81) (150 mM to 50 mM in dH20) 
3.0 1-11 
500 III 
137 111 
10 III 
1001-11 
50 1-11 
2001-11 
1.00 ml 
The reaction was initiated in the cuvette by the addition of freshly prepared (S)-
aspartate ~-semialdehyde (11), mixed by inversion of the cuvette. i!A340 was measured 
over 300 seconds at 30 DC, blanked against dH20. 
Run 1: 
[(S)-Glutarnic acid (81)] = 0 mM 
[(S)-ASA] l/[(S)-ASA] Rate 1 IRate 
Mx 10-4 M-1 X 103 I-1mol·s-1mg-1 x 10-1 mg,s'llmol-1 
2.50 4.00 3.42 2.92 
2.50 4.00 3.06 3.27 
1.25 8.00 2.13 4.70 
1.25 8.00 2.92 3.43 
0.85 11.8 1.77 5.66 
0.85 11.8 2.19 4.57 
0.65 15.4 1.69 5.90 
0.65 15.4 1.63 6.15 
Lineweaver-Burk plot 
Experimental 235 
[(S)-Glutamic acid (81)] = 10 mM 
[(S)-ASA] l/[(S)-ASA] Rate 1 IRate 
M x 10-4 M-I X 103 /-Lmol·s-Img-I x 10-1 mg,s'/-Lmol- I 
2.50 4.00 2.56 3.91 
2.50 4.00 3.48 2.87 
l.25 8.00 2.20 4.54 
l.25 8.00 2.39 4.19 
0.85 11.8 l.75 5.72 
0.85 11.8 l.89 5.30 
0.65 15.4 l.49 6.72 
0.65 15.4 2.03 4.94 
Lineweaver-Burk plot Vrnax = 3.87 X 10-1 /-Lmol·s-Img-I Km = 0.865 X 10-4 M 
[(S)-Glutamic acid (81)] = 20 mM 
[(S)-ASA] l/[(S)-ASA] Rate 1 IRate 
Mx 10-4 M-I X 103 !lmol·s-Img-I x 10-1 mg,s'/-Lmol- I 
2.50 4.00 2.16 4.62 
2.50 4.00 3.24 3.09 
l.25 8.00 2.26 4.43 
l.25 8.00 2.14 4.66 
0.85 11.8 l.60 6.25 
0.85 1l.8 l.60 6.23 
0.65 15.4 l.37 7.31 
0.65 15.4 l.31 7.62 
Lineweaver-Burk plot 
[(S)-Glutamic acid (81)] = 30 mM 
[(S)-ASA] 1/[(S)-ASA] Rate 
M x 10-4 M-1 X 103 J.lmol·s-lmg-1 x 10-1 
2.50 4.00 0.947 
2.50 4.00 1.03 
1.25 8.00 1.31 
1.25 8.00 1.37 
0.85 11.8 0.734 
0.85 11.8 0.813 
0.65 15.4 0.923 
0.65 15.4 0.811 
Lineweaver-Burk plot 
Determination of K . '. 
[(S)-ASA] [(S)-Glutamic lIRate 
Mx 10-4 acid] mg,s·J.lmo 1-1 
M x 10-3 
,... J:!A 0 
-
I 10 L.:Jl 
? ". 
I 20 
2.50 30 
1.25 0 
1.25 10 
1.25 20 
1.25 30 
0.85 0 
0.8 10 
0.85 20 
0.85 30 
O'~R 0 0.6 10 
0.65 20 
0.65 30 
Uncompetitive inhibition: 
K;' (Modified Dixon) 4.37 x 10-3 M 
4.35 X 10-3 M 
2.92 3.27 
3.91 2.87 
4.62 3.09 
10.6 9.73 
4.70 3.43 
4.54 4.19 
4.43 4.66 
7.66 7.31 
5.66 4.5 
5.72 5.3 
6.25 6.23 
13.6 12.3 
5.90 6.15 
6.72 4.94 
7.31 7.62 
12.3 12.3 
Experimental 236 
lIRate 
mg,s·J.lmol-1 
10.6 
9.73 
7.66 
7.31 
13.6 
12.3 
10.8 
12.3 
[( S)-ASA ]lRate 
s·mg·r1 x 102 
7.30 8.18 
9.78 7.18 
11.6 7.73 
26.5 24.3 
5.88 4.29 
5.68 5.24 
5.54 5.83 
9.58 ~.14 
4.81 3.38 
L 4.51 
1 5.30 
11.6 i 10.5 
,., Oil 4.00 
4.37 3.21 
4.75 4.95 
7.02 8.00 
Experimental 237 
Run 2: 
[(S)-Glutamic acid (81)] = 0 mM 
[(S)-ASAJ 1/[(S)-ASAJ Rate lIRate 
M x 10-4 M-1 X 103 /lmol·s-1mg-1 x 10-1 mg,s'/lmol- I 
2.50 4.00 3.72 2.69 
2.50 4.00 3.71 2.70 
1.25 8.00 2.55 3.93 
1.25 8.00 2.56 3.91 
0.85 11.8 1.91 5.23 
0.85 11.8 1.92 5.22 
0.65 15.4 1.74 5.76 
0.65 15.4 1.59 6.27 
Lineweaver-Burk plot 
[(S)-Glutamic acid (81)] = 10 mM 
[(S)-ASAJ 1/[(S)-ASAJ Rate lIRate 
Mx 10-4 M-1 X 103 /lmol·s-1mg-1 x 10-1 mg,s'/lmol- I 
2.50 4.00 2.91 3.44 
2.50 4.00 3.25 3.07 
1.25 8.00 1.97 5.08 
1.25 8.00 2.07 4.84 
0.85 11.8 1.73 5.79 
0.85 11.8 1.75 5.71 
0.65 15.4 1.29 7.78 
0.65 15.4 1.51 6.64 
Lineweaver-Burk plot 
Experimental 238 
[(S)-Glutamic acid (81)] = 20 mM 
[(S)-ASA] l/[(S)-ASA] Rate lIRate 
M x 10-4 M-I X 103 Ilmol·s-Img-I x 10-1 mg,s'llmol-1 
2.50 4.00 2.13 4.69 
2.50 4.00 2.36 4.24 
1.25 8.00 1.65 6.06 
1.25 8.00 1.53 6.54 
0.85 11.8 1.38 7.25 
0.85 11.8 1.40 7.17 
0.65 15.4 1.19 8.40 
0.65 15.4 1.15 8.73 
Lineweaver-Burk plot 
[(S)-Glutamic acid (81)] = 25 mM 
[(S)-ASA] l/[(S)-ASA] Rate lIRate 
M x 10-4 M- I X 103 Ilmol·s- Img-I x 10-1 mg,s·J.1,ffiol- 1 
2.50 4.00 1.80 5.55 
2.50 4.00 1.66 6.04 
1.25 8.00 1.24 8.06 
1.25 8.00 1.10 9.07 
0.85 11.8 0.957 10.4 
0.85 11.8 0.863 11.5 
0.65 15.4 0.942 10.6 
0.65 15.4 0.844 11.8 
Lineweaver-Burk plot 
Determination of K: 
[(S)-ASA] [(S)-Glutamic 
M x 10-4 acid] 
M x 10-3 
2.50 0 
2.50 10 
20 
2.50 25 
1.25 0 
1.25 10 
5 20 
1.25 25 
0.85 0 
0.85 10 
0.85 20 
0.85 25 
0.65 0 
0.65 10 
0.65 20 
0.65 25 
Uncompetitive inhibition: 
~' (Modified Dixon) 0.88 x 10-2 M 
1.22 X 10-2 M 
1.56 X 10-2 M 
1.57 X 10-2 M 
1.57 X 10-2 M 
Experimental 239 
lIRate [(S)-ASA]lRate 
mg,s'/lmo I-I s·mg·l- I x 102 
6.73 6.35 
60 7.68 
11.7 10.6 
13.9 15.1 
4.91 4.89 
4.84 6.35 6.05 
6.06 6.54 7.58 8.18 
8.06 9.07 10.1 11.3 
5.23 5.22 4.45 4.44 
5.79 5.71 4.92 4.85 
7.25 6.09 
lOA 9.78 
5.76 4.08 
7.78 4.32 
8040 5.67 
10.6 7.67 
Experimental 240 
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Experimental 241 
Experimental Part IV 
Analogues of Dipicolinate Species 
DHDPS activity at high (S)-aspartate p-semialdehyde (11) and high 
pyruvate (17) concentrations 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25°C) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (100 mM to 10 mM in dH20) 
Pyruvate (17) (100 mM to 10 mM in dH20) 
3.0 III 
500 III 
287 III 
10 III 
100 III 
100 III 
100 blJ 
1.00 ml 
The reaction was initiated in the cuvette by addition of freshly prepared (S)-aspartate 
p-semialdehyde (11), mixed by inversion of the cuvettte. ilA340 was measured over 300 
seconds at 30°C, blanked against dH20. 
[(S)-ASA] = [Pyruvate] Rate 
Mx 10-3 Ilmol·s-Img-I x 10-1 
1.00 6.55 
1.00 9.40 
2.50 9.34 
2.50 9.87 
5.00 11.8 
5.00 13.4 
10.0 13.7 
Comparison of Mops and phosphate buffers 
Assay: 
NADPH (54 mM in dH20) 
Buffer (1M Tris.HCI pH 8.5 at 25°C, 80 mM pyruvate (17)) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 mM) 
3 III 
500 III 
337 III 
10 III 
100 III 
2QJJl 
1.00 m1 
Experimental 242 
The reaction was initiated in the cuvette by addition of freshly prepared (S)-aspartate 
~-semialdehyde (11), mixed by inversion of the cuvettte. AA340 was measured over 300 
seconds at 30°C, blanked against dH20. 
DHDPSk' llletlcs USlllt: 200mMM opsp_ at 
[(S)-ASA] 1/[(S)-ASA] Rate lIRate 
Mx 104 M-1 X 103 J,.Lmol·s-1mg-1 x 10-1 mg,s·J,.Lmol- 1 
2.50 4.00 4.16 2.40 
2.50 4.00 5.14 1.95 
1.50 6.67 4.33 2.31 
1.50 6.67 4.31 2.32 
1.00 10.0 2.78 3.62 
1.00 10.0 3.28 3.04 
0.80 12.5 2.74 3.65 
0.80 12.5 2.53 3.95 
0.60 16.7 2.31 4.33 
0.60 16.7 2.47 4.05 
Lineweaver-Burk plot 
DHDPSk' metlcs usmg 200 mM Ph h b ff H 7 2 25°C OSP! ate u er PJ at 
[(S)-ASA] lI[(S)-ASA] Rate lIRate 
Mx 104 M-1 X 103 J,.Lmol·s·1mg-1 x 10-1 mg·s·J,.Lmof l 
2.50 4.00 9.05 1.10 
2.50 4.00 4.11 2.43 
1.25 8.00 3.56 2.81 
1.25 8.00 3.33 3.00 
0.85 11.8 3.33 3.00 
0.85 11.8 2.95 3.39 
0.65 15.4 2.63 3.80 
0.65 15.4 2.56 3.91 
Lineweaver-Burk plot 
NMR studies on the enzymatic reaction of DHDPS 
General method 
Experimental 243 
(S)-Aspartate ~-semialdehyde (11) and pyruvate (17) in 500 rnM phosphate buffer 
pH 7.2 at 25°C were analysed by IH NMR. The phosphate buffer was made up at 
pH 7.4 which dropped to pH 7.2 on the addition of the (S )-aspartate ~-semialdehyde (11) 
which was present as the trifiuoroacetate salt. DHDPS enzyme was then added and the 
reaction followed by IH NMR (300 MHz, D20). 
Run 1 
(S)-Aspartate ~-semialdehyde (11) (10 Ilmol, 2.5 mg) 
Pyruvate (17) (10 Ilmol, 1.1 mg) 
500 rnM phosphate buffer pH 7.2 at 25°C (180 !-LI in D20) 
DHDPS enzyme (20 !-LI, concentration of 1.2 mgml"l) was added. 
Time Substrates New resonaces 
10 mins (S)-ASA and pyruvate 8H 5.92, 7.15 ppm 
present 
40 mins (S )-ASA and pyruvate 8H 5.92, 7.15, 7.69 - 7.87 
present (m), 8.27 - 8.49 (m) pQm 
170 mins No (S)-ASA 8H 5.92, 7.15, 7.69 - 7.87 
Pyruvate present (m), 8.27 - 8.49 (m) ppm 
Run 2 
(S)-Aspartate ~-semialdehyde (11) (10 Ilmol, 2.5 mg). 
Pyruvate (17) (10 Ilmol, 1.1 mg). 
500 rnM phosphate buffer pH 7.2 at 25°C (170 III in D20). 
DHDPS enzyme (30 !-LI, dialysed into D20) was added. 
Performed under nitrogen. 
Changes occurred in the reaction and in the control. 
Colour 
Clear 
Clear 
Light red 
Time Substrates New resonaces 
10 mins (S)-ASA and pyruvate OH 7.8 - 8.6 ppm 
present 
15 mins (S)-ASA -CH2CHNH2 OH 7.8 - 8.6 ppm 
peaks have decreased 
Pyruvate present 
85 mins (S)-ASA -CH2CHNH2 OH 7.5 - 8.0 (m), 8.25 - 8.4 
peaks have decreased (m), 8.4 - 8.55 (m) ppm 
Pyruvate present 
24 hours No (S)-ASA or OH 7.5 - 8.0 (m), 8.25 - 8.4 
pyruvate present (m), 8.4 - 8.55 (m) ppm 
Run 3 
(S)-Aspartate ~-semialdehyde (11) (10 ~mol, 2.5 mg) 
Pyruvate (17) (10 ~mol, 1.1 mg) 
500 ruM phosphate buffer pH 7.2 at 25 DC (170 ~l in D20) 
DHDPS enzyme (30 ~l, concentration of 0.201 mgrnl- l ) 
Experimental 244 
Colour 
Clear 
Clear 
Light red 
Red 
Time Substrates ilA1dO from the coupled assay 
5 mins (S)-ASA and pyruvate present 5.26 x 10-3 Aus- l 
15 mins (S)-ASA present 2.12 x 10-3 Aus- l 
Pyruvate resonace has decreas~d 
25 mins (S)-ASA -CH(OH)2 have o Aus-l 
disappeared 
Pyruvate resonace has decreased 
40 mins (S)-ASA -CH(OH)2 have o Aus·] 
disappeared 
Pyruvate resonace has decreased 
60 mins (S)-ASA -CH(OH)2 have o Aus·! 
disappeared Purple (semi-quantitative) assay 
Pyruvate resonace has decreased gave a negative result 
Experimental 245 
RUIl 4 
(S)-Aspartate ~-semialdehyde (11) (20 Ilmol, 5.0 mg) 
Pyruvate (17) (20 Ilmol, 2.2 mg) 
500 mM phosphate buffer pH 7.2 at 25 DC (340 III in D20). 
DHDPS enzyme (60 Ill) was added. 
Time Substrates New resonances 
1 min (S)-ASA and pyruvate 
present 
10 mins (S)-ASA and pyruvate are 
disappearing 
20 mins (S)-ASA and pyruvate are DR 3.4 - 4.2 ppm 
disappearing 
40 mins (S)-ASA and pyruvate are DR 1.6 - 2.6, 3.4 - 4.4 ppm 
disappearing 
6 hI'S (S)-ASA is disappearing DR 1.6 - 2.6, 3.4 - 4.4 ppm 
No pyruvate 
Inhibiton of DHDPS by cyclic compounds 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC, pyruvate (17) 80 mM) 
dH20 
DHDPS (2.0 x 10-4 U, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (11) (5.0 mM in dH20) 
Inhibitor (appropriate concentration, in methanol if required) 
Purple assay 
Positive 
Positive 
Positive 
Positive 
Positive 
3.0 Jll 
500 Jll 
237 Jll 
10 Jll 
100 Jll 
50 Jll 
100 btl 
1.00 ml 
The reaction was initiated in the cuvette by addition of freshly prepared (S)-aspartate 
~-semialdehyde (11), mixed by inversion of the cuvettte. ~A340 was measured over 300 
seconds at 30 DC, blanked against dH20, containing 10% methanol ifrequired. (S)-
Aspartate ~-semialdehyde was present in a concentration of 0.25 mM. The activity is the 
rate of reaction with inhibitor present relative to the rate of reaction in the absence of the 
inhibitor. 
Experimental 246 
Compound Concentration Activity 
ruM % 
2-Aminoacetophenone (94) 10 0 
in 10% methanol 1.0 1.4 
0.1 92.8 
Benzoic acid (93) 50 14.7 
in 10% methanol 10 61.1 
1.0 95.0 
Dipicolinic acid (36) 2.5 83.6 
1.0 97.8 
Isophthalic acid (41) 10 72.2 
5.0 94.8 
2-Methylpyridine (90) 100 100 
Morpholine (98) 100 100 
Nicotinic acid (91) 50 14.2 
10 100 
Phthalic acid (96) 12.5 5.1 
in 10% methanol 10 29.5 
1.0 100 
Phthalimide (95) 1.0 77.0 
in 10% methanol 0.1 88.2 
Picolinic acid (42) 100 9.4 
50 20.0 
10 95.0 
1.0 100 
Piperidine (97) 100 0 
10 100 
Pyridine (89) 100 100 
Pyridoxal 5-phosphate (92) 2.5 5.1 
1.0 47.2 
0.1 100 
Inhibition of DHDPR by cyclic compounds 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC, pyruvate (17) 80 mM) 
dH20 
DHDPS (10 fold excess) 
(S)-ASA (11) (5.0 mM in dH20) 
DHDPR (2.25 x 10-4 D, 1.0 X 10-4 mg) 
Inhibitor (appropriate concentration, in methanol if required) 
Experimental 247 
3.0 JlI 
500 ~l 
237 ~l 
100 ~l 
50 JlI 
10 JlI 
100 III 
1.00 rnl 
The (S )-aspartate ~-semialdehyde was added prior to initiation of the reaction to form 
the substrate. The reaction was then initiated in the cuvette by addition of DHDPR, mixed 
by inversion of the cuvettte. L'lA34o was measured over 300 seconds at 30 DC, blanked 
against dH20, containing 10% methanol if required. The activity is the rate of reaction 
with inhibitor present relative to the rate of reaction in the absence of the inhibitor. 
Compound Concentration Activity 
mM % 
2-Aminoacetophenone (94) 10 19.7 
in 10% methanol 1.0 17.1 
0.1 100 
Benzoic acid (93) 50 0 
in 10% methanol 10 100 
Dipicolinic acid (36) 2.5 19.7 
1.0 25.1 
0.1 90.1 
0.01 100 
Isophthalic acid (41) 2.5 78.8 
in 10% methanol 1.0 100 
2-Methylpyridine (90) 100 100 
Morpholine (98) 100 15.7 
50 55.2 
25 77.4 
1.0 100 
Experimental 248 
Compound Concentration Activity 
mM % 
Nicotinic acid (91) 50 45.0 
10 77.5 
1.0 100 
Phthalic acid (96) 10 28.3 
in 10% methanol 1.0 69.9 
0.1 100 
Phthalimide (95) 1.0 100 
in 10% methanol 
Picolinic acid (42) 100 39.7 
50 78.1 
10 100 
Piperidine (97) 100 0 
50 11.5 
10 53.5 
1.0 100 
Pyridine (89) 100 100 
Pyridoxal 5-phosphate (92) 2.5 0 
1.0 10.8 
0.1 100 
Effect of dipicolinic acid (36) on DHDPR kinetics with respect the 
substrate 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25°C, pyruvate (17) 80 mM) 
dH20 
DHDPS (10 fold excess) 
(R,S)-ASA (11) (3.0 mM to 10 mM in dH20) 
DHDPR (2.25 x 10-4 U, 1.0 X 10-4 mg) 
Dipicolinic acid (36) (1.0 mM to 10 mM in dH20) 
3.0 III 
500 III 
237 III 
100 III 
50 III 
10 ~ll 
100 "1 
1.00 ml 
The (R,S)-aspartate ~-semialdehyde was added prior to initiation of the reaction to 
form the substrate. The reaction was then initiated in the cuvette by addition of DHDPR, 
mixed by inversion of the cuvettte. AA340 was measured over 300 seconds at 30°C, 
blanked against dH20. 
Run 1: 
[D" r 'd (36)] 0 M IplCO 1ll1C aCl = m 
[DHDPA] 1/[DHDPA] 
M x 10-4 M-1 X 103 
2.50 4.00 
2.50 4.00 
1.50 6.67 
1.50 6.67 
1.00 10.0 
1.00 10.0 
0.75 13.3 
0.75 13.3 
Lineweaver -B urk plot 
[Dipicolinic acid (36)] = 0.10 mM 
[DHDPA] 1/[DHDPA] 
M x 10-4 M-1 X 103 
2.50 4.00 
2.50 4.00 
1.50 6.67 
1.50 6.67 
1.00 10.0 
1.00 10.0 
0.75 13.3 
0.75 13.3 
Lineweaver-Burk plot 
Experimental 249 
Rate lIRate 
~mo1· S-Img-I mg·s·~mo1-1 
2.09 0.478 
2.42 0.412 
1.12 0.895 
2.12 0.472 
1.65 0.672 
1.25 0.798 
1.14 0.876 
1.09 0.916 
Rate lIRate 
Ilmo1·s-1mg-1 mg,s'llmo1- 1 
2.50 0.400 
2.03 0.493 
1.69 0.593 
1.66 0.602 
1.29 0.773 
1.13 0.884 
1.08 0.926 
0.753 1.33 
Experimental 250 
[D" r' 'd (36)] 040 mM IplCO lruC aCl = 
[DHDPA] 1 I [DHDPA] Rate lIRate 
M x 10-4 M-1 X 103 !-lmol. s-lmg-1 mg,s'!lmol- 1 
2.50 4.00 1.41 0.711 
2.50 4.00 2.01 0.498 
1.50 6.67 1.50 0.667 
1.50 6.67 1.49 0.671 
1.00 10.0 0.804 1.24 
1.00 10.0 0.838 1.19 
0.75 13.3 0.583 1.72 
0.75 13.3 0.920 1.09 
Lineweaver-Burk plot 
[Dipicolinic acid (36)] = 0.80 mM 
[DHDPA] 1/[DHDPA] Rate lIRate 
Mx 10-4 M- 1 X 103 !-lmol·s-1mg-1 mg,s'!-lmol- 1 
2.50 4.00 1.14 0.880 
2.50 4.00 1.56 0.640 
1.50 6.67 1.14 0.874 
1.50 6.67 1.11 0.905 
1.00 10.0 0.690 1.45 
1.00 10.0 0.576 1.74 
0.75 13.3 0.308* 3.25* 
0.75 13.3 0.499 2.00 
Lineweaver-Burk plot 
Determination of K' 
[DHDPA] [Dipicolinic 
M x 10-4 acid] 
Mx 10-3 
2.50 0 
2.50 0.10 
2.50 0.40 
2.50 0.80 
1.50 0 
1.50 0.10 
1.50 0.40 
1.50 0.80 
1.00 0 
1.00 0.10 
1.00 0.40 
1.00 0.80 
0.75 0 
0.75 0.10 
0.75 0.40 
0.75 0.80 
Competitive inhibition: 
~ (Dixon) 3.19 x 10-4 M 
4.57 x 1O-4 M 
5.69 x 1O-4 M 
lIRate 
mg.s'llmo 
0.478 
0.400 
0.711 
0.880 
0.895 
0.583 
0.667 
0.874 
0.672 
I 0.773 
i 1.24 
1.45 
0.876 
1.72 
3.25* 
Experimental 251 
[DHDPA]lRate 
I-I s·mg·l- I x 102 
0.412 1.20 1.03 
0.493 1.00 1.23 
0.498 1.78 1.25 
0.640 2.20 1.60 
0.472 1.34 0.708 
0.602 0.890 0.903 
0.671 1.00 1.01 
0.905 1.31 1.36 
0.798 0.672 -
0.884 0.773 0.884 
1. 1.19 
1. I 
0.9 I .657 0.687 
1. kO;;; 0.998 
1.09 1.29 0.818 
2.00 2.44* 1.50 
Run 2: 
[D" r 'd(36)] OmM IPICO Imc aCl == 
[DHDPA] 1 I [DHDPA] 
M x 10-4 M'l X 103 
2.50 4.00 
2.50 4.00 
1.50 6.67 
1.50 6.67 
1.00 10.0 
1.00 10.0 
0.75 13.3 
0.75 13.3 
Lineweaver-Burk plot 
[Dipicolinic aicd (36)] = 0.10 mM 
[DHDPA] 1/[DHDPA] 
M x 10-4 M-1 X 103 
2.50 4.00 
2.50 4.00 
1.50 6.67 
1.50 6.67 
1.00 10.0 
1.00 10.0 
0.75 13.3 
0.75 13.3 
Lineweaver-Burk plot 
Experimental 252 
Rate 1 IRate 
!-tmol. s'lmg'l mg·s·!-tmo}"l 
1.32 0.755 
1.82 0.550 
1.49 0.670 
1.73 0.577 
1.39 0.719 
1.23 0.813 
0.974 1.03 
1.63* 0.615* 
Rate 1 IRate 
Ilmol's,lmg-' mg,s·jl.mol- 1 
2.15 0.465 
1.77 0.563 
1.28 0.783 
1.40 0.712 
0.909 1.10 
0.777 1.29 
0.667 1.50 
0.840 1.19 
Experimental 253 
[Dipicolinic acid (36)] = 0.50 mM 
[DHDPA] 1/[DHDPA] Rate lIRate 
M x 10-4 M-1 X 103 Ilmol·s-Img-I mg,s'llmo I-I 
2.50 4.00 1.50 0.665 
2.50 4.00 1.49 0.669 
1.50 6.67 1.11 0.903 
1.50 6.67 0.950 1.05 
1.00 10.0 0.555 1.80 
1.00 10.0 0.880 1.14 
0.75 13.3 0.675 1.48 
0.75 13.3 0.388 2.58 
Lineweaver-Burk plot 
[Dipicolinic acid (36)] = 1.0 mM 
[DHDPA] 1/[DHDPA] Rate lIRate 
M x 10-4 M-1 X 103 Ilmol·s-lmg-l mg,s'llmol-1 
2.50 4.00 0.628* 1.59* 
2.50 4.00 1.06 0.941 
1.50 6.67 0.823 1.22 
1.50 6.67 0.839 1.19 
1.00 10.0 0.504 1.98 
1.00 10.0 0.483 2.07 
0.75 13.3 0.472 2.12 
0.75 13.3 0.403 2.48 
Lineweaver-Burk plot 
Determination of K' 
[DHDPA] [Dipicolinic 
M x 10-4 acid] 
Mx 10-3 
2.50 0 
2.50 0.10 
2.50 0.50 
2.50 1.0 
1.50 0 
1.50 0.10 
1.50 0.50 
1.50 1.0 
1.00 0 
1.00 0.10 
1.00 0.50 
1.00 1.0 
0.75 0 
0.75 0.10 
0.75 0.50 
0.75 1.0 
Competitive inhibition: 
Ki (Dixon) 4.32 x 10-4 M 
4.39 x 1O-4 M 
4.43 x 10-4 M 
lIRate 
mg,s·f.lmo 
0.755 
0.465 
0.665 
1.59* 
0.670 
0.783 
0.903 
1.22 
0.719 
1.10 
1.80 
1.98 
1.03 
1.50 
1.48 
2.12 
Experimental 254 
[DHDPA]lRate 
1-1 s·mg·I- 1 x 102 
0.550 1.89 1.38 
0.565 1.16 1.41 
0.669 1.66 1.67 
0.941 3.98* 2.35 
0.577 1.01 0.866 
0.712 1.17 1.07 
1.05 1.35 1.58 
1.19 1.83 1.79 
0.813 0.719 0.813 
1.29 1.10 1.29 
1.14 1.80 1.14 
2.07 1.98 2.07 
0.615* 0.773 0.461 * 
1.19 1.13 0.893 
2.58 1.11 1.94 
2.48 1.59 1.86 
Effect of isophthalic acid (41) on DHDPR kinetics with respect to the 
substrate 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC, pyruvate (17) 80 mM) 
dH20 
DHDPS (10 fold excess) 
(R,S)-ASA (11) (3.0 mM to 10 mM in dH20) 
DHDPR (2.25 x 10-4 D, 1.0 X 10-4 mg) 
Isophthalic acid (41) (25 mM to 75 mM in dH20) 
3.0 f.ll 
500 f.ll 
237 f.11 
100 ~ll 
50 f.ll 
10 f.11 
100 IJI 
1.00 rnl 
Experimental 255 
The (R, S)-aspartate ~-semialdehyde was added prior to initiation of the reaction to 
form the substrate. The reaction was then initiated in the cuvette by addition of DHDPR, 
mixed by inversion of the cuvettte. i1A340 was measured over 300 seconds at 30°C, 
blanked against dH20. 
Run 1: 
hthalic acid (41)] = 0 mM 
[DHDPA] 1/[DHDPA] Rate 1 IRate 
M x 10-4 M-1 X 103 Ilmol. S-lmg-l mg,s·J..Lmol- 1 
2.50 4.00 2.07 0.483 
2.50 4.00 2.02 0.495 
1.50 6.67 1.91 0.523 
1.50 6.67 1.81 0.553 
1.00 10.0 1.65 0.605 
1.00 10.0 1.28 0.782 
0.75 13.3 0.968 1.03 
0.75 13.3 0.943 1.06 
Lineweaver-Burk plot 
[Isophthalic acid (41)] =2.5 mM 
[DHDPA] 1/[DHDPA] Rate 1 IRate 
Mx 104 M-1 X 103 jlmol·s-1mg-1 mg·s·Jlmof l 
2.50 4.00 1.90 0.525 
2.50 4.00 2.11 0.475 
1.50 6.67 1.52 0.657 
1.50 6.67 1.40 0.716 
1.00 10.0 0.895 1.12 
1.00 10.0 1.05 0.949 
0.75 13.3 0.801 1.25 
0.75 13.3 0.789 1.27 
Lineweaver-Burk plot 
Experimental 256 
[I h h l' 'd (41)] 50 mM SOP! ta c aCI = 
[DHDPA] 1/[DHDPA] Rate lIRate 
M x 10-4 M-1 X 103 !-Lmo1·s-1mg-1 mg,s'!-Lmo1- 1 
2.50 4.00 l.73 0.579 
2.50 4.00 l.68 0.594 
l.50 6.67 l.22 0.823 
l.50 6.67 l.03 0.970 
l.00 10.0 0.803 l.25 
l.00 10.0 0.880 l.14 
0.75 13.3 0.415* 2.41 * 
0.75 13.3 0.341 * 2.94* 
Lineweaver-Burk plot 
[1sophthalic acid (41)] = 6.5 mM 
[DHDPA] 11 [DHDPA] Rate lIRate 
M x 10-4 M-1 X 103 !-lmo1·s-1mg-1 mg,s'!-lmo1- 1 
2.50 4.00 l.98 0.505 
2.50 4.00 l.78 0.562 
l.50 6.67 l.28 0.783 
l.50 6.67 0.955 l.05 
l.00 10.0 0.823 l.22 
l.00 10.0 0.554 l.81 
0.75 13.3 0.761 l.31 
0.75 13.3 0.534 l.87 
Lineweaver-Burk plot 
Determination of K' 
[DHDPA] [Isophthalic 
M x 10-4 acid] 
Mx 10-3 
2.50 0 
2.50 2.5 
2.50 5.0 
2.50 6.5 
1.50 0 
1.50 2.5 
1.50 5.0 
1.50 6.5 
1.00 0 
1.00 2.5 
1.00 5.0 
1.00 6.5 
0.75 0 
0.75 2.5 
0.75 5.0 
0.75 6.5 
Competitive inhibition: 
Kj (Dixon) 1.03 x 10-3 M 
1.97 X 10-3 M 
2.85 X 10-3 M 
lIRate 
mg,s'llmo 
0.483 
0.525 
0.579 
0.505 
0.523 
0.657 
0.823 
0.783 
0.605 
1.12 
1.25 
1.22 
1.03 
1.25 
2.41 * 
1.31 
Experimental 257 
[DHDPA]lRate 
I-I s·mg·l- I x 102 
0.495 1.21 1.24 
0.475 1.31 1.19 
0.594 1.45 1.49 
0.562 1.26 1.41 
0.553 0.785 0.830 
0.716 0.986 1.07 
0.970 1.23 1.46 
1.05 1.17 1.58 
0.782 0.605 0.782 
0.949 1.12 0.949 
1.14 1.25 1.14 
1.81 1.22 1.81 
1.06 0.773 0.795 
1.27 0.938 0.953 
2.94* 1.81 * 2.21 * 
1.87 0.983 1.40 
Experimental 258 
Run 2: 
[Isophthalic acid (41)] = 0 mM 
[DHDPA] 1/[DHDPA] Rate lIRate 
Mx 10-4 M-1 X 103 j.Lmol·s-1mg-1 mg,s'!-lmol- 1 
2.50 4.00 2.28 0.439 
2.50 4.00 2.20 0.454 
1.50 6.67 2.52 0.397 
1.50 6.67 2.25 0.445 
1.00 10.0 1.55 0.644 
1.00 10.0 1.28 0.780 
0.75 13.3 0.906 1.10 
0.75 13.3 0.960 1.04 
Lineweaver-Burk plot 
[Isophthalic acid (41)] =2.5 mM 
[DHDPA] 1 I [DHDPA] Rate lIRate 
Mx 10-4 M-1 X 103 !lmol. s-lmg-1 mg,s'!lmol-1 
2.50 4.00 2.06 0.484 
2.50 4.00 1.80 0.557 
1.50 6.67 1.28 0.779 
1.50 6.67 1.52 0.656 
1.00 10.0 0.978 1.02 
1.00 10.0 0.923 1.08 
0.75 13.3 0.780 1.28 
0.75 13.3 0.655 1.53 
Lineweaver-Burk plot 
Experimental 259 
[lsophthalic acid (41)] == 5.0 mM 
[DHDPA] 1/[DHDPA] Rate lIRate 
Mx 10-4 M-1 X 103 !.Lmo}. s-lmg-1 mg,s·!.Lffiol- 1 
2.50 4.00 1.67 0.600 
2.50 4.00 1.56 0.642 
1.50 6.67 1.91 0.524 
1.50 6.67 1.75 0.570 
1.00 10.0 1.46 0.685 
1.00 10.0 1.03 0.970 
0.75 13.3 0.793 1.26 
0.75 13.3 0.781 1.28 
Lineweaver-Burk plot 
[I hth r 'd (41)] 75 mM SOP] a IC aCI == 
[DHDPA] lI[DHDPA] Rate lIRate 
Mx 10-4 M-1 X 103 J,lmol. s-lmg-1 mg,s'J,lffiol- 1 
2.50 4.00 1.55 0.650 
2.50 4.00 1.65 0.605 
1.50 6.67 1.30 0.767 
1.50 6.67 lAO 0.713 
1.00 10.0 0.720 1.39 
1.00 10.0 0.712 lAO 
0.75 13.3 0.597 1.68 
0.75 13.3 0.691 1045 
Lineweaver-Burk plot 
Determination of K;: 
[DHDPA] [Isophthalic 
M x 10-4 acid] 
M x 10-3 
2.50 0 
2.50 2.5 
[ 2.50 5.0 2.50 7.5 
1.50 0 
1.50 2.5 
1. 5.0 
1.50 7.5 
1.00 0 
~ 2.5 5.0 
1.00 7.5 
0.75 0 
0.75 2.5 
0.75 5.0 
0.75 7.5 
Competitive inhibition: 
Kj (Dixon) 5.43 x 10-3 M 
5.60 X 10-3 M 
5.62 X 10-3 M 
Experimental 260 
lIRate [DHDP A ]IRate 
mg,s'Jlmo 1-1 s·mg·l-1 x 102 
0.439 0.454 1.10 1.14 
0.484 0.557 1.21 1.39 
0.600 0.642 1.50 1.61 
0.650 0.605 1.63 1.51 
0.397 0.445 0.596 0.668 
0.779 0.656 1.17 0.984 
0.524 0.570 0.786 0.855 
0.767 0.713 1.15 1.07 
0.644 ti°.644 0.780 1.02 1.02 1.08 
0.685 0.970 0.685 0.970 
1.39 1.40 1.39 1.40 
1.10 1.04 0.825 0.780 
1.28 1.53 0.960 1.15 
1.26 1.28 0.945 0.960 
1.68 1.45 1.26 1.09 
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L\3-Tetrahydroisophthalic acid (99)1 
Isophthalic acid (41) (2.08 g, 12.5 mmol) was dissolved in a slight excess of sodium 
carbonate (1.43 g, 13.5 mmol) in distilled water (16.0 ml). To this solution was added 
sodium amalgam 3.5 % (130 g).2 The solution was heated to 70°C and stirred for 48 
hours. The reaction progress was monitored by IH NMR; a small aliquot was removed 
and the water removed in vacuo. When it appeared that all the isophthalic acid (41) had 
reacted, and all the sodium had been consumed, the reaction was cooled to room 
temperature. To aid in the removal of the mercury from the gelatinous reaction mixture 
further distilled water (16.0 ml) was added. The liquid was decanted off the mercury, 
and then acidified to pH 3 by the addition of concentrated hydrochloric acid ( ~ 10 ml). 
The resulting grey precipitate was removed by filtration over a Buchner funnel; the 
precipitate contained mainly sodium salts. The resulting yellow solid was purified by 
fractional crystallisation during which a considerable amount of isophthalic acid (41) was 
recovered. L\3-Tetrahydroisophthalic acid (99) was obtained as a fine white powder. 
The yield of L\3-tetrahydroisophthalic acid (99) was 100 mg (0.589 mmol, 4.7%). 
Mp 212 -217°C, literature 237 - 240 °C1 
IH NMR (300 MHz, CD30D) DH 1.35 - 1.48 (1H, m, -CH2-), 1.76 - 1.80 (lH, m, 
-CH2-), 2.00 - 2.08 (2H, m, -CH2C=), 2.08 - 2.17 (1H, m, -CHCOOH), 2.29 - 2.37 
(2H, m, -CH2C=), 6.76 (1H, s, =CH-) ppm. 
l3C NMR (75 MHz, D20) Dc 25.53 (-CH2CH2CH=), 26.25 (-CHCOOH), 27.92 
(-CH2CH=), 40.32 (-CH2CCOOH), 135.17 (-CHCOOH), 140.64 (=CH-) ppm. 
IR (KEr disc) u max 3400 (O-H (w», 2876 (=C~H (m», 2552 (C-H (w)), 1695 (C=O (s)), 
1647 (C=C (w», 1420 (s), 1279 (s), 953 (s) 'cm-I. 
HRMS mlz (FAB(NOBA» 171.06529 (MH\ 100% (CgHl10 4 requires 171.06573)). 
MS mlz (FAB(NOBA)) 171 (MH+, 30%), 154 (M-OH+, 100%), 136 (98%). 
L\2., L\3., L\4.Tetrahydroisophthalic acid (100, 99, 101)1 
Isophthalic acid (41) (5.60 g, 33.7 mmol) was dissolved in a slight excess of sodium 
carbonate (3.93 g, 37.1 mmol) in distilled water (150 ml). To this solution was added 
sodium amalgam 3.5 % (250 g).2 The solution was heated to 45°C and stirred for 48 
hours under a steady flow of carbon dioxide. The supernatant was then decanted off the 
mercury, and acidified with concentrated hydrochloric acid (~50 ml). The precipitated 
sodium salts were then filtered off. The aqueous layer was extracted with diethyl ether (3 
x 150 ml), the ethereal layer being dried over calcium chloride and concentrated to 
dryness in vacuo, yielding a yellow solid (2.82 g). Repeated attempts at fractional 
crystallisation gave a pale yellow solid. 
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The yield of reduced material was 1.99 g. 
IH NMR (300 MHz CD30D) ()H 1.64 1.90 (m), 2.09 - 2.39 (m), 2.54 - 2.65 (m), 3.18 
- 3.29 (m), 5.79 (bs/m) ppm. 
Cyclohexanone cyanohydrin (103)3 
Potassium cyanide (38.5 g, 0.591 mol) and water (l73 ml) were stirred in a flask 
fitted with a thermometer and a pressure equalising dropping funnneL Cyclohexanone 
(102) (50.0 g, 0.509 mol) in diethyl ether (208 rnl) was then added. Over four hours 
concentrated sulfuric acid (150 ml) was added dropwise while maintaning the temperature 
below 15 20°C. The reaction was then stirred for a further hour, and left overnight. 
Water (1 OOmI) was added to the supernatant which had been decanted off the precipitated 
salts. The organic and aqueous layers were then separated The ethereal layer was dried 
over sodium sulfate then concentrated in vacuo to a brown oil. 
The yield of cyclohexanone cyanohydrin (103) was 42.2 g (0.337 mol, 66.3%). 
IH NMR (300 MHz, CDCI3) ()H 1.19 - 1.31 (lH, m), 1.46 1.67 (5H, m), 1.70 - 1.87 
(2H, m), 2.04 2.09 (2H, m) ppm. 
2-Cyano-1-cyclohexene (104)3 
Cyclohexanone cyanohydrin (103) (42.2 g, 0.337 mol) was dissolved in toluene 
(100 rnl) and then dried with sodium sulfate. The solution was filtered into a two-necked 
round bottom flask fitted with a thermometer and a pressure equalising dropping funnel. 
Thionyl chloride (100 g, 61.3 ml, 0.841 mol) was then added dropwise to the solution 
stirred in an ice-salt bath overnight. The material was then fractionally distilled under 
vacuum, initially at -20 mm Hg to remove the toluene and thionyl chloride, followed by 
distillation at -1.5 rum Hg. Two fractions of product were obtained, the first containing 
the product and toluene, the second being pure product. 
The yield of the pure 2-cyano-1-cyclohexene (104) was 6.83 g (63.8 mmol, 18.9%). 
IH NMR (300 MHz, CDCI3) ()H 1.63 - 1.70 (4H, m, 2 x -CH2CH2CH=), 2.17 - 2.21 
(4H, m, 2 x-CH2C=), 6.62 (lH, bs, =CH-) ppm. 
IR (thin film) 'Ornax 2937 (=C-H (s»), 2864 (C-H (s», 2214 (C=N (s)), 1638 (C=C (s)), 
1448 (m), 1437 (s), 1425 (m) cm-I. 
HRMS rn/z (El) 107.07340 (M+, 79% (C7H9N requires 107.07350». 
GCMS rn/z (El) 107 (M+, 79%), 92 (100%), 79 (90%),67 (39%). 
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Ethyl tetrahydrobenzoate (105)4 
In a 50 ml round bottom flask fitted with a reflux condenser were mixed 2-cyano-l-
cyclohexene (104) (3.83 g, 35.8 mmol), ethanol (6.79 g, 8.5 ml), and concentrated 
sulfuric acid (6.97 g, 3.8 ml). The mixture was stirred and heated under reflux overnight 
in an oil bath at 120°C. The reaction was cooled to room temperature and partitioned 
between water (18.5 ml) and diethyl ether (2 x 18.5 ml). The ethereal layers were 
combined and washed with a saturated aqueous sodium carbonate solution (10 ml), then 
dried with magnesium sulfate. The solvent was removed in vacuo yielding the titled 
product as a yellow oil. Further product was extracted from the aqueous layer with ethyl 
acetate (2 x 18.5 ml) after the addition of sodium chloride. This material was obtained as 
a yellow semi-solid oil. 
The yield of the ethyl tetrahydrobenzoate (105) as an oil was 2.31 g (15.0 mmol, 
41.9%), while the yield of the semi-solid oil was 0.819 g (5.31 mmol, 14.8%). 
TLC (pet ether and diethyl ether (1:1» Rf O.63. 
IH NMR (300 MHz, CDCl3) OH 1.24 (3H, t, J = 7.0 -CH3), 1.54 - 1.63 (4H, m, 2 x 
-CH2CH2C=), 2.13 - 2.15 (2H, m, -CH2C=), 2.15 - 2.57 (2H, m, -CH2C=), 4.14 (2H, 
q, J 7.0 Hz, -C02CH2CH3), 6.93 (lH, s, =CH-) ppm. 
HC NMR (75 MHz, CDCI3) OH 13.65 (-CHzCH3), 20.86, 21.47, 23.86, 25.12, 59.52 
(-CH2CH3), 129.84 (=CC02CH2CH3), 138.79 (=CH-), 167.03 (-C02-) ppm. 
IR (KEr disc) 'Umax 2980 (=C-H (w», 2937 (C-H (s», 2862 (w), 1713 (C=O (s», 1649 
(C=C (s», 1275 (s), 1236 (m), 1089 (m), 1045 (m) cm-I. 
HRMS mlz(EI) 154.09924 (M+, 31 % (C9HI40 2 requires 154.09938». 
GCMS m/z (El) 154 (M+, 31 %), 126 (12%); 109 (40%), 81.07255 (100%), 53 (23%). 
Ethyl 3-carbethoxy-Ll2·cyclohexeneglyoxalate (107)5 
A mixture of ethyl tetrahydrobenzoate (105) (1.00 g, 6.49 mmol) and diethyl oxalate 
(106) (1.00 6.90 mmol) was added to an ice-cold solution of sodium (0.15 g, 6.52 
mmol, 1.0 equivalent) in ethanol (4.0 ml) with constant stirring. The reaction turned 
bright yellow in colour and was stirred in an ice bath at 4 °C overnight. To the resulting 
solid was added water (10 ml), followed by 5% sulfuric acid (3 ml). The organic layer 
was then extracted with ether (10 ml), washed with water (10 ml), dried over magnesium 
sulfate, and concentrated in vacuo to a yellow oil, 1.01 g. No product was obtained. 
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Ethyl dicarboxypimelate (110)5,6 
To a 500 ml three-necked round bottom flask fitted with a reflux condenser and a 
thermometer was added dry ethanol (215 ml) and sodium (9.84 g, 0.428 mmol). Diethyl 
malonate (109) (68.6 g, 0.428 mmol) was added dropwise via a dropping funnel while 
the reaction vessel was maintained at -60°C over an oil bath. 1,3-Dibromopropane (108) 
(43.2 g, 0.214 fPIIlol) was then added dropwise, again while maintaining the reaction 
vessel at -60°C. The reaction was then heated under reflux for three and a half hours, 
pH 7. The ethanol was removed in vacuo, and the residue diluted with water 
(100 ml) and brought to pH 3 by the addition of 5% sulfuric acid (15 ml). The organic 
material was extracted with ethyl acetate (250 ml, 2 x 100 ml). The ethyl acetate layers 
were combined and dried over magnesium sulfate, the solvent was then removed in vacuo 
to yield a yellow solution. This material was fractionally distilled under vacuum, with the 
titled product distilling at 160 - 185°C (-1.5 mm Hg). 
The yield of the ethyl dicarboxypimelate (110) was 16.6g (46.0 mmol, 21.5%). 
Bp 160 -185°C (-1.5 mm Hg). 
IH NMR (300 MHz, CDCI3) OR 1.26 (12H, t, J = 7.3 Hz, 4 x -C02CH2CH3), 1.29-
1.38 (2H, m, -CH2CH2CH2-), 1.92 (4H, q, J = 8.3 Hz, 2 x -CH2CH-), 3.31 (2H, t, J = 
7.3 Hz, 2x -CH-), 4.19 (8H, q, J = 7.8 Hz, 4 x -C02CH2CH3) ppm. 
l3C NMR (75 MHz, CDCI3) Oc 13.96 (-CH3), 24.97 (-CH2CH2CH2-), 28.19 
(-CH2CH-), 51.60 (-CH-), 61.27 (-OCH2CH3), 169.1 (-C=O) ppm. 
IR (thin film) u max 2984 (C-H (s)), 1732 (C=O (s)), 1464 (m), 1369(m), 1246 (s), 
1151 (s), 1097 (m), 1028 (m), 862 (m) cm- l . 
HRMS rnIz (EI) 315.14441 (M-OCH2CH3+, 7% (C15H2307 requires 315.14438)). 
MS rnIz (EI) 315 (M-OCH2CH3+, 7%), 269 (10%), 235 (29%), 201 (68%), 173 (100%), 
109 (56%). 
Ethyl cyclohexanone-2,6-dicarboxylate (111)5 
Ethyl dicarboxypimelate (110) (4.98 g, 13.8 mmol) was added to sodium (0.58 g, 
25.2 mmol) in dry ethanol (10.0 ml) and heated under reflux for three hours (bath 
tempertaure 135°C). Further sodium (0.60 g, 26.1 mmol) in dry ethanol (10.0 ml) was 
added, the reaction was heated under reflux for a further 16 hours. The ethyl carbonate 
and ethanol were then removed in vacuo. The residue was diluted with water (8.3 ml), 
and acidified to pH 3 by the addition of 20% sulfuric acid while being maintained at 0 dc. 
Further water (40 ml) was added andthe organic material was extracted with diethyl ether 
(2 x 40 ml). The combined ethereal layers were dried over magnesium sulfate and the 
solvent removed in vacuo, yielding a yellow oil. The product was purified by radial 
chromatography (4 mm silica plate). The solvent was removed in vacuo to yield the ethyl 
cyclohexanone-2,6-dicarboxy late (111) as a clear oil. 
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The yield of ethyl cyclohexanone-2,6-dicarboxylate (111) was 1.26 g (5.18 mmol, 
37.5%). 
IH NMR (300 MHz, CDC13) bH 1.26 - 1.28 (6H, m, 2 x -OCH2CH3), 1.55 - 1.60 (1H, 
m, -CH2CH2CH2-), 1.60 - 1.77 (1H, m, -CH2CH2CH2-), 2.20 - 2.29 (4H, m, 2 x 
-CH2CHC=O), 3.31 - 3.35 (2H, m, 2 x -CHC=O), 4.174.26 (4H, m, 2 x -OCH2CH3); 
enol form 1.26 - 1.28 (6H, m, 2 x -OCH2CH3), 1.55 - 1.60 OH, m, -CH2CH2CH2-), 
1.60 - 1.77 (lH, m, -CH2CH2CH2-), 1.93 - 1.95 (2H, m, -CH2CHC=), 2.20 - 2.29 
(2H, m, -CH2C=), 3.35 - 3.41 (1H, m, -CHC=), 4.17 - 4.26 (4H, m, 2 x -OCH2CH3) 
ppm. 
13C NMR (75 MHz, CDC13) be 14.2 (-OCH2CH3), 20.6 (-CH2CH2CH2-), 30.0 
(-CH2CHC=O), 57.5 (-CHC=O), 61.2 (-OCH2CH3), 155.7 (-CHC=OCH-), 166.7 
(-C=O), 169.0 (-C=O); enol form 14.2 (-OCH2CH3), 20.6 (-CH2CH2CH2-), 22.2 
(-CH2C=), 26.3 (-CH2CHC=), 45.7 (-CHC=), 61.2 (-OCH2CH3), 99.8 (=COH), 
166.7 (-C=O), 169.0 (-C=O) ppm. 
IR (CHC13) 'Umax 2943 (C-H (w», 1730 (HOC=O (s», 1657 (C=O (s», 1620 (w), 
1400 (w), 1379 (w), 1298 (m), 1269 (m), 1256 (m), 1198 (m), 1178 (m) cm-I. 
HRMS m1z (EI) 242.11567 (M+, 21 % (C12HIS0 5 requires 242.11542». 
MS m1z (EI) 242 (M+, 21 %), 196 (50%), 168 (100%), 140 (39%), 123 (30%), 
95 (32%). 
Ethyl cyclohexanol-2,6-dicarboxylate (112)5 
Ethyl cyclohexanone-2,6-dicarboxylate (111) (4.13 g, 17.0 mmol) in ethanol (95%) 
(33.0 ml), ferrous chloride solution (0.13 gl-I) (165 ~l), and platinum oxide catalyst (330 
mg) were stirred vigorously in a hydrogen atmosphere. After 20 hours the catalyst was 
reactivated by stirring in air for one hour. The reaction was then stirred in hydrogen for a 
further 20 hours. The catalyst was removed by filtration and the solvent removed in 
vacuo to yield a clear oil. The product was purified by radial chromatography (4 mm silica 
plate). The solvent was removed in vacuo to yield the ethyl cyclohexanol-2,6-
dicarboxylate (112) as a clear oil. 
The yield of ethyl cyclohexanol-2,6-dicarboxylate (112) was 3.84 g (15.7 mmol, 
92.4%). 
IH NMR (300 MHz, CDC13) bH 1.21 - 1.35 (6H, m, 2 x -OCH2CH3), 1.43 - 1.55 (1H, 
m, -CH2CH2CH2-), 1.58 - 1.69 (lH, m, -CH2CH2CH2-), 1.76 - 1.91 (2H, m, 2 x 
-CH2CHCHOH), 2.33 - 2.39 (2H, m, 2 x -CH2CHCHOH), 2.85 - 2.94 (2H, m, 2x 
-CHCHOH), 4.14 - 4.23 (4H, m, 2 x -OCH2CH3), 4.63 (1H, bs, -CHOH) ppm. 
l3C NMR (75 MHz, CDC}3) be 14.1 (-OCH2CH3), 21.6 (-CH2CH2CH2-), 24.3 
(-CH2CHCHOH), 46.9 (-CHCHOH), 60.7 (-OCH2CH3), 66.6 (-CHOH), 174.2 
(-C=O) ppm. 
IR (thin film) 'Umax 3512 (O-H (m», 2941 (C-H (s», 1728 (HOC=O (s», 1448 (m), 
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1375 (m), 1310 (m), 1180 (s), 1036 (m), 982 (w) cm- l . 
GCMS mJz (El) 244 (M+, 1 %), 181 (100%), 152 (48%), 124 (47%), 101 (38%),73 
(50%),55 (53%); 244 (M+, 7%), 181 (100%), 152 (65%), 125 (68%), 101 (58%),73 
(75%),55 (66%). 
Ethyl ~2-tetrahydroisophthalic acid (113)5,7 
Thionyl chloride (2.36 g, 19.9 mmol) was added dropwise to ethyl cyc1ohexanol-
2,6-dicarboxylate (112) (49.7 mg, 0.203 mmol) in pyridine (709 mg, 8.96 mmol), whilst 
stirring at ODC. The reaction was stirred for 30 minutes while slowly warming from to 
ODC room temperature, then stirred for a further hour. The reaction was added to water 
(2.18 ml) at ODC, and extracted with diethyl ether (2 x 5.0 ml). The combined ethereal 
layers were dried over magnesium sulfate, then the solvent removed in vacuo to yield a 
yellow oil. The product was purified by radial chromatography (2 mm silica plate). The 
solvent was removed in vacuo to yield the ethyl ~2-tetrahydroisophthalic acid (113) as a 
clear oil. 
The yield of the ethyl ~2-tetrahydroisophthalic acid (113) was 16.4 mg (0.072 mmol, 
35.7%). 
IH NMR (300 MHz, CDCI3) OR 1.26 - 1.32 (6H, m, 2 x-OCH2CH3), 1.59 - 1.65 (2H, 
m, -CH2CH2CH2-), 1.80 - 1.93 (2H, m, -CH2CHCH=), 2.24 - 2.30 (2H, m, -CH2C=), 
3.20 - 3.26 (1H, m, -CHCH=), 4.17 - 4.21 (4H, m, 2 x -OCH2CH3), 7.00 (1H, bs, 
=CH-) ppm. 
13C NMR (75 MHz, CDCI3) Oc 14.1 (-OCH2CH3), 14.2 (-OCH2CH3), 20.6 
(-CH2CH2CH2-), 23.9 (-CH2C=), 24.4 (-CH2CHC=), 41.9 (-CHCH=), 60.5 
(-OCH2CH3), 60.9 (-OCH2CH3), 132.4 (=C-), 135.2 (=CH-) ppm. 
lR (thin film) 'U
max 2941 (C-H (s)), 2361 (s), 1713 (C=O (s)), 1651 (m), 1448 (m), 
1367 (m), 1238 (s), 1174 (s),' 1087 (m), 1030 (m), 922 (m), 748 (m) cm- l . 
GCMS mJz (El) 226 (M+, 2%), 180 (61 %), 152 (65%), 79 (100%). 
~2-Tetrahydroisophthalic acid (100)5,8 
Ethyl ~2-tetrahydroisophthalate (113) (560 mg, 2.48 mmol) and potassium carbonate 
(686 mg, 4.96 mmol) were heated under reflux in methanol (62 ml) and water (6.2 ml) 
for 20 hours. The methanol was removed in vacuo, following which water (24.8 ml) and 
10% aqueous hydrochloric acid (124 ml) were added. The water was removed in vacuo to 
yield a white solid. The organic soluble components were taken up in methanol (50 ml). 
The methanol was then removed in vacuo. The residue was dissolved in aqueous sodium 
hydroxide (15 ml), pH >10, and extracted with diethyl ether (15 ml). Aqueous 
hydrochloric acid was added, pH 7, and the solution was again extracted with diethyl 
ether (15 ml). Further aqueous hydrochloric acid was added, pH <3, and the solution 
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was extracted with diethyl ether (2 x 15 rnI). The final ethereal layer was dried over 
magnesium sulfate and the solvent removed in vauco to a white solid. 
The yield of L~?-tetrahydroisophthalate (100) was 201 mg (1.18 mmol, 47.5%). 
Mp 171 - 174°C. 
IH NMR (300 MHz, CD30D) OH 1.60 1.65 (2H, m, -CH2CH2CH2-), 1.72 - 1.93 (2H, 
m, -CH2CHC=), 2.19 - 2.24 (2H, m, -CH2C=), 3.23 - 3.25 (lH, m, -CHCH=), 7.02 -
7.03 (lH, bs, -CH=) ppm. 
BC NMR (75 MHz, CD30D) oe 22.1 (-CH2CH2CH2-), 25.3 (-CH2C=), 25.9 
(-CH2CHC=), 43.1 (-CHCH=), 133.4 (:::C-), 137.8 (=CH-), 170.8 (-C=O), 176.8 
(-C=O) ppm. 
IR (KBr disc) 'Urnax 2945 (C-H (m», 1686 (C:::O (s», 1265 (w), 1094 (w), 953 (m), 
797 (w) em-I. 
HRMS mlz (EI) 152.04738 (M-H20+, 20% (CgHg03 requires 152.04734». 
MS mlz (EI) 152 (M-H20+, 23%),124 (51 %),97 (5%), 79 (100%),53 (17%). 
A2.Tetrahydroisophthalic acid (100) and A3.tetrahydroisophthalic acid (99) 
inhibition of DHDPS and DHDPR 
DHDPS 
Assay: 
NADPH (54 mM in dH20) 
Buffer (200 mM Mops pH 7.2 at 25 DC, pyruvate (17) 80 mM) 
dH20 
DHDPS (2.0 x 10-4 D, 4.8 X 10-4 mg) 
DHDPR (10 fold excess) 
(S)-ASA (l1) (5.0 mM in dH20) 
Inhibitor (appropriate concentration, in methanol if required) 
3.0 III 
500 III 
237 III 
10 III 
100 III 
50 ~Ll 
100 ",,1 
LOOmi 
The reaction was initiated in the cuvette by addition of freshly prepared (S)-aspartate 
~-semialdehyde (11), mixed by inversion of the cuvettte. M 340 was measured over 300 
seconds at 30°C, blanked against dHzO, containing 10% methanol if required. (S)-
Aspartate ~-semialdehyde was present in a concentration of 0.25 mM. The activity is the 
rate of reaction with inhibitor present relative to the rate of reaction in the absence of the 
inhibitor. 
Compound Concentration 
il2-Tetrahydroisophthalic acid (100) 
il3 - Tetrahydroisophthalic acid (99) 
(in methanol) 
ICso (il3-tetrahydroisophthalic acid (99» -1.5 x 10-2 M. 
DHDPR 
Assay: 
NADPH (54 mM in dH20) 
ruM 
40 
20 
10 
5 
30 
10 
5.0 
Buffer (200 mM Mops pH 7.2 at 25°C, pyruvate (17) 80 mM) 
dH20 
DHDPS (10 fold excess) 
(S)-ASA (11) (5.0 mM in dH20, gives DHDPA) 
DHDPR (2.25 x 10-4 U, 1.0 X 10-4 mg) 
Inhibitor (appropriate concentration, in methanol if required) 
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Activity 
% 
76.7 
82.5 
87.0 
85.0 
9.23 
61.3 
77.9 
3.0 III 
500 III 
237 III 
100 III 
50 Jll 
10 Jll 
100 III 
1.00 ml 
The (S )-aspartate ~-semialdehyde was added prior to initiation of the reaction to form 
the substrate. The reaction was then initiated in the cuvette by addition of DHDPR, mixed 
by inversion of the cuvettte. ilA340 was measured over 300 seconds at 30°C, blanked 
against dH20, containing 10% methanol if required. The activity is the rate of reaction 
with inhibitor present relative to the rate of reaction in the absence of the inhibitor. 
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Compound Concentration Activity 
mM % 
A2-Tetrahydroisophthalic acid (100) 40 79.8 
20 83.6 
10 91.1 
5 78.0 
A3-Tetrahydroiophthalic acid (99) 30 15.7 
10 34.0 
5.0 41.7 
1.0 100 
ICso (A3-tetrahydroisophthalic acid (99)) ~4 x 10-3 M. 
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Appendix 
Appendix 
Enzyme Kinetics and Inhibition 
Enzyme ldnetics 
Major sources 
A. Cornish-Bowden Biochem. J. 137,143 (1974). 
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A. Cornish-Bowden, C.W. Wharton 'Enzyme Kinetics' IRL Press, Oxford (1988). 
M. Dixon Biochem. J. 170 (1953) 
M. Dixon, B.C. Webb 'Enzymes' 3rd edn, Academic Press (1979). 
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Oxford (1992). 
Enzyme catalysed reaction 
The enzyme catalysed reaction converting the substrate to the product is shown in 
figure A-I. 
Figure A -1: Enzyme catalysed reaction 
E+S ~ ES E+P 
fast slow 
Steady state occurs when the enzyme is operating at maximum efficiency, that is at 
enzyme saturation where there is no free enzyme available, see figure A-2. 
Figure A-2: Substrate curve 
Rate 
Vo 
V max _ ................................. _ .... -_ ..... -- --- .... ---- -_ .. -- ---- ... -_ .. -_ ...... .. 
112 Vrnax 
[S] =Krn 
Michaelis Menten constant 
Michaelis-Menten equation 
k.2 is assumed to be zero. 
Rate of formation of ES = kJ [E] [S] 
[Eh total concentration of enzyme 
[Substrate] 
[E] = free enzyme 
[E] = [E]T [ES] 
At saturation Vo = Vrnax ' and there is no free enzyme, [E] = 0 
[Eh = [ES] 
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[Eh« [S] if there is a very large amount of substrate compared to the amount of 
enzyme. 
Rate of formation of ES = kj([E]T [ES])[S] 
Rate of breakdown of ES = k_j[ES] + k2[ES] 
At steady state the rate of formation of equal to the rate of breakdown. 
kj([Eh [ES])[S] = k_j[ES] +k2[ES] 
kj[E]T[S] - kj[ES][S] = k_j[ES] + k2[ES] 
[ES](k_ j + k2 + kj[S]) = kj[Eh[S] 
[ES] = (kj[E]T[S])/(kJS] + k_l +k2) 
[ES] ([Eh[S])/([S] + (k-j + k2)/k,) 
k2[ES] = (k2[Eh[S])/([S] + (k_l + k2)lk1) 
The conversion of the enzyme substrate complex, ES, to the product and regenerated 
enzyme, E + P, is the rate determining step. 
Vo k2[ES] 
Vrnax= k:2[Eh 
Krn = (k_l + k2)lkj 
Michaelis-Menten equation Vo = (VrnaJS])/([S] + Krn) 
When rate is half Vrnax (Vo = 112 Vrnax) 
112 Vmax = (Vrnax[S])/([S] + Km) 
112 = [S]/([S] + Km) 
[S] + Km = 2[S] 
Km = [S] 
That is Km is the substrate concentration when Vo is half Vmax' 
When the substrate concentration is very large the rate is approximately equal to Vmax ' 
Vo (VmaJlarge S])/([large S] + KJ 
VO - (Vmax[large S])/[large S] 
Lineweaver-Burk plot 
Vo = (VrnaJS])/([S] + Km) Michaelis-Menten equation 
lIVo = [S]/(Vmax[S]) + Km/(Vmax[S]) 
lIVo = 11Vmax + Km/(Vmax[S]) 
lIVo = (KmIVmax)(lI[SJ) + lIVmax 
Plot of lIVo against lI[S] gives a slope of KJVmax and a y-intercept of I/V max' see figure 
A-3. 
When [S] is very large then Km/(Vmax[S]) - 0 
lIVn lIVmax 
When Vo is very large llVo .::: 0 
o (KmIVma;J(lI[S]) + lIVmax 
(KmIVmax)(lI[SD::: -lIVmax 
lI[S]::: l/Km 
The x-intercept::: -l/Km 
Figure A-3: Lineweaver-Burk plot 
1IVo 
l/Vmax 
Eadie-Hofstee plot 
llVo::: (KjVmaJ(l/[S]) + llVmax from above 
[S]IVo ::: KjVmax + [S]IVmax 
[S]IVo ::: (Km + [S])IVmax 
Vmax ::: V/[S](Km + [S]) 
Vmax ::: Km(V/[S]) + Vo 
Vo::: Vmax - Km(V irS]) 
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1I[S] 
Plot of Vo against V J[S] gives a slope of -Km' the y-intercept is Vmax' and the x-intercept 
is Vma/Km' see figure A-4. 
Figure A-4: Eadie-Hofstee plot 
Vmax 
/ 
VJ[S] 
Direct linear plot 
Va = Vmax - Km(Vi[8D from above 
Vmax = Va + (Vi[8DKm 
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~nax and Km are treated as variables and Va and [8] are treated as constants, so a family of 
lines is obtained. The line is all possible pairs of Km and V max that satisfy an observed rate 
Va at substrate concetration [8]. 
Va is plotted against -[8], the x-intercept is Km, while the y-intercept is V max' 
Each point of intersection provides an estimate of Km and Vmax' of which the median is 
normally quoted, see figure A-5. 
Figure A -5: Direct linear plot 
-[S] 
Inhibition kinetics 
Irreversible inhibition normally occurs when a covalent bond is formed between the 
enzyme and the inhibitor, thus altering the kirietics. It also includes mechanism-based 
inhibitors (so called suicide inhibitors), and transition state analogues. 
The other type of inhibition is reversible and is normally divided into four 
catergories, competitive, noncompetitive, uncompetitive, and mixed inhibition. These 
catergories are greatly simplified, as true examples are rarely just one type of inhibition. 
(i) Competitive inhibition 
The inhibitor competes with the substrate to bind to the active site, see figure A-6. 
The inhibitor can be 'washed out' by increasing the concentration of the substrate. Thus 
Vmax stays the same while Km increases with increasing concentration of the inhibitor. A 
Dixon plot gives Ki' the dissociation constant of EI, see figure A-9. 
Figure A-6: Competitive inhibition 
~ ~ E+S ~ E+P 
+ 
I 
EI 
(ii) Noncompetitive inhibition 
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The inhibitor binds to a site on the enzyme away from the active site altering catalysis 
but not substrate binding, see figure A-7. Some enzymologists do not include this as a 
distinct class, as binding at a second site must affect the binding of the substrate, even if 
this is a very small effect. With noncompetitive inhibition Vrnax decreases while Krn stays 
constant with increasing inhibitor concentration. Both a Dixon plot and a modified Dixon 
plot will give Ki, the dissociation constant of EI, which is equal to Ki', the dissociation 
constant of EIS, see figure A-9. 
Figure A-7: Noncompetitive inhibition 
E+S ~ ES E+P 
+ + 
I I 
kr H 
~ 
H kr
EI+S .....-- EIS 
k-l 
(iii) Uncompetitive inhibition 
The inhibitor binds only to the enzyme-substrate complex, see figure A-8. Vrnax 
decreases with increasing inhibitor concentration, as the enzyme is less catalytically 
effective. Krn also decreases with increasing inhibitor concentraion, as the inhibitor 
removes some of the enzyme substrate complex. A modified Dixon plot will give K/ ' see 
figure A-9. 
Figure A-8: Uncompetitive inhibition 
E+S ES 
+ 
I 
ESI 
E+P 
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(iv) Mixed inhibition 
The inhibitor binds to both the free enzyme and the enzyme substrate complex. The 
binding of the inhibitor may affect both Vrnax and Km; Vmax may decrease and Km may also 
decrease, stay the same, or increase. Mixed inhibition is often said to show competitive 
and uncompetitive effects simultaneously. A Dixon plot will give~, the dissociation 
constant of the EI complex, and a modified Dixon plot will give ~', the dissociation 
constant of the EIS complex, where Kj does not necessarily equal K j', see figure A-9. 
Dixon plots and modified Dixon plots for enzyme inhibition 
Vo:::: (VmaJ/«Km(1 + ([I]/Kj» + [S](1 + ([I]/K/») 
Kj = the dissociation constant of the EI complex 
Kj ' = the dissociation constant of the EIS complex 
Plotting lIVo against [1] gives a Dixon plot that estimates Ki• 
[S]/Vo = (K,,/Vmax)(1 + [I]/Kj) + ([S]/Vmax)(1 + [I]/K/) 
Plotting [S]/Vo aganst [I] gives a modified Dixon plot that estimates K;'. 
Figure A-9: Dixon and modified Dixon plots 
Dixon plots, lIVo against I Modified Dixon plots, [S]IVo against I 
Competitive inhibition 
[S]lVo 
~S] 
I 
Noncompetitve inhibition 
[S]IVo 
1 I t 
-Kj=-Kj' -Kj'=-Ki 
I 
I 
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Figure A-9: Dixon and modified Dixon plots, continued 
Dixon plots, IIVo against I Modified Dixon plots, [S]lVo against I 
Uncompetitive inhibition 
I 
Mixed inhibition 
\[S] 
.. [I-(Kj/Kj')]/Vrnax 
I 
-Kj 
Units used in the kinetic plots 
Lineweaver-Burk plot 
[S]/Vo 
t I 
-Kj' 
[S]/Vo 
Krn[l-(Kj'/Kj)]lVrnax 
The substrate concentration is given in M (mol·I,I), giving the inverse of the 
substrate concentration in M-I (l·mol,I). The rate is given in ~mol·s-Img'l, that is the 
micromoles of substrate turned over per second per milligram of protein. Thus, the 
inverse of the rate is mg·s·~mol"l. 
Eadie-Hofstee plot 
I 
The rate is given in llmol·s,lmg,l. The rate/substrate concentration has the units of 
l·s,lmg-l. These units come from the rate, in ~mol·s'lmg-\ being divided by the 
substrate concentration, in M (mol·I,I), where the moles cancel leaving l·s-lmg-I. 
Direct linear plot 
For the direct linear plots the rate is given in ~mol·s'lmg'l and the substrate 
concentration is given in M (mol·}"I). 
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Dixon plot 
The rate is given in /lmol·s-1mg- l , while the inhibitor concentration is given in mM 
(mmoH-1). 
Modified Dixon plot 
The rate substrate concentration/rate is given in s·mg·l"l, this comes from the 
substrate concentration, in M (mol·rl), being divided by the rate, in /lmoI·s·lmg- l , where 
the moles cancel leaving s.mg·t i . The inhibitor concentration is given in mM 
(mmol·I- i ). 
